FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Gazes, RP
   Lutz, MC
   Meyer, MJ
   Hassett, TC
   Hampton, RR
AF Gazes, Regina Paxton
   Lutz, Meredith C.
   Meyer, Mark J.
   Hassett, Thomas C.
   Hampton, Robert R.
TI Influences of demographic, seasonal, and social factors on automated
   touchscreen computer use by rhesus monkeys (Macaca mulatta) in a large
   naturalistic group
SO PLOS ONE
LA English
DT Article
ID FEEDING COMPETITION; COGNITIVE PERFORMANCE; MOUNTAIN CHICKADEES;
   ACTIVITY BUDGETS; TEST SYSTEMS; BABOONS; PAPIO; MODELS; WILD; SEX
AB Animals housed in naturalistic social groups with access to automated cognitive testing vary in whether and how much they participate in cognitive testing. Understanding how demographic, seasonal, and social factors relate to participation is essential to evaluating the usefulness of these systems for studying cognition and in assessing the data produced. We evaluated how sex, age, reproductive experience, seasonality, and rank related to patterns of participation in a naturalistic group of rhesus monkeys over a 4-year period. Females interacted with the touchscreen systems more than males and were more likely to complete initial training. Age was positively correlated with touchscreen activity through adolescence in females, at which point seasonality and reproductive experience were stronger associates of participation. While monkeys in different rank categories did not differ in how much they interacted with the touchscreen systems, monkeys of different ranks tended not to work at the same times, perhaps reflecting avoidance of high ranking animals by those of lower rank. Automated cognitive testing systems for naturalistic social groups of rhesus monkeys can yield quality cognitive data from individuals of all ages and ranks, but participation biases may make it difficult to study sex differences or seasonal variation in cognition.
C1 [Gazes, Regina Paxton] Bucknell Univ, Dept Psychol, Lewisburg, PA 17837 USA.
   [Gazes, Regina Paxton; Lutz, Meredith C.] Bucknell Univ, Program Anim Behav, Lewisburg, PA 17837 USA.
   [Lutz, Meredith C.] Bucknell Univ, Dept Math, Lewisburg, PA 17837 USA.
   [Meyer, Mark J.] Georgetown Univ, Dept Math & Stat, Washington, DC USA.
   [Hassett, Thomas C.; Hampton, Robert R.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.
   [Hampton, Robert R.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA.
   [Lutz, Meredith C.] Univ Calif Davis, Anim Behav Grad Grp, Davis, CA 95616 USA.
RP Gazes, RP (reprint author), Bucknell Univ, Dept Psychol, Lewisburg, PA 17837 USA.; Gazes, RP (reprint author), Bucknell Univ, Program Anim Behav, Lewisburg, PA 17837 USA.
EM reggie.gazes@bucknell.edu
OI Lutz, Meredith/0000-0001-7678-6423; Gazes, Regina/0000-0002-6727-0721
FU Griffith Faculty fellowship; National Science Foundation [IOS-1146316,
   BCS-0745573, BCS-1632477]; National Institutes of Health [RO1MH082819];
   ORIP/OD [P51OD011132]
FX This work was supported by a Griffith Faculty fellowship to RPG; by
   National Science Foundation (www.nsf.gov) awards IOS-1146316,
   BCS-0745573, and BCS-1632477 to RRH; by National Institutes of Health
   (www.nih.gov), Grant #RO1MH082819 and was supported in part by ORIP/OD
   P51OD011132 to RRH. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agresti A, 2012, CATEGORICAL DATA ANA
   An YS, 2011, BEHAVIOUR, V148, P55, DOI 10.1163/000579510X545829
   ANDREWS MW, 1994, J COMP PSYCHOL, V108, P358, DOI 10.1037/0735-7036.108.4.358
   Auerbach KG, 1979, LAB PRIMATE NEWSL, V18, P7
   Baldellou M, 1997, PRIMATES, V38, P31, DOI 10.1007/BF02385920
   BARTON RA, 1993, ANIM BEHAV, V46, P791, DOI 10.1006/anbe.1993.1256
   BELZUNG C, 1986, BEHAV PROCESS, V12, P307, DOI 10.1016/0376-6357(86)90001-X
   Benaglia T, 2009, J STAT SOFTW, V32, P1
   Bennett AJ, 2016, AM J PRIMATOL, V78, P1250, DOI 10.1002/ajp.22579
   BERNSTEIN IS, 1993, AM J PRIMATOL, V31, P41, DOI 10.1002/ajp.1350310105
   Bernstein IS, 1970, PRIMATE BEHAV
   Bonte E, 2011, BEHAV BRAIN RES, V222, P176, DOI 10.1016/j.bbr.2011.03.034
   Boogert NJ, 2006, ANIM BEHAV, V72, P1229, DOI 10.1016/j.anbehav.2006.02.021
   Brent LJN, 2013, BEHAV ECOL SOCIOBIOL, V67, P349, DOI 10.1007/s00265-012-1455-8
   Brown EK, 2016, INT C COMP COGN MELB
   Cauchard L, 2013, ANIM BEHAV, V85, P19, DOI 10.1016/j.anbehav.2012.10.005
   Cauchoix M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13179-5
   CHENEY DL, 1978, ANIM BEHAV, V26, P1038, DOI 10.1016/0003-3472(78)90093-3
   Claidiere N, 2017, BEHAV RES METHODS, V49, P24, DOI 10.3758/s13428-015-0686-9
   COLVIN JD, 1983, AM J PRIMATOL, V4, P328
   Cronin KA, 2017, PEERJ, V5, P35
   Croston R, 2016, ANIM BEHAV, V111, P225, DOI 10.1016/j.anbehav.2015.10.015
   Dahl CD, 2013, ELIFE, V2, DOI 10.7554/eLife.00932
   De Vries H, 2000, ANIM BEHAV, V59, P239, DOI 10.1006/anbe.1999.1299
   Domjan M, 2004, ESSENTIALS CONDITION
   Drea CM, 1998, J COMP PSYCHOL, V112, P170, DOI 10.1037/0735-7036.112.2.170
   Drea CM, 1999, P NATL ACAD SCI USA, V96, P12965, DOI 10.1073/pnas.96.22.12965
   Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104
   Dubuc C, 2007, INT J PRIMATOL, V28, P357, DOI 10.1007/s10764-007-9118-8
   EHARDT CL, 1987, AM J PRIMATOL, V13, P255, DOI 10.1002/ajp.1350130304
   Fagot J, 2014, AM J PRIMATOL, V76, P56, DOI 10.1002/ajp.22193
   Fagot J, 2011, PSYCHOL SCI, V22, P1304, DOI 10.1177/0956797611422916
   Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507
   Fagot J, 2009, BEHAV RES METHODS, V41, P396, DOI 10.3758/BRM.41.2.396
   Gazes RP, 2013, ANIM COGN, V16, P445, DOI 10.1007/s10071-012-0585-8
   GORE MA, 1993, ANIM BEHAV, V45, P773, DOI 10.1006/anbe.1993.1091
   HAUSER MD, 1993, BEHAV ECOL, V4, P194, DOI 10.1093/beheco/4.3.194
   HAUSER MD, 1993, ANIM BEHAV, V45, P817, DOI 10.1006/anbe.1993.1096
   IMAKAWA S, 1990, PRIMATES, V31, P509, DOI 10.1007/BF02382534
   ISBELL LA, 1993, BEHAV ECOL SOCIOBIOL, V32, P377, DOI 10.1007/BF00168821
   JANUS M, 1989, INT J PRIMATOL, V10, P243, DOI 10.1007/BF02735203
   Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006
   Kapsalis E, 1996, BEHAVIOUR, V133, P1209, DOI 10.1163/156853996X00378
   Krasheninnikova A, 2014, ANIM COGN, V17, P1227, DOI 10.1007/s10071-014-0744-1
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Langbein J, 2009, APPL ANIM BEHAV SCI, V120, P150, DOI 10.1016/j.applanim.2009.07.006
   Langley EJG, 2018, ROY SOC OPEN SCI, V5, P9
   Li YH, 2014, FOLIA PRIMATOL, V85, P335, DOI 10.1159/000368831
   Maattanen I, 2013, PSYCHONEUROENDOCRINO, V38, P2243, DOI 10.1016/j.psyneuen.2013.04.009
   Biondi LM, 2010, ANIM COGN, V13, P701, DOI 10.1007/s10071-010-0319-8
   MathWorks I, 2015, MATLAB STAT TOOLB RE
   McBride SD, 2016, J NEUROSCI METH, V265, P25, DOI 10.1016/j.jneumeth.2015.08.025
   Micheletta J, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150109
   Morand-Ferron J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133821
   Overdorff DJ, 1997, AM J PRIMATOL, V43, P211, DOI 10.1002/(SICI)1098-2345(1997)43:3<211::AID-AJP2>3.3.CO;2-V
   Pinheiro J, 2018, NLME LINEAR NONLINEA
   Pravosudov VV, 2003, HORM BEHAV, V44, P93, DOI 10.1016/S0018-506X(03)00119-3
   Pritchard DJ, 2016, J EXP ANAL BEHAV, V105, P41, DOI 10.1002/jeab.195
   Rebout N, 2017, AGGRESSIVE BEHAV, V43, P513, DOI 10.1002/ab.21709
   Rowe C, 2014, BEHAV ECOL, V25, P1287, DOI 10.1093/beheco/aru090
   Sade D.S., 1967, P99
   Shettleworth S. J., 2010, COGNITION EVOLUTION
   Silk MJ, 2017, ANIM BEHAV, V132, P137, DOI 10.1016/j.anbehav.2017.08.005
   Stahl D, 2003, PRIMATES, V44, P203, DOI 10.1007/s10329-002-0012-x
   Steurer MM, 2012, BEHAV RES METHODS, V44, P909, DOI 10.3758/s13428-012-0198-9
   Team R. C. R, 2017, R LANG ENV STAT COMP
   THIERRY B, 1985, AGGRESSIVE BEHAV, V11, P223, DOI 10.1002/1098-2337(1985)11:3<223::AID-AB2480110305>3.0.CO;2-A
   van Horik JO, 2017, BEHAV PROCESS, V134, P22, DOI 10.1016/j.beproc.2016.07.001
   VANDENBERGH JG, 1968, J REPROD FERTIL, V15, P71, DOI 10.1530/jrf.0.0150071
   Wood S., 2018, MGCV MIXED GAM COMPU
   WOOD S, 2006, GEN ADDITIVE MODELS
   Yamanashi Y, 2011, AM J PRIMATOL, V73, P1231, DOI 10.1002/ajp.20995
   Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57
   Zuur Alain F., 2009, P1
   2007, SOC NETWORKS, V29, P173, DOI DOI 10.1016/J.SOCNET.2006.08.002
NR 75
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 24
PY 2019
VL 14
IS 4
AR e0215060
DI 10.1371/journal.pone.0215060
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HU6FU
UT WOS:000465375400033
PM 31017920
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Dolor, A
   Sampson, SL
   Lazar, AA
   Lotz, JC
   Szoka, FC
   Fields, AJ
AF Dolor, Aaron
   Sampson, Sara L.
   Lazar, Ann A.
   Lotz, Jeffrey C.
   Szoka, Francis C.
   Fields, Aaron J.
TI Matrix modification for enhancing the transport properties of the human
   cartilage endplate to improve disc nutrition
SO PLOS ONE
LA English
DT Article
ID INTERVERTEBRAL DISC; NUCLEUS PULPOSUS; COLLAGEN; EXPRESSION; THERAPY;
   CELLS; PERMEABILITY; DEGENERATION; VIABILITY; PRODUCTS
AB Poor solute transport through the cartilage endplate (CEP) impairs disc nutrition and could be a key factor that limits the success of intradiscal biologic therapies. Here we demonstrate that treating the CEP with matrix metalloproteinase-8 (MMP-8) reduces the matrix constituents that impede solute uptake and thereby improves nutrient diffusion. Human CEP tissues harvested from four fresh cadaveric lumbar spines (age range: 38-66 years old) were treated with MMP-8. Treatment caused a dose-dependent reduction in sGAG, localized reductions to the amount of collagen, and alterations to collagen structure. These matrix modifications corresponded with 16-24% increases in the uptake of a small solute (376 Da). Interestingly, the effects of MMP-8 treatment depended on the extent of non-enzymatic glycation: treated CEPs with high concentrations of advanced glycation end products (AGEs) exhibited the lowest uptake compared to treated CEPs with low concentrations of AGEs. Moreover, AGE concentrations were donor-specific, and the donor tissues with the highest AGE concentrations appeared to have lower uptake than would be expected based on the initial amounts of collagen and sGAG. Finally, increasing solute uptake in the CEP improved cell viability inside diffusion chambers, which supports the nutritional relevance of enhancing the transport properties of the CEP. Taken together, our results provide new insights and in vitro proof-of-concept for a treatment approach that could improve disc nutrition for biologic therapy: specifically, matrix reduction by MMP-8 can enhance solute uptake and nutrient diffusion through the CEP, and AGE concentration appears to be an important, patient-specific factor that influences the efficacy of this approach.
C1 [Dolor, Aaron; Szoka, Francis C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.
   [Sampson, Sara L.; Lotz, Jeffrey C.; Fields, Aaron J.] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA.
   [Lazar, Ann A.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA.
   [Lazar, Ann A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
RP Fields, AJ (reprint author), Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA.
EM aaron.fields@ucsf.edu
RI Fields, Aaron/P-4793-2019
OI Fields, Aaron/0000-0001-6460-4506
FU North American Spine Society; Research Allocation Committee at UCSF;
   Core Center for Musculoskeletal Biology & Medicine at UCSF; Center for
   Disruptive Musculoskeletal Innovation at UCSF; National Institutes of
   Health [R01 AR070198, P30 AR066262, T32 GM007175]; National Science
   Foundation; National Center for Advancing Translational Sciences,
   National Institutes of Health through UCSF, CTSI [UL1 TR001872]
FX This research was supported by grants from the North American Spine
   Society (AJF), the Research Allocation Committee at UCSF (AJF), the Core
   Center for Musculoskeletal Biology & Medicine at UCSF (AJF), the Center
   for Disruptive Musculoskeletal Innovation at UCSF (AJF), the National
   Institutes of Health (AJF: R01 AR070198 and P30 AR066262; AD: T32
   GM007175), and the National Science Foundation (AD). The authors also
   acknowledge generous financial assistance from Professor Jean Frechet to
   the Szoka laboratory. This publication was supported by the National
   Center for Advancing Translational Sciences, National Institutes of
   Health, through UCSF, CTSI Grant Number UL1 TR001872. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Antoniou J, 1996, SPINE, V21, P1153, DOI 10.1097/00007632-199605150-00006
   Bachmeier BE, 2009, EUR SPINE J, V18, P1573, DOI 10.1007/s00586-009-1031-8
   Bae WC, 2011, ORTHOP CLIN N AM, V42, P585, DOI 10.1016/j.ocl.2011.07.004
   Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09
   BISHOP PB, 1993, J ORTHOP RES, V11, P324, DOI 10.1002/jor.1100110303
   Cheng J, 2007, MOL THER, V15, P1982, DOI 10.1038/sj.mt.6300264
   Chou D, 2011, SPINE, V36, pS43, DOI 10.1097/BRS.0b013e31822ef700
   DeGroot J, 2001, ARTHRITIS RHEUM, V44, P2562, DOI 10.1002/1529-0131(200111)44:11<2562::AID-ART437>3.0.CO;2-1
   DeLucca JF, 2016, J BIOMECH, V49, P550, DOI 10.1016/j.jbiomech.2016.01.007
   Dolor A, 2018, MOL PHARMACEUT, V15, P2069, DOI 10.1021/acs.molpharmaceut.8b00319
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fields Aaron J, 2018, Curr Mol Biol Rep, V4, P151, DOI 10.1007/s40610-018-0105-y
   Fields AJ, 2015, J ORTHOP RES, V33, P738, DOI 10.1002/jor.22807
   Fields AJ, 2014, J ORTHOP RES, V32, P245, DOI 10.1002/jor.22516
   Gawri R, 2013, EUR CELLS MATER, V26, P107, DOI 10.22203/eCM.v026a08
   Grant MP, 2016, EUR CELLS MATER, V32, P137, DOI 10.22203/eCM.v032a09
   Hadley JC, 1998, GLYCOCONJUGATE J, V15, P835, DOI 10.1023/A:1006928403140
   Haralson RH, 2009, JAMA-J AM MED ASSOC, V302, P1586, DOI 10.1001/jama.2009.1489
   Horner HA, 2001, SPINE, V26, P2543, DOI 10.1097/00007632-200112010-00006
   Huang YC, 2014, NAT REV RHEUMATOL, V10, P561, DOI 10.1038/nrrheum.2014.91
   Illien-Junger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064302
   Jackson AR, 2009, ANN BIOMED ENG, V37, P2566, DOI 10.1007/s10439-009-9792-0
   Jazini E, 2012, SPINE, V37, pE209, DOI 10.1097/BRS.0b013e31822ce81f
   Krishnamoorthy D, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036012
   Krock E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17472-1
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c
   Lotz JC, 2013, GLOB SPINE J, V3, P153, DOI 10.1055/s-0033-1347298
   MAROUDAS A, 1977, ANN RHEUM DIS, V36, P399, DOI 10.1136/ard.36.5.399
   MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0
   MAROUDAS A, 1975, J ANAT, V120, P113
   Mok W, 2007, CANCER RES, V67, P10664, DOI 10.1158/0008-5472.CAN-07-3107
   Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016
   ROBERTS S, 1991, SPINE, V16, P1030, DOI 10.1097/00007632-199109000-00003
   Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003
   Sakai D, 2017, J ORTHOP TRANSL, V9, P8, DOI 10.1016/j.jot.2017.02.002
   Sampson SL, 2019, J BIOMECH, V83, P273, DOI 10.1016/j.jbiomech.2018.12.004
   Shirazi-Adl A, 2010, J BIOMECH, V43, P1330, DOI 10.1016/j.jbiomech.2010.01.023
   Singh KK, 2014, MOL BIOTECHNOL, V56, P1121, DOI 10.1007/s12033-014-9792-7
   Sivan SS, 2006, BIOCHEM J, V399, P29, DOI 10.1042/BJ20060579
   Sockolosky JT, 2013, PROTEIN EXPRES PURIF, V87, P129, DOI 10.1016/j.pep.2012.11.002
   Thirkettle S, 2013, J BIOL CHEM, V288, P16282, DOI 10.1074/jbc.M113.464230
   Tsai TT, 2014, J ORTHOP RES, V32, P238, DOI 10.1002/jor.22508
   Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52
   Vadala G, 2016, WORLD J STEM CELLS, V8, P185, DOI 10.4252/wjsc.v8.i5.185
   Vashishth Deepak, 2009, IBMS Bonekey, V6, P268
   Vedicherla S, 2016, J ORTHOP RES, DOI [10.1002/JOOR.23268, DOI 10.1002/JOOR.23268]
   Vo NV, 2013, SPINE J, V13, P331, DOI 10.1016/j.spinee.2012.02.027
   Wang Z, 2013, SPINE, V38, P2008, DOI 10.1097/BRS.0b013e3182a76fec
   West PA, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854131
   Wong J, 2019, OSTEOARTHR CARTILAGE, V27, P956, DOI 10.1016/j.joca.2019.01.013
   Woods BI, 2011, ORTHOP CLIN N AM, V42, P563, DOI 10.1016/j.ocl.2011.07.002
   Wu YR, 2016, J BIOMECH, V49, P2756, DOI 10.1016/j.jbiomech.2016.06.008
   Zhu QQ, 2016, J ORTHOP RES, V34, P699, DOI 10.1002/jor.23061
NR 54
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 10
PY 2019
VL 14
IS 4
AR e0215218
DI 10.1371/journal.pone.0215218
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HS6PA
UT WOS:000463992600062
PM 30970007
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Cornelis, MC
   Wang, YM
   Holland, T
   Agarwal, P
   Weintraub, S
   Morris, MC
AF Cornelis, Marilyn C.
   Wang, Yamin
   Holland, Thomas
   Agarwal, Puja
   Weintraub, Sandra
   Morris, Martha Clare
TI Age and cognitive decline in the UK Biobank
SO PLOS ONE
LA English
DT Article
ID SEX-DIFFERENCES; MEMORY; ABILITY; HEALTH; KINDER; FLUID; DISEASE; GROWTH
AB Objectives
   Age-related cognitive decline is a well-known phenomenon after age 65 but little is known about earlier changes and prior studies are based on relatively small samples. We investigated the impact of age on cognitive decline in the largest population sample to date including young to old adults.
   Method
   Between 100,352 and 468,534 participants aged 38-73 years from UK Biobank completed at least one of seven self-administered cognitive functioning tests: prospective memory (PM), pairs matching (Pairs), fluid intelligence (FI), reaction time (RT), symbol digit substitution, trail making A and B. Up to 26,005 participants completed at least one of two follow-up assessments of PM, Pairs, FI and RT. Multivariable regression models examined the association between age (<45[reference], 45-49, 50-54, 55-59, 60-64, 65+) and cognition scores at baseline. Mixed models estimated the impact of age on cognitive decline over follow-up (similar to 5.1 years).
   Results
   FI was higher between ages 50 and 64 and lower at 65+ compared to <45 at baseline. Performance on all other baseline tests was lower with older age: with increasing age category, difference in test scores ranged from 2.5 to 7.8%(P< 0.0001). Compared to <45 at baseline, RT and Pairs performance declined faster across all older age cohorts (3.0 and 1.2% change, respectively, with increasing age category, P< 0.0001). Cross-sectional results yielded 8 to 12-fold higher differences in RT and Pairs with age compared to longitudinal results.
   Conclusions
   Our findings suggest that declines in cognitive abilities <65 are small. The cross-sectional differences in cognition scores for middle to older adult years may be due in part to age cohort effects.
C1 [Cornelis, Marilyn C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
   [Wang, Yamin; Holland, Thomas; Agarwal, Puja; Morris, Martha Clare] Rush Univ, Rush Inst Hlth Aging, Chicago, IL 60612 USA.
   [Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Mesulam Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA.
   [Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA.
RP Cornelis, MC (reprint author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
EM marilyn.cornelis@northwestern.edu
FU National Institute on Aging [K01AG053477]
FX This work was funded by the National Institute on Aging (K01AG053477 to
   MCC). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Backman L, 1996, EUR PSYCHOL, V1, P27, DOI 10.1027/1016-9040.1.1.27
   Bayley N., 1970, CARMICHAELS MANUAL C, V1, P1163
   BRAYNE C, 1992, NEUROEPIDEMIOLOGY, V11, P88, DOI 10.1159/000110997
   Bycroft C, BIORXIV
   Christensen H, 2001, PSYCHOL MED, V31, P15, DOI 10.1017/S0033291799002834
   Christensen H, 2001, AUST NZ J PSYCHIAT, V35, P768, DOI 10.1046/j.1440-1614.2001.00966.x
   CHRISTENSEN H, 1991, PSYCHOL MED, V21, P935, DOI 10.1017/S0033291700029925
   Cleutjens FAHM, 2014, J AM MED DIR ASSOC, V15, P214, DOI 10.1016/j.jamda.2013.12.007
   Cullen B, 2015, EUR PSYCHIAT, V30, P950, DOI 10.1016/j.eurpsy.2015.08.006
   Cullen B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30568-6
   Davies G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04362-x
   De Jager C, 2005, AM J GERIAT PSYCHIAT, V13, P735, DOI 10.1176/appi.ajgp.13.8.735
   Deary IJ, 1998, INTELLIGENCE, V26, P357, DOI 10.1016/S0160-2896(99)00005-7
   DOPPELT J E, 1955, J Abnorm Psychol, V51, P312, DOI 10.1037/h0044391
   Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31
   FOX C, 1949, J GERONTOL, V4, P19
   Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246
   Ge Tian, 2018, Cereb Cortex, DOI 10.1093/cercor/bhy216
   Ghisletta P, 2012, INTELLIGENCE, V40, P260, DOI 10.1016/j.intell.2012.02.008
   Hagenaars SP, 2016, MOL PSYCHIATR, V21, P1624, DOI 10.1038/mp.2015.225
   Hagenaars SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02837-3
   Hartshorne JK, 2015, PSYCHOL SCI, V26, P433, DOI 10.1177/0956797614567339
   Hess TM, 2005, PSYCHOL BULL, V131, P383, DOI 10.1037/0033-2909.131.3.383
   Hill WD, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.246
   HORN JL, 1966, J EDUC PSYCHOL, V57, P253, DOI 10.1037/h0023816
   Hughes ML, 2018, J INT NEUROPSYCH SOC, V24, P805, DOI [10.1017/S1355617718000425, 10.1080/09546634.2018.1484875, 10.1044/2018_JSLHR-H-17-0458]
   HULTSCH DF, 1992, PSYCHOL AGING, V7, P571, DOI 10.1037/0882-7974.7.4.571
   Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110
   Kievit RA, 2018, WELLCOME OPEN RES, P3
   Kievit RA, 2016, NEUROPSYCHOLOGIA, V91, P186, DOI 10.1016/j.neuropsychologia.2016.08.008
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Li RN, 2014, FRONT NEUROENDOCRIN, V35, P385, DOI 10.1016/j.yfrne.2014.01.002
   Lundervold AJ, 2014, SCAND J PSYCHOL, V55, P225, DOI 10.1111/sjop.12114
   Lyall DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154222
   McDaniel MA, 2010, MEM COGNITION, V38, P221, DOI 10.3758/MC.38.2.221
   MILLER DI, 2014, SCI ENG ETHICS, V18, P37, DOI DOI 10.1016/J.TICS.2013.10.011
   Nevado-Holgado AJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012177
   Owens WA, 1959, J GERONTOLOGY
   Rabbitt P, 2001, NEUROPSYCHOLOGIA, V39, P532, DOI 10.1016/S0028-3932(00)00099-3
   Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3
   Salthouse TA, 2004, DEV PSYCHOL, V40, P813, DOI 10.1037/0012-1649.40.5.813
   Salthouse TA, 2013, INTELLIGENCE, V41, P501, DOI 10.1016/j.intell.2013.07.005
   Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023
   SCHAIE KW, 1994, AM PSYCHOL, V49, P304, DOI 10.1037/0003-066X.49.4.304
   SCHAIE KW, 1996, INTELLECTUAL DEV ADU
   Schaie KW, 1988, COGNITIVE DEV ADULTH, P241, DOI DOI 10.1007/978-1-4612-3852-2_8
   Shen X, 2018, BIOL PSYCHIAT COGNIT
   Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622
   Sliwinski M, 1999, PSYCHOL AGING, V14, P18, DOI 10.1037/0882-7974.14.1.18
   Sorenson H, 1933, J APPL PSYCHOL, V17, P729, DOI 10.1037/h0072233
   Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003
   UK Biobank Coordinating Centre, 2006, UK BIOB TOUCH SCREEN
   UK Biobank Coordinating Centre, 2006, COGN FUNCT TESTS ASS
   UK Biobank Coordinating Centre, 2014, COGN FUNCT TESTS ONL
   UK Biobank Coordinating Centre, 2007, UK BIOB PROT LARG SC
NR 55
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 18
PY 2019
VL 14
IS 3
AR e0213948
DI 10.1371/journal.pone.0213948
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HP1JR
UT WOS:000461423500043
PM 30883587
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hessl, D
   Harvey, D
   Sansone, S
   Crestodina, C
   Chin, J
   Joshi, R
   Hagerman, RJ
   Berry-Kravis, E
AF Hessl, David
   Harvey, Danielle
   Sansone, Stephanie
   Crestodina, Crystal
   Chin, Jamie
   Joshi, Reshma
   Hagerman, Randi J.
   Berry-Kravis, Elizabeth
TI Effects of mavoglurant on visual attention and pupil reactivity while
   viewing photographs of faces in Fragile X Syndrome
SO PLOS ONE
LA English
DT Article
ID SOCIAL-BEHAVIOR; UNDERLYING FACE; YOUNG MALES; MOUSE MODEL; GAZE; BOYS;
   PROFILE; CHILDREN; DEFICITS; ANXIETY
AB Background
   Numerous preclinical studies have supported the theory that enhanced activation of mGluR5 signaling, due to the absence or reduction of the FMR1 protein, contributes to cognitive and behavioral deficits in patients with fragile X syndrome (FXS). However multiple phase 2 controlled trials in patients with FXS have failed to demonstrate efficacy of compounds that negatively modulate mGluR5, including two phase 2b randomized controlled trials (RCT) of mavoglurant (AFQ056, Novartis Pharma AG), when the primary measures of interest were behavioral ratings. This has cast some doubt onto the translation of the mGluR5 theory from animal models to humans with the disorder.
   Methods
   We evaluated social gaze behavior-a key phenotypic feature of the disorder-and sympathetic nervous system influence on pupil size using a previously-validated eye tracking paradigm as a biobehavioral probe, in 57 adolescent or adult patients with FXS at baseline and following three months of blinded treatment with one of three doses of mavoglurant or placebo, within the context of the AFQ056 RCTs.
   Results
   Patients with FXS treated with mavoglurant demonstrated increased total absolute looking time and number of fixations to the eye region while viewing human faces relative to baseline, and compared to those treated with placebo. In addition, patients had greater pupil reactivity to faces relative to baseline following mavoglurant treatment compared to placebo.
   Discussion
   The study shows that negative modulation of mGluR5 activity improves eye gaze behavior and alters sympathetically-driven reactivity to faces in patients with FXS, providing preliminary evidence of this drug's impact on behavior in humans with the disorder.
C1 [Hessl, David; Sansone, Stephanie; Hagerman, Randi J.] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA.
   [Hessl, David; Sansone, Stephanie] Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA.
   [Harvey, Danielle] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Div Biostat, Sacramento, CA 95817 USA.
   [Crestodina, Crystal; Chin, Jamie; Joshi, Reshma; Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA.
   [Hagerman, Randi J.] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA.
   [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.
   [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA.
RP Hessl, D (reprint author), Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA.; Hessl, D (reprint author), Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA.
EM drhessl@ucdavis.edu
OI Joshi, Reshma/0000-0001-7617-8890
FU Novartis Pharma AG, Basel, Switzerland; MIND Institute Intellectual and
   Developmental Disabilities Research Center [U54 HD079125]; Intellectual
   and Developmental Disabilities Research Center
FX These studies were supported by Novartis Pharma AG, Basel, Switzerland
   and the MIND Institute Intellectual and Developmental Disabilities
   Research Center (U54 HD079125). Novartis had a role in the original
   clinical trial design, but had no role in the eyetracking data
   collection or analysis, decision to publish, or preparation of this
   manuscript. The National Institute of Child Health and Human
   Development, funder of the Intellectual and Developmental Disabilities
   Research Center, had no role in the study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR AMAN MG, 1985, AM J MENT DEF, V89, P485
   Backes M, 2000, AM J MED GENET, V95, P150
   BAUMGARDNER TL, 1995, PEDIATRICS, V95, P744
   Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009
   Berry- Kravis E, 2010, ARBACLOFEN TREATMENT
   Berry-Kravis E, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-016-9181-6
   Berry-Kravis E, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab4109
   Berry-Kravis E, 2013, J DEV BEHAV PEDIATR, V34, P508, DOI 10.1097/DBP.0b013e31829d1f20
   Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214
   Bruno JL, 2014, AM J PSYCHIAT, V171, P1099, DOI 10.1176/appi.ajp.2014.13111464
   Budimirovic DB, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9193-x
   Codreiro L, 2010, J NEURODEV DISORD
   COHEN IL, 1988, AM J MENT RETARD, V92, P436
   Cornish K, 2004, BRAIN COGNITION, V54, P235, DOI 10.1016/j.bandc.2004.02.017
   Cornish K, 2001, REV NEUROLOGIA, V33, pS24, DOI 10.33588/rn.33S1.2001356
   Dalton KM, 2008, AUTISM RES, V1, P231, DOI 10.1002/aur.32
   de Esch CEF, 2015, NEUROBIOL DIS, V75, P31, DOI 10.1016/j.nbd.2014.12.021
   de Vries PJ, 2010, NEUROTHERAPEUTICS, V7, P275, DOI 10.1016/j.nurt.2010.05.001
   Diggle PJ, 2002, ANAL LONGITUDINAL DA
   Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722
   Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001
   Erickson CA, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9186-9
   Farzin F, 2011, J AUTISM DEV DISORD, V41, P1515, DOI 10.1007/s10803-011-1176-2
   Farzin F, 2009, J AUTISM DEV DISORD, V39, P946, DOI 10.1007/s10803-009-0744-1
   Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860
   Gantois I, 2013, BEHAV BRAIN RES, V239, P72, DOI 10.1016/j.bbr.2012.10.059
   Garrett AS, 2004, ARCH GEN PSYCHIAT, V61, P281, DOI 10.1001/archpsyc.61.3.281
   Gross C, 2015, NEUROTHERAPEUTICS, V12, P584, DOI 10.1007/s13311-015-0355-9
   Hall SS, 2008, AM J MENT RETARD, V113, P44, DOI 10.1352/0895-8017(2008)113[44:CSAABI]2.0.CO;2
   Heneghan C, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1870-2
   Hessl D, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e88
   Hessl D, 2008, J AUTISM DEV DISORD, V38, P184, DOI 10.1007/s10803-007-0365-5
   Hessl D, 2006, J CHILD PSYCHOL PSYC, V47, P602, DOI 10.1111/j.1469-7610.2005.01556.x
   Hessl D, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9167-4
   Holsen LM, 2008, NEUROIMAGE, V43, P592, DOI 10.1016/j.neuroimage.2008.08.009
   Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708
   Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1
   Kau ASM, 2004, AM J MED GENET A, V126A, P9, DOI 10.1002/ajmg.a.20218
   Kau ASM, 2000, AM J MENT RETARD, V105, P286, DOI 10.1352/0895-8017(2000)105<0286:EBSOPP>2.0.CO;2
   Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101
   Munir F, 2000, NEUROPSYCHOLOGIA, V38, P1261, DOI 10.1016/S0028-3932(00)00036-1
   Roid G., 2013, LEITER INT PERFORMAN
   Roid G. H, 2003, STANFORD BINET INTEL
   Sullivan K, 2007, J INTELL DISABIL RES, V51, P54, DOI 10.1111/j.1365-2788.2006.00899.x
   Sullivan K, 2007, AM J MED GENET B, V144B, P517, DOI 10.1002/ajmg.b.30504
   Suvrathan A, 2010, P NATL ACAD SCI USA, V107, P11591, DOI 10.1073/pnas.1002262107
   Symons FJ, 2003, AM J MED GENET A, V118A, P115, DOI 10.1002/ajmg.a.10078
   Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006
   Watson C, 2008, ARCH GEN PSYCHIAT, V65, P1315, DOI 10.1001/archpsyc.65.11.1315
   Wilding J, 2002, NEUROPSYCHOLOGIA, V40, P1343, DOI 10.1016/S0028-3932(01)00212-3
   Woodcock K, 2009, J INTELL DISABIL RES, V53, P265, DOI 10.1111/j.1365-2788.2008.01122.x
NR 53
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 17
PY 2019
VL 14
IS 1
AR e0209984
DI 10.1371/journal.pone.0209984
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH8WT
UT WOS:000456015500021
PM 30653533
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Fickler, A
   Staats, S
   Rimbach, G
   Schulz, C
AF Fickler, Anna
   Staats, Stefanie
   Rimbach, Gerald
   Schulz, Carsten
TI Screening dietary biochanin A, daidzein, equol and genistein for their
   potential to increase DHA biosynthesis in rainbow trout (Oncorhynchus
   mykiss)
SO PLOS ONE
LA English
DT Article
ID FATTY-ACID-COMPOSITION; COA DESATURASE 1; FISH-OIL; OVARIECTOMIZED RATS;
   GENE-EXPRESSION; VEGETABLE-OILS; SOY; PHYTOESTROGENS; GROWTH; LIVER
AB Plant oil utilization in aquafeeds is still the most practical option, although it decreases the content of the nutritionally highly valuable omega-3 fatty acids eicosapentaenoic acid (20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA) in fish. Phytoestrogens and their metabolites are putatively able to affect genes encoding proteins centrally involved in the biosynthesis of EPA and DHA due to their estrogenic potential. Thus, the aim of the study was to screen the potential of the phytoestrogens to stimulate the biosynthesis of EPA and DHA in rainbow trout (Oncorhynchus mykiss). Additionally, the potential effects on growth performance, nutrient composition and hepatic lipid metabolism in rainbow trout were investigated. For that, a vegetable oil based diet served as a control diet (C) and was supplemented with 15 g/kg dry matter of biochanin A (BA), daidzein (DA), genistein (G) and equol (EQ), respectively. These five diets were fed to rainbow trout (initial body weight 83.3 +/- 0.4 g) for 52 days. Growth performance and nutrient composition of whole body homogenates were not affected by the dietary treatments. Furthermore, feeding EQ to rainbow trout significantly increased DHA levels by +8% in whole body homogenates compared to samples of fish fed the diet C. A tendency towards increased DHA levels in whole body homogenates was found for fish fed the diet G. Fish fed diets BA and DA lacked these effects. Moreover, EQ and G fed fish showed significantly decreased hepatic mRNA steady state levels for fatty acyl desaturase 2a (delta-6) (fads2a(d6)). In contrast, carnitine palmitoyl transferases 1 (cpt1) hepatic mRNA steady state levels and hepatic Fads2a(d6) protein contents were not affected by the dietary treatment. In conclusion, when combined with dietary vegetable oils, equol and genistein seem to stimulate the biosynthesis of DHA and thereby increase tissue DHA levels in rainbow trout, however, only to a moderate extent.
C1 [Fickler, Anna; Schulz, Carsten] GMA Gesell Marine Aquakultur mbH, Busum, Germany.
   [Fickler, Anna; Schulz, Carsten] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany.
   [Staats, Stefanie; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany.
RP Fickler, A (reprint author), GMA Gesell Marine Aquakultur mbH, Busum, Germany.; Fickler, A (reprint author), Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany.
EM fickler@gma-buesum.de
RI Schulz, Carsten/C-2127-2017
FU Federal Office for Agriculture and Food [BLE 2815NA044]; Land
   Schleswig-Holstein
FX The funder (Federal Office for Agriculture and Food - BLE 2815NA044)
   provided support in the form of salaries for Anna Fickler, but did not
   have any additional role in the study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   specific roles of this author is articulated in the 'author
   contributions' section. Further, the Gesellschaft fur Marine Aquakultur
   mbH (GMA) is a non-profit company working in aquaculture research which
   is shared by public institutions. GMA provided research infrastructure,
   but were not included in conceptualisation of experimental design, data
   collection and analysis and MS preparation. We acknowledge financial
   support by Land Schleswig-Holstein within the funding programme Open
   Access Publikationsfonds for the publication fee.; We acknowledge
   financial support by Land Schleswig-Holstein within the funding
   programme Open Access Publikationsfonds. We would like to thank Dr.
   Mario Hasler and Jonas Schaler for their statistical advice and Dr.
   Hubert Wehage at the LUFA-ITL in Kiel, Germany, for the fatty acid
   analysis. Further, the authors would like to thank Bahne Christiansen,
   Julian Wessel, Sandra Nevermann and Petra Rettmann for their assistance
   during the experimental period and in the lab. In addition, we are
   grateful for the guidance given by Markus Griese, Michael Schlachter and
   all GMA colleagues for their help during sampling.
CR [Anonymous], 2015, AQUACULTURE, V448, P365
   Bell JG, 2004, LIPIDS, V39, P223, DOI 10.1007/s11745-004-1223-5
   Bell MV, 2001, LIPIDS, V36, P1153, DOI 10.1007/s11745-001-0826-1
   Bretz F., 2010, MULTIPLE COMP USING, DOI [10.1201/9781420010909-f, DOI 10.1201/9781420010909-F]
   Buzzi M, 1996, BBA-LIPID LIPID MET, V1299, P235, DOI 10.1016/0005-2760(95)00211-1
   Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3
   Chacko BK, 2007, J NUTR, V137, P351
   Childs CE, 2012, PROSTAG LEUKOTR ESS, V86, P141, DOI 10.1016/j.plefa.2012.03.007
   Cleveland BM, 2015, COMP BIOCHEM PHYS C, V170, P28, DOI 10.1016/j.cbpc.2015.02.001
   Crespillo A, 2011, BRIT J PHARMACOL, V164, P1899, DOI 10.1111/j.1476-5381.2011.01477.x
   Dixon RA, 2002, PHYTOCHEMISTRY, V60, P205, DOI 10.1016/S0031-9422(02)00116-4
   Drew MD, 2007, AQUACULTURE, V267, P260, DOI 10.1016/j.aquaculture.2007.01.002
   FAO, 2015, STAT WORLD FISH AQ 2
   Fickler A, 2018, LIPIDS, V53, P809, DOI 10.1002/lipd.12092
   Geay F, 2012, MAR GENOM, V5, P7, DOI 10.1016/j.margen.2011.08.003
   Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167
   Gontier-Latonnelle K, 2007, GEN COMP ENDOCR, V150, P298, DOI 10.1016/j.ygcen.2006.10.001
   Gonzalez-Bengtsson A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164241
   Hernandez-Montes E, 2006, BIOCHEM BIOPH RES CO, V346, P851, DOI 10.1016/j.bbrc.2006.05.197
   Ishak SD, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-56
   Jourdehi AY, 2014, FISH PHYSIOL BIOCHEM, V40, P117, DOI 10.1007/s10695-013-9829-z
   Karalazos V, 2007, AQUACULT NUTR, V13, P256, DOI 10.1111/j.1365-2095.2007.00471.x
   Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011
   Kitson AP, 2013, PROSTAG LEUKOTR ESS, V89, P81, DOI 10.1016/j.plefa.2013.05.003
   Kitson AP, 2010, LIPIDS, V45, P209, DOI 10.1007/s11745-010-3391-6
   Klejdus B, 2001, ANAL CHIM ACTA, V450, P81, DOI 10.1016/S0003-2670(01)01370-8
   Kolditz C, 2008, AM J PHYSIOL-REG I, V294, pR1154, DOI 10.1152/ajpregu.00766.2007
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Latonnelle K, 2002, GEN COMP ENDOCR, V126, P39, DOI 10.1006/gcen.2001.7773
   Marks KA, 2013, PROSTAG LEUKOTR ESS, V89, P89, DOI 10.1016/j.plefa.2013.05.002
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   Mezei O, 2003, J NUTR, V133, P1238
   Miller MR, 2008, NUTR RES REV, V21, P85, DOI 10.1017/S0954422408102414
   Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x
   Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106
   NRC, 2011, NUTR REQ FISH SHRIMP, DOI [10.17226/13039, DOI 10.17226/13039]
   Richard N, 2006, BRIT J NUTR, V96, P299, DOI 10.1079/BJN20061821
   Rochfort S, 2007, J AGR FOOD CHEM, V55, P7981, DOI 10.1021/jf071704w
   RuizLarrea MB, 1997, FREE RADICAL RES, V26, P63, DOI 10.3109/10715769709097785
   Sargent John R., 2002, P181
   Schiller V.A., 2012, LIPIDS, V47, P897, DOI DOI 10.1007/S11745-012-3697-7
   Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S
   Setchell KDR, 2002, J NUTR, V132, P3577
   SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569
   Setchell KDR, 2002, AM J CLIN NUTR, V76, P447
   Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S
   Setchell KDR, 2009, AM J CLIN NUTR, V90, P1029, DOI 10.3945/ajcn.2009.27981
   Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015
   Tocher DR, 2015, AQUACULTURE, V449, P94, DOI 10.1016/j.aquaculture.2015.01.010
   Torno C, 2019, ANIMAL, V13, P933, DOI 10.1017/S1751731118002458
   Torno C, 2017, MAR DRUGS, V15, DOI 10.3390/md15080252
   Trattner S, 2008, LIPIDS, V43, P999, DOI 10.1007/s11745-008-3229-7
   Turchini G.M., 2010, FISH OIL REPLACEMENT
   Turchini GM, 2011, FOOD CHEM, V124, P609, DOI 10.1016/j.foodchem.2010.06.083
   Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874
   Verbeke G, 2000, LINEAR MIXED MODELS, DOI [10.1007/978-1-4419-0300-6, DOI 10.1007/978-1-4419-0300-6]
   Vestergren ALS, 2011, NEUROENDOCRINOL LETT, V32, P41
   VOSS A, 1991, J BIOL CHEM, V266, P19995
   Wiseman H, 2000, AM J CLIN NUTR, V72, P395
   Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004
NR 60
TC 1
Z9 1
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 15
PY 2019
VL 14
IS 1
AR e0210197
DI 10.1371/journal.pone.0210197
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH6AH
UT WOS:000455810200020
PM 30645603
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Heggeseth, BC
   Aleman, A
AF Heggeseth, Brianna C.
   Aleman, Alvaro
TI Early-life environmental exposures and childhood growth: A comparison of
   statistical methods
SO PLOS ONE
LA English
DT Article
ID LONGITUDINAL DATA; EFFECTS MODELS; DOSE-RESPONSE; SAS PROCEDURE;
   MIXED-MODELS; MIXTURE; CHAMACOS; OBESITY; BMI; GEE
AB There is a growing literature that suggests environmental exposure during key developmental periods could have harmful impacts on growth and development of humans. Understanding and estimating the relationship between early-life exposure and human growth is vital to studying the adverse health impacts of environmental exposure. We compare two statistical tools, mixed-effects models with interaction terms and growth mixture models, used to measure the association between exposure and change over time within the context of non-linear growth and non-monotonic relationships between exposure and growth. We illustrate their strengths and weaknesses through a real data example and simulation study. The data example, which focuses on the relationship between phthalates and the body mass index growth of children, indicates that the conclusions from the two models can differ. The simulation study provides a broader understanding of the robustness of these models in detecting the relationships between any exposure and growth that could be observed. Data-driven growth mixture models are more robust to non-monotonic growth and stochastic relationships but at the expense of interpretability. We offer concrete modeling strategies to estimate complex relationships with growth patterns.
C1 [Heggeseth, Brianna C.; Aleman, Alvaro] Williams Coll, Dept Math & Stat, Williamstown, MA 01267 USA.
   [Heggeseth, Brianna C.] Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA.
RP Heggeseth, BC (reprint author), Williams Coll, Dept Math & Stat, Williamstown, MA 01267 USA.; Heggeseth, BC (reprint author), Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA.
EM bheggese@macalester.edu
FU Williams College
FX The author(s) received internal research funding from Williams College
   to complete this work. The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2000, CONTROL CFD PREVENTI
   Asparouhov T, 2016, STRUCT EQU MODELING, V23, P1, DOI 10.1080/10705511.2014.947375
   Bates D, 2015, J STAT SOFTW, V67, P1
   Bennette C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-21
   Berkey CS, 2007, ANN EPIDEMIOL, V17, P44, DOI 10.1016/j.annepidem.2006.07.014
   Braun JM, 2017, NAT REV ENDOCRINOL, V13, P161, DOI 10.1038/nrendo.2016.186
   de Boor C., 1972, Journal of Approximation Theory, V6, P50, DOI 10.1016/0021-9045(72)90080-9
   de Boor C., 1976, APPROXIMATION THEORY, VII, P1
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   Eskenazi B, 2005, ENVIRON HEALTH PERSP, V113, P1419, DOI 10.1289/ehp.7670
   Eskenazi B, 2003, J CHILD HLTH, V1, P3, DOI DOI 10.3109/713610244
   Everitt B. S., 1981, FINITE MIXTURE DISTR
   Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52
   Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578
   Friedman J., 2001, ELEMENTS STAT LEARNI, V1
   Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478
   GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005
   Harley KG, 2017, PEDIATR RES, V82, P405, DOI 10.1038/pr.2017.112
   Harley KG, 2013, ENVIRON HEALTH PERSP, V121, P514, DOI 10.1289/ehp.1205548
   Heggeseth BC, 2018, MODEL COMP SIMULATIO, DOI [10.5281/zenodo.1491879, DOI 10.5281/ZENODO.1491879]
   Heggeseth B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131443
   Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90
   Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005
   Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364
   Lagarde F, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-13
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267
   McLachlan G.J., 2000, WILEY SER PROB STAT
   Muthen B, 1999, BIOMETRICS, V55, P463, DOI 10.1111/j.0006-341X.1999.00463.x
   Proust C, 2005, COMPUT METH PROG BIO, V78, P165, DOI 10.1016/j.cmpb.2004.12.004
   Proust-Lima C, 2014, LCMM ESTIMATION EXTE
   R Core Team, 2018, R LANG ENV STAT COMP
   Ruppert D, 2002, J COMPUT GRAPH STAT, V11, P735, DOI 10.1198/106186002853
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
   Singer JD, 2003, APPL LONGITUDINAL DA
   Strauss RS, 1997, BRIT MED BULL, V53, P81
   Valvi D, 2015, ENVIRON HEALTH PERSP, V123, P1022, DOI 10.1289/ehp.1408887
   Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2
   Warner M, 2014, AM J EPIDEMIOL, V179, P1312, DOI 10.1093/aje/kwu046
   WATERNAUX C, 1989, J AM STAT ASSOC, V84, P33, DOI 10.2307/2289844
   Wedel M, 2002, STAT NEERL, V56, P362, DOI 10.1111/1467-9574.t01-1-00072
NR 41
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 17
PY 2018
VL 13
IS 12
AR e0209321
DI 10.1371/journal.pone.0209321
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE5TK
UT WOS:000453451000093
PM 30557389
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gurari, N
   Drogos, JM
   Dewald, JPA
AF Gurari, Netta
   Drogos, Justin M.
   Dewald, Julius P. A.
TI Ability of individuals with chronic hemiparetic stroke to locate their
   forearms during single-arm and between-arms tasks
SO PLOS ONE
LA English
DT Article
ID LIMB POSITION SENSE; FUSIMOTOR STIMULATION; MUSCLE-SPINDLES; BODY SHAPE;
   ASYMMETRIES; MOVEMENT; ERROR; REPRESENTATION; THIXOTROPY; FREQUENCY
AB Background
   According to between-arms assessments, more than 50% of individuals with stroke have an impaired position sense. Our previous work, which employed a clinical assessment and slightly differing tasks, indicates that individuals who have a deficit on a between-forearms position-localization task do not necessarily have a deficit on a single-forearm position-localization task.
   Objective
   Our goal here was to, using robotics tools, determine whether individuals with stroke who have a deficit when matching forearm positions within an arm also have a deficit when mirroring forearm positions between arms, independent of the arm that leads the task.
   Methods
   Eighteen participants with chronic hemiparetic stroke and nine controls completed a single-arm position-matching experiment and between-arms position-mirroring experiment. For each experiment, the reference forearm (left/right) passively rotated about the elbow joint to a reference target location (flexion/extension), and then the participant actively rotated their same/opposite forearm to match/mirror the reference forearm's position. Participants with stroke were classified as having a position-matching/-mirroring deficit based on a quantitative threshold that was derived from the controls' data.
   Results
   On our single-arm task, one participant with stroke was classified as having a position-matching deficit with a mean magnitude of error greater than 10.7 degrees when referencing their paretic arm. Position-matching ability did not significantly differ for the controls and the remaining seventeen participants with stroke. On our between-arms task, seven participants with stroke were classified as having a position-mirroring deficit with a mean magnitude of error greater than 10.1 degrees. Position-mirroring accuracy was worse for these participants with stroke, when referencing their paretic arm, than the controls.
   Concluding remark
   Findings underscore the need for assessing within-arm position-matching deficits, in addition to between-arms position-mirroring deficits when referencing each arm, to comprehensively evaluate an individual's ability to locate their forearm(s).
C1 [Gurari, Netta; Drogos, Justin M.; Dewald, Julius P. A.] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.
   [Dewald, Julius P. A.] Northwestern Univ, Dept Phys Med & Rehabil, Evanston, IL USA.
   [Dewald, Julius P. A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Dewald, Julius P. A.] Univ Twente, Fac Engn Technol, Dept Biomech Engn, Enschede, Netherlands.
RP Gurari, N (reprint author), Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.
EM netta.gurari@northwestern.edu
FU  [NIH R01HD039343]
FX This work was supported by grant NIH R01HD039343 (PI: JPA Dewald)
   (https://www.nih.gov/).The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Academy of Neurologic Physical Therapy, 2011, STROKEEDGE DOCUMENTS
   Adamovich SV, 1999, EXP BRAIN RES, V125, P200, DOI 10.1007/s002210050674
   Bastian HC, 1887, BRAIN, V10, P1, DOI DOI 10.1093/BRAIN/10.1.1
   Bates D, 2015, J STAT SOFTW, V67, P1
   Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485
   BROWN MC, 1969, J PHYSIOL-LONDON, V205, P677, DOI 10.1113/jphysiol.1969.sp008990
   Carey LM, 2011, J REHABIL MED, V43, P257, DOI 10.2340/16501977-0662
   Carey LM, 1996, ARCH PHYS MED REHAB, V77, P1271, DOI 10.1016/S0003-9993(96)90192-6
   CARSON RG, 1990, NEUROPSYCHOLOGIA, V28, P99, DOI 10.1016/0028-3932(90)90090-B
   Chapman CD, 2001, BRAIN COGNITION, V46, P62, DOI 10.1016/S0278-2626(01)80035-X
   Christensen R., 2015, PACKAGE IMERTEST
   COLLEY A, 1984, CORTEX, V20, P47, DOI 10.1016/S0010-9452(84)80022-2
   Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674
   Corkin S, T AM NEUROLOGICAL AS, V98, P118
   dos Santos CM, 2012, REV BRAS MED ESPORTE, V18, P38, DOI 10.1590/S1517-86922012000100008
   Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267
   EKLUND G, 1972, J NEUROL NEUROSUR PS, V35, P606, DOI 10.1136/jnnp.35.5.606
   FISH DR, 1985, PHYS THER, V65, P1666, DOI 10.1093/ptj/65.11.1666
   Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009
   FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13
   GANDEVIA SC, 1992, TRENDS NEUROSCI, V15, P62, DOI 10.1016/0166-2236(92)90028-7
   Goble DJ, 2007, EXP BRAIN RES, V180, P693, DOI 10.1007/s00221-007-0890-7
   Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399
   Goble DJ, 2009, EXP BRAIN RES, V197, P403, DOI 10.1007/s00221-009-1922-2
   Goble DJ, 2006, EXP BRAIN RES, V168, P307, DOI 10.1007/s00221-005-0280-y
   Goble DJ, 2005, HUM MOVEMENT SCI, V24, P155, DOI 10.1016/j.humov.2005.05.004
   GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382
   Gurari N, 2018, EXP BRAIN RES, V236, P765, DOI 10.1007/s00221-018-5173-y
   Gurari N, 2017, CLIN NEUROPHYSIOL, V128, P18, DOI 10.1016/j.clinph.2016.10.009
   Gurari N, 2014, J NEUROSCI METH, V235, P169, DOI 10.1016/j.jneumeth.2014.07.001
   Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556
   HENRY FM, 1974, J MOTOR BEHAV, V6, P149, DOI 10.1080/00222895.1974.10734991
   Hillier S, 2015, NEUROREHAB NEURAL RE, V29, P933, DOI 10.1177/1545968315573055
   Hirayama K, 1999, J NEUROL SCI, V167, P45, DOI 10.1016/S0022-510X(99)00136-7
   HOLM S, 1979, SCAND J STAT, V6, P65
   Imanaka K, 1995, BRAIN COGNITION, V29, P232, DOI 10.1006/brcg.1995.1280
   JONES B, 1972, PERCEPT PSYCHOPHYS, V12, P95, DOI 10.3758/BF03212850
   Kim JS, 1996, STROKE, V27, P677, DOI 10.1161/01.STR.27.4.677
   LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01
   Lincoln NB, 1998, PHYSIOTHERAPY, V84, P358, DOI DOI 10.1016/S0031-9406(05)61454-X
   Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107
   Lonn J, 2000, ARCH PHYS MED REHAB, V81, P592, DOI 10.1016/S0003-9993(00)90040-6
   MARTENIUK RG, 1973, J MOTOR BEHAV, V5, P249, DOI 10.1080/00222895.1973.10734972
   MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763
   MCCLOSKEY DI, 1973, BRAIN, V96, P269, DOI 10.1093/brain/96.2.269
   MORGAN DL, 1984, J PHYSIOL-LONDON, V356, P465, DOI 10.1113/jphysiol.1984.sp015477
   Niessen MH, 2008, ARCH PHYS MED REHAB, V89, P333, DOI 10.1016/j.apmr.2007.08.157
   NISHIZAWA S, 1987, CORTEX, V23, P485, DOI 10.1016/S0010-9452(87)80009-6
   ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737
   Paillard J, 1968, NEUROPSYCHOLOGY SPAT, P37
   Pinheiro J., 2012, LINEAR NONLINEAR MIX
   PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N
   Proske U, 2014, EXP BRAIN RES, V232, P3397, DOI 10.1007/s00221-014-4088-5
   Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011
   ROY EA, 1978, CORTEX, V14, P250, DOI 10.1016/S0010-9452(78)80051-3
   SCHUTZ RW, 1973, J MOTOR BEHAV, V5, P141, DOI 10.1080/00222895.1973.10734959
   Simo L, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-77
   Sukal TM, 2007, EXP BRAIN RES, V183, P215, DOI 10.1007/s00221-007-1029-6
   van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525
   Walsh LD, 2004, J PHYSIOL-LONDON, V558, P705, DOI 10.1113/jphysiol.2004.062703
   Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851
   Winter JA, 2005, J PHYSIOL-LONDON, V568, P1035, DOI 10.1113/jphysiol.2005.092619
   WORRINGHAM CJ, 1985, EXP BRAIN RES, V61, P38
   Zia S, 2002, CLIN ANAT, V15, P23, DOI 10.1002/ca.1087
NR 66
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 29
PY 2018
VL 13
IS 10
AR e0206518
DI 10.1371/journal.pone.0206518
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GY5SG
UT WOS:000448641200042
PM 30372499
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Elizaga, ML
   Li, SS
   Kochar, NK
   Wilson, GJ
   Allen, MA
   Tieu, HVN
   Frank, I
   Sobieszczyk, ME
   Cohen, KW
   Sanchez, B
   Latham, TE
   Clarke, DK
   Egan, MA
   Eldridge, JH
   Hannaman, D
   Xu, R
   Ota-Setlik, A
   Mcelrath, MJ
   Hay, CM
AF Elizaga, Marnie L.
   Li, Shuying S.
   Kochar, Nidhi K.
   Wilson, Gregory J.
   Allen, Mary A.
   Tieu, Hong Van N.
   Frank, Ian
   Sobieszczyk, Magdalena E.
   Cohen, Kristen W.
   Sanchez, Brittany
   Latham, Theresa E.
   Clarke, David K.
   Egan, Michael A.
   Eldridge, John H.
   Hannaman, Drew
   Xu, Rong
   Ota-Setlik, Ayuko
   Mcelrath, M. Juliana
   Hay, Christine Mhorag
CA NIAID HIV Vaccine Trials Network H
TI Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with
   IL-12 plasmid DNA via electroporation, boosted with a recombinant
   vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a
   randomized, controlled clinical trial
SO PLOS ONE
LA English
DT Article
ID GENE-THERAPY; INTRAMUSCULAR ELECTROPORATION; INTERLEUKIN-12; DELIVERY;
   IMMUNOGENICITY; EFFICACY; MICE; STRATEGIES; RESPONSES; VECTOR
AB Background
   The addition of plasmid cytokine adjuvants, electroporation, and live attenuated viral vectors may further optimize immune responses to DNA vaccines in heterologous prime-boost combinations. The objective of this study was to test the safety and tolerability of a novel prime-boost vaccine regimen incorporating these strategies with different doses of IL-12 plasmid DNA adjuvant.
   Methods
   In a phase 1 study, 88 participants received an HIV-1 multiantigen (gag/pol, env, nef/tat/vif) DNA vaccine (HIV-MAG, 3000 mu g) co-administered with IL-12 plasmid DNA adjuvant at 0, 250, 1000, or 1500 mu g (N = 22/group) given intramuscularly with electroporation (Ichor Tri-Grid (TM) Delivery System device) at 0, 1 and 3 months; followed by attenuated recombinant vesicular stomatitis virus, serotype Indiana, expressing HIV-1 Gag (VSV-Gag), 3.4 subset of 10(7) plaque-forming units (PFU), at 6 months; 12 others received placebo. Injections were in both deltoids at each timepoint. Participants were monitored for safety and tolerability for 15 months.
   Results
   The dose of IL-12 pDNA did not increase pain scores, reactogenicity, or adverse events with the co-administered DNA vaccine, or following the VSV-Gag boost. Injection site pain and reactogenicity were common with intramuscular injections with electroporation, but acceptable to most participants. VSV-Gag vaccine often caused systemic reactogenicity symptoms, including a viral syndrome (in 41%) of fever, chills, malaise/fatigue, myalgia, and headache; and decreased lymphocyte counts 1 day after vaccination.
   Conclusions
   HIV-MAG DNA vaccine given by intramuscular injection with electroporation was safe at all doses of IL-12 pDNA. The VSV-Gag vaccine at this dose was associated with fever and viral symptoms in some participants, but the vaccine regimens were safe and generally well-tolerated.
C1 [Elizaga, Marnie L.; Li, Shuying S.; Kochar, Nidhi K.; Cohen, Kristen W.; Sanchez, Brittany; Mcelrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Wilson, Gregory J.] Vanderbilt Univ, Med Ctr, Div Pediat Infect Dis, Nashville, TN USA.
   [Allen, Mary A.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Tieu, Hong Van N.] New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA.
   [Frank, Ian] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Sobieszczyk, Magdalena E.] Columbia Univ, Div Infect Dis, Med Ctr, New York, NY USA.
   [Latham, Theresa E.; Clarke, David K.; Egan, Michael A.; Eldridge, John H.; Xu, Rong; Ota-Setlik, Ayuko] Profectus BioSci Inc, Pearl River, NY USA.
   [Hannaman, Drew] Ichor Med Syst Inc, San Diego, CA USA.
   [Mcelrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.
   [Mcelrath, M. Juliana] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Mcelrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA USA.
   [Hay, Christine Mhorag] Univ Rochester, Med Ctr, Infect Dis Div, Rochester, NY 14642 USA.
   [Egan, Michael A.] Takeda Pharmaceut, Boston, MA USA.
RP Elizaga, ML (reprint author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
EM melizaga@gmail.com
FU National Institute of Allergy and Infectious Diseases (NIAID) U.S.
   Public Health Service [UM1 AI068614, UM1 AI068635, UM1 AI068618, UM1
   AI069470, UM1 AI069534, P30 AI 045008, UM1 AI069511, UM1 AI069439];
   NIH/NIAID HIV Vaccine Design and Development Team [NO1-AI-80061,
   NO1-AI-80062]; HIV Vaccine Trials Network (HVTN); NIAID; Profectus
   Biosciences, Inc.; Ichor Medical Systems, Inc.
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases (NIAID) (https://www.niaid.nih.gov/) U.S. Public
   Health Service Grants UM1 AI068614 [LOC: HIV Vaccine Trials Network],
   UM1 AI068635 [SDMC: HIV Vaccine Trials Network], UM1 AI068618 [LC: HIV
   Vaccine Trials Network], UM1 AI069470 [Columbia Partnership for
   Prevention and Control of HIV/AIDS Clinical Trials Unit: College of
   Physicians & Surgeons and New York Blood Center Clinical Research
   Sites], UM1 AI069534 and P30 AI 045008 [Philadelphia HIV Therapeutics
   and Prevention Clinical Trials Unit], UM1 AI069511 [University of
   Rochester HIV/AIDS Clinical Trials Unit], and UM1 AI069439 [Vanderbilt
   HIV Clinical Trials Unit]. The development of the vaccines was supported
   by NIH/NIAID HIV Vaccine Design and Development Team grants NO1-AI-80061
   and NO1-AI-80062 to John H. Eldridge, Ph.D at Profectus Biosciences,
   Inc. The content is solely the responsibility of the authors and does
   not necessarily represent the official views of the NIAID or the
   National Institutes of Health (NIH). Role of the funding sources: within
   the terms of the Grant Award of the Cooperative Agreement with the HIV
   Vaccine Trials Network (HVTN), the study sponsor, NIAID, reviewed and
   approved the study design, contributed to the review and analysis of
   data, concurred with the decision to publish, and assisted with the
   preparation of the manuscript. NIAID was not involved in the data
   collection and did not perform statistical analyses. Coauthor Mary Allen
   is employed by the National Institute of Allergy and Infectious Diseases
   (NIAID), the study sponsor. NIAID provided partial salary support for
   MLE, SSL, NKK, GJW, HVNT, IF, MES, KWC, BSP, JHE, MJM and CMH. The
   corresponding author had full access to all of the data in the study and
   had final responsibility for the decision to submit for publication. We
   report the following commercial affiliations: Profectus Biosciences,
   Inc. (http://www.profectusbiosciences.com) provided research materials,
   and salary support for authors (TEK, DKC, MAE, JHE, RX, AOS), who
   participated in study design, support, supervision, assays for IL-12
   neutralizing antibody, rVSV culture and rVSV RNA (RT-PCR), reporting
   those results, writing, review and editing of the manuscript. Ichor
   Medical Systems, Inc. (http://www.ichorms.com) provided salary support
   (DH), electroporation materials and expertise, and training for the
   study under contract to Profectus. The specific roles of these authors
   are indicated in the 'author contributions' section.
CR AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381
   Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867
   Babiuk S, 2004, J BIOTECHNOL, V110, P1, DOI 10.1016/j.biotec.2004.01.015
   Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4
   CHANG DC, 1990, BIOPHYS J, V58, P1, DOI 10.1016/S0006-3495(90)82348-1
   Clarke DK, 2006, SPRINGER SEMIN IMMUN, V28, P239, DOI 10.1007/s00281-006-0042-3
   Clarke DK, 2016, VACCINE, V34, P6597, DOI 10.1016/j.vaccine.2016.06.071
   Cooper D, 2008, J VIROL, V82, P207, DOI 10.1128/JVI.01515-07
   Dolter KE, 2011, VACCINE, V29, P795, DOI 10.1016/j.vaccine.2010.11.011
   Dunachie SJ, 2003, J EXP BIOL, V206, P3771, DOI 10.1242/jeb.00642
   Egan MA, 2005, AIDS RES HUM RETROV, V21, P629, DOI 10.1089/aid.2005.21.629
   Egan MA, 2006, VACCINE, V24, P4510, DOI 10.1016/j.vaccine.2005.08.024
   FAGUET GB, 1981, J INFECT DIS, V143, P252, DOI 10.1093/infdis/143.2.252
   Fauci AS, 2014, SCIENCE, V344, P49, DOI 10.1126/science.1250672
   FEATHERSTONE C, 1993, AM BIOTECHNOL LAB, V11, P16
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Fuchs JD, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv082
   Gherardi MM, 1999, J IMMUNOL, V162, P6724
   Haefeli M, 2006, EUR SPINE J, V15, pS17, DOI 10.1007/s00586-005-1044-x
   Haidari G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13331-1
   Heller LC, 2010, CURR GENE THER, V10, P312
   Heller R, 2011, IEEE ENG MED BIO, P736, DOI 10.1109/IEMBS.2011.6090167
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Hensley TR, 2012, JOVE-J VIS EXP, DOI 10.3791/4302
   Hensley-McBain T, 2014, J IMMUNOL METHODS, V411, P23, DOI 10.1016/j.jim.2014.06.002
   Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1
   Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236
   Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231
   KEATING A, 1990, PROG CLIN BIOL RES, V333, P491
   Kraynyak KA, 2009, HUM GENE THER, V20, P1143, DOI 10.1089/hum.2009.025
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lambricht L, 2016, EXPERT OPIN DRUG DEL, V13, P295, DOI 10.1517/17425247.2016.1121990
   Lee K, 2000, J INTERF CYTOK RES, V20, P589
   Li SYS, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00263-17
   Matthews K E, 1995, Methods Mol Biol, V48, P273
   Mpendo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134287
   Murakami T, 2011, CURR GENE THER, V11, P447, DOI 10.2174/156652311798192860
   Muturi-Kioi V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157385
   Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216
   Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x
   Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252
   Yamashita Y, 2001, CANCER RES, V61, P1005
   Zak D, 2012, P NATL ACAD SCI US
   Zhu SG, 2010, J IMMUNOL, V184, P2348, DOI 10.4049/jimmunol.0902371
NR 45
TC 2
Z9 2
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 20
PY 2018
VL 13
IS 9
AR e0202753
DI 10.1371/journal.pone.0202753
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GU8XH
UT WOS:000445626400015
PM 30235286
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shafran, R
   Wroe, A
   Nagra, S
   Pissaridou, E
   Coughtrey, A
AF Shafran, Roz
   Wroe, Abigail
   Nagra, Sasha
   Pissaridou, Eleni
   Coughtrey, Anna
TI Cognitive behaviour treatment of co-occurring depression and generalised
   anxiety in routine clinical practice
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; TRANSDIAGNOSTIC TREATMENT; SYMPTOM CHANGE;
   THERAPY; DISORDERS; SEVERITY; ADULTS; METAANALYSIS; COMORBIDITY;
   IMPAIRMENT
AB Background
   Anxiety and depression are closely associated. However, they are typically treated separately and there is a dearth of information on tackling them together.
   Aims
   The study's purpose was to establish how best to treat co-occurring anxiety and depression in a routine clinical service D specifically, to compare cognitive behaviour therapy (CBT) focusing only on depression (CBT-D) to a broader CBT focusing on both depression and anxiety (CBT-DA).
   Method
   Case notes of 69 patients with equally severe clinical levels of depression and anxiety seen in a routine clinical service were randomly selected to review from a pool of 990 patients. The mean age was 44.61 years (SD = 12.97). 65% of the sample were female and 88% reported their ethnicity white. The content of electronic records reporting techniques used and scores on a measure of depression (The Patient Health Questionnaire) and anxiety (The Generalized Anxiety Disorder Assessment) were reviewed to categorise therapy as CBT-D or CBT-DA.
   Results
   Results indicated significant overall improvement with CBT; 70% and 77% of the sample met criteria for reliable improvement on The Patient Health Questionnaire and The Generalized Anxiety Disorder Assessment respectively. Fewer patients who received CBT-DA met The Generalized Anxiety Disorder Assessment recovery criteria at the end of treatment than those who received CBT-D. Mean post treatment PHQ-9 and GAD-7 scores remained above threshold for those receiving CBT_DA but not those receiving CBT-D. There was no evidence suggesting CBT-DA was superior to CBT-D.
   Conclusions
   In patients with equally severe clinical levels of depression and anxiety, a broader treatment addressing both anxiety and depression does not appear to be associated with improved outcomes compared to treatment focused on depression.
C1 [Shafran, Roz; Pissaridou, Eleni; Coughtrey, Anna] UCL, Great Ormond St Inst Child Hlth, Fac Populat Hlth Sci, Populat Policy & Practice, London, England.
   [Wroe, Abigail; Nagra, Sasha] Berkshire Healthcare NHS Fdn Trust, Reading, Berks, England.
RP Shafran, R (reprint author), UCL, Great Ormond St Inst Child Hlth, Fac Populat Hlth Sci, Populat Policy & Practice, London, England.
EM r.shafran@ucl.ac.uk
OI Shafran, Roz/0000-0003-2729-4961
FU British Association for Behavioural and Cognitive Psychotherapies
FX This study was funded by the British Association for Behavioural and
   Cognitive Psychotherapies to RS. The funder had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Barlow DH, 2014, CLIN PSYCHOL SCI, V2, P344, DOI 10.1177/2167702613505532
   Beck A. T., 1979, COGNITIVE THERAPY DE
   Beck J. S., 1995, COGNITIVE THERAPY BA
   Bomyea J, 2015, PSYCHIAT RES, V229, P133, DOI 10.1016/j.psychres.2015.07.056
   Craske MG, 2007, BEHAV RES THER, V45, P1095, DOI 10.1016/j.brat.2006.09.006
   Craske MG, 2012, DEPRESS ANXIETY, V29, P749, DOI 10.1002/da.21992
   Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658
   Dugas M. J., 2007, COGNITIVE BEHAV TREA
   Dugas MJ, 2010, BEHAV THER, V41, P46, DOI 10.1016/j.beth.2008.12.004
   Farchione TJ, 2012, BEHAV THER, V43, P666, DOI 10.1016/j.beth.2012.01.001
   Gibbons CJ, 2008, BEHAV THER, V39, P117, DOI 10.1016/j.beth.2007.05.006
   Gyani A, 2014, BEHAV THER, V45, P199, DOI 10.1016/j.beth.2013.10.004
   Gyani A, 2013, BEHAV RES THER, V51, P597, DOI 10.1016/j.brat.2013.06.004
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001
   Mazzucchelli T, 2009, CLIN PSYCHOL-SCI PR, V16, P383, DOI 10.1111/j.1468-2850.2009.01178.x
   McManus S., 2009, ADULT PSYCHIAT MORBI
   Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461
   National Institute for Health and Care Excellence, 2009, DEPR TREATM MAN DEPR
   National Institute for Health and Care Excellence, 2011, GEN ANX DIS PAN DIS
   Newby JM, 2015, CLIN PSYCHOL REV, V40, P91, DOI 10.1016/j.cpr.2015.06.002
   Pinheiro J, 2009, R PACKAGE VERSION, V3, P96
   Porter E, 2017, J NERV MENT DIS, V205, P656, DOI 10.1097/NMD.0000000000000666
   R Core Team, 2016, R LANG ENV STAT COMP
   Roth AD, 2008, BEHAV COGN PSYCHOTH, V36, P129, DOI 10.1017/S1352465808004141
   SCOGIN F, 1990, PROF PSYCHOL-RES PR, V21, P42, DOI 10.1037/0735-7028.21.1.42
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Stewart RE, 2012, PROF PSYCHOL-RES PR, V43, P100, DOI 10.1037/a0025694
   Strunk DR, 2010, J CONSULT CLIN PSYCH, V78, P429, DOI 10.1037/a0019631
   Titov N, 2015, J ANXIETY DISORD, V35, P88, DOI 10.1016/j.janxdis.2015.08.002
   Waller G, 2009, BEHAV RES THER, V47, P119, DOI 10.1016/j.brat.2008.10.018
NR 36
TC 1
Z9 1
U1 2
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 26
PY 2018
VL 13
IS 7
AR e0201226
DI 10.1371/journal.pone.0201226
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO4DQ
UT WOS:000439952400062
PM 30048513
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Oskrochi, G
   Bani-Mustafa, A
   Oskrochi, Y
AF Oskrochi, G.
   Bani-Mustafa, Ahmed
   Oskrochi, Y.
TI Factors affecting psychological well-being: Evidence from two nationally
   representative surveys
SO PLOS ONE
LA English
DT Article
ID LONGITUDINAL DATA; HEALTH; INCOME; MODELS; ADOLESCENCE; INEQUALITY
AB Financial status is thought to be an important determinant of psychological well-being. We investigate this relationship, and the effect of other factors, using a parametric mixed modelling approach for panel data, controlling the problem of unobservable heterogeneity.
   Two nationally representative surveys, the British Household Panel Survey (BHPS) and the Understanding Society Survey (USS), were used to construct a unified data set which measured psychological well-being and associated factors using the 12-item General Health Questionnaire (GHQ-12). The GHQ-12 score for the head of the household was used as the dependant variable and its relationship with multiple independent demographic and financial status variables was investigated. Following assessment of growth curve characteristics with linear, curvilinear and higher-order polynomial modelling; several variance covariance structures were tested to assess the error covariance structure of the longitudinal data. The random intercept and random slope were allowed to vary across participants, and methods such as natural splines and B-splines were used to improve the fit of some variables. Our final model demonstrated the most important variables affecting self-reported psychological well-being, as determined by GHQ-12, were perception and expectation of future financial situation and problems meeting household expenditure. Gender, age, marital status, number of children at home, highest qualification and job status were also significantly implicated. Unlike previous studies however we did not find that size of income was significant. These results provide further strong evidence of the impact that financial concerns have on self-reported measures of psychological well-being.
C1 [Oskrochi, G.; Bani-Mustafa, Ahmed] Amer Univ Middle East, Coll Engn, Egaila, Kuwait.
   [Oskrochi, Y.] Publ Hlth Registrar, South London, England.
RP Oskrochi, G (reprint author), Amer Univ Middle East, Coll Engn, Egaila, Kuwait.
EM Gholamreza.oskrochi@AUM.edu.kw
RI Bani-Mustafa, Ahmed/K-8552-2019; Oskrochi, Gholamreza/R-4435-2019;
   Oskrochi, Youssof/N-4158-2014; Bani-Mustafa, Ahmed/V-9297-2018
OI Oskrochi, Youssof/0000-0001-6748-0457; Bani-Mustafa,
   Ahmed/0000-0003-4083-1952
CR Adams P, 2003, J ECONOMETRICS, V112, P3, DOI 10.1016/S0304-4076(02)00145-8
   AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Brown S, 2014, J ECON PSYCHOL, V45, P197, DOI 10.1016/j.joep.2014.10.006
   Clark A., 2003, WORKING PAPER
   Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7
   Craig R, 2015, HLTH SURVEY ENGLAND
   CULYER AJ, 1993, J HEALTH ECON, V12, P431, DOI 10.1016/0167-6296(93)90004-X
   De Witte H, 1999, EUROPEAN J WORK ORG, V8, P155, DOI DOI 10.1080/135943299398302
   Deaton A, 2003, J ECON LIT, V41, P113, DOI 10.1257/002205103321544710
   Ecob R, 1999, SOC SCI MED, V48, P693, DOI 10.1016/S0277-9536(98)00385-2
   Ettner SL, 1996, J HEALTH ECON, V15, P67, DOI 10.1016/0167-6296(95)00032-1
   Faraway J, 2002, PRACTICAL REGRESSION
   Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P450, DOI 10.1136/jech.56.6.450
   Frank R, 1985, CHOOSING RIGHT POND
   Fuller E, 2017, HLTH SURVEY ENGLAND
   Goldberg D, 1988, USERS GUIDE GEN HLTH
   GROTEVANT HD, 1986, HUM DEV, V29, P82, DOI 10.1159/000273025
   Hegyi G, 2011, BEHAV ECOL SOCIOBIOL, V65, P69, DOI 10.1007/s00265-010-1036-7
   Hox J. J., 2010, MULTILEVEL ANAL TECH
   Jones AM, 2008, J HEALTH ECON, V27, P308, DOI 10.1016/j.jhealeco.2007.05.007
   Kreft IG, 2005, ARE MULTI LEVEL TECH
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Likert RA., 1952, EDUC PSYCHOL MEAS, V12, P313, DOI DOI 10.1177/001316445201200214
   MORRIS CN, 1995, J EDUC BEHAV STAT, V20, P190, DOI 10.2307/1165356
   Newman D., 2010, MULTIPLE LINEAR REGR, V36, P1
   Nomaguchi KM, 2012, SOC SCI RES, V41, P489, DOI 10.1016/j.ssresearch.2011.08.001
   Oskrochi G, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030274
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149
   Raudenbus SW, 2002, HIERARCHICAL LINEAR
   Ryan RM, 1999, PERS SOC PSYCHOL B, V25, P1509, DOI 10.1177/01461672992510007
   Schultz M., 2002, MULTIPLE LINEAR REGR, V28, P18
   Senik C, 2004, J PUBLIC ECON, V88, P2099, DOI 10.1016/S0047-2727(03)00066-5
   Shanahan L, 2007, DEV PSYCHOL, V43, P551, DOI 10.1037/0012-1649.43.3.551
   Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P42, DOI 10.1100/tsw.2011.2
   Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003
   Sverke Magnus, 2002, J Occup Health Psychol, V7, P242, DOI 10.1037/1076-8998.7.3.242
   Tabachnick B. G., 2007, USING MULTIVARIATE S
   UMBERSON D, 1989, J MARRIAGE FAM, V51, P999, DOI 10.2307/353212
   Van Stolk C, 2014, PSYCHOL WELLBEING WO
   Wilkinson R. G., 1996, UNHEALTHY SOC AFFLIC
   Wilson CM, 2005, 1619 I STUD LAB
NR 42
TC 6
Z9 6
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 13
PY 2018
VL 13
IS 6
AR e0198638
DI 10.1371/journal.pone.0198638
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ2HI
UT WOS:000435090700062
PM 29897963
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU ElHassan, NO
   Bai, S
   Gibson, N
   Holland, G
   Robbins, JM
   Kaiser, JR
AF ElHassan, Nahed O.
   Bai, Shasha
   Gibson, Neal
   Holland, Greg
   Robbins, James M.
   Kaiser, Jeffrey R.
TI The impact of prematurity and maternal socioeconomic status and
   education level on achievement-test scores up to 8th grade
SO PLOS ONE
LA English
DT Article
ID LATE-PRETERM INFANTS; LOW-BIRTH-WEIGHT; CHILDREN BORN;
   BRAIN-DEVELOPMENT; GESTATIONAL-AGE; NEURODEVELOPMENTAL OUTCOMES; SCHOOL
   PERFORMANCE; EARLY-TERM; METAANALYSIS; ASSOCIATION
AB Background
   The relative influence of prematurity vs. maternal social factors (socioeconomic status and education level) on academic performance has rarely been examined.
   Objective
   To examine the impact of prematurity and maternal social factors on academic performance from 3rd through 8th grade.
   Methods
   We conducted a retrospective cohort study of infants born in 1998 at the University of Arkansas for Medical Sciences. The study sample included 58 extremely low gestational age newborns (ELGANs, 23-<28 weeks), 171 preterm (>= 28-<34 weeks), 228 late preterm (>= 34-<37 weeks), and 967 term ((>= 37-<42 weeks) infants. Neonatal and maternal variables were collected including maternal insurance status (proxy measure for socioeconomic status) and education level. The primary outcomes were literacy and mathematics achievement-test scores from 3rd through 8th grade. Linear mixed models were used to identify significant predictors of academic performance. All two-way interactions between grade level, gestational-age (GA) groups, and social factors were tested for statistical significance.
   Results
   Prematurity, social factors, gender, race, gravidity, and Apgar score at one minute were critical determinants of academic performance. Favorable social factors were associated with a significant increase in both literacy and mathematic scores, while prematurity was associated with a significant decrease in mathematic scores. Examination of GA categories and social factors interaction suggested that the impact of social factors on test scores was similar for all GA groups. Furthermore, the impact of social factors varied from grade to grade for literacy, while the influence of either GA groups or social factors was constant across grades for mathematics. For example, an ELGAN with favorable social factors had a predicted literacy score 104.1 (P < .001), 98.2 (P < .001), and 76.4 (P < .01) points higher than an otherwise similar disadvantaged term infant at grades 3, 5, and 8, respectively. The difference in their predicted mathematic scores was 33.4 points for all grades (P < .05).
   Conclusion
   While there were significant deficits in academic performance for ELGANs compared to PT, LPT, and term infants, the deficit could be offset by higher SES and better-educated mothers. These favorable social factors were critical to a child's academic achievement. The role of socioeconomic factors should be incorporated in discussions on outcome with families of preterm infants.
C1 [ElHassan, Nahed O.] Univ Arkansas Med Sci, Dept Pediat, Div Neonatol, Little Rock, AR 72205 USA.
   [Bai, Shasha] Univ Arkansas Med Sci, Dept Pediat, Div Biostat, Little Rock, AR 72205 USA.
   [Gibson, Neal; Holland, Greg] Univ Cent Arkansas, Arkansas Res Ctr, Conway, AR USA.
   [Robbins, James M.] Univ Arkansas Med Sci, Dept Pediat, Div Child Hlth Serv Res, Little Rock, AR 72205 USA.
   [Robbins, James M.] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA.
   [Kaiser, Jeffrey R.] Milton S SHershey Med Ctr, Dept Pediat, Div Neonatol, Hershey, PA USA.
   [Kaiser, Jeffrey R.] Milton S SHershey Med Ctr, Dept Obstet & Gynecol, Hershey, PA USA.
RP ElHassan, NO (reprint author), Univ Arkansas Med Sci, Dept Pediat, Div Neonatol, Little Rock, AR 72205 USA.
EM ElhassanNahed@uams.edu
OI Elhassan, Nahed/0000-0003-0868-8420
CR Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816
   BARKER DJP, 1989, LANCET, V2, P577
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879
   Brody GH, 2017, JAMA PEDIATR, V171, P46, DOI 10.1001/jamapediatrics.2016.2988
   Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011
   Chan E, 2016, CHILD CARE HLTH DEV, V42, P297, DOI 10.1111/cch.12320
   Chyi LJ, 2008, J PEDIATR-US, V153, P25, DOI 10.1016/j.jpeds.2008.01.027
   Doyle LW, 2015, PEDIATRICS, V136, pE1513, DOI 10.1542/peds.2015-2006
   Dubow EF, 2009, MERRILL PALMER QUART, V55, P224
   Finn AS, 2014, PSYCHOL SCI, V25, P736, DOI 10.1177/0956797613516008
   Garfield CF, 2017, JAMA PEDIATR, V171, P764, DOI 10.1001/jamapediatrics.2017.1020
   Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040
   Hair NL, 2015, JAMA PEDIATR, V169, P822, DOI 10.1001/jamapediatrics.2015.1475
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Johnson SB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3075
   Kaiser JR, 2015, JAMA PEDIATR, V169, P913, DOI 10.1001/jamapediatrics.2015.1631
   Kidokoro H, 2014, PEDIATRICS, V134, pE444, DOI 10.1542/peds.2013-2336
   Kirkegaard I, 2006, PEDIATRICS, V118, P1600, DOI 10.1542/peds.2005-2700
   Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103
   Kovachy VN, 2015, DEV MED CHILD NEUROL, V57, P410, DOI 10.1111/dmcn.12652
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667
   Lawrence E, 2017, SOCIOL FORUM, V32, P635, DOI 10.1111/socf.12352
   Lipkind HS, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.007
   MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289
   Manley BJ, 2015, J PEDIATR-US, V166, P870, DOI 10.1016/j.jpeds.2014.12.016
   Martin Joyce A, 2007, Natl Vital Stat Rep, V56, P1
   Mathiasen R, 2010, PEDIATRICS, V126, pE1553, DOI 10.1542/peds.2009-0829
   Moore GP, 2013, JAMA PEDIATR, V167, P967, DOI 10.1001/jamapediatrics.2013.2395
   Morse SB, 2009, PEDIATRICS, V123, pE622, DOI 10.1542/peds.2008-1405
   Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983
   Peacock PJ, 2012, ARCH DIS CHILD, V97, P118, DOI 10.1136/adc.2011.300925
   Quigley MA, 2012, ARCH DIS CHILD-FETAL, V97, pF167, DOI 10.1136/archdischild-2011-300888
   Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018
   Ritchie SJ, 2013, PSYCHOL SCI, V24, P1301, DOI 10.1177/0956797612466268
   Simms V, 2013, ARCH DIS CHILD-FETAL, V98, pF457, DOI 10.1136/archdischild-2013-303777
   Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235
   Taylor HG, 2009, DEV DISABIL RES REV, V15, P52, DOI 10.1002/ddrr.51
   Treyvaud K, 2012, J EXP CHILD PSYCHOL, V112, P326, DOI 10.1016/j.jecp.2012.02.009
   Voyer D, 2014, PSYCHOL BULL, V140, P1174, DOI 10.1037/a0036620
   Williams BL, 2013, PEDIATRICS, V131, P693, DOI 10.1542/peds.2012-1408
   Wong HS, 2013, MATERN CHILD HLTH J, V17, P1689, DOI 10.1007/s10995-012-1183-8
NR 43
TC 0
Z9 0
U1 4
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2018
VL 13
IS 5
AR e0198083
DI 10.1371/journal.pone.0198083
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH8CD
UT WOS:000433893200028
PM 29851971
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhang, Q
   Yu, Y
   Zhang, J
   Liang, H
AF Zhang, Qi
   Yu, Yao
   Zhang, Jun
   Liang, Hua
TI Using single-index ODEs to study dynamic gene regulatory network
SO PLOS ONE
LA English
DT Article
ID VARIABLE SELECTION; BAYESIAN NETWORKS; SEMIPARAMETRIC ESTIMATION;
   REGRESSION; MODELS; MBP1; INFERENCE
AB With the development of biotechnology, high-throughput studies on protein-protein, protein- gene, and gene-gene interactions become possible and attract remarkable attention. To explore the interactions in dynamic gene regulatory networks, we propose a singleindex ordinary differential equation (ODE) model and develop a variable selection procedure. We employ the smoothly clipped absolute deviation penalty (SCAD) penalized function for variable selection. We analyze a yeast cell cycle gene expression data set to illustrate the usefulness of the single-index ODE model. In real data analysis, we group genes into functional modules using the smoothing spline clustering approach. We estimate state functions and their first derivatives for functional modules using penalized spline-based nonparametric mixed-effects models and the spline method. We substitute the estimates into the single-index ODE models, and then use the penalized profile leastsquares procedure to identify network structures among the models. The results indicate that our model fits the data better than linear ODE models and our variable selection procedure identifies the interactions that may be missed by linear ODE models but confirmed in biological studies. In addition, Monte Carlo simulation studies are used to evaluate and compare the methods.
C1 [Zhang, Qi] Qingdao Univ, Dept Stat, Qingdao, Peoples R China.
   [Yu, Yao] Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY USA.
   [Zhang, Jun] Shenzhen Univ, Inst Stat Sci, Shenzhen, Peoples R China.
   [Liang, Hua] George Washington Univ, Dept Stat, Washington, DC 20052 USA.
RP Liang, H (reprint author), George Washington Univ, Dept Stat, Washington, DC 20052 USA.
EM hliang@gwu.edu
OI Zhang, Jun/0000-0003-4332-5182
FU NSF [DMS-1418042, DMS-1620898]; National Natural Science Foundation of
   China [11529101]
FX Liang's research was partially supported by NSF grants DMS-1418042 and
   DMS-1620898, and by Award Number 11529101, made by National Natural
   Science Foundation of China. This study was supported by all these
   external funding, and there was no additional external funding received
   for this study.
CR ALTHAM PME, 1984, J ROY STAT SOC B MET, V46, P118
   Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003
   Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus
   Bouquin N, 1999, MOL BIOL CELL, V10, P3389, DOI 10.1091/mbc.10.10.3389
   Brumback BA, 1999, J AM STAT ASSOC, V94, P794, DOI 10.2307/2669991
   Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8
   D'haeseleer P, 1999, Pac Symp Biocomput, P41
   Davidian M, 1995, NONLINEAR MODELS REP
   DUAN N, 1991, ANN STAT, V19, P505, DOI 10.1214/aos/1176348109
   Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655
   Fan J., 1996, LOCAL POLYNOMIAL MOD, V66
   Fan JQ, 2010, STAT SINICA, V20, P101
   Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273
   Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961
   GU C., 2002, SPR S STAT
   HARDLE W, 1993, ANN STAT, V21, P157, DOI 10.1214/aos/1176349020
   Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004
   Heinrich R., 1996, REGULATION CELLULAR
   Horowitz JL, 1996, J AM STAT ASSOC, V91, P1632, DOI 10.2307/2291590
   Horowitz JL, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-92870-8_1
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   ICHIMURA H, 1993, J ECONOMETRICS, V58, P71, DOI 10.1016/0304-4076(93)90114-K
   KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0
   Kong EF, 2007, BIOMETRIKA, V94, P217, DOI 10.1093/biomet/asm008
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090
   Liang H, 2005, BIOMETRICAL J, V47, P358, DOI 10.1002/bimj.200310113
   Liang H, 2005, STAT SINICA, V15, P99
   Liang H, 2008, J AM STAT ASSOC, P103
   Liang H, 2010, ANN STAT, V38, P3811, DOI 10.1214/10-AOS835
   Lu T, 2011, J AM STAT ASSOC, V106, P1242, DOI 10.1198/jasa.2011.ap10194
   Luan Y, 2004, BIOINFORMATICS, V20, P332, DOI 10.1093/bioinformatics/btg413
   Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013
   Ma P, 2008, J AM STAT ASSOC, V103, P625, DOI 10.1198/016214508000000247
   Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107
   Naik PA, 2001, BIOMETRIKA, V88, P821, DOI 10.1093/biomet/88.3.821
   Nair M, 2003, BIOCHEMISTRY-US, V42, P1266, DOI 10.1021/bi0205247
   Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129
   Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071
   POWELL JL, 1989, ECONOMETRICA, V57, P1403, DOI 10.2307/1913713
   Rao Arvind, 2007, Comput Syst Bioinformatics Conf, V6, P145
   Ruppert D, 2000, AUST NZ J STAT, V42, P205, DOI 10.1111/1467-842X.00119
   Ruppert D., 2003, SEMIPARAMETRIC REGRE
   Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273
   Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231
   Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447
   Taylor IA, 2000, BIOCHEMISTRY-US, V39, P3943, DOI 10.1021/bi992212i
   THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   van Berlo RJP, 2003, SIMUL-T SOC MOD SIM, V79, P689, DOI 10.1177/003754903040942
   Wang H, 2007, BIOMETRIKA, V94, P553, DOI 10.1093/biomet/asm053
   Wang LF, 2007, BIOINFORMATICS, V23, P1486, DOI 10.1093/bioinformatics/btm125
   Wessels L F, 2001, Pac Symp Biocomput, P508
   Zhang J, 2012, ELECTRON J STAT, V6, P2235, DOI 10.1214/12-EJS744
   Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x
   Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735
   Zou H, 2009, ANN STAT, V37, P1733, DOI 10.1214/08-AOS625
NR 58
TC 0
Z9 0
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 23
PY 2018
VL 13
IS 2
AR e0192833
DI 10.1371/journal.pone.0192833
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX4LV
UT WOS:000426049500042
PM 29474376
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Laxer, RE
   Cooke, M
   Dubin, JA
   Brownson, RC
   Chaurasia, A
   Leatherdale, ST
AF Laxer, Rachel E.
   Cooke, Martin
   Dubin, Joel A.
   Brownson, Ross C.
   Chaurasia, Ashok
   Leatherdale, Scott T.
TI Behavioural patterns only predict concurrent BMI status and not BMI
   trajectories in a sample of youth in Ontario, Canada
SO PLOS ONE
LA English
DT Article
ID BODY-MASS INDEX; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; RISK-FACTORS;
   WEIGHT PERCEPTION; OVERWEIGHT; CHILDREN; ADOLESCENCE; ASSOCIATION;
   CHILDHOOD
AB Background & para;& para;Youth are engaging in multiple risky behaviours, increasing their risk of overweight, obesity, and related chronic diseases. The objective of this study was to examine the effect of engaging in unique clusters of unhealthy behaviours on youths' body mass index (BMI) trajectories.& para;& para;Methods & para;& para;This study used a linked-longitudinal sample of Grades 9 and 10 students (13 to 17 years of age) participating in the COMPASS host study. Students reported obesity-related and other risky behaviours at baseline and height and weight (to derive BMI) at baseline (2012/2013) and annually for 2 years post-baseline (2013/14 and 2014/15). Students were grouped into behavioural clusters based on response probabilities. Linear mixed effects models, using BMI as a continuous outcome measure, were used to examine the effect of engaging in clusters of risky behaviours on BMI trajectories.& para;& para;Results & para;& para;There were significant differences in BMI of the four behavioural clusters at baseline that remained consistent over time. Higher BMI values were found among youth classified at baseline to be Typical High School Athletes (beta = 0.232 2g/m(2) , [confidence interval (CI): 0.03-0.50]), Inactive High Screen-User (beta = 0.348 kg/m(2) , CI: 0.11-0.59) and Moderately Active Substance Users (beta = 0.759 kg/m(2) , CI: 0.36-1.15) compared to students classified as Health Conscious. Despite these baseline differences, BMI appeared to increase across all behavioural clusters annually by the same amount (beta = 0.6097 kg/m(2) , (CI) = 0.57-0.64).& para;& para;Conclusions & para;& para;Although annual increases in BMI did not differ by behavioural clusters, membership in a particular behavioural cluster was associated with baseline BMI, and these differences remained consistent over time. Results indicate that intervening and modifying unhealthy behaviours earlier might have a greater impact than during adolescence. Health promotion strategies targeting the highest risk youth as they enter secondary school might be promising means to prevent or delay the onset of obesity.
C1 [Laxer, Rachel E.; Cooke, Martin; Dubin, Joel A.; Chaurasia, Ashok; Leatherdale, Scott T.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.
   [Brownson, Ross C.] Washington Univ, Brown Sch, St Louis, MO USA.
   [Brownson, Ross C.] Washington Univ, Sch Med, St Louis, MO USA.
RP Laxer, RE (reprint author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.
EM rlaxer@uwaterloo.ca
FU Canadian Institutes of Health Research (CIHR) Institute of Population
   and Public Health (IPPH) [MOP-114875]; Canadian Institutes of Health
   Research (CIHR) Institute of Nutrition, Metabolism and Diabetes (INMD)
   through the "Obesity - Interventions to Prevent or Treat" [OOP-110788]
FX The COMPASS study was supported by a bridge grant from the Canadian
   Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism
   and Diabetes (INMD) through the "Obesity - Interventions to Prevent or
   Treat" priority funding awards (OOP-110788; grant awarded to S.
   Leatherdale) and an operating grant from the Canadian Institutes of
   Health Research (CIHR) Institute of Population and Public Health (IPPH)
   (MOP-114875; grant awarded to S. Leatherdale). S. Leatherdale is a
   CIHR-PHAC Chair in Applied Public Health Research.
CR Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001
   Battista K, 2017, HEALTH PROMOT CHRON, V37, P194, DOI 10.24095/hpcdp.37.6.03
   Berkey CS, 2003, INT J OBESITY, V27, P1258, DOI 10.1038/sj.ijo.0802402
   Berkey CS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e56
   Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-26
   Brault MC, 2015, PHYSIOL BEHAV, V142, P111, DOI 10.1016/j.physbeh.2015.02.001
   Burke V, 2005, INT J OBESITY, V29, P15, DOI 10.1038/sj.ijo.0802750
   Canadian Press, 2017, TORONTO STAR
   Carson V, 2015, INT J PUBLIC HEALTH, V60, P551, DOI 10.1007/s00038-015-0685-8
   Chinapaw MJ, 2011, OBESITY REV, V12
   Collins L. M., 2013, LATENT CLASS LATENT
   de Winter AF, 2016, PREV MED, V84, P76, DOI 10.1016/j.ypmed.2015.11.028
   Delva J, 2007, AM J PREV MED, V33, pS178, DOI 10.1016/j.amepre.2007.07.008
   deRuiter WK, 2014, AM J PREV MED, V47, P283, DOI 10.1016/j.amepre.2014.04.019
   Dietz WH, 2001, ANNU REV PUBL HEALTH, V22, P337, DOI 10.1146/annurev.publhealth.22.1.337
   Elgar FJ, 2005, PUBLIC HEALTH, V119, P518, DOI 10.1016/j.puhe.2004.10.011
   Field AE, 2003, INT J OBESITY, V27, P821, DOI 10.1038/sj.ijo.0802297
   Flegal KM, 2006, HEALTH EDUC RES, V21, P755, DOI 10.1093/her/cyl1128
   Fulton JE, 2009, AM J PREV MED, V37, pS40, DOI 10.1016/j.amepre.2009.04.010
   Gordon-Larsen P, 2002, OBES RES, V10, P141, DOI 10.1038/oby.2002.23
   GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406
   Haerens L, 2010, PUBLIC HEALTH NUTR, V13, P1722, DOI 10.1017/S1368980010002284
   Hayward J, 2014, INT J OBESITY, V38, P1328, DOI 10.1038/ijo.2014.78
   Henry KL, 2007, J SCHOOL HEALTH, V77, P29, DOI 10.1111/j.1746-1561.2007.00159.x
   Jauregui A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-109
   Kemper HC, 1999, INT J OBES, V23
   KUSKOWSKAWOLK A, 1989, INT J OBESITY, V13, P441
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602
   Laxer RE, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4034-0
   Leatherdale ST, 2015, CANCER CAUSE CONTROL, V26, P519, DOI 10.1007/s10552-015-0529-0
   Leatherdale ST, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-331
   Leatherdale ST, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-569
   Leatherdale ST, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-42
   Leatherdale ST, 2010, J ADOLESCENT HEALTH, V47, P315, DOI 10.1016/j.jadohealth.2010.02.012
   Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4
   Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42
   Mitchell JA, 2013, INT J OBESITY, V37, P54, DOI 10.1038/ijo.2012.41
   Moore LL, 2003, PREV MED, V37, P10, DOI 10.1016/S0091-7435(03)00048-3
   Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064
   Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926
   Nelson MC, 2009, J NUTR EDUC BEHAV, V41, P287, DOI 10.1016/j.jneb.2008.05.005
   Nonnemaker JM, 2009, OBESITY, V17, P1274, DOI 10.1038/oby.2009.5
   Pasch KE, 2012, J YOUTH ADOLESCENCE, V41, P14, DOI 10.1007/s10964-011-9706-y
   Patrick K, 2004, ARCH PEDIAT ADOL MED, V158, P385, DOI 10.1001/archpedi.158.4.385
   Patte KA, 2016, AM J HEALTH BEHAV, V40, P614, DOI 10.5993/AJHB.40.5.8
   Qian W, 2015, COMPASS TECHNICAL RE
   Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748
   Rodd C, 2016, CAN MED ASSOC J, V188, pE313, DOI 10.1503/cmaj.150854
   Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588
   Ruel E, 2010, HEALTH PLACE, V16, P191, DOI 10.1016/j.healthplace.2009.09.009
   Sallis JF, 2000, MED SCI SPORT EXER, V32, P963
   Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x
   Taylor WC, 2002, PEDIATR EXERC SCI, V14, P418
   Troiano RP, 2000, AM J CLIN NUTR, V72, p1343S, DOI 10.1093/ajcn/72.5.1343s
   van der Sluis ME, 2010, PUBLIC HEALTH NUTR, V13, P1716, DOI 10.1017/S1368980010002272
   White HR, 2006, J STUD ALCOHOL, V67, P810, DOI 10.15288/jsa.2006.67.810
NR 57
TC 1
Z9 1
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 2
PY 2018
VL 13
IS 1
AR e0190405
DI 10.1371/journal.pone.0190405
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FR5JA
UT WOS:000419101600111
PM 29293654
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kinney, MJ
   Kacev, D
   Kohin, S
   Eguchi, T
AF Kinney, Michael J.
   Kacev, David
   Kohin, Suzanne
   Eguchi, Tomoharu
TI An analytical approach to sparse telemetry data
SO PLOS ONE
LA English
DT Article
ID SOUTHERN CALIFORNIA BIGHT; STATE-SPACE MODELS; MOVEMENT PATTERNS; ANIMAL
   MOVEMENT; ALOPIAS-VULPINUS; ECOLOGY; HABITAT; TURTLES; OCEAN; MIGRATION
AB Horizontal behavior of highly migratory marine species is difficult to decipher because animals are wide-ranging, spend minimal time at the ocean surface, and utilize remote habitats. Satellite telemetry enables researchers to track individual movements, but population level inferences are rare due to data limitations that result from difficulty of capture and sporadic tag reporting. We introduce a Bayesian modeling framework to address population level questions with satellite telemetry data when data are sparse. We also outline an approach for identifying informative variables for use within the model. We tested our modeling approach using a large telemetry dataset for Shortfin Makos (Isurus oxyrinchus), which allowed us to assess the effects of various degrees of data paucity. First, a permuted Random Forest analysis is implemented to determine which variables are most informative. Next, a generalized additive mixed model is used to help define the relationship of each remaining variable with the response variable. Using jags and rjags for the analysis of Bayesian hierarchical models using Markov Chain Monte Carlo simulation, we then developed a movement model to generate parameter estimates for each of the variables of interest. By randomly reducing the tagging dataset by 25, 50, 75, and 90 percent and recalculating the parameter estimates, we demonstrate that the proposed Bayesian approach can be applied in data-limited situations. We also demonstrate how two commonly used linear mixed models with maximum likelihood estimation (MLE) can be similarly applied. Additionally, we simulate data from known parameter values to test each model's ability to recapture those values. Despite performing similarly, we advocate using the Bayesian over the MLE approach due to the ability for later studies to easily utilize results of past study to inform working models, and the ability to use prior knowledge via informed priors in systems where such information is available.
C1 [Kinney, Michael J.; Kacev, David] NOAA, Ocean Associates, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, San Diego, CA 92127 USA.
   [Kohin, Suzanne; Eguchi, Tomoharu] NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, San Diego, CA USA.
RP Kinney, MJ (reprint author), NOAA, Ocean Associates, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, San Diego, CA 92127 USA.
EM michael.kinney@noaa.gov
RI Kinney, Mike/Q-3787-2019
OI Kinney, Mike/0000-0001-7846-8349
CR Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x
   Allen CD, 2013, MAR ECOL PROG SER, V472, P275, DOI 10.3354/meps10023
   Bates D, 2015, J STAT SOFTW, V67, P1
   Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082
   Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Breiman L, 2002, MANUAL SETTING USING
   Carlin B., 1997, STAT COMPUT, V7, P153, DOI DOI 10.1023/A:1018577817064
   Cartamil D, 2010, MAR FRESHWATER RES, V61, P596, DOI 10.1071/MF09153
   Cartamil D, 2010, MAR ECOL PROG SER, V404, P249, DOI 10.3354/meps08495
   Cartamil DP, 2011, MAR BIOL, V158, P935, DOI 10.1007/s00227-010-1620-4
   Clark J. S., 2007, MODELS ECOLOGICAL DA
   Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x
   Clegg SM, 2003, MOL ECOL, V12, P819, DOI 10.1046/j.1365-294X.2003.01757.x
   De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x
   Delgado-Baquerizo M, 2016, NATURE COMMUNICATION, P7
   Eguchi T, 2016, FISH OCEANOGR
   Eguchi T, 2009, ECOL MODEL, V220, P1620, DOI 10.1016/j.ecolmodel.2009.04.011
   Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x
   Gelman A, 2007, DATA ANAL USING REGR
   Gelman A., 2014, BAYESIAN DATA ANAL
   Gillespie TW, 2001, PROG PHYS GEOG, V25, P355, DOI 10.1177/030913330102500303
   Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012
   Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091
   Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642
   Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394
   Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013
   JONES K, 1992, T I BRIT GEOGR, V17, P434, DOI 10.2307/622709
   Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008
   Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x
   Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852
   Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670
   Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1
   Klueter A, 2015, METABOLITES, V5, P74, DOI 10.3390/metabo5010074
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680
   Luo JG, 2006, FISH OCEANOGR, V15, P208, DOI 10.1111/j.1365-2419.2006.00360.x
   Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x
   McClintock BT, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1751
   McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697
   Menard F, 2007, MAR BIOL, V153, P141, DOI 10.1007/s00227-007-0789-7
   Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105
   Nelson ME, 2004, J MAMMAL, V85, P505, DOI 10.1644/BOS-120
   Nielsen J. L., 2009, TAGGING TRACKING MAR
   Papastamatiou YP, 2012, J FISH BIOL, V80, P1342, DOI 10.1111/j.1095-8649.2012.03232.x
   Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009
   Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281
   Plummer M., R PACKAGE VERSION 4
   R Core Team, 2015, R LANG ENV STAT COMP
   Ripley B, PACKAGE MASS
   Rooney SM, 1998, MAMMAL REV, V28, P89, DOI 10.1046/j.1365-2907.1998.00028.x
   Runcie R, 2016, FISH RES, V183, P233, DOI 10.1016/j.fishres.2016.06.010
   Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x
   Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066
   Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403
   Sibert JR, 2001, ELECT TAGGING TRACKI
   STRENIO JF, 1983, BIOMETRICS, V39, P71, DOI 10.2307/2530808
   Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25
   Sundstrom LF, 2001, ENVIRON BIOL FISH, V60, P225, DOI 10.1023/A:1007657505099
   Teo S, 2016, NOAATMNMFSSWFSC557
   Thomas DL, 2006, J WILDLIFE MANAGE, V70, P404, DOI 10.2193/0022-541X(2006)70[404:ABREDM]2.0.CO;2
   Udyawer V, 2016, MAR ECOL PROG SER, V546, P249, DOI 10.3354/meps11632
   Venables W. N, 2002, MODERN APPL STAT S
   Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x
   Wakefield ED, 2009, MAR ECOL PROG SER, V391, P165, DOI 10.3354/meps08203
   Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x
   Wood S, 2015, PACKAGE GAMM4
NR 67
TC 0
Z9 0
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 28
PY 2017
VL 12
IS 11
AR e0188660
DI 10.1371/journal.pone.0188660
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FN9ZL
UT WOS:000416402000048
PM 29182675
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Silveira, LJ
   Strand, M
   Van Dyke, MV
   Mroz, MM
   Faino, AV
   Dabelea, DM
   Maier, LA
   Fingerlin, TE
AF Silveira, Lori J.
   Strand, Matthew
   Van Dyke, Michael V.
   Mroz, Margaret M.
   Faino, Anna V.
   Dabelea, Dana M.
   Maier, Lisa A.
   Fingerlin, Tasha E.
TI Clinical tool for disease phenotyping in granulomatous lung disease
SO PLOS ONE
LA English
DT Article
ID CHRONIC BERYLLIUM DISEASE; CYSTIC-FIBROSIS; SEVERITY; HLA-DPB1; RISK;
   SENSITIZATION; POLYMORPHISMS; EXPOSURE; WORKERS
AB Background
   Exposure to beryllium may lead to granuloma formation and fibrosis in those who develop chronic beryllium disease (CBD). Although disease presentation varies from mild to severe, little is known about CBD phenotypes. This study characterized CBD disease phenotypes using longitudinal measures of lung function.
   Methods
   Using a case-only study of 207 CBD subjects, subject-specific trajectories over time were estimated from longitudinal pulmonary function and exercise-tolerance tests. To estimate linear combinations of the 30-year values that define underlying patterns of lung function, we conducted factor analysis. Cluster analysis was then performed on all the predicted lung function values at 30 years. These estimates were used to identify underlying features and subgroups of CBD.
   Results
   Two factors, or composite measures, explained nearly 70% of the co-variation among the tests; one factor represented pulmonary function in addition to oxygen consumption and workload during exercise, while the second factor represented exercise tests related to gas exchange. Factors were associated with granulomas on biopsy, exposure, steroid use and lung inflammation. Three clusters of patients (n = 53, n = 59 and, n = 95) were identified based on the collection of test values. Lower levels of each of the factor composite scores and cluster membership were associated with baseline characteristics of patients.
   Conclusions
   Using factor analysis and cluster analysis, we identified disease phenotypes that were associated with baseline patient characteristics, suggesting that CBD is a heterogeneous disease with varying severity. These clinical tools may be used in future basic and clinical studies to help define the mechanisms and risk factors for disease severity.
C1 [Silveira, Lori J.; Strand, Matthew; Faino, Anna V.] Natl Jewish Hlth, Div Biostat & Informat, Denver, CO USA.
   [Silveira, Lori J.; Strand, Matthew; Dabelea, Dana M.; Maier, Lisa A.; Fingerlin, Tasha E.] Univ Colorado, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Van Dyke, Michael V.] Colorado Dept Publ Hlth & Environm, Denver, CO USA.
   [Mroz, Margaret M.; Maier, Lisa A.] Natl Jewish Hlth, Div Environm & Occupat Hlth, Denver, CO USA.
   [Maier, Lisa A.; Fingerlin, Tasha E.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Fingerlin, Tasha E.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA.
RP Fingerlin, TE (reprint author), Univ Colorado, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA.; Fingerlin, TE (reprint author), Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Fingerlin, TE (reprint author), Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA.
EM mrozp@njhealth.org; maieril@njhealth.org; fingerlint@njhealth.org
OI Strand, Matthew/0000-0002-9083-5989
FU National Institute of Environmental Health Sciences [P01 ES11810-A1];
   Colorado Clinical and Translational Sciences Institute; National
   Institutes of Health/National Center for Advancing Translational
   Sciences [UL1 TR000154]
FX This work was supported by National Institute of Environmental Health
   Sciences Grant number P01 ES11810-A1 (to LAM) and by the Colorado
   Clinical and Translational Sciences Institute, which was supported in
   part by National Institutes of Health/National Center for Advancing
   Translational Sciences Grant number UL1 TR000154 to the Colorado
   Clinical and Translational Science Award program. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR [Anonymous], 2009, SASSTAT 9 2 USER S G
   Deubner D, 2001, Appl Occup Environ Hyg, V16, P579
   Kumar M, 2007, COMPUT STAT DATA AN, V51, P6084, DOI 10.1016/j.csda.2006.12.012
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Mack DG, 2010, AM J RESP CRIT CARE, V181, P1241, DOI 10.1164/rccm.201001-0025OC
   Maier LA, 1999, AM J RESP CRIT CARE, V159, P1342, DOI 10.1164/ajrccm.159.4.9806106
   McCanlies EC, 2003, AM J EPIDEMIOL, V157, P388, DOI 10.1093/aje/kwg001
   McCarthy C, 2013, CHEST, V143, P1358, DOI 10.1378/chest.12-2022
   Mroz MM, 2009, AM J IND MED, V52, P762, DOI 10.1002/ajim.20736
   NEWMAN LS, 1994, AM J RESP CRIT CARE, V150, P135, DOI 10.1164/ajrccm.150.1.8025739
   NEWMAN LS, 1992, AM REV RESPIR DIS, V146, P39, DOI 10.1164/ajrccm/146.1.39
   Osborne J. W., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI DOI 10.4135/9781412995627.D8
   Palmer BE, 2007, J ALLERGY CLIN IMMUN, V120, P184, DOI 10.1016/j.jaci.2007.03.009
   PAPPAS GP, 1993, AM REV RESPIR DIS, V148, P661, DOI 10.1164/ajrccm/148.3.661
   RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536
   Rodrigues EG, 2008, AM J IND MED, V51, P512, DOI 10.1002/ajim.20585
   Rossman MD, 2009, AM J RESP CRIT CARE, V179, P173, DOI 10.1164/ajrccm.179.2.173a
   Rummel R., UNDERSTANDING FACTOR
   Sarcoidosis, 2011, MED CLIN N AM
   Sato H, 2010, EUR RESPIR J, V36, P331, DOI 10.1183/09031936.00107809
   Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC
   Schuler CR, 2012, SCAND J WORK ENV HEA, V38, P270, DOI 10.5271/sjweh.3192
   Silveira LJ, 2012, J IMMUNOL, V189, P4014, DOI 10.4049/jimmunol.1200798
   Tinkle SS, 2003, SEMIN RESP CRIT CARE, V24, P169, DOI 10.1055/s-2003-39016
   Van Dyke MV, 2011, OCCUP ENVIRON MED, V68, P842, DOI 10.1136/oem.2010.064220
   Van Dyke MV, 2011, AM J RESP CRIT CARE, V183, P1680, DOI 10.1164/rccm.201002-0254OC
   Wasfi YS, 2006, CHEST, V129, P1234, DOI 10.1378/chest.129.5.1234
NR 27
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 16
PY 2017
VL 12
IS 11
AR e0188119
DI 10.1371/journal.pone.0188119
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM8YO
UT WOS:000415378800067
PM 29145499
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tonoyan, Y
   Chanwimalueang, T
   Mandic, DP
   Van Hulle, MM
AF Tonoyan, Yelena
   Chanwimalueang, Theerasak
   Mandic, Danilo P.
   Van Hulle, Marc M.
TI Discrimination of emotional states from scalp- and intracranial EEG
   using multiscale Renyi entropy
SO PLOS ONE
LA English
DT Article
ID ELECTRICAL-STIMULATION; TEMPORAL DYNAMICS; RESPONSES; AMYGDALA;
   COMPLEXITY; ERP; IDENTIFICATION; NONLINEARITY; RECOGNITION; THETA
AB A data-adaptive, multiscale version of Renyi's quadratic entropy (RQE) is introduced for emotional state discrimination from EEG recordings. The algorithm is applied to scalp EEG recordings of 30 participants watching 4 emotionally-charged video clips taken from a validated public database. Krippendorffs inter-rater statistic reveals that multiscale RQE of the mid-frontal scalp electrodes best discriminates between five emotional states. Multiscale RQE is also applied to joint scalp EEG, amygdala- and occipital pole intracranial recordings of an implanted patient watching a neutral and an emotionally charged video clip. Unlike for the neutral video clip, the RQEs of the mid-frontal scalp electrodes and the amygdala-implanted electrodes are observed to coincide in the time range where the crux of the emotionally-charged video clip is revealed. In addition, also during this time range, phase synchrony between the amygdala and mid-frontal recordings is maximal, as well as our 30 participants inter-rater agreement on the same video clip. A source reconstruction exercise using intracranial recordings supports our assertion that amygdala could contribute to mid-frontal scalp EEG. On the contrary, no such contribution was observed for the occipital poles intracranial recordings. Our results suggest that emotional states discriminated from mid-frontal scalp EEG are likely to be mirrored by differences in amygdala activations in particular when recorded in response to emotionally-charged scenes.
C1 [Tonoyan, Yelena; Van Hulle, Marc M.] Res Grp Neurophysiol, Lab Neuro & Psychophysiol, Leuven, Belgium.
   [Chanwimalueang, Theerasak; Mandic, Danilo P.] Imperial Coll London, Dept Elect & Elect Engn, Commun & Signal Proc Res Grp, London, England.
RP Tonoyan, Y (reprint author), Res Grp Neurophysiol, Lab Neuro & Psychophysiol, Leuven, Belgium.
EM elenatonoyan@gmail.com
FU Interuniversity Attraction Poles Programme Belgian Science Policy [IUAP
   P7/11]; KU Leuven [PFV/10/008, IDO/12/007, IOF/HB/12/021]; Belgian Fund
   for Scientific Research Flanders [G088314N, G0A0914N]; Flemish Regional
   Ministry of Education (Belgium) [GOA 10/019]; Hercules Foundation [AKUL
   043]; EPSRC [EP/K025643/1]
FX YT is supported by the Interuniversity Attraction Poles Programme
   Belgian Science Policy (IUAP P7/11). MMVH is supported by research
   grants received from the Financing program (PFV/10/008), an
   interdisciplinary research project (IDO/12/007), and an industrial
   research fund project (IOF/HB/12/021) of the KU Leuven, the Belgian Fund
   for Scientific Research Flanders (G088314N, G0A0914N), the
   Interuniversity Attraction Poles Programme Belgian Science Policy (IUAP
   P7/11), the Flemish Regional Ministry of Education (Belgium) (GOA
   10/019), and the Hercules Foundation (AKUL 043). DM is supported by an
   EPSRC grant (EP/K025643/1).; The authors are grateful to Prof. Alexandre
   Schaefer (School of Business, Monash University, Victoria, Malaysia) for
   his valuable input to the interpretation of the video clip data and to
   Prof. Alfred Meurs, Dr. Evelien Carrette, and Prof. Paul Boon (Neurology
   Department, Ghent University Hospital), Prof. Dirk Van Roost (Department
   of Neurosurgery, Ghent University Hospital) for their assistance in the
   ECoG experiment and Mansoureh Fahimi Hnazaee (Laboratory of Neuro- and
   Psychophysiology, KU Leuven) for performing the source reconstruction
   analysis. YT is supported by the Interuniversity Attraction Poles
   Programme Belgian Science Policy (IUAP P7/11). MMVH is supported by
   research grants received from the Financing program (PFV/10/008), an
   interdisciplinary research project (IDO/12/007), and an industrial
   research fund project (IOF/HB/12/021) of the KU Leuven, the Belgian Fund
   for Scientific Research-Flanders (G088314N, G0A0914N), the
   Interuniversity Attraction Poles Programme-Belgian Science Policy (IUAP
   P7/11), the Flemish Regional Ministry of Education (Belgium) (GOA
   10/019), and the Hercules Foundation (AKUL 043).Part of the reported
   work was done while MVH was a Visiting Academic at Imperial College
   London. DM is supported by an EPSRC grant (EP/K025643/1).
CR Aftanas LI, 1998, INT J PSYCHOPHYSIOL, V28, P63, DOI 10.1016/S0167-8760(97)00067-6
   Aggleton J. P., 1986, EMOTION THEORY RES E, V3, P281
   Ahmed MU, 2012, B POL ACAD SCI-TECH, V60, P433, DOI 10.2478/v10175-012-0055-0
   Arefian N. M., 2009, TANAFFOS - Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, V8, P46
   Bajaj V, 2015, INTEL SYST REF LIBR, V74, P215, DOI 10.1007/978-3-319-10978-7_8
   Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004
   Bartolic EI, 1999, NEUROPSYCHOLOGIA, V37, P677, DOI 10.1016/S0028-3932(98)00123-7
   Bekkedal MYV, 2011, NEUROSCI BIOBEHAV R, V35, P1959, DOI 10.1016/j.neubiorev.2011.05.001
   Choppin A., 2000, THESIS
   Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008
   Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906
   Croft RJ, 2005, PSYCHOPHYSIOLOGY, V42, P16, DOI 10.1111/j.1469-8986.2005.00264.x
   Daly I, 2014, NEUROSCI LETT, V573, P52, DOI 10.1016/j.neulet.2014.05.003
   DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T
   FISH DR, 1993, BRAIN, V116, P397, DOI 10.1093/brain/116.2.397
   Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3
   Gautama T, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL VI, PROCEEDINGS, P29
   Gautama T, 2003, IEEE T MED IMAGING, V22, P636, DOI 10.1109/TMI.2003.812248
   Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4
   Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45
   Guillory SA, 2014, SOC COGN AFFECT NEUR
   HALGREN E, 1978, BRAIN, V101, P83, DOI 10.1093/brain/101.1.83
   Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664
   Holt DJ, 2006, SCHIZOPHR RES, V82, P153, DOI 10.1016/j.schres.2005.09.021
   Hosseini S. A., 2011, INT J IMAGE GRAPH SI, V3, p[30, 30], DOI [10.5815/ijigsp.2011.05.05, DOI 10.5815/IJIGSP.2011.05.05]
   Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193
   Jausovec N, 2001, NEUROSCI LETT, V311, P93, DOI 10.1016/S0304-3940(01)02141-3
   Jessen S, 2011, NEUROIMAGE, V58, P665, DOI 10.1016/j.neuroimage.2011.06.035
   Jie X, 2014, BIO-MED MATER ENG, V24, P1185, DOI 10.3233/BME-130919
   JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779
   Kantz H., 2004, NONLINEAR TIME SERIE, V7
   Kostyunina M B, 1996, Neurosci Behav Physiol, V26, P340, DOI 10.1007/BF02359037
   Krolak-Salmon P, NEURON
   Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lanteaume L, 2007, CEREB CORTEX, V17, P1307, DOI 10.1093/cercor/bhl041
   Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008
   Meletti S, 2006, EPILEPSIA, V47, P47, DOI 10.1111/j.1528-1167.2006.00877.x
   Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161
   Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.05005742102
   Nijholt A, 2009, LECT NOTES COMPUTER, V2008, P225
   Nunez PL, 1995, NEOCORTICAL DYNAMICS
   Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010
   Oya H, 2002, J NEUROSCI, V22, P9502
   Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5
   Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005
   Pourtois G, 2010, COGN AFFECT BEHAV NE, V10, P83, DOI 10.3758/CABN.10.1.83
   Principe JC, 2010, INFORM SCI STAT, P1, DOI 10.1007/978-1-4419-1570-2
   Rehman N, 2010, P ROY SOC A-MATH PHY, V466, P1291, DOI 10.1098/rspa.2009.0502
   Renyi A, 1961, P 4 BERK S MATH STAT, V1, P547, DOI DOI 10.1021/JP106846B
   Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039
   Sato W, 2011, NEUROPSYCHOLOGIA, V49, P612, DOI 10.1016/j.neuropsychologia.2010.12.025
   Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322
   Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635
   Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002
   Sharma R, 2015, ENTROPY-SWITZ, V17, P669, DOI 10.3390/e17020669
   Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3
   Shemyakina N. V., 2004, Fiziologiya Cheloveka, V30, P22
   Soleymani M, 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), P803, DOI 10.1109/FG.2011.5771352
   Sourina O, 2011, BIOSIGNALS 2011, P82
   Spreckelmeyer KN, 2009, BRAIN COGNITION, V69, P121, DOI 10.1016/j.bandc.2008.06.003
   Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041
   STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349
   Tonoyan Y, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S0129065716500052
   VANRIJN AC, 1991, MED BIOL ENG COMPUT, V29, P433, DOI 10.1007/BF02441666
   Vecchiato G, 2010, BRAIN TOPOGR, V23, P165, DOI 10.1007/s10548-009-0127-0
   Verbeke G, 2009, SPRINGER SER STAT, P1
   Wang XW, 2014, NEUROCOMPUTING, V129, P94, DOI 10.1016/j.neucom.2013.06.046
   Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188
NR 69
TC 3
Z9 3
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 3
PY 2017
VL 12
IS 11
AR e0186916
DI 10.1371/journal.pone.0186916
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL6TA
UT WOS:000414377900011
PM 29099846
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rose, S
   Bennuri, SC
   Murray, KF
   Buie, T
   Winter, H
   Frye, RE
AF Rose, Shannon
   Bennuri, Sirish C.
   Murray, Katherine F.
   Buie, Timothy
   Winter, Harland
   Frye, Richard Eugene
TI Mitochondrial dysfunction in the gastrointestinal mucosa of children
   with autism: A blinded case-control study
SO PLOS ONE
LA English
DT Article
ID ADOLESCENT RATS RELEVANCE; CHAIN FATTY-ACIDS; PROPIONIC-ACID; SPECTRUM
   DISORDERS; OXIDATIVE STRESS; PHYSIOLOGICAL ABNORMALITIES;
   SOCIAL-BEHAVIOR; MICROBIOTA; THERAPY; MICROFLORA
AB Gastrointestinal (GI) symptoms are prevalent in autism spectrum disorder (ASD) but the pathophysiology is poorly understood. Imbalances in the enteric microbiome have been associated with ASD and can cause GI dysfunction potentially through disruption of mitochondrial function as microbiome metabolites modulate mitochondrial function and mitochondrial dysfunction is highly associated with GI symptoms. In this study, we compared mitochondrial function in rectal and cecum biopsies under the assumption that certain microbiome metabolites, such as butyrate and propionic acid, are more abundant in the cecum as compared to the rectum. Rectal and cecum mucosal biopsies were collected during elective diagnostic colonoscopy. Using a single-blind case-control design, complex I and IV and citrate synthase activities and complex I-V protein quantity from 10 children with ASD, 10 children with Crohn's disease and 10 neurotypical children with nonspecific GI complaints were measured. The protein for all complexes, except complex II, in the cecum as compared to the rectum was significantly higher in ASD samples as compared to other groups. For both rectal and cecum biopsies, ASD samples demonstrated higher complex I activity, but not complex IV or citrate synthase activity, compared to other groups. Mitochondrial function in the gut mucosa from children with ASD was found to be significantly different than other groups who manifested similar GI symptomatology suggesting a unique pathophysiology for GI symptoms in children with ASD. Abnormalities localized to the cecum suggest a role for imbalances in the microbiome, potentially in the production of butyrate, in children with ASD.
C1 [Rose, Shannon; Bennuri, Sirish C.; Frye, Richard Eugene] Arkansas Childrens Res Inst, Autism Res Program, Little Rock, AR 72202 USA.
   [Murray, Katherine F.; Winter, Harland] MassGen Hosp Children, Dept Pediat Gastroenterol & Nutr, Boston, MA USA.
   [Buie, Timothy] Boston Childrens Hosp, Dept Gastroenterol, Boston, MA USA.
RP Frye, RE (reprint author), Arkansas Childrens Res Inst, Autism Res Program, Little Rock, AR 72202 USA.
EM REFrye@uams.edu
OI Frye, Richard/0000-0003-4442-2937
FU Arkansas Biosciences Institute (Little Rock, AR); Autism Research
   Institute
FX This research was supported by the Arkansas Biosciences Institute
   (Little Rock, AR) to REF, Autism Research Institute to HW, and
   philanthropic support from Martin Schlaff (HW). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams JB, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-111
   Alvarez B, 2008, J CELL PHYSIOL, V214, P474, DOI 10.1002/jcp.21215
   Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094
   Angelidou A, 2011, J AUTISM DEV DISORD, V41, P1579, DOI 10.1007/s10803-010-1171-z
   APA, 1994, DIAGN STAT MAN MENT
   Bhardwaj J, 2012, J PEDIATR GASTR NUTR, V55, P194, DOI 10.1097/MPG.0b013e3182514805
   Bresnahan M, 2015, JAMA PSYCHIAT, V72, P466, DOI 10.1001/jamapsychiatry.2014.3034
   Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338
   Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C
   Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D
   Chaidez V, 2014, J AUTISM DEV DISORD, V44, P1117, DOI 10.1007/s10803-013-1973-x
   Cybulsky AV, 2009, AM J PHYSIOL-RENAL, V297, pF971, DOI 10.1152/ajprenal.00294.2009
   De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993
   Delhey LM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6020018
   Dharmasena MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163511
   Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018
   Douglas-Escobar M, 2013, JAMA PEDIATR, V167, P374, DOI 10.1001/jamapediatrics.2013.497
   Farup PG, 2016, BMC GASTROENTEROL, P16
   Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914
   Finegold SM, 2008, MED HYPOTHESES, V70, P508, DOI 10.1016/j.mehy.2007.07.019
   Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018
   Foley KA, 2015, BEHAV BRAIN RES, V278, P244, DOI 10.1016/j.bbr.2014.09.032
   Franklin A.E., 2008, AM J BIOCH BIOTECHNO, V4, P146, DOI DOI 10.3844/AJBBSP.2008.146.166
   Frye R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.189
   Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.51
   Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143
   FRYE RE, 2015, MICROB ECOL HEALTH D, V26
   Frye RE, 2012, N AM J MED SCI, V5, P141, DOI DOI 10.7156/V5I3P141
   Frye RE, 2015, MICROBIAL ECOLOGY HL
   Frye RE, 2016, CLIN MED INSIGHTS-PE, V10, P43, DOI 10.4137/CMPed.S38337
   Frye Richard E, 2013, Front Public Health, V1, P31, DOI 10.3389/fpubh.2013.00031
   Frye RE, 2014, BIOMARK MED, V8, P321, DOI 10.2217/bmm.13.158
   Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530
   Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507
   Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b
   Gorrindo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068444
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Hornig M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003140
   Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024
   Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001
   Kang DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0225-7
   Kesli Recep, 2014, J Immunoassay Immunochem, V35, P101, DOI 10.1080/15321819.2013.792834
   Kim JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104927
   Knight DJW, 2003, LANCET, V361, P1831, DOI 10.1016/S0140-6736(03)12489-0
   Kratsman N, 2016, NEUROPHARMACOLOGY, V102, P136, DOI 10.1016/j.neuropharm.2015.11.003
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Macfabe Derrick, 2013, Glob Adv Health Med, V2, P52, DOI 10.7453/gahmj.2013.089
   MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025
   MacFabe Derrick F., 2012, Microbial Ecology in Health and Disease, V23, P19260, DOI 10.3402/mehd.v23i0.19260
   MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005
   MACFABE DF, 2015, MICROB ECOL HEALTH D, V26
   Metzler-Zebeli BU, 2012, J NUTR, V142, P668, DOI 10.3945/jn.111.153007
   Nankova BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103740
   Nissenkorn A, 1999, ARCH DIS CHILD, V81, P209, DOI 10.1136/adc.81.3.209
   Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63
   Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44
   Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0
   Richler J, 2006, J AUTISM DEV DISORD, V36, P299, DOI 10.1007/s10803-005-0070-1
   Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979
   Rose S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.15
   Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61
   Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Saba H, 2008, RENAL FAILURE, V30, P125, DOI 10.1080/08860220701813327
   Sajdel-Sulkowska EM, 2011, CEREBELLUM, V10, P43, DOI 10.1007/s12311-010-0223-4
   Sajdel-Sulkowska EM, 2009, CEREBELLUM, V8, P366, DOI 10.1007/s12311-009-0105-9
   Slattery J, 2016, CURR PHARM DESIGN, V22, P6107, DOI 10.2174/1381612822666160905123953
   Slattery J, 2016, CLIN MED INSIGHTS-PE, V10, P91, DOI [10.4137/cmped.s38338, 10.4137/CMPed.S38338]
   Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Sukhodolsky DG, 2013, PEDIATRICS, V132, pE1341, DOI 10.1542/peds.2013-1193
   Takuma K, 2014, PHARMACOL BIOCHEM BE, V126, P43, DOI 10.1016/j.pbb.2014.08.013
   Taurines R, 2012, ADHD-ATTEND DEFICIT, V4, P115, DOI 10.1007/s12402-012-0086-2
   Thomas RH, 2010, J NEUROCHEM, V113, P515, DOI 10.1111/j.1471-4159.2010.06614.x
   Valeur J, 2010, CLIN EXP GASTROENTER, V3, P65
   Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585
   Wingate M, 2014, MMWR SURVEILL SUMM, V63
   Yang S, 2016, FASEB J, V30
NR 79
TC 10
Z9 11
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 13
PY 2017
VL 12
IS 10
AR e0186377
DI 10.1371/journal.pone.0186377
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FJ7ZQ
UT WOS:000412980300031
PM 29028817
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yamao, S
   Matsumoto, C
   Nomoto, H
   Numata, T
   Eura, M
   Yamashita, M
   Hashimoto, S
   Okuyama, S
   Kimura, S
   Yamanaka, K
   Chiba, Y
   Aihara, M
   Shimomura, Y
AF Yamao, Sayaka
   Matsumoto, Chota
   Nomoto, Hiroki
   Numata, Takuya
   Eura, Mariko
   Yamashita, Marika
   Hashimoto, Shigeki
   Okuyama, Sachiko
   Kimura, Shinji
   Yamanaka, Kenzo
   Chiba, Yasutaka
   Aihara, Makoto
   Shimomura, Yoshikazu
TI Effects of head tilt on visual field testing with a head-mounted
   perimeter imo
SO PLOS ONE
LA English
DT Article
ID STATIC OCULAR COUNTERROLL; ROLL; TORSION; HUMANS
AB Purpose A newly developed head-mounted perimeter termed imo enables visual field (VF) testing without a fixed head position. Because the positional relationship between the subject's head and the imo is fixed, the effects of head position changes on the test results are small compared with those obtained using a stationary perimeter. However, only ocular counterroll (OCR) induced by head tilt might affect VF testing. To quantitatively reveal the effects of head tilt and OCR on the VF test results, we investigated the associations among the headtilt angle, OCR amplitude and VF testing results.
   Subjects and methods For 20 healthy subjects, we binocularly recorded static OCR (s-OCR) while tilting the subject's head at an arbitrary angle ranging from 0 degrees to 60 degrees rightward or leftward in 10 E increments. By monitoring iris patterns, we evaluated the s-OCR amplitude. We also performed blind spot detection while tilting the subject's head by an arbitrary angle ranging from 0 degrees to 50 degrees rightward or leftward in 10 E increments to calculate the angle by which the blind spot rotates because of head tilt.
   Results The association between s-OCR amplitude and head-tilt angle showed a sinusoidal relationship. In blind spot detection, the blind spot rotated to the opposite direction of the head tilt, and the association between the rotation angle of the blind spot and the head-tilt angle also showed a sinusoidal relationship. The rotation angle of the blind spot was strongly correlated with the s-OCR amplitude (R-2 >= 0.94, p< 0.0001). A head tilt greater than 20 degrees with imo causes interference between adjacent test areas.
   Conclusions Both the s-OCR amplitude and the rotation angle of the blind spot were correlated with the head-tilt angle by sinusoidal regression. The rotated VF was correlated with the s-OCR amplitude. During perimetry using imo, the change in the subject's head tilt should be limited to 20 degrees.
C1 [Yamao, Sayaka; Matsumoto, Chota; Nomoto, Hiroki; Numata, Takuya; Eura, Mariko; Yamashita, Marika; Hashimoto, Shigeki; Okuyama, Sachiko; Shimomura, Yoshikazu] Kindai Univ, Fac Med, Dept Ophthalmol, Osaka, Japan.
   [Kimura, Shinji; Yamanaka, Kenzo] CREWT Med Syst Inc, Tokyo, Japan.
   [Chiba, Yasutaka] Kindai Univ Hosp, Clin Res Ctr, Osaka, Japan.
   [Aihara, Makoto] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.
   [Aihara, Makoto] Univ Tokyo, Fac Med, Tokyo, Japan.
RP Yamao, S (reprint author), Kindai Univ, Fac Med, Dept Ophthalmol, Osaka, Japan.
EM s-shimada@med.kindai.ac.jp
FU CREWT Medical Systems, Inc.
FX YS and CM received funding from CREWT Medical Systems, Inc. The funder
   had a role in providing the device. Co-authors SK and KY are employed by
   CREWT Medical Systems, Inc.
CR Bockisch CJ, 2001, VISION RES, V41, P2127, DOI 10.1016/S0042-6989(01)00094-3
   Diamond S G, 1989, Acta Otolaryngol Suppl, V468, P267
   DIAMOND SG, 1979, ACTA OTO-LARYNGOL, V87, P490, DOI 10.3109/00016487909126457
   Goltz HC, 2009, VISION RES, V49, P1848, DOI 10.1016/j.visres.2009.04.021
   Groen E, 1999, J VESTIBUL RES-EQUIL, V9, P27
   Hamasaki I, 2005, JPN J OPHTHALMOL, V49, P497, DOI 10.1007/s10384-005-0254-4
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Matsumoto C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161974
   Ohtsuki H, 2009, JPN ORTHOPTIC J, V38, P35
   Ooi D, 2004, VISION RES, V44, P2825, DOI 10.1016/j.visres.2004.06.014
   Otero-Millan Jorge, ACTA OTOLARYNGOL
   Pansell T, 2005, STRABISMUS, V13, P115, DOI 10.1080/09273970500216408
   Schmid-Priscoveanu A, 2000, EXP BRAIN RES, V134, P212
   Schworm HD, 2002, INVEST OPHTH VIS SCI, V43, P662
   Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035
   Tarnutzer AA, 2009, EXP BRAIN RES, V195, P621, DOI 10.1007/s00221-009-1823-4
   Yagi T, 2005, EQUILIBRIUM RES, V64, P258
NR 17
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 25
PY 2017
VL 12
IS 9
AR 0185240
DI 10.1371/journal.pone.0185240
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI0UK
UT WOS:000411645100034
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Soeria-Atmadja, S
   Osterberg, E
   Gustafsson, LL
   Dahl, ML
   Eriksen, J
   Rubin, J
   Naver, L
AF Soeria-Atmadja, Sandra
   Osterberg, Emma
   Gustafsson, Lars L.
   Dahl, Marja-Liisa
   Eriksen, Jaran
   Rubin, Johanna
   Naver, Lars
TI Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation
   in efavirenz plasma concentrations of HIV-infected children with diverse
   ethnic origin
SO PLOS ONE
LA English
DT Article
ID AFRICAN HIV/AIDS PATIENTS; POPULATION PHARMACOKINETICS; HIV-1-INFECTED
   CHILDREN; ANTIRETROVIRAL THERAPY; POLYMORPHISMS; VARIABILITY;
   METABOLISM; PHARMACOGENETICS; GUIDELINES; NEVIRAPINE
AB Background
   Approximately 2.6 million children live with HIV globally, and efavirenz (EFV) is one of the most widely used antiretroviral agents for HIV treatment in children and adults. There are concerns about the appropriateness of current EFV dosing and it has been discussed whether EFV dosing should be adapted according to genotype in children as suggested for adults.
   Aim
   To investigate if pediatric EFV dosing should be guided by genetic variation in drug metabolizing enzymes rather than by body weight.
   Method
   EFV plasma concentrations measured for clinical purposes from all children less than 18 years old at Karolinska University Hospital, Stockholm, Sweden, treated with EFV were collected retrospectively. They were genotyped for eleven polymorphisms in genes coding for drug-metabolizing enzymes and P-glycoprotein, of potential importance for EFV disposition. Data on country of origin, sex, age, weight, HIV RNA, viral resistance patterns, CD4 cells, adherence to treatment, subjective health status and adverse events were collected from their medical records.
   Results
   Thirty-six patients and 182 (mean 5 samples/patient) EFV plasma concentration measurements from children of African, Asian and Latin American origin were included. EFV plasma concentration varied 21-fold between measurements (n = 182) (0.85 - 19.3 mg/L) and 9-fold measured as mean EFV plasma concentration across the subjects (1.55-13.4 mg/L). A multivariate mixed-effects restricted maximum likelihood regression model, including multiple gene polymorphisms, identified CYP2B6*6 T/T (p < 0.0005), CYP2B6*11 G/G (p < 0.0005), CYP2A6*9 A/C (p = 0.001) genotypes, age at treatment initiation (p = 0.002) and time from treatment initiation (p < 0.0005) as independent factors significantly related to log(e) concentration/(dose/weight). The contribution of the model to the intra-and interindividual variation were 6 and 75%, respectively (Bryk/Raudenbush R-squared level).
   Conclusion
   Genetic polymorphisms in CYP2B6 and CYP2A6 explained a significant proportion of variability in EFV plasma concentration in HIV-infected children in a multi-ethnic outpatient clinic. Knowledge about individual variants in key drug metabolizing enzyme genes could improve clinical safety and genotype directed dosing could achieve more predictable EFV plasma concentrations in HIV-infected children.
C1 [Soeria-Atmadja, Sandra; Osterberg, Emma; Rubin, Johanna; Naver, Lars] Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden.
   [Soeria-Atmadja, Sandra; Rubin, Johanna; Naver, Lars] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden.
   [Gustafsson, Lars L.; Dahl, Marja-Liisa; Eriksen, Jaran] Karolinska Univ Hosp, Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden.
RP Naver, L (reprint author), Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden.; Naver, L (reprint author), Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden.
EM lars.naver@ki.se
RI Naver, Lars/E-5085-2013
OI Naver, Lars/0000-0001-6027-0211
FU Swedish Order of Freemason Foundation for Children; Samariten
   Foundation; Jerring Foundation; Karolinska Institutet Funds
   [2013tobi37895]; Swedish Research Council [2011-3440, VR-Link 2012-3466]
FX The study was supported by grants from the Swedish Order of Freemason
   Foundation for Children (LN), the Samariten Foundation (SSA), the
   Jerring Foundation (LN), Karolinska Institutet Funds (2013tobi37895)
   (LN) and the Swedish Research Council (2011-3440 and VR-Link 2012-3466)
   (LLG). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.; The
   study was supported by grants from the Swedish Order of Freemason
   Foundation for Children (LN), the Samariten Foundation (SSA), the
   Jerring Foundation (LN), Karolinska Institutet Funds (LN) and the
   Swedish Research Council (2011-3440 and VR-Link 20123466) (LLG). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Amin J, 2015, LANCET INFECT DIS, V15, P793, DOI 10.1016/S1473-3099(15)70060-5
   Barrett JS, 2002, INT J CLIN PHARM TH, V40, P507
   BRYK AS, 1988, PSYCHOL BULL, V104, P396, DOI 10.1037/0033-2909.104.3.396
   Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x
   Dalgaard LS, 2012, SCAND J INFECT DIS, V44, P108, DOI 10.3109/00365548.2011.616223
   Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94
   Fillekes Q, 2011, JAIDS-J ACQ IMM DEF, V58, P392, DOI 10.1097/QAI.0b013e318235e560
   Gutierrez F, 2005, CLIN INFECT DIS, V41, P1648, DOI 10.1086/497835
   Hellwig S.M., 2003, J INFECT DIS, V188, P738
   Hirt D, 2009, ANTIMICROB AGENTS CH, V53, P4407, DOI 10.1128/AAC.01594-08
   Holzinger ER, 2012, PHARMACOGENET GENOM, V22, P858, DOI 10.1097/FPC.0b013e32835a450b
   Hoody Dorie W, 2003, Semin Pediatr Infect Dis, V14, P286, DOI 10.1053/j.spid.2003.09.004
   Kwara A, 2009, AIDS, V23, P2101, DOI 10.1097/QAD.0b013e3283319908
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Luo M, 2016, ANTIMICROB AGENTS CH, V60, P3676, DOI 10.1128/AAC.02678-15
   Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011
   Mirghani RA, 2006, PHARMACOGENET GENOM, V16, P637, DOI 10.1097/01.fpc.0000230411.89973.1b
   Moore CB, 2017, AIDS, V31, P1129, DOI 10.1097/QAD.0000000000001463
   Mukonzo JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086919
   Mukonzo JK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-261
   Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x
   Mutwa PR, 2012, JAIDS-J ACQ IMM DEF, V60, P400, DOI 10.1097/QAI.0b013e3182569f57
   Naidoo P, 2014, EUR J CLIN PHARMACOL, V70, P379, DOI 10.1007/s00228-013-1634-1
   Ngaimisi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067946
   Pfister M, 2003, ANTIMICROB AGENTS CH, V47, P130, DOI 10.1128/AAC.47.1.130-137.2003
   Pinillos F, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1381-x
   Puthanakit T, ANTIVIR THER
   Ren Y, 2007, JAIDS-J ACQ IMM DEF, V45, P133, DOI 10.1097/QAI.0b013e31805c9d52
   Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470
   Rodriguez-Novoa S, 2005, CLIN INFECT DIS, V40, P1358, DOI 10.1086/429327
   Saitoh A, 2007, JAIDS-J ACQ IMM DEF, V45, P280
   Salem AH, 2014, ANTIMICROB AGENTS CH, V58, P136, DOI 10.1128/AAC.01738-13
   Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x
   Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0
   Sinxadi PZ, 2015, BRIT J CLIN PHARMACO, V80, P146, DOI 10.1111/bcp.12590
   Stahle L, 2004, THER DRUG MONIT, V26, P267
   Stohr W, 2008, ANTIVIR THER, V13, P675
   Sukasem C, 2014, INFECTION, V42, P469, DOI 10.1007/s15010-013-0560-6
   Swart M, 2013, PHARMACOGENET GENOM, V23, P415, DOI 10.1097/FPC.0b013e328363176f
   Swart Marelize, 2012, Frontiers in Genetics, V3, P236, DOI 10.3389/fgene.2012.00236
   Heine R, 2008, ANTIVIR THER, V13, P779
   Usach I, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18567
   Van Leth F, 2006, AIDS RES HUM RETROV, V22, P232
   Viljoen M, 2012, EUR J CLIN PHARMACOL, V68, P339, DOI 10.1007/s00228-011-1148-7
   Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601
   WHO, CONS US ANT DRUGS TR
NR 46
TC 4
Z9 4
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 8
PY 2017
VL 12
IS 9
AR e0181316
DI 10.1371/journal.pone.0181316
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG2YO
UT WOS:000410001100002
PM 28886044
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Arpawong, TE
   Pendleton, N
   Mekli, K
   McArdle, JJ
   Gatz, M
   Armoskus, C
   Knowles, JA
   Prescott, CA
AF Arpawong, Thalida E.
   Pendleton, Neil
   Mekli, Krisztina
   McArdle, John J.
   Gatz, Margaret
   Armoskus, Chris
   Knowles, James A.
   Prescott, Carol A.
TI Genetic variants specific to aging-related verbal memory: Insights from
   GWASs in a population-based cohort
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; MILD COGNITIVE IMPAIRMENT; ALZHEIMER-DISEASE;
   EPISODIC MEMORY; INDIVIDUAL-DIFFERENCES; QUANTITATIVE TRAITS; PROCESSING
   SPEED; AGE-DIFFERENCES; APOE; TOMM40
AB Verbal memory is typically studied using immediate recall (IR) and delayed recall (DR) scores, although DR is dependent on IR capability. Separating these components may be useful for deciphering the genetic variation in age-related memory abilities. This study was conducted to (a) construct individual trajectories in IR and independent aspects of delayed recall, or residualized- DR (rDR), across older adulthood; and (b) identify genetic markers that contribute to four estimated phenotypes: IR and rDR levels and changes after age 60. A cognitively intact sample (N = 20,650 with 125,164 observations) was drawn from the U.S. Health and Retirement Study, a nationally representative study of adults aged 50 and older. Mixed effects regression models were constructed using repeated measures from data collected every two years (1996-2012) to estimate level at age 60 and change in memory post-60 in IR and rDR. Genome-wide association scans (GWAS) were conducted in the genotypic subsample (N = 7,486) using similar to 1.2 million single nucleotide polymorphisms (SNPs). One SNP (rs2075650) in TOMM40 associated with rDR level at the genome-wide level (p = 5.0x10(-08)), an effect that replicated in an independent sample from the English Longitudinal Study on Ageing (N = 6,898 with 41,328 observations). Meta-analysis of rDR level confirmed the association (p = 5.0x10(-11)) and identified two others in TOMM40 (rs71352238 p = 1.0x(-10) - 10; rs157582 p = 7.0x10(-09)), and one in APOE (rs7694 49 p = 3.1 x10(-12)). Meta-analysis of IR change identified associations with three of the same SNPs in TOMM40 (rs157582 p = 8.3x10(-10); rs71352238 p = 1.9x10(-09)) and APOE (rs769449 p = 2.2x10(-08)). Conditional analyses indicate GWAS signals on rDR level were driven by APOE, whereas signals on IR change were driven by TOMM40. Additionally, we found that TOMM40 had effects independent of APOE e4 on both phenotypes. Findings from this first U.S. population-based GWAS study conducted on both age-related immediate and delayed verbal memory merit continued examination in other samples and additional measures of verbal memory.
C1 [Arpawong, Thalida E.; McArdle, John J.; Prescott, Carol A.] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Psychol, Los Angeles, CA 90007 USA.
   [Pendleton, Neil] Univ Manchester, Sch Biol Sci, Div Neurosci & Expt Psychol, Manchester, Lancs, England.
   [Mekli, Krisztina] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England.
   [McArdle, John J.; Gatz, Margaret; Prescott, Carol A.] Univ Southern Calif, Davis Sch Gerontol, Los Angeles, CA USA.
   [Gatz, Margaret; Armoskus, Chris] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA.
   [Knowles, James A.] Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA USA.
RP Arpawong, TE (reprint author), Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Psychol, Los Angeles, CA 90007 USA.
EM arpawong@usc.edu
RI Pendleton, Neil/F-2333-2015
OI Pendleton, Neil/0000-0003-0794-2386; Gatz, Margaret/0000-0002-1071-9970;
   Arpawong, Thalida/0000-0001-9671-9535
FU National Institute on Aging, of the National Institutes of Health
   [F32AG048681, P30AG017265]; National Institute on Aging [U01AG009740,
   RC2AG036495, RC4AG039029, 2R01AG7644-01A1, 2R01AG017644]; English
   Longitudinal Study of Ageing; National Institute of Aging grants
FX This research was supported by the National Institute on Aging, of the
   National Institutes of Health, under award numbers F32AG048681 (PI: TEA)
   and P30AG017265 (Subcontract: CAP). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. The Health and
   Retirement Study [genetic] data is sponsored by the National Institute
   on Aging (grant numbers U01AG009740, [RC2AG036495, and RC4AG039029]) and
   was conducted by the University of Michigan. Funding for the English
   Longitudinal Study of Ageing is provided by the National Institute of
   Aging [grants 2R01AG7644-01A1 and 2R01AG017644] and a consortium of UK
   government departments coordinated by the Office for National
   Statistics. Funding for the English Longitudinal Study of Ageing
   genotyping data was provided by the Economic and Social Research Council
   (ESRC) and by the National Institute of Aging grants. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Alarcon M, 1998, BEHAV GENET, V28, P255, DOI 10.1023/A:1021667213066
   Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591
   [Anonymous], 1998, J AM GERIATR SOC, V46, P1493
   Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045
   BOUCHARD TJ, 1990, ACTA GENET MED GEMEL, V39, P193, DOI 10.1017/S0001566000005420
   Cacabelos R, 2014, J PHARMACOGENOMICS P, V2014
   Caselli RJ, 2012, ALZHEIMERS DEMENT, V8, P490, DOI 10.1016/j.jalz.2011.11.006
   Chang CC, 2014, ARXIV14104803
   Chen KHM, 2010, BRAIN COGNITION, V72, P400, DOI 10.1016/j.bandc.2009.11.007
   CIDR, 2012, CIDR HLTH RET STUD I
   Cohen RM, 2001, NEUROLOGY, V57, P2223, DOI 10.1212/WNL.57.12.2223
   Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048
   Davies G, 2014, MOL PSYCHIATR, V19, P76, DOI 10.1038/mp.2012.159
   Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4
   Elger CE, 1997, NEUROPSYCHOLOGIA, V35, P657, DOI 10.1016/S0028-3932(96)00110-8
   Faul J, 2014, HLTH RETIREMENT STUD
   Ferencz B, 2013, FRONT HUM NEUROSCI, P7
   Ferencz B, 2015, NEUROPSYCHOL REV, V25, P113, DOI 10.1007/s11065-014-9276-3
   Finkel D, 2005, BEHAV GENET, V35, P535, DOI 10.1007/s10519-005-3281-5
   FINKEL D, 1995, PSYCHOL AGING, V10, P437, DOI 10.1037/0882-7974.10.3.437
   GOLOMB J, 1994, LEARN MEMORY, V1, P45
   Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96
   Greenaway MC, 2006, COGN BEHAV NEUROL, V19, P79, DOI 10.1097/01.wnn.0000208290.57370.a3
   Greenbaum L, 2014, EUR NEUROPSYCHOPHARM, V24, P1492, DOI 10.1016/j.euroneuro.2014.06.002
   Hayden KM, 2012, ALZHEIMERS DEMENT, V8, P381, DOI 10.1016/j.jalz.2011.10.005
   Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5
   Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323
   Helmstaedter C, 1997, BRAIN COGNITION, V35, P110, DOI 10.1006/brcg.1997.0930
   Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803
   HORN JL, 1992, EXP AGING RES, V18, P117, DOI 10.1080/03610739208253916
   HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X
   HRS, 2012, QUAL CONTR REP GEN D
   HRS, 2014, COGN BEH PHEN SNPS I
   Johansson B, 1999, J GERONTOL B-PSYCHOL, V54, pP173, DOI 10.1093/geronb/54B.3.P173
   Johnson SC, 2011, ALZHEIMERS DEMENT, V7, P456, DOI 10.1016/j.jalz.2010.11.012
   Kao PF, 2012, J NEUROPATH EXP NEUR, V71, P654, DOI 10.1097/NEN.0b013e31825d06b7
   Kremen WS, 2014, PSYCHOL AGING, V29, P404, DOI 10.1037/a0035962
   Laczo J, 2015, NEUROBIOL AGING, V36, P2024, DOI 10.1016/j.neurobiolaging.2015.03.004
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516
   Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296
   Lind J, 2006, BRAIN, V129, P1240, DOI 10.1093/brain/awl054
   Lindenberger U, 2008, FRONT NEUROSCI, V2, P39
   LOFTUS GR, 1985, J EXP PSYCHOL LEARN, V11, P397, DOI 10.1037/0278-7393.11.2.397
   Luciano M, 2001, BEHAV GENET, V31, P581, DOI 10.1023/A:1013397428612
   Lyall DM, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.006
   Ma XY, 2013, NEUROMOL MED, V15, P279, DOI 10.1007/s12017-012-8217-7
   Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402
   Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003
   McArdle JJ, 2002, DEV PSYCHOL, V38, P115, DOI 10.1037//0012-1649.38.1.115
   McArdle JJ, 2007, PSYCHOL AGING, V22, P525, DOI 10.1037/0882-7974.22.3.525
   McArdle JJ, 2011, ASTA-ADV STAT ANAL, V95, P453, DOI 10.1007/s10182-011-0168-z
   McArdle JJ, 2009, BEHAV GENET, V39, P472, DOI 10.1007/s10519-009-9272-1
   Nilsson LG, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.107.s179.5.x
   Nilsson LG, 2002, NEUROSCI BIOBEHAV R, V26, P841, DOI 10.1016/S0149-7634(02)00070-2
   Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331
   O'Hara R, 2006, NEUROSCI LETT, V409, P205, DOI 10.1016/j.neulet.2006.09.047
   Ofstedal MB, 2005, DOCUMENTATION COGNIT
   Oldmeadow C, 2014, J ALZHEIMERS DIS, V42, P391, DOI 10.3233/JAD-140846
   Panizzon MS, 2011, NEUROPSYCHOLOGY, V25, P488, DOI 10.1037/a0022569
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005
   Papenberg G, 2015, TRENDS COGN SCI, V19, P506, DOI 10.1016/j.tics.2015.06.008
   Papenberg G, 2015, NEUROPSYCHOL REV, V25, P47, DOI 10.1007/s11065-015-9279-8
   Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190
   Payton A, 2016, NEUROBIOL AGING, V39, DOI 10.1016/j.neurobiolaging.2015.11.017
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813
   Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Radmanesh F, 2014, EUR J HUM GENET, V22, P1239, DOI 10.1038/ejhg.2013.308
   Reynolds CA, 2005, DEV PSYCHOL, V41, P3, DOI 10.1037/0012-1649.41.1.3
   Reynolds CA, 2002, EXP AGING RES, V28, P407, DOI 10.1080/03610730290103104
   Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516
   Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3
   Ronnlund M, 2000, INT J PSYCHOL, V35, P366
   Rosen AC, 2003, BEHAV NEUROSCI, V117, P1150, DOI 10.1037/0735-7044.117.6.1150
   Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69
   Roses AD, 2013, ALZHEIMERS DEMENT, V9, P132, DOI 10.1016/j.jalz.2012.10.009
   Salthouse TA, 2003, ALZ DIS ASSOC DIS, V17, P162, DOI 10.1097/00002093-200307000-00008
   SAS, 2013, SAS I VERS 9 4
   SCHAIE KW, 1996, INTELLECTUAL DEV ADU
   Seripa D, 2012, J ALZHEIMERS DIS, V31, P731, DOI 10.3233/JAD-2012-120403
   Serre D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001382
   Shega JW, 2014, J GERONTOL B-PSYCHOL, V69, pS166, DOI 10.1093/geronb/gbu106
   SLAMECKA NJ, 1983, J EXP PSYCHOL LEARN, V9, P384, DOI 10.1037/0278-7393.9.3.384
   Stephan Y, 2014, AM J GERIAT PSYCHIAT, V22, P1180, DOI 10.1016/j.jagp.2013.03.007
   Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168
   Swan GE, 1999, ARCH NEUROL-CHICAGO, V56, P1127, DOI 10.1001/archneur.56.9.1127
   Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268
   Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114
   Volk HE, 2006, TWIN RES HUM GENET, V9, P623, DOI 10.1375/twin.9.5.623
   Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522
   WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016
   WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037//0882-7974.17.2.179
   Wolk DA, 2011, NEUROIMAGE, V54, P1530, DOI 10.1016/j.neuroimage.2010.09.005
   Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011
   Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002
   Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196
   Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.0210
NR 102
TC 3
Z9 3
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 11
PY 2017
VL 12
IS 8
AR e0182448
DI 10.1371/journal.pone.0182448
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD3KL
UT WOS:000407431800018
PM 28800603
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Graczyk, MB
   Queiros, SMD
AF Graczyk, Michelle B.
   Durate Queiros, Silvio M.
TI Intraday seasonalities and nonstationarity of trading volume in
   financial markets: Collective features
SO PLOS ONE
LA English
DT Article
ID TRADED VOLUME; STATISTICAL PROPERTIES; CROSS-CORRELATIONS; PRICE
   CHANGES; MODEL; HETEROSKEDASTICITY; DEPENDENCE; MIXTURE
AB Employing Random Matrix Theory and Principal Component Analysis techniques, we enlarge our work on the individual and cross-sectional intraday statistical properties of trading volume in financial markets to the study of collective intraday features of that financial observable. Our data consist of the trading volume of the Dow Jones Industrial Average Index components spanning the years between 2003 and 2014. Computing the intraday time dependent correlation matrices and their spectrum of eigenvalues, we show there is a mode ruling the collective behaviour of the trading volume of these stocks whereas the remaining eigenvalues are within the bounds established by random matrix theory, except the second largest eigenvalue which is robustly above the upper bound limit at the opening and slightly above it during the morning-afternoon transition. Taking into account that for price fluctuations it was reported the existence of at least seven significant eigenvalues-and that its autocorrelation function is close to white noise for highly liquid stocks whereas for the trading volume it lasts significantly for more than 2 hours-, our finding goes against any expectation based on those features, even when we take into account the Epps effect. In addition, the weight of the trading volume collective mode is intraday dependent; its value increases as the trading session advances with its eigenversor approaching the uniform vector as well, which corresponds to a soar in the behavioural homogeneity. With respect to the nonstationarity of the collective features of the trading volume we observe that after the financial crisis of 2008 the coherence function shows the emergence of an upset profile with large fluctuations from that year on, a property that concurs with the modification of the average trading volume profile we noted in our previous individual analysis.
C1 [Graczyk, Michelle B.; Durate Queiros, Silvio M.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, RJ, Brazil.
   [Durate Queiros, Silvio M.] Natl Inst Sci Technol Complex Syst, Rio De Janeiro, RJ, Brazil.
RP Queiros, SMD (reprint author), Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, RJ, Brazil.; Queiros, SMD (reprint author), Natl Inst Sci Technol Complex Syst, Rio De Janeiro, RJ, Brazil.
EM sdqueiro@google.com
CR Admati AR, 1988, REV FINANC STUD, V1, P3, DOI 10.1093/rfs/1.1.3
   Allez R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025010
   Andersen T. G., 1997, J EMPIR FINANC, V4, P115, DOI DOI 10.1016/S0927-5398(97)00004-2
   [Anonymous], 2007, PHYS REV E, V76
   Bahcall SR, 1996, PHYS REV LETT, V77, P5276, DOI 10.1103/PhysRevLett.77.5276
   Baik J, 2005, ANN PROBAB, V33, P1643, DOI 10.1214/009117905000000233
   Beenakker CWJ, 1997, REV MOD PHYS, V69, P731, DOI 10.1103/RevModPhys.69.731
   BOHIGAS O, 1984, PHYS REV LETT, V52, P1, DOI 10.1103/PhysRevLett.52.1
   Bouchaud JP, 2000, INTRO ECONOPHYSICS C
   Bouchaud JP, 2011, OXFORD HDB RANDOM MA
   Camargo S, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-30974-9
   CLARK PK, 1973, ECONOMETRICA, V41, P135, DOI 10.2307/1913889
   COPELAND TE, 1976, J FINANC, V31, P1149, DOI 10.2307/2326280
   de Souza J, 2006, EUR PHYS J B, V50, P165, DOI 10.1140/epjb/e2006-00130-1
   Queiros SMD, 2016, CHAOS SOLITON FRACT, V88, P24, DOI 10.1016/j.chaos.2015.12.024
   Duarte Queiros SM, 2017, J NETWORK THEORY FIN
   Eisler Z, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/28001
   Eisler Z, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046109
   Eisler Z, 2006, EUR PHYS J B, V51, P145, DOI 10.1140/epjb/e2006-00189-6
   Embrechts P., 1997, MODELLING EXTREMAL E
   Engle R, 2002, J BUS ECON STAT, V20, P339, DOI 10.1198/073500102288618487
   Engle RF, 2008, HDB FINANCE, V3
   EPPS TW, 1976, ECONOMETRICA, V44, P305, DOI 10.2307/1912726
   EPPS TW, 1979, J AM STAT ASSOC, V74, P291, DOI 10.2307/2286325
   Gopikrishnan P, 2000, PHYS REV E, V62, pR4493, DOI 10.1103/PhysRevE.62.R4493
   Graczyk MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165057
   HARRIS L, 1987, J FINANC QUANT ANAL, V22, P127, DOI 10.2307/2330708
   Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126
   JAIN PC, 1988, J FINANC QUANT ANAL, V23, P269, DOI 10.2307/2331067
   JONES CM, 1994, REV FINANC STUD, V7, P631, DOI 10.1093/rfs/7.4.631
   KARPOFF JM, 1987, J FINANC QUANT ANAL, V22, P109, DOI 10.2307/2330874
   Kritchman S, 2009, IEEE T SIGNAL PROCES, V57, P3930, DOI 10.1109/TSP.2009.2022897
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Laloux L, 2000, INT J THEOR APPL FIN, V03, P391, DOI DOI 10.1142/S0219024900000255
   LAMOUREUX CG, 1990, J FINANC, V45, P221, DOI 10.2307/2328817
   Li W, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046112
   Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290
   Mantegna R. N., 1999, INTRO ECONOPHYSICS C
   Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929
   Markowitz HM, 2009, H MARKOWITZ SELECTED
   Mezard Parisi G, 1986, SPIN GLASS THEORY
   Moyano LG, 2006, PHYSICA A, V371, P118, DOI 10.1016/j.physa.2006.04.098
   Mu GH, 2009, EUR PHYS J B, V68, P145, DOI 10.1140/epjb/e2009-00059-9
   Osorio R, 2004, NONEXTENSIVE ENTROPY
   Plerou V, 1999, PHYS REV LETT, V83, P1471, DOI 10.1103/PhysRevLett.83.1471
   Plerou V, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046109
   Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106
   Queiros SMD, 2007, PHYSICA A, V383, P10, DOI 10.1016/j.physa.2007.04.082
   Queiros SMD, 2005, EUROPHYS LETT, V71, P339, DOI 10.1209/epl/i2005-10109-0
   Rebonato R, 2011, MOST GEN METHODOLOGY
   Rocha P, 2015, J PHYS CONF SER, V574, DOI 10.1088/1742-6596/574/1/012148
   Rue H., 2005, GAUSSIAN MARKOV RAND
   Sornette D., 2006, CRITICAL PHENOMENA N
   TAUCHEN GE, 1983, ECONOMETRICA, V51, P485, DOI 10.2307/1912002
   TITMAN S, 1988, J FINANC, V43, P1, DOI 10.2307/2328319
   WIGNER EP, 1951, ANN MATH, V53, P36, DOI 10.2307/1969342
   Wigner EP, 1951, P CAMBRIDGE PHILOS S, V47, P479
   Wigner EP, 1956, C NEUTR PHYS TIM FLI
NR 58
TC 1
Z9 1
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 28
PY 2017
VL 12
IS 7
AR e0179198
DI 10.1371/journal.pone.0179198
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC1ED
UT WOS:000406579300002
PM 28753676
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhao, R
   Catalano, P
   DeGruttola, VG
   Michor, F
AF Zhao, Rui
   Catalano, Paul
   DeGruttola, Victor G.
   Michor, Franziska
TI Estimating mono- and bi-phasic regression parameters using a mixture
   piecewise linear Bayesian hierarchical model
SO PLOS ONE
LA English
DT Article
ID MIXED-EFFECTS MODELS; DYNAMICS; THERAPY; SELECTION; VARIABLES; KINETICS;
   CRITERIA; CELLS
AB The dynamics of tumor burden, secreted proteins or other biomarkers over time, is often used to evaluate the effectiveness of therapy and to predict outcomes for patients. Many methods have been proposed to investigate longitudinal trends to better characterize patients and to understand disease progression. However, most approaches assume a homogeneous patient population and a uniform response trajectory over time and across patients. Here, we present a mixture piecewise linear Bayesian hierarchical model, which takes into account both population heterogeneity and nonlinear relationships between biomarkers and time. Simulation results show that our method was able to classify subjects according to their patterns of treatment response with greater than 80% accuracy in the three scenarios tested. We then applied our model to a large randomized controlled phase III clinical trial of multiple myeloma patients. Analysis results suggest that the longitudinal tumor burden trajectories in multiple myeloma patients are heterogeneous and nonlinear, even among patients assigned to the same treatment cohort. In addition, between cohorts, there are distinct differences in terms of the regression parameters and the distributions among categories in the mixture. Those results imply that longitudinal data from clinical trials may harbor unobserved subgroups and nonlinear relationships; accounting for both may be important for analyzing longitudinal data.
C1 [Zhao, Rui; Catalano, Paul; DeGruttola, Victor G.; Michor, Franziska] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [Zhao, Rui; Catalano, Paul; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA.
RP Zhao, R (reprint author), Harvard Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.; Zhao, R (reprint author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA.
EM rzhao@hsph.harvard.edu
FU Dana-Farber Cancer Institute Physical Sciences Oncology Center
   [U54CA143798]; NIH [R37 51164]
FX This work was supported by the Dana-Farber Cancer Institute Physical
   Sciences Oncology Center (U54CA143798) and NIH grant R37 51164. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469
   Arnaout RA, 2000, P ROY SOC B-BIOL SCI, V267, P1347, DOI 10.1098/rspb.2000.1149
   Basseville Michele, 1993, DETECTION ABRUPT CHA, V104
   BELIN TR, 1995, STAT MED, V14, P747, DOI 10.1002/sim.4780140805
   BESAG J, 1995, STAT SCI, V10, P3, DOI 10.1214/ss/1177010123
   Carlin B. P., 1995, J ROYAL STAT SOC B, V57, P473
   CARLIN BP, 1992, APPL STAT-J ROY ST C, V41, P389
   Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122
   Chen J., 2011, PARAMETRIC STAT CHAN
   Cudeck R, 2002, PSYCHOL METHODS, V7, P41, DOI 10.1037//1082-989X.7.1.41
   Fitzmaurice GM, 2012, APPL LONGITUDINAL AN, V998
   GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777
   Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340
   Hammer SM, 2002, JAMA-J AM MED ASSOC, V288, P169, DOI 10.1001/jama.288.2.169
   HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190
   Harring JR, 2006, MULTIVAR BEHAV RES, V41, P579, DOI 10.1207/s15327906mbr4104_7
   Held L, 2004, J COMPUTATIONAL GRAP, V13
   HINKLEY DV, 1969, BIOMETRIKA, V56, P635, DOI 10.2307/2334671
   Jessica M, 2012, J BIOMETRICS BIOSTAT
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Leisch F., 2004, J STAT SOFTWARE
   LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014
   Lu X, 2014, STAT MED
   Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669
   MORRELL CH, 1995, J AM STAT ASSOC, V90, P45, DOI 10.2307/2291128
   Naumova EN, 2001, INT J EPIDEMIOL, V30, P1332, DOI 10.1093/ije/30.6.1332
   Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103
   NISHII R, 1984, ANN STAT, V12, P758, DOI 10.1214/aos/1176346522
   Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208
   Pauler DK, 2000, BIOMETRICS, V56, P464, DOI 10.1111/j.0006-341X.2000.00464.x
   Perelson AS, 1997, EXPERT REV MOL MED
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   R Core Team, 2014, R LANG ENV STAT COMP
   San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479
   SHIBATA R, 1976, BIOMETRIKA, V63, P117
   Stein AM, 2011, CLIN CANCER RES, V17, P6812, DOI 10.1158/1078-0432.CCR-11-0396
   Tsiang M, 1999, HEPATOLOGY, V29, P1863, DOI 10.1002/hep.510290626
   van den Hout A, 2011, STAT MED, V30, P599, DOI 10.1002/sim.4127
   Verbeke G, 1996, J AM STAT ASSOC, V91, P217, DOI 10.2307/2291398
   Verbeke G, 2009, SPRINGER SER STAT, P1
   Xu W, 2001, J Biopharm Stat, V11, P253, DOI 10.1081/BIP-120008848
NR 42
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 19
PY 2017
VL 12
IS 7
AR e0180756
DI 10.1371/journal.pone.0180756
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB3UH
UT WOS:000406067800023
PM 28723910
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gurari, N
   Okamura, AM
   Kuchenbecker, KJ
AF Gurari, Netta
   Okamura, Allison M.
   Kuchenbecker, Katherine J.
TI Perception of force and stiffness in the presence of low-frequency
   haptic noise
SO PLOS ONE
LA English
DT Article
ID GOLGI TENDON ORGANS; GLABROUS SKIN; DELAYED STIFFNESS; MUSCULAR SENSE;
   HUMAN HAND; SOFTNESS; DISCRIMINATION; RESPONSES; POSITION; MUSCLE
AB Objective
   This work lays the foundation for future research on quantitative modeling of human stiffness perception. Our goal was to develop a method by which a human's ability to perceive suprathreshold haptic force stimuli and haptic stiffness stimuli can be affected by adding haptic noise.
   Methods
   Five human participants performed a same-different task with a one-degree-of-freedom force-feedback device. Participants used the right index finger to actively interact with variations of force (similar to 5 and similar to 8 N) and stiffness (similar to 290 N/m) stimuli that included one of four scaled amounts of haptically rendered noise (None, Low, Medium, High). The haptic noise was zero-mean Gaussian white noise that was low-pass filtered with a 2 Hz cut-off frequency; the resulting low-frequency signal was added to the force rendered while the participant interacted with the force and stiffness stimuli.
   Results
   We found that the precision with which participants could identify the magnitude of both the force and stiffness stimuli was affected by the magnitude of the low-frequency haptically rendered noise added to the haptic stimulus, as well as the magnitude of the haptic stimulus itself. The Weber fraction strongly correlated with the standard deviation of the low-frequency haptic noise with a Pearson product-moment correlation coefficient of rho > 0.83. The mean standard deviation of the low-frequency haptic noise in the haptic stimuli ranged from 0.184 N to 1.111 N across the four haptically rendered noise levels, and the corresponding mean Weber fractions spanned between 0.042 and 0.101.
   Conclusions
   The human ability to perceive both suprathreshold haptic force and stiffness stimuli degrades in the presence of added low-frequency haptic noise. Future work can use the reported methods to investigate how force perception and stiffness perception may relate, with possible applications in haptic watermarking and in the assessment of the functionality of peripheral pathways in individuals with haptic impairments.
C1 [Gurari, Netta] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.
   [Okamura, Allison M.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.
   [Kuchenbecker, Katherine J.] Max Planck Inst Intelligent Syst, Hapt Intelligence Dept, Stuttgart, Germany.
   [Kuchenbecker, Katherine J.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.
RP Gurari, N (reprint author), Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.
EM netta.gurari@northwestern.edu
OI Okamura, Allison/0000-0002-6912-1666
FU NCATS NIH HHS [UL1 TR001422]
CR Allin S, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P299, DOI 10.1109/HAPTIC.2002.998972
   ANDERSON JH, 1974, BRAIN RES, V67, P531, DOI 10.1016/0006-8993(74)90501-0
   Ben Porquis L, 2011, IEEE INT CONF ROBOT, P1380
   Bicchi A, 2000, IEEE T ROBOTIC AUTOM, V16, P496, DOI 10.1109/70.880800
   Brewer BR, 2005, IEEE T NEUR SYS REH, V13, P1, DOI 10.1109/TNSRE.2005.843443
   BROWN MC, 1967, J PHYSIOL-LONDON, V192, P773, DOI 10.1113/jphysiol.1967.sp008330
   Choi S, 2004, PRESENCE-TELEOP VIRT, V13, P395, DOI 10.1162/1054746041944867
   CLARK FJ, 1985, J NEUROPHYSIOL, V54, P1529
   Collins JJ, 1997, PHYS REV E, V56, P923, DOI 10.1103/PhysRevE.56.923
   Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM
   Gurari N., 2009, CHARACTERIZATION HUM
   Gurari N, 2014, J NEUROSCI METH, V235, P169, DOI 10.1016/j.jneumeth.2014.07.001
   Gurari N, 2013, IEEE T HUM-MACH SYST, V43, P102, DOI 10.1109/TSMCA.2012.2221038
   Gurari N, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P121, DOI 10.1109/WHC.2009.4810845
   Ikeda A, 2013, IEEE SYS MAN CYBERN, P3384, DOI 10.1109/SMC.2013.577
   JAMI L, 1992, PHYSIOL REV, V72, P623
   JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619
   JOHANSSON RS, 1982, BRAIN RES, V244, P17, DOI 10.1016/0006-8993(82)90899-X
   JONES LA, 1990, EXP BRAIN RES, V79, P150
   Jones LA., 2000, HUMAN AND MACHINE HA
   Kildal Johan, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P191, DOI 10.1007/978-3-642-31404-9_33
   Kildal Johan, 2010, INT C MULT INT WORKS, P21
   Kuchenbecker KJ, 2006, IEEE T VISUALIZATION, P219
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LaMotte RH, 2000, J NEUROPHYSIOL, V83, P1777
   Luu BL, 2011, J PHYSIOL-LONDON, V589, P3135, DOI 10.1113/jphysiol.2011.208447
   Macmillan NA, 2005, DETECTION THEORY USE
   Maher C, 1995, Aust J Physiother, V41, P161, DOI 10.1016/S0004-9514(14)60426-8
   MATTHEWS PBC, 1982, ANNU REV NEUROSCI, V5, P189, DOI 10.1146/annurev.ne.05.030182.001201
   Mugge W, 2009, J NEUROSCI, V29, P5476, DOI 10.1523/JNEUROSCI.0116-09.2009
   Nisky I, 2008, IEEE T HAPTICS, V1, P73, DOI 10.1109/ToH.2008.17
   Oberfeld D, 2013, BEHAV RES METHODS, V45, P792, DOI 10.3758/s13428-012-0281-2
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   Prattichizzo D, 2007, IEEE MULTIMEDIA, V14, P84, DOI 10.1109/MMUL.2007.58
   Pressman A, 2007, INT J ROBOT RES, V26, P1191, DOI 10.1177/0278364907082611
   Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011
   ROLAND PE, 1977, BRAIN, V100, P671, DOI 10.1093/brain/100.4.671
   SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88
   STAUFFER EK, 1977, J NEUROPHYSIOL, V40, P681
   Tan H, 1992, ADV ROBOTICS, V42, P13
   TAN HZ, 1995, PERCEPT PSYCHOPHYS, V57, P495, DOI 10.3758/BF03213075
   Tiest WMB, 2008, LECT NOTES COMPUT SC, V5024, P255, DOI 10.1007/978-3-540-69057-3_30
   VEDEL JP, 1982, NEUROSCI LETT, V34, P289, DOI 10.1016/0304-3940(82)90190-2
   Visell Y, 2014, LECT NOTES COMPUT SC, V8618, P478, DOI 10.1007/978-3-662-44193-0_60
   WESTLING G, 1987, EXP BRAIN RES, V66, P128
NR 45
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2017
VL 12
IS 6
AR e0178605
DI 10.1371/journal.pone.0178605
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW6MJ
UT WOS:000402624300072
PM 28575068
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Booth, TC
   Larkin, TJ
   Yuan, Y
   Kettunen, MI
   Dawson, SN
   Scoffings, D
   Canuto, HC
   Vowler, SL
   Kirschenlohr, H
   Hobson, MP
   Markowetz, F
   Jefferies, S
   Brindle, KM
AF Booth, Thomas C.
   Larkin, Timothy J.
   Yuan, Yinyin
   Kettunen, Mikko I.
   Dawson, Sarah N.
   Scoffings, Daniel
   Canuto, Holly C.
   Vowler, Sarah L.
   Kirschenlohr, Heide
   Hobson, Michael P.
   Markowetz, Florian
   Jefferies, Sarah
   Brindle, Kevin M.
TI Analysis of heterogeneity in T-2-weighted MR images can differentiate
   pseudoprogression from progression in glioblastoma
SO PLOS ONE
LA English
DT Article
ID CEREBRAL BLOOD-VOLUME; NEWLY-DIAGNOSED GLIOBLASTOMA; GLIOMAS RESPONSE
   ASSESSMENT; HIGH-GRADE GLIOMAS; PROGNOSTIC-FACTORS; RADIATION-THERAPY;
   WHITE-MATTER; 3.0 T; PERFUSION; BRAIN
AB Purpose
   To develop an image analysis technique that distinguishes pseudoprogression from true progression by analyzing tumour heterogeneity in T-2-weighted images using topological descriptors of image heterogeneity called Minkowski functionals (MFs).
   Methods
   Using a retrospective patient cohort (n = 50), and blinded to treatment response outcome, unsupervised feature estimation was performed to investigate MFs for the presence of outliers, potential confounders, and sensitivity to treatment response. The progression and pseudoprogression groups were then unblinded and supervised feature selection was performed using MFs, size and signal intensity features. A support vector machine model was obtained and evaluated using a prospective test cohort.
   Results
   The model gave a classification accuracy, using a combination of MFs and size features, of more than 85% in both retrospective and prospective datasets. A different feature selection method (Random Forest) and classifier (Lasso) gave the same results. Although not apparent to the reporting radiologist, the T-2-weighted hyperintensity phenotype of those patients with progression was heterogeneous, large and frond-like when compared to those with pseudoprogression.
   Conclusion
   Analysis of heterogeneity, in T-2-weighted MR images, which are acquired routinely in the clinic, has the potential to detect an earlier treatment response allowing an early change in treatment strategy. Prospective validation of this technique in larger datasets is required.
C1 [Booth, Thomas C.; Larkin, Timothy J.; Kettunen, Mikko I.; Canuto, Holly C.; Kirschenlohr, Heide; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge, England.
   [Booth, Thomas C.; Larkin, Timothy J.; Yuan, Yinyin; Kettunen, Mikko I.; Canuto, Holly C.; Vowler, Sarah L.; Markowetz, Florian; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England.
   [Dawson, Sarah N.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Clin Trials Unit, Cambridge, England.
   [Scoffings, Daniel] Addenbrookes Hosp, Dept Radiol, Cambridge, England.
   [Hobson, Michael P.] Univ Cambridge, Cavendish Lab, Battock Ctr Expt Astrophys, Cambridge, England.
   [Jefferies, Sarah] Addenbrookes Hosp, Dept Oncol, Cambridge, England.
RP Brindle, KM (reprint author), Univ Cambridge, Dept Biochem, Cambridge, England.; Brindle, KM (reprint author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England.
EM kmb1001@cam.ac.uk
OI Dawson, Sarah/0000-0001-7401-2192; Yuan, Yinyin/0000-0002-8556-4707
FU Medical Research Council/Royal College of Radiologists (UK) Clinical
   Research Fellowship [G1000265]; Cancer Research UK Clinical Research
   Fellowship; Addenbrookes Charitable Trust Award; Cancer Research UK
   Programme grant [C197/A3514]
FX Funded by Medical Research Council/Royal College of Radiologists (UK)
   Clinical Research Fellowship (G1000265); Cancer Research UK Clinical
   Research Fellowship; Addenbrookes Charitable Trust Award to TCB. Cancer
   Research UK Programme grant (C197/A3514) to KM B. www.mrc.ac.uk;
   www.cancerresearchuk.org/;; http//www act4addenbrookes.org.uk. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alvarez-Linera J, 2008, EUR J RADIOL, V67, P415, DOI 10.1016/j.ejrad.2008.02.045
   Bauchet L, 2010, NEURO-ONCOLOGY, V12, P725, DOI 10.1093/neuonc/noq030
   BLEEHEN NM, 1991, BRIT J CANCER, V64, P769, DOI 10.1038/bjc.1991.396
   Boss A, 2007, J MAGN RESON IMAGING, V25, P924, DOI 10.1002/jmri.20893
   Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Canuto HC, 2009, MAGN RESON MED, V61, P1218, DOI 10.1002/mrm.21946
   Cerasa A, 2015, BEHAV NEUROL, DOI 10.1155/2015/924814
   Chamberlain MC, 2007, J NEURO-ONCOL, V82, P81, DOI 10.1007/s11060-006-9241-y
   Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199
   Chaskis C, 2009, SURG NEUROL, V72, P423, DOI 10.1016/j.surneu.2008.09.023
   Chu HH, 2013, RADIOLOGY, V269, P831, DOI 10.1148/radiol.13122024
   Chu RX, 2016, J NEUROIMAGING, V26, P62, DOI 10.1111/jon.12271
   Deistung A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057924
   Dhermain FG, 2010, LANCET NEUROL, V9, P906, DOI 10.1016/S1474-4422(10)70181-2
   Dydak U, 2006, NEUROIMAG CLIN N AM, V16, P269, DOI 10.1016/j.nic.2006.02.002
   Ellingson BM, 2015, NEURO-ONCOLOGY, V17, P1188, DOI 10.1093/neuonc/nov095
   Ellingson BM, 2014, NEURO-ONCOLOGY, V16, P2, DOI 10.1093/neuonc/nou224
   Ellingson BM, 2012, NEURO-ONCOLOGY, V14, P333, DOI 10.1093/neuonc/nor220
   European Medicines Agency, 2014, REF CHANG MARK AUTH
   Filippini G, 2008, NEURO-ONCOLOGY, V10, P79, DOI 10.1215/15228517-2007-038
   Gahramanov S, 2013, RADIOLOGY, V266, P842, DOI 10.1148/radiol.12111472
   Galanis E, 2006, NEURO-ONCOLOGY, V8, P156, DOI 10.1215/15228517-2005005
   Galban CJ, 2011, CLIN CANCER RES, V17, P4751, DOI 10.1158/1078-0432.CCR-10-2098
   Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028
   Gutierrez DR, 2014, AM J NEURORADIOL, V35, P1009, DOI 10.3174/ajnr.A3784
   Hamel L, KNOWLEDGE DISCOVERY
   Hastie T. J., 2009, ELEMENTS STAT LEARNI
   Henson JW, 2008, AM J NEURORADIOL, V29, P419, DOI 10.3174/ajnr.A0963
   Hockstein NG, 2004, LARYNGOSCOPE, V114, P1701, DOI 10.1097/00005537-200410000-00005
   Hodgdon T, 2015, RADIOLOGY, V276, P787, DOI 10.1148/radiol.2015142215
   Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743
   Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377
   Hu LS, 2012, NEURO-ONCOLOGY, V14, P919, DOI 10.1093/neuonc/nos112
   da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397
   Jain R, 2014, RADIOLOGY, V272, P484, DOI 10.1148/radiol.14131691
   JOHNSON PC, 1989, RADIOLOGY, V170, P211, DOI 10.1148/radiology.170.1.2535765
   Julesz B., 1962, Institute of Radio Engineers Transactions on Information Theory, VIT-8, P84, DOI 10.1109/TIT.1962.1057698
   Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lamborn KR, 2004, NEURO-ONCOLOGY, V6, P227, DOI 10.1215/S1152851703000620
   Larkin TJ, 2014, MAGN RESON MED, V71, P402, DOI 10.1002/mrm.24644
   Lee MC, 2005, J MAGN RESON IMAGING, V21, P683, DOI 10.1002/jmri.20298
   Liu HL, 2011, MED PHYS, V38, P802, DOI 10.1118/1.3534197
   Lupo JM, 2006, J MAGN RESON IMAGING, V24, P520, DOI 10.1002/jmri.20673
   Lupo JM, 2005, AM J NEURORADIOL, V26, P1446
   Lutz K, 2011, CLIN NEURORADIOL, V21, P199, DOI 10.1007/s00062-011-0080-7
   MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277
   Mangla R, 2010, RADIOLOGY, V256, P575, DOI 10.1148/radiol.10091440
   Martin-Landrove M, 2007, P ANN INT IEEE EMBS, P1306, DOI 10.1109/IEMBS.2007.4352537
   MECKE KR, 1994, ASTRON ASTROPHYS, V288, P697
   Mehrkens JH, 2008, J NEURO-ONCOL, V88, P27, DOI 10.1007/s11060-008-9526-4
   Michielsen K, 2001, PHYS REP, V347, P462
   Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102
   Nagesh V, 2008, INT J RADIAT ONCOL, V70, P1002, DOI [10.1016/j.ijrobp.2007.08.020, 10.1016/i.ijrobp.2007.08.020]
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565
   Peters AM, 2007, MAGN RESON IMAGING, V25, P748, DOI 10.1016/j.mri.2007.02.014
   Piroth MD, 2011, INT J RADIAT ONCOL, V80, P176, DOI 10.1016/j.ijrobp.2010.01.055
   Polley MYC, 2010, NEURO-ONCOLOGY, V12, P274, DOI 10.1093/neuonc/nop034
   Price SJ, 2003, CLIN RADIOL, V58, P455, DOI 10.1016/S0009-9260(03)00115-6
   Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003
   Sanghera P, 2012, CLIN ONCOL-UK, V24, P216, DOI 10.1016/j.clon.2011.06.004
   Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306
   Stivaros SM, 2016, PEDIATR RADIOL, V46, P73, DOI 10.1007/s00247-015-3444-3
   Suh CH, 2013, AM J NEURORADIOL, V34, P2278, DOI 10.3174/ajnr.A3634
   Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125
   Tsien C, 2010, J CLIN ONCOL, V28, P2293, DOI 10.1200/JCO.2009.25.3971
   Tung GA, 2003, NEURORADIOLOGY, V45, P357, DOI 10.1007/s00234-003-0994-0
   Ulmer S, 2012, NEURO-ONCOLOGY, V14, P482, DOI 10.1093/neuonc/nos003
   Valery CA, 2001, J NEUROSURG, V94, P433, DOI 10.3171/jns.2001.94.3.0433
   Vogelbaum MA, 2012, NEUROSURGERY, V70, P234, DOI 10.1227/NEU.0b013e318223f5a7
   [ Wang Jianfeng], 2002, [, Engineering science], V4, P22
   Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541
   Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7
   Yongbi MN, 2002, RADIOLOGY, V222, P569, DOI 10.1148/radiol.2222001697
   Young RJ, 2013, CLIN IMAG, V37, P41, DOI 10.1016/j.clinimag.2012.02.016
NR 77
TC 4
Z9 5
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2017
VL 12
IS 5
AR e0176528
DI 10.1371/journal.pone.0176528
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV1DX
UT WOS:000401487700020
PM 28520730
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Michl, SC
   Ratten, JM
   Beyer, M
   Hasler, M
   LaRoche, J
   Schulz, C
AF Michl, Stephanie Celine
   Ratten, Jenni-Marie
   Beyer, Matt
   Hasler, Mario
   LaRoche, Julie
   Schulz, Carsten
TI The malleable gut microbiome of juvenile rainbow trout (Oncorhynchus
   mykiss): Diet-dependent shifts of bacterial community structures
SO PLOS ONE
LA English
DT Article
ID MULTIPLE CONTRAST TESTS; PLANT-BASED DIET; GLUCOSE-METABOLISM;
   FISH-MEAL; INTESTINAL MICROBIOTA; SALMO-SALAR; ZEBRAFISH; PROTEIN;
   REPLACEMENT; CARP
AB Plant-derived protein sources are the most relevant substitutes for fishmeal in aquafeeds. Nevertheless, the effects of plant based diets on the intestinal microbiome especially of juvenile Rainbow trout (Oncorhynchus mykiss) are yet to be fully investigated. The present study demonstrates, based on 16S rDNA bacterial community profiling, that the intestinal microbiome of juvenile Rainbow trout is strongly affected by dietary plant protein inclusion levels. After first feeding of juveniles with either 0%, 50% or 97% of total dietary protein content derived from plants, statistically significant differences of the bacterial gut community for the three diet-types were detected, both at phylum and order level. The microbiome of juvenile fish consisted mainly of the phyla Proteobacteria, Firmicutes, Bacteroidetes, Fusobacteria and Actinobacteria, and thus fits the salmonid core microbiome suggested in previous studies. Dietary plant proteins significantly enhanced the relative abundance of the orders Lactobacillales, Bacillales and Pseudomonadales. Animal proteins in contrast significantly promoted Bacteroidales, Clostridiales, Vibrionales, Fusobacteriales and Alteromonadales. The overall alpha diversity significantly decreased with increasing plant protein inclusion levels and with age of experimental animals. In order to investigate permanent effects of the first feeding diet-type on the early development of the microbiome, a diet change was included in the study after 54 days, but no such effects could be detected. Instead, the microbiome of juvenile trout fry was highly dependent on the actual diet fed at the time of sampling.
C1 [Michl, Stephanie Celine; Schulz, Carsten] Gesell Marine Aquakultur mbH GMA Busum, Busum, Germany.
   [Michl, Stephanie Celine; Schulz, Carsten] Christian Albrechts Univ Kiel, Inst Anim Breeding & Husb, Dept Marine Aquaculture, Kiel, Germany.
   [Michl, Stephanie Celine] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.
   [Ratten, Jenni-Marie; Beyer, Matt; LaRoche, Julie] Dalhousie Univ, Halifax, NS, Canada.
   [Hasler, Mario] Christian Albrechts Univ Kiel, Lehrfach Variat Stat, Kiel, Germany.
RP Michl, SC (reprint author), Gesell Marine Aquakultur mbH GMA Busum, Busum, Germany.; Michl, SC (reprint author), Christian Albrechts Univ Kiel, Inst Anim Breeding & Husb, Dept Marine Aquaculture, Kiel, Germany.; Michl, SC (reprint author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.
EM michl@gma-buesum.de
RI Schulz, Carsten/C-2127-2017
FU Helmholtz Graduate School for Ocean System Science and Technology
   (HOSST); Geomar Helmholtz Centre for Ocean Research Kiel; NSERC CREATE
   Transatlantic Ocean System Science and Technology (TOSST); Dalhousie
   University; NSERC DISCOVERY; Land Schleswig-Holstein within the funding
   programme Open Access Publikationsfonds
FX SCM was supported by the Helmholtz Graduate School for Ocean System
   Science and Technology (HOSST); Geomar Helmholtz Centre for Ocean
   Research Kiel; http://www.geomar.de/ studieren/phd/hosst/. JMR was
   supported by the NSERC CREATE Transatlantic Ocean System Science and
   Technology (TOSST); Dalhousie University; http://www.tosst.org/; NSERC
   DISCOVERY grant to JLR. The authors also acknowledge financial support
   from Land Schleswig-Holstein within the funding programme Open Access
   Publikationsfonds. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; We are very grateful for the support of the Skretting
   Aquaculture Research Centre (Stavanger, Norway) by providing the
   chemical analysis of dietary fatty acids and amino acids. There are no
   conflicts of interest. We would like to thank Jennifer Tolman for her
   assistance during DNA sample preparation, Jackie Zorz and Dhwani Desai
   for their help during the QIIME data processing and our colleagues from
   GMA for substantial support during sampling. We acknowledge financial
   support by Land Schleswig-Holstein within the funding programme Open
   Access Publikationsfonds.
CR Askarian F, 2012, AQUACULTURE, V326, P1, DOI 10.1016/j.aquaculture.2011.10.016
   Atienza E, 2015, ANAEROBE, P7
   Austin B, 2006, THESCIENTIFICWORLDJO, V6, P931, DOI 10.1100/tsw.2006.181
   Bakke A, 2014, AQUACULT NUTR, V20, P381
   Balasubramanian MN, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2804-1
   Boutin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084772
   Bretz F., 2011, MULTIPLE COMP USING
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16
   Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Dawood MAO, 2015, BIOMED RES INT, DOI 10.1155/2015/514196
   Dehler CE, 2017, AQUACULTURE, V467, P149, DOI 10.1016/j.aquaculture.2016.07.017
   Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Fang L, 2014, BRIT J NUTR, V111, P808, DOI 10.1017/S0007114513003243
   Gajardo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30893
   Geurden I, 2007, AM J PHYSIOL-REG I, V292, pR2275, DOI 10.1152/ajpregu.00444.2006
   Geurden I, 2014, J EXP BIOL, V217, P3396, DOI 10.1242/jeb.106062
   Geurden I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083162
   Ghanbari M, 2015, AQUACULTURE, V448, P464, DOI 10.1016/j.aquaculture.2015.06.033
   Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108
   Hanley B, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003338
   Hardy RW, 2013, SPECIES PROFILE RAIN
   Hartung J, 1999, MULTIVARIATE STAT LE
   Hasler M, 2008, BIOMETRICAL J, V50, P793, DOI 10.1002/bimj.200710466
   Hasler M, 2014, INT J BIOSTAT, V10, P17, DOI 10.1515/ijb-2012-0015
   Hothorn T., 2008, MULTCOMP SIMULTANEOU
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Ingerslev HC, 2014, AQUACULTURE, V424, P24, DOI 10.1016/j.actuaculture.2013.12.032
   Ingerslev HC, 2014, FISH SHELLFISH IMMUN, V40, P624, DOI 10.1016/j.fsi.2014.08.021
   Izquierdo MS, 2015, AQUACULTURE, V449, P18, DOI 10.1016/j.aquaculture.2015.03.032
   JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574
   KAUSHIK SJ, 1995, AQUACULTURE, V133, P257, DOI 10.1016/0044-8486(94)00403-B
   Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010
   Li TT, 2015, MICROB ECOL, V69, P25, DOI 10.1007/s00248-014-0480-8
   Lowrey LT, 2013, FISH SHELLFISH IMMUN, V34, P1721, DOI 10.1016/j.fsi.2013.03.261
   Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x
   NRC ( National Research Council), 2011, NUTR REQ FISH SHRIMP
   Oksanen J., 2016, VEGAN COMMUNITY ECOL
   R Core Team, 2006, R LANG ENV STAT COMP
   Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043
   Ringo E, 2016, AQUACULT NUTR, V22, P219, DOI 10.1111/anu.12346
   Ringo E, 2000, J APPL MICROBIOL, V89, P317, DOI 10.1046/j.1365-2672.2000.01116.x
   Rocha F, 2015, BRIT J NUTR, V113, P403, DOI 10.1017/S0007114514003869
   Ruppert D., 1988, TRANSFORMATION WEIGH
   Schaperclaus W, 1998, LEHRBUCH TEICHWIRTSC
   Schmidt V, APPL ENV MICROBIOL
   Shafaeipour A, 2008, AQUACULT NUTR, V14, P110, DOI 10.1111/j.1365-2095.2007.00509.x
   Slawski H, 2012, AQUACULT INT, V20, P443, DOI 10.1007/s10499-011-9476-2
   Tacon AGJ, 2015, REV FISH SCI AQUAC, V23, P1, DOI 10.1080/23308249.2014.987209
   Thu TTN, 2011, AQUACULT NUTR, V17, P80, DOI 10.1111/j.1365-2095.2009.00732.x
   van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41
   Verbeke G, 2000, LINEAR MIXED MODELS
   Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883
   Wilkins LGE, 2016, MOL ECOL
   Wong S, 2013, APPL ENVIRON MICROB, V79, P4974, DOI 10.1128/AEM.00924-13
   Xia J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-634
   Yan QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030603
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
NR 63
TC 14
Z9 14
U1 4
U2 33
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 12
PY 2017
VL 12
IS 5
AR e0177735
DI 10.1371/journal.pone.0177735
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EU8UR
UT WOS:000401314500044
PM 28498878
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mori, Y
   Miyata, K
   Ono, T
   Yagi, Y
   Kamiya, K
   Amano, S
AF Mori, Yosai
   Miyata, Kazunori
   Ono, Takashi
   Yagi, Yusuke
   Kamiya, Kazutaka
   Amano, Shiro
TI Comparison of laser in situ ketatomileusis and photorefractive
   keratectomy for myopia using a mixed-effects model
SO PLOS ONE
LA English
DT Article
ID 10-YEAR FOLLOW-UP; LONG-TERM; THAN-6 DIOPTERS; KERATOMILEUSIS; SURGERY;
   LASIK
AB Purpose
   To compare the results of laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) for myopia using a mixed-effects model.
   Methods
   This comparative retrospective study was conducted in 1,127 eyes of 579 patients after LASIK and 270 eyes of 144 patients after PRK who had two or more postoperative followups after 3 months. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest refractive spherical equivalent (MRSE), percentage of eyes within 0.5 diopters (D) and 1.0 D of targeted refraction, and central corneal thickness were compared between PRK and LASIK groups using a mixed-effects model.
   Results
   Compared with the LASIK group, UCVA in the PRK group was significantly worse in the initial year but was significantly better after 4 years. The average BSCVA was not significantly different between the LASIK and PRK groups after 4 years. The average gain of BSCVA in the PRK group was significantly larger than that of the LASIK group after 2 years. MRSE in the LASIK and PRK groups showed a gradual myopic shift until 6 years after surgery. After 6 years, MRSE in the PRK group remained stable whereas MRSE in the LASIK group continued a myopic shift. The percentages of eyes within +/- 0.5 D or +/- 1.0 D in the LASIK group were significantly higher than those in the PRK group at 3 months but were significantly lower than those in the PRK group at 10 years.
   Conclusions
   PRK for myopia shows better efficacy than LASIK for myopia after 4 years.
C1 [Mori, Yosai; Miyata, Kazunori; Ono, Takashi; Yagi, Yusuke] Miyata Eye Hosp, Miyakonojo, Japan.
   [Kamiya, Kazutaka] Kitasato Univ, Sch Med, Dept Ophthalmol, Tokyo, Kanagawa, Japan.
   [Amano, Shiro] Inouye Eye Hosp, Tokyo, Japan.
RP Amano, S (reprint author), Inouye Eye Hosp, Tokyo, Japan.
EM amanoshiro1126@gmail.com
RI Ono, Takashi/Q-7570-2019
OI Ono, Takashi/0000-0002-1288-2798
CR Alio JL, 2009, BRIT J OPHTHALMOL, V93, P1313, DOI 10.1136/bjo.2007.131748
   Alio JL, 2008, AM J OPHTHALMOL, V145, P55, DOI 10.1016/j.ajo.2007.08.035
   Alio JL, 2008, AM J OPHTHALMOL, V145, P37, DOI 10.1016/j.ajo.2007.09.009
   Alio JL, 2008, AM J OPHTHALMOL, V145, P46, DOI 10.1016/j.ajo.2007.09.010
   Alio JL, 2008, AM J OPHTHALMOL, V145, P29, DOI 10.1016/j.ajo.2007.09.007
   Dirani M, 2010, J CATARACT REFR SURG, V36, P1709, DOI 10.1016/j.jcrs.2010.04.041
   El Danasoury MA, 1999, OPHTHALMOLOGY, V106, P411, DOI 10.1016/S0161-6420(99)90084-2
   El-Maghraby A, 1999, OPHTHALMOLOGY, V106, P447, DOI 10.1016/S0161-6420(99)90102-1
   Erie JC, 2006, AM J OPHTHALMOL, V141, P799, DOI 10.1016/j.ajo.2005.12.014
   Fitzmaurice GM, 2011, APPL LONGITUDINAL AN
   Hersh PS, 2000, OPHTHALMOLOGY, V107, P925, DOI 10.1016/S0161-6420(00)00059-2
   Hersh PS, 1998, OPHTHALMOLOGY, V105, P1512, DOI 10.1016/S0161-6420(98)98038-1
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Miyai T, 2008, J CATARACT REFR SURG, V34, P1527, DOI 10.1016/j.jcrs.2008.04.038
   O'Brart DPS, 2014, AM J OPHTHALMOL, V158, P651, DOI 10.1016/j.ajo.2014.06.013
   Pedersen T, 2005, J CATARACT REFR SURG, V31, P21
   Rajan MS, 2004, OPHTHALMOLOGY, V111, P1813, DOI 10.1016/j.ophtha.2004.05.019
   Rosman M, 2010, J REFRACT SURG, V26, P168, DOI 10.3928/1081597X-20100224-02
   Shortt AJ, 2006, OPHTHALMOLOGY, V113, P1897, DOI 10.1016/j.ophtha.2006.08.013
   Vestergaard AH, 2013, J REFRACT SURG, V29, P312, DOI 10.3928/1081597X-20130415-02
   Wang Z, 1997, J REFRACT SURG, V13, P528
   Yuen LH, 2010, OPHTHALMOLOGY, V117, P1236, DOI 10.1016/j.ophtha.2009.10.042
NR 22
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 31
PY 2017
VL 12
IS 3
AR e0174810
DI 10.1371/journal.pone.0174810
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER9VK
UT WOS:000399175000037
PM 28362808
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Khachatryan, E
   Camarrone, F
   Fias, W
   Van Hulle, MM
AF Khachatryan, Elvira
   Camarrone, Flavio
   Fias, Wim
   Van Hulle, Marc M.
TI ERP Response Unveils Effect of Second Language Manipulation on First
   Language Processing
SO PLOS ONE
LA English
DT Article
ID EVENT-RELATED POTENTIALS; LEXICAL ACCESS; PHONOLOGICAL REPRESENTATIONS;
   INTERLINGUAL HOMOGRAPHS; BILINGUALS; N400; TRANSLATION; ACTIVATION;
   BRAIN; RECOGNITION
AB Lexical access in bilinguals has been considered either selective or non-selective and evidence exists in favor of both hypotheses. We conducted a linguistic experiment to assess whether a bilingual's language mode influences the processing of first language information. We recorded event related potentials during a semantic priming paradigm with a covert manipulation of the second language (L2) using two types of stimulus presentations (short and long). We observed a significant facilitation of word pairs related in L2 in the short version reflected by a decrease in N400 amplitude in response to target words related to the English meaning of an inter-lingual homograph (homograph-unrelated group). This was absent in the long version, as the N400 amplitude for this group was similar to the one for the control-unrelated group. We also interviewed the participants whether they were aware of the importance of L2 in the experiment. We conclude that subjects participating in the long and short versions were in different language modes: closer to monolingual mode for the long and closer to bilingual mode for the short version; and that awareness about covert manipulation of L2 can influence the language mode, which in its turn influences the processing of the first language.
C1 [Khachatryan, Elvira; Camarrone, Flavio; Van Hulle, Marc M.] Katholieke Univ Leuven, Dept Neurosci, Lab Neuro & Psychophysiol, Leuven, Belgium.
   [Khachatryan, Elvira] Yerevan State Med Univ, Dept Neurol, Yerevan, Armenia.
   [Fias, Wim] Univ Ghent, Dept Expt Psychol, Ghent, Belgium.
RP Khachatryan, E (reprint author), Katholieke Univ Leuven, Dept Neurosci, Lab Neuro & Psychophysiol, Leuven, Belgium.; Khachatryan, E (reprint author), Yerevan State Med Univ, Dept Neurol, Yerevan, Armenia.
EM elvira.khachatryan@med.kuleuven.be
RI Fias, Wim/D-6861-2010
OI Fias, Wim/0000-0002-5788-7306
FU Belgian Fund for Scientific Research - Flanders [GOA0914N, G088314N,
   G0A0914N]; Agency for Innovation by Science and Technology in Flanders
   (IWT); Ghent University Multidisciplinary Research Partnership "The
   integrative neuroscience of behavioral control"; Interuniversity
   Attraction Poles Program of the Belgian Federal Government [P7/11];
   program Financing program [PFV/10/008]; interdisciplinary research
   project [IDO/12/007]; industrial research fund project of the KU Leuven
   [IOF/HB/12/021]; Interuniversity Attraction Poles Programme - Belgian
   Science Policy [IUAP P7/11]; Flemish Regional Ministry of Education
   (Belgium) [GOA 10/019]; Hercules Foundation [AKUL 043]
FX EK is supported by the Belgian Fund for Scientific Research - Flanders
   (GOA0914N). FC is supported by the Agency for Innovation by Science and
   Technology in Flanders (IWT). WF is supported by Ghent University
   Multidisciplinary Research Partnership "The integrative neuroscience of
   behavioral control"; and by the Interuniversity Attraction Poles Program
   of the Belgian Federal Government [grant number P7/11]. MMVH is
   supported by research grants received from the program Financing program
   (PFV/10/008), an interdisciplinary research project (IDO/12/007), and an
   industrial research fund project (IOF/HB/12/021) of the KU Leuven, the
   Belgian Fund for Scientific Research - Flanders (G088314N, G0A0914N),
   the Interuniversity Attraction Poles Programme - Belgian Science Policy
   (IUAP P7/11), the Flemish Regional Ministry of Education (Belgium) (GOA
   10/019), and the Hercules Foundation (AKUL 043). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Antoniou M, 2013, J ACOUST SOC AM, V133, P2397, DOI 10.1121/1.4792358
   Antoniou M, 2012, J PHONETICS, V40, P582, DOI 10.1016/j.wocn.2012.05.005
   Bates D., 2014, J STAT SOFTWAR UNPUB, DOI DOI 10.18637/JSS.V067.I01
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bonfiglio L, 2015, ARCH ITAL BIOL, V153, P1, DOI 10.4449/aib.v153i1.3629
   Bornkessel-Schlesewsky I, 2009, PROCESSING SYNTAX MO
   Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357
   CARAMAZZA A, 1979, B PSYCHONOMIC SOC, V13, P212, DOI 10.3758/BF03335062
   Carrasco-Ortiz H, 2012, PSYCHOPHYSIOLOGY, V49, P531, DOI 10.1111/j.1469-8986.2011.01333.x
   Chauncey K, 2008, BRAIN LANG, V105, P161, DOI 10.1016/j.bandl.2007.11.006
   Coe R., 2002, BRIT ED RES ASS ANN, P1
   Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1
   Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010
   De Bruijn E. R. A., 2001, BILING-LANG COGN, V4, P155, DOI [10.1017/S1366728901000256, DOI 10.1017/S1366728901000256]
   De Deyne S, 2008, BEHAV RES METHODS, V40, P213, DOI 10.3758/BRM.40.1.213
   de Groot AMB, 2000, Q J EXP PSYCHOL-A, V53, P397, DOI 10.1080/713755891
   Dewaele JM, 2014, INT J MULTILING, V11, P225, DOI 10.1080/14790718.2013.878347
   Dijkstra T., 1998, BILING-LANG COGN, V1, P51, DOI DOI 10.1017/S1366728998000121
   Dunn a. L, 2012, INT J BILINGUAL, P1
   Elston-Guttler KE, 2005, COGNITIVE BRAIN RES, V25, P57, DOI 10.1016/j.cogbrainres.2005.04.007
   Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8
   GERARD LD, 1989, J EXP PSYCHOL LEARN, V15, P305, DOI 10.1037/0278-7393.15.2.305
   Grosjean F., 1999, ONE MIND 2 LANGUAGES, P1
   Grosjean F., 1994, ENCY LANG LINGUIST
   Hoffer BL, 2005, INTERCULTURAL COMMUN, V14, P53
   Hoversten L, 2015, J COGNITIVE NEUROSCI, V23, P1
   Jared D, 2001, J MEM LANG, V44, P2, DOI 10.1006/jmla.2000.2747
   Kerkhofs R, 2006, BRAIN RES, V1068, P170, DOI 10.1016/j.brainres.2005.10.087
   Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643
   Kiss G. R., 1973, COMPUTER LIT STUDIES, P153
   KOYAMA S, 1992, BRAIN LANG, V43, P668, DOI 10.1016/0093-934X(92)90089-W
   KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008
   Kutas M, 2009, SCHOLARPEDIA, V4, P7790, DOI [DOI 10.4249/SCHOLARPEDIA.7790, DOI 10.4249/SCH0LARPEDIA.7790]
   Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lau EF, 2013, J NEUROSCI, V 33, P17174, DOI 10.1523/JNEUROSCI.1018-13.2013
   Luck SJ, 2005, MONOGRAPHS SOC RES C
   Mari-Beffa P, 2007, BRAIN RES, V1147, P209, DOI 10.1016/j.brainres.2007.01.124
   Marian V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043230
   Martin CD, 2009, NEUROIMAGE, V47, P326, DOI 10.1016/j.neuroimage.2009.04.025
   McKinney Wes, 2012, PYTHON DATA ANAL
   Midgley KJ, 2008, BRAIN RES, V1246, P123, DOI 10.1016/j.brainres.2008.09.078
   Moon J, 2012, BILING-LANG COGN, V15, P173, DOI 10.1017/S1366728911000022
   Moreno EM, 2008, J NEUROLINGUIST, V21, P477, DOI 10.1016/j.jneuroling.2008.01.003
   NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226
   Nunez PL, 2010, CLIN NEUROPHYSIOL, V121, P2177, DOI 10.1016/j.clinph.2010.04.029
   Okita T, 1998, PSYCHOPHYSIOLOGY, V35, P260, DOI 10.1017/S0048577298961042
   Paulmann S, 2006, NEUROREPORT, V17, P727, DOI 10.1097/01.wnr.0000214400.88845.fa
   Proverbio AM, 2002, J COGNITIVE NEUROSCI, V14, P994, DOI 10.1162/089892902320474463
   Rodriguez-Fornells A, 2002, NATURE, V415, P1026, DOI 10.1038/4151026a
   Roelofs A, 2002, BILING-LANG COGN, V5, P214, DOI 10.1017/S1366728902263014
   SOARES C, 1984, MEM COGNITION, V12, P380, DOI 10.3758/BF03198298
   Spivey MJ, 1999, PSYCHOL SCI, V10, P281, DOI 10.1111/1467-9280.00151
   Team RDC, 2008, R LANG ENV STAT COMP
   Thierry G, 2007, P NATL ACAD SCI USA, V104, P12530, DOI 10.1073/pnas.0609927104
   van Hell JG, 2002, PSYCHON B REV, V9, P780, DOI 10.3758/BF03196335
   van Heuven WJB, 2010, BRAIN RES REV, V64, P104, DOI 10.1016/j.brainresrev.2010.03.002
   van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584
   Van Petten C, 2014, INT J PSYCHOPHYSIOL, V94, P407, DOI 10.1016/j.ijpsycho.2014.10.012
   Van Vliet M, 2014, PLOS ONE, P9
   van Vliet M, 2016, IEEE T BIO-MED ENG, V63, P55, DOI 10.1109/TBME.2015.2468588
   Verbeke G, 2000, LINEAR MIXED MODELS
   Wong B, 2016, BIOMED RES INT, DOI 10.1155/2016/7069274
   Wu Y., 2010, FRONTIERS LANGUAGE S, V1, P1
   Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305
NR 65
TC 2
Z9 2
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 28
PY 2016
VL 11
IS 11
AR e0167194
DI 10.1371/journal.pone.0167194
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE3FE
UT WOS:000389472400099
PM 27893807
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Neveu, R
   Neveu, D
   Barbalat, G
   Schmidt, U
   Coricelli, G
   Nicolas, A
AF Neveu, Remi
   Neveu, Dorine
   Barbalat, Guillaume
   Schmidt, Ulrike
   Coricelli, Giorgio
   Nicolas, Alain
TI The Sequential Binge, a New Therapeutic Approach for Binge Eating: A
   Pilot Study
SO PLOS ONE
LA English
DT Article
ID COGNITIVE-BEHAVIORAL THERAPY; SENSORY-SPECIFIC SATIETY; BULIMIA-NERVOSA
   PATIENTS; RESPONSE-INHIBITION; FOOD SELECTION; OBESE WOMEN; DISORDER;
   PREDICTORS; ATTENTION; IMPULSIVITY
AB Background and Objectives
   A sizeable proportion of patients experiencing binge eating do not respond to cognitive behavioral therapy (CBT). We present the sequential binge (SB), a new behavioral intervention that complements CBT, and preliminary results of its effects. SB breaks up the binge into repeated identical sequences of eating separated by incremental pauses. This pattern of ingestion aims at facilitating boredom toward the ingested foods and at turning cognitive control away from binge food restriction. SB is hypothesized to reduce food intake during the binge and the number of daily binges.
   Methods
   Prospective pilot study. Fifteen binging patients with previous unsuccessful intensive CBT were given SB as an adjunct to their treatment and were followed up for 16 weeks from admission. All patients were reassessed 47 weeks on average after discharge.
   Results
   SB was associated with a 44% relative reduction in the planned food intake (p<0.001), a longer consecutive binge refractory period compared to regular binges (median: 48 hours versus 4 hours, p = 0.002) and an average relative reduction by 26% of binge number the day after each SB (p = 0.004). 47% of patients reached binge abstinence for four consecutive weeks 16 weeks after the first SB.
   Conclusion
   This case series shows promising evidence for the use of SB in patients with refractory binge eating. Further evaluation in a prospective randomized controlled trial would be justified.
C1 [Neveu, Remi] Univ Lyon 1, Team Olfact Coding Memory, Neurosci Res Ctr, CNRS,UMR5292,INSERM,U1028, F-69366 Lyon, France.
   [Neveu, Dorine] Univ Montpellier I, Montpellier, France.
   [Neveu, Dorine] INSERM, U1058, Montpellier, France.
   [Neveu, Dorine] CHU Montpellier, Dept Informat Med, Montpellier, France.
   [Barbalat, Guillaume] Greenlane Clin Ctr, Reg Eating Disorders Serv, Auckland, New Zealand.
   [Schmidt, Ulrike] Kings Coll London, Inst Psychiat, Sect Eating Disorders PO59, De Crespigny Pk, London SE5 8AF, England.
   [Coricelli, Giorgio] Univ Southern Calif, Los Angeles, CA USA.
   [Coricelli, Giorgio] Univ Trento, Interdept Ctr Mind Brain Sci CIMeC, Trento, Italy.
   [Nicolas, Alain] Hop Vinatier, Bron, France.
RP Neveu, R (reprint author), Univ Lyon 1, Team Olfact Coding Memory, Neurosci Res Ctr, CNRS,UMR5292,INSERM,U1028, F-69366 Lyon, France.
EM remi.neveu@isc.cnrs.fr
FU Praxis and European Research Council (ERC Consolidator) grant [617629];
   CNRS (Centre National de la Recherche Scientifique); Montpellier
   hospital
FX This work was funded by Praxis and European Research Council (ERC
   Consolidator grant 617629) grant, and supported by CNRS (Centre National
   de la Recherche Scientifique) and Montpellier hospital. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Agras WS, 2000, AM J PSYCHIAT, V157, P1302, DOI 10.1176/appi.ajp.157.8.1302
   AGRAS WS, 1995, J CONSULT CLIN PSYCH, V63, P356, DOI 10.1037/0022-006X.63.3.356
   Alvarez-Moya EM, 2009, J INT NEUROPSYCH SOC, V15, P302, DOI 10.1017/S1355617709090377
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Avena NM, 2012, NEUROPHARMACOLOGY, V63, P87, DOI 10.1016/j.neuropharm.2011.11.010
   Bacaltchuk J, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003385
   Baer R. A., 2005, J RATION-EMOT COGN-B, V23, P281, DOI DOI 10.1007/S10942-005-0015-9
   Bartholome LT, 2013, EUR J NUTR, V52, P193, DOI 10.1007/s00394-012-0302-z
   Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004
   Bellisle F, 2003, PHYSIOL BEHAV, V79, P183, DOI 10.1016/S0031-9384(03)00088-X
   Brandimonte MA, 2011, MEMORY, V19, P56, DOI 10.1080/09658211.2010.535657
   Brondel L, 2009, APPETITE, V53, P203, DOI 10.1016/j.appet.2009.06.009
   Brownstone LM, 2013, INT J EAT DISORDER, V46, P66, DOI 10.1002/eat.22066
   Bulik CM, 1999, INT J EAT DISORDER, V26, P137, DOI 10.1002/(SICI)1098-108X(199909)26:2<137::AID-EAT2>3.3.CO;2-E
   Byrne SM, 2011, BEHAV RES THER, V49, P219, DOI 10.1016/j.brat.2011.01.006
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   Diggle PJ, 2002, ANAL LONGITUDINAL DA
   Duggan C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-335
   Fairburn C. G., 2008, COGNITIVE BEHAV THER
   Fairburn C. G., 1995, OVERCOMING BINGE EAT
   Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1
   FAIRBURN CG, 1993, BINGE EATING NATURE
   Fay SH, 2011, APPETITE, V56, P284, DOI 10.1016/j.appet.2011.01.006
   Fernandez-Aranda F, 2015, CYBERPSYCH BEH SOC N, V18, P744, DOI 10.1089/cyber.2015.0265
   Flament MF, 2012, INT J NEUROPSYCHOPH, V15, P189, DOI 10.1017/S1461145711000381
   Goldstein M, 2014, EUR EAT DISORD REV, V22, P217, DOI 10.1002/erv.2281
   HADIGAN CM, 1989, AM J CLIN NUTR, V50, P759
   Hay PPJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000562.pub3
   HETHERINGTON M, 1989, APPETITE, V12, P57, DOI 10.1016/0195-6663(89)90068-8
   Hetherington MM, 1996, NEUROSCI BIOBEHAV R, V20, P113, DOI 10.1016/0149-7634(95)00048-J
   Johansson Linda, 2005, Eat Behav, V6, P271, DOI 10.1016/j.eatbeh.2004.11.001
   Kahn BE, 2004, J CONSUM RES, V30, P519, DOI 10.1086/380286
   Keel PK, 1997, AM J PSYCHIAT, V154, P313
   Kissileff HR, 2008, PHYSIOL BEHAV, V93, P481, DOI 10.1016/j.physbeh.2007.10.007
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   McClelland A, 2006, J CLIN PSYCHOL, V62, P355, DOI 10.1002/jclp.20216
   Meister R, 2016, J CLIN EPIDEMIOL, V71, P97, DOI 10.1016/j.jclinepi.2015.10.007
   National Institute for Clinical Excellence (NICE), 2004, EAT DIS COR INT TREA
   Neef NA, 2001, J APPL BEHAV ANAL, V34, P397, DOI 10.1901/jaba.2001.34-397
   Neveu R, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00065, 10.3339/fnbeh.2016.00065]
   Neveu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105657
   Perroud A, 2001, FAIRE FACE BOULIMIE
   Piqueras-Fiszman B, 2014, COLOUR PLEASANTNESS
   Polivy J, 2005, INT J EAT DISORDER, V38, P301, DOI 10.1002/eat.20195
   Raymond NC, 2007, INT J EAT DISORDER, V40, P67, DOI 10.1002/eat.20312
   Rigaud DJ, 2011, JPEN-PARENTER ENTER, V35, P356, DOI 10.1177/0148607110382422
   Rosval L, 2006, INT J EAT DISORDER, V39, P590, DOI 10.1002/eat.20296
   Vansteelandt S, 2009, EPIDEMIOLOGY, V20, P851, DOI 10.1097/EDE.0b013e3181b6f4c9
   Wansink B, 2003, J CONSUM RES, V30, P455, DOI 10.1086/378621
   Wilkinson LL, 2013, APPETITE, V60, P175, DOI 10.1016/j.appet.2012.10.001
   Wilson GT, 1999, J CONSULT CLIN PSYCH, V67, P451, DOI 10.1037/0022-006X.67.4.451
   Wilson GT, 1996, BEHAV RES THER, V34, P197, DOI 10.1016/0005-7967(95)00068-2
NR 52
TC 2
Z9 2
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 10
PY 2016
VL 11
IS 11
AR e0165696
DI 10.1371/journal.pone.0165696
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB9ON
UT WOS:000387725000026
PM 27832121
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Musekiwa, A
   Manda, SOM
   Mwambi, HG
   Chen, DG
AF Musekiwa, Alfred
   Manda, Samuel O. M.
   Mwambi, Henry G.
   Chen, Ding-Geng
TI Meta-Analysis of Effect Sizes Reported at Multiple Time Points Using
   General Linear Mixed Model
SO PLOS ONE
LA English
DT Article
ID MULTIVARIATE METAANALYSIS; REGRESSION; OUTCOMES; PACKAGE; TRIALS
AB Meta-analysis of longitudinal studies combines effect sizes measured at pre-determined time points. The most common approach involves performing separate univariate metaanalyses at individual time points. This simplistic approach ignores dependence between longitudinal effect sizes, which might result in less precise parameter estimates. In this paper, we show how to conduct a meta-analysis of longitudinal effect sizes where we contrast different covariance structures for dependence between effect sizes, both within and between studies. We propose new combinations of covariance structures for the dependence between effect size and utilize a practical example involving meta-analysis of 17 trials comparing postoperative treatments for a type of cancer, where survival is measured at 6, 12, 18 and 24 months post randomization. Although the results from this particular data set show the benefit of accounting for within-study serial correlation between effect sizes, simulations are required to confirm these results.
C1 [Musekiwa, Alfred; Manda, Samuel O. M.; Mwambi, Henry G.] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa.
   [Manda, Samuel O. M.] South African Med Res Council, Biostat Unit, Pretoria, South Africa.
   [Chen, Ding-Geng] Univ N Carolina, Sch Social Work, Chapel Hill, NC USA.
   [Chen, Ding-Geng] Univ Pretoria, Dept Stat, Pretoria, South Africa.
RP Musekiwa, A (reprint author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa.
EM Alfred.Musekiwa@gmail.com
CR Ahn JE, 2010, J PHARMACOKINET PHAR, V37, P179, DOI 10.1007/s10928-010-9152-6
   Al-Jewair TS, 2009, J DENT EDUC, V73, P730
   Bax L, 2006, MIX COMPREHENSIVE FR
   Berkey CS, 1998, STAT MED, V17, P2537, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2537::AID-SIM953>3.0.CO;2-C
   Borenstein M, 2005, COMPREHENSIVE METAAN
   Borenstein M., 2009, INTRO METAANALYSIS
   BRADBURN M, 1998, STATA TECH B, V44, P1
   Cooper H, 2009, HDB RES SYNTHESIS ME
   Egger M, 2008, SYSTEMATIC REV HLTH
   FINE HA, 1993, CANCER, V71, P2585, DOI 10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S
   Gasparrini A, 2012, STAT MED, V31, P3821, DOI 10.1002/sim.5471
   Gleser LJ, 1994, HDB RES SYNTHESIS, P339
   Hedges L. V., 1985, STAT METHODS METAANA
   Higgins JP, 2008, COCHRANE HDB SYSTEMA
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Ishak KJ, 2007, CLIN TRIALS, V4, P525, DOI 10.1177/1740774507083567
   Jackson D, 2011, STAT MED, V30, P2481, DOI 10.1002/sim.4172
   Kirkham JJ, 2012, STAT MED, V31, P2179, DOI 10.1002/sim.5356
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406
   Lipsey M., 2001, PRACTICAL METAANALYS
   Litell J, 2008, SYSTEMATIC REV METAA
   Liu YX, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005467.pub2
   Luo S, 2014, J STAT SOFTW, V56, P1
   Mavridis D, 2012, STAT METHODS MED RES, P1
   MayoSmith MF, 1997, JAMA-J AM MED ASSOC, V278, P144, DOI 10.1001/jama.278.2.144
   Musekiwa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077014
   Pigott T., 2012, ADV METAANALYSIS, DOI [10.1007/978-1-4614-2278-5, DOI 10.1007/978-1-4614-2278-5]
   RAUDENBUSH SW, 1988, PSYCHOL BULL, V103, P111, DOI 10.1037/0033-2909.103.1.111
   Riley RD, 2009, J R STAT SOC A STAT, V172, P789, DOI 10.1111/j.1467-985X.2008.00593.x
   Rosenberg MS, 2000, STAT SOFTWARE META A
   ROSENTHAL R, 1986, PSYCHOL BULL, V99, P400, DOI 10.1037/0033-2909.99.3.400
   SAS Institute Inc, 2013, SAS STAT 9 3 US GUID
   Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007
   Sohn SY, 2000, NAV RES LOG, V47, P500, DOI 10.1002/1520-6750(200009)47:6<500::AID-NAV3>3.0.CO;2-Z
   Sutton AJ, 2000, METHODS METAANALYSIS
   The Nordic Cochrane Centre, 2014, REV MAN REVMAN COMP
   Trikalinos TA, 2013, AHRQ PUBLICATION, V13(14)-EHC084-EF
   Trikalinos TA, 2014, STAT MED, V33, P1441, DOI 10.1002/sim.6044
   Trikalinos TA, 2012, CLIN TRIALS, V9, P610, DOI 10.1177/1740774512453218
   Uman LS, 2008, J PEDIATR PSYCHOL, V33, P842, DOI 10.1093/jpepsy/jsn031
   van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040
   Verbeke G, 2000, LINEAR MIXED MODELS, DOI [10.1007/978-1-4419-0300-6, DOI 10.1007/978-1-4419-0300-6]
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   Wallace BC, 2012, J STAT SOFTW, V49, P1
   Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80
   White IR, 2009, STATA J, V9, P40, DOI 10.1177/1536867X0900900103
   Whitehead A, 2002, METAANALYSIS CONTROL, DOI [10.1002/0470854200, DOI 10.1002/0470854200]
NR 49
TC 5
Z9 5
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 31
PY 2016
VL 11
IS 10
AR e0164898
DI 10.1371/journal.pone.0164898
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EA6BX
UT WOS:000386711100015
PM 27798661
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tabatabai, MA
   Kengwoung-Keumo, JJ
   Oates, GR
   Guemmegne, JT
   Akinlawon, A
   Ekadi, G
   Fouad, MN
   Singh, KP
AF Tabatabai, Mohammad A.
   Kengwoung-Keumo, Jean-Jacques
   Oates, Gabriela R.
   Guemmegne, Juliette T.
   Akinlawon, Akinola
   Ekadi, Green
   Fouad, Mona N.
   Singh, Karan P.
TI Racial and Gender Disparities in Incidence of Lung and Bronchus Cancer
   in the United States: A Longitudinal Analysis
SO PLOS ONE
LA English
DT Article
ID MIXED EFFECTS MODELS; SOCIOECONOMIC-STATUS; SMOKING; MORTALITY; BLACKS;
   WHITES; TRENDS; RATES
AB Background
   Certain population groups in the United States carry a disproportionate burden of cancer. This work models and analyzes the dynamics of lung and bronchus cancer age-adjusted incidence rates by race (White and Black), gender (male and female), and prevalence of daily smoking in 38 U.S. states, the District of Columbia, and across eight U.S. geographic regions from 1999 to 2012.
   Methods
   Data, obtained from the U.S. Cancer Statistics Section of the Centers for Disease Control and Prevention, reflect approximately 77% of the U.S. population and constitute a representative sample for making inferences about incidence rates in lung and bronchus cancer (henceforth lung cancer). A longitudinal linear mixed-effects model was used to study lung cancer incidence rates and to estimate incidence rate as a function of time, race, gender, and prevalence of daily smoking.
   Results
   Between 1999 and 2012, age-adjusted incidence rates in lung cancer have decreased in all states and regions. However, racial and gender disparities remain. Whites continue to have lower age-adjusted incidence rates for this cancer than Blacks in all states and in five of the eight U.S. geographic regions. Disparities in incidence rates between Black and White men are significantly larger than those between Black and White women, with Black men having the highest incidence rate of all subgroups. Assuming that lung cancer incidence rates remain within reasonable range, the model predicts that the gender gap in the incidence rate for Whites would disappear by mid-2018, and for Blacks by 2026. However, the racial gap in lung cancer incidence rates among Black and White males will remain. Among all geographic regions, the Mid-South has the highest overall lung cancer incidence rate and the highest incidence rate for Whites, while the Midwest has the highest incidence rate for Blacks. Between 1999 and 2012, there was a downward trend in the prevalence of daily smokers in both genders. However, males have significantly higher rates of cigarette smoking than females at all time points. The highest and lowest prevalence of daily smoking are found in the Mid-South and New England, respectively. There was a significant correlation between lung cancer incidence rates and smoking prevalence in all geographic regions, indicating a strong influence of cigarette smoking on regional lung cancer incidence rates.
   Conclusion
   Although age-adjusted incidence rates in lung cancer have decreased throughout the U.S., racial and gender disparities remain. This longitudinal model can help health professionals and policy makers make predictions of age-adjusted incidence rates for lung cancer in the U.S. in the next five to ten years.
C1 [Tabatabai, Mohammad A.; Ekadi, Green] Meharry Med Coll, Sch Grad Studies & Res, Nashville, TN 37208 USA.
   [Kengwoung-Keumo, Jean-Jacques] Cameron Univ, Dept Math Sci, Lawton, OK 73505 USA.
   [Oates, Gabriela R.; Fouad, Mona N.; Singh, Karan P.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35294 USA.
   [Guemmegne, Juliette T.] Univ New Mexico, Dept Econ, MSC 05 3060, Albuquerque, NM 87131 USA.
   [Akinlawon, Akinola] Cameron Univ, Dept Comp & Technol, Lawton, OK 73505 USA.
   [Fouad, Mona N.; Singh, Karan P.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA.
RP Singh, KP (reprint author), Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35294 USA.; Singh, KP (reprint author), Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA.
EM kpsingh@uab.edu
RI Oates, Gabriela/M-3365-2015
OI Oates, Gabriela/0000-0003-4052-1524
FU National Cancer Institute [P30 CA013148, 2U54-CA118948]; National
   Institute on Minority Health and Health Disparities [U54MD008176];
   Cameron University, Lawton, Oklahoma
FX This research was supported by the National Cancer Institute
   (http://www.cancer.gov/) grant P30 CA013148. Mona N. Fouad and Karan P.
   Singh received this funding. National Cancer Institute grant
   2U54-CA118948 also supported this work. Mona N. Fouad and Karan P. Singh
   received this funding. This work was also supported in part by the
   National Institute on Minority Health and Health Disparities
   (http://www.nimhd.nih.gov/) (grant U54MD008176, Mona N. Fouad, P.I.).
   Mona Fouad, Karan P. Singh, and Gabriela R. Oates were supported by this
   funding. Also, this work was supported intramurally by Cameron
   University, Lawton, Oklahoma (http://www.cameron.edu/) (Jean-Jacques
   Kengwoung-Keumo and Akinola Akinlawon were supported by this funding).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; This research
   was supported by the National Cancer Institute (grants P30 CA013148 and
   2U54-CA118948), the National Institute on Minority Health and Health
   Disparities (grant U54MD008176), and intramurally by Cameron University,
   Lawton, Oklahoma.
CR Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873
   Aldrich MC, 2013, J THORAC ONCOL, V8, P1248, DOI 10.1097/JTO.0b013e3182a406f6
   [Anonymous], 2015, US CANC STAT WONDER
   [Anonymous], 2014, BEH RISK FACT SURV S, DOI DOI 10.1002/SIM.1572
   Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606
   Byers T, 2010, ANNU REV PUBL HEALTH, V31, P121, DOI 10.1146/annurev.publhealth.121208.131047
   Centers for Disease Control and Prevention, 2016, WHAT AR RISK FACT LU
   Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1434
   Centers for Disease Control and Prevention Division of Cancer Prevention and Control, 2016, LUNG CANC RAT RAC ET
   Davis VN, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120271
   Dwyer-Lindgren L, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-5
   Farjah F, 2009, ARCH SURG-CHICAGO, V144, P14, DOI 10.1001/archsurg.2008.519
   Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P3
   Freeman Harold P, 2005, Surg Oncol Clin N Am, V14, P655, DOI 10.1016/j.soc.2005.06.002
   Freeman HP, 2004, CA-CANCER J CLIN, V54, P72, DOI 10.3322/canjclin.54.2.72
   Gadgeel SM, 2003, CANCER METAST REV, V22, P39, DOI 10.1023/A:1022207917249
   Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808
   Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250
   Harper S, 2008, AM J EPIDEMIOL, V167, P889, DOI 10.1093/aje/kwn016
   Houston KA, 2014, LUNG CANCER, V86, P22, DOI 10.1016/j.lungcan.2014.08.001
   Hu SS, 2016, MMWR-MORBID MORTAL W, V65, P685, DOI 10.15585/mmwr.mm6527a1
   Jemal A., 2013, JNCI-J NATL CANCER I, V105, P175, DOI [10.1093/jnci/dis491, DOI 10.1093/JNCI/DIS491]
   Jemal A, 2009, CANCER EPIDEM BIOMAR, V18, P3349, DOI 10.1158/1055-9965.EPI-09-0740
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087
   Meza R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121323
   Narcisse MR, 2009, SOCIOL HEALTH ILL, V31, P583, DOI 10.1111/j.1467-9566.2009.01159.x
   Pampel FC, 2004, J HEALTH SOC BEHAV, V45, P306, DOI 10.1177/002214650404500305
   Pampel F, 2015, SOC SCI MED, V127, P41, DOI 10.1016/j.socscimed.2014.06.033
   Plescia M, 2014, AM J PUBLIC HEALTH, V104, pS388, DOI 10.2105/AJPH.2013.301609
   Tabatabai M, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-14
   Tabatabai MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107242
   Torre Lindsey A, 2016, Adv Exp Med Biol, V893, P1, DOI 10.1007/978-3-319-24223-1_1
   Trichopoulos D, 2000, BMJ-BRIT MED J, V320, P321, DOI [10.1002/1097-0142(20010101)91:1+&LT;205::AID-CNCR5&GT;3.0.CO;2-K, DOI 10.1002/1097-0142(20010101)91:1+&LT;205::AID-CNCR5&GT;3.0.CO;2-K]
   Underwood JM, 2012, CANCER-AM CANCER SOC, V118, P1910, DOI 10.1002/cncr.26479
   Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78
   Williams M D, 2001, Cancer Treat Res, V105, P31
   Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572
NR 38
TC 4
Z9 4
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 29
PY 2016
VL 11
IS 9
AR e0162949
DI 10.1371/journal.pone.0162949
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DX4CV
UT WOS:000384328500017
PM 27685944
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU de Diego-Balaguer, R
   Schramm, C
   Rebeix, I
   Dupoux, E
   Durr, A
   Brice, A
   Charles, P
   de Langavant, LC
   Youssov, K
   Verny, C
   Damotte, V
   Azulay, JP
   Goizet, C
   Simonin, C
   Tranchant, C
   Maison, P
   Rialland, A
   Schmitz, D
   Jacquemot, C
   Fontaine, B
   Bachoud-Levi, AC
AF de Diego-Balaguer, Ruth
   Schramm, Catherine
   Rebeix, Isabelle
   Dupoux, Emmanuel
   Durr, Alexandra
   Brice, Alexis
   Charles, Perrine
   de langavant, Laurent Cleret
   Youssov, Katia
   Verny, Christophe
   Damotte, Vincent
   Azulay, Jean-Philippe
   Goizet, Cyril
   Simonin, Clemence
   Tranchant, Christine
   Maison, Patrick
   Rialland, Amandine
   Schmitz, David
   Jacquemot, Charlotte
   Fontaine, Bertrand
   Bachoud-Levi, Anne-Catherine
CA French Speaking Huntington Grp
TI COMT Val(158)Met Polymorphism Modulates Huntington's Disease Progression
SO PLOS ONE
LA English
DT Article
ID TRINUCLEOTIDE REPEAT LENGTH; AGE-OF-ONSET; PARKINSONS-DISEASE; COGNITIVE
   DECLINE; CLINICAL PROGRESSION; GENETIC MODIFIERS; LONGITUDINAL DATA;
   DOPAMINE; GENOTYPE; NEURODEGENERATION
AB Little is known about the genetic factors modulating the progression of Huntington's disease (HD). Dopamine levels are affected in HD and modulate executive functions, the main cognitive disorder of HD. We investigated whether the Val (158)Met polymorphism of the catechol-O-methyltransferase (COMT) gene, which influences dopamine (DA) degradation, affects clinical progression in HD. We carried out a prospective longitudinal multicenter study from 1994 to 2011, on 438 HD gene carriers at different stages of the disease (34 pre-manifest; 172 stage 1; 130 stage 2; 80 stage 3; 17 stage 4; and 5 stage 5), according to Total Functional Capacity (TFC) score. We used the Unified Huntington's Disease Rating Scale to evaluate motor, cognitive, behavioral and functional decline. We genotyped participants for COMT polymorphism (107 Met-homozygous, 114 Val-homozygous and 217 heterozygous). 367 controls of similar ancestry were also genotyped. We compared clinical progression, on each domain, between groups of COMT polymorphisms, using latent-class mixed models accounting for disease duration and number of CAG (cytosine adenine guanine) repeats. We show that HD gene carriers with fewer CAG repeats and with the Val allele in COMT polymorphism displayed slower cognitive decline. The rate of cognitive decline was greater for Met/Met homozygotes, which displayed a better maintenance of cognitive capacity in earlier stages of the disease, but had a worse performance than Val allele carriers later on. COMT polymorphism did not significantly impact functional and behavioral performance. Since COMT polymorphism influences progression in HD, it could be used for stratification in future clinical trials. Moreover, DA treatments based on the specific COMT polymorphism and adapted according to disease duration could potentially slow HD progression.
C1 [de Diego-Balaguer, Ruth; Schramm, Catherine; de langavant, Laurent Cleret; Youssov, Katia; Maison, Patrick; Jacquemot, Charlotte; Bachoud-Levi, Anne-Catherine] INSERM, U955, Equipe Neuropsychol Intervent 01, F-94000 Creteil, France.
   [de Diego-Balaguer, Ruth; Schramm, Catherine; Dupoux, Emmanuel; de langavant, Laurent Cleret; Youssov, Katia; Maison, Patrick; Jacquemot, Charlotte; Bachoud-Levi, Anne-Catherine] PSL Res Univ, Dept Etud Cognit, Ecole Normale Super, F-75005 Paris, France.
   [de Diego-Balaguer, Ruth; Schramm, Catherine; de langavant, Laurent Cleret; Youssov, Katia; Maison, Patrick; Jacquemot, Charlotte; Bachoud-Levi, Anne-Catherine] Univ Paris Est, Fac Med, F-94000 Creteil, France.
   [de Diego-Balaguer, Ruth] ICREA, Barcelona 08010, Spain.
   [de Diego-Balaguer, Ruth] Univ Barcelona, Dept Cognicio Desenvolupament & Psicol Educ, Barcelona 08035, Spain.
   [de Diego-Balaguer, Ruth] IDIBELL, Unitat Cognicio & Plasticitat Cerebral, Lhospitalet De Llobregat 08907, Spain.
   [de Diego-Balaguer, Ruth] Univ Barcelona, Inst Neurociencia, Barcelona, Spain.
   [Rebeix, Isabelle; Durr, Alexandra; Brice, Alexis; Damotte, Vincent] INSERM UPMC CNRS, UMR 7225 1127, Inst Cerveau Moelle, Hop Pitie Salpetriere, F-74013 Paris, France.
   [Rebeix, Isabelle; Damotte, Vincent; Fontaine, Bertrand] Hop La Pitie Salpetriere, AP HP, Dept Malad Syst Nerveux, F-74013 Paris, France.
   [Dupoux, Emmanuel] ENS EHESS CNRS, Lab Sci Cognit & Psycholinguist, F-75005 Paris, France.
   [Durr, Alexandra; Brice, Alexis; Charles, Perrine; Fontaine, Bertrand] Hop La Pitie Salpetriere, AP HP, Dept Genet, F-74013 Paris, France.
   [de langavant, Laurent Cleret; Youssov, Katia; Bachoud-Levi, Anne-Catherine] Hop Henri Mondor Albert Chenevier, AP HP, Ctr Reference Malad Huntington, Serv Neurol, F-94000 Creteil, France.
   [Verny, Christophe] CHU Angers, Ctr Reference Malad Neurogenerat, Serv Neurol, F-49933 Angers, France.
   [Azulay, Jean-Philippe] CHU Marseille, Hop Timone, Serv Neurol & Pathol Mouvement, F-13385 Marseille, France.
   [Goizet, Cyril] CHU Bordeaux, GH Sud, Hop Haut Leveque, Serv Neurol, F-33604 Pessac, France.
   [Simonin, Clemence] CHRU Lille, Serv Neurol & Pathol Mouvement, F-59000 Lille, France.
   [Simonin, Clemence] Univ Lille, INSERM UMR S 1172, JPArc, Ctr Rech Jean Pierre Aubert Neurosci & Canc, F-59000 Lille, France.
   [Tranchant, Christine] CHU Strasbourg, Serv Neurol, Hop Hautepierre, F-67098 Strasbourg, France.
   [Maison, Patrick; Rialland, Amandine; Schmitz, David] Hop Henri Mondor, AP HP, Unite Rech Clin, F-94000 Creteil, France.
RP Bachoud-Levi, AC (reprint author), INSERM, U955, Equipe Neuropsychol Intervent 01, F-94000 Creteil, France.; Bachoud-Levi, AC (reprint author), PSL Res Univ, Dept Etud Cognit, Ecole Normale Super, F-75005 Paris, France.; Bachoud-Levi, AC (reprint author), Univ Paris Est, Fac Med, F-94000 Creteil, France.; Bachoud-Levi, AC (reprint author), Hop Henri Mondor Albert Chenevier, AP HP, Ctr Reference Malad Huntington, Serv Neurol, F-94000 Creteil, France.
EM bachoud@gmail.com
RI UBneuro, UBneuro/U-8656-2017
OI Cleret de Langavant, Laurent/0000-0001-6551-4641; Bachoud-Levi,
   Anne-Catherine/0000-0003-3000-2210; Simonin,
   Clemence/0000-0002-2282-4372; Jacquemot, Charlotte/0000-0002-6611-0742;
   Damotte, Vincent/0000-0002-7321-8575
FU Gis [A02216JS/A04159JS]; Assistance Publique-Hopitaux de Paris
   (Departement de la Recherche Clinique et du Developpement); INSERM;
   French Ministry of Health; Ministerio de Economia y Competitividad
   (MINECO) [PSI2011-23624]; NeuroStemcell Consortium (European Community
   Seventh Framework Program) [222943]; investment for the future
   NeurATRIS: Infrastructure de recherche translationnelle pour les
   biotherapies en Neurosciences [ANR-11-INBS-0011]; IHU grant
   [ANR-10-IAIHU-06]; AP-HP/CEA interface contract;  [ANR-10-LBX-0087 IEC];
    [ANR-10-IDEX-0001-02 PSL*]; ICREA
FX A-C Bachoud-Levi is the PI of the biomarker program initially funded by
   Gis A02216JS/A04159JS and then by Assistance Publique-Hopitaux de Paris
   (Departement de la Recherche Clinique et du Developpement); she had full
   access to all of the data for this study and takes responsibility for
   the integrity of the data and the accuracy of data analysis. She is
   supported by an interface contract from INSERM and is the Head of the
   French National Center for Huntington's Disease (funded by the French
   Ministry of Health). R de Diego-Balaguer was supported by grant
   PSI2011-23624 from the Ministerio de Economia y Competitividad (MINECO).
   C Schramm was supported by the NeuroStemcell Consortium (European
   Community Seventh Framework Program grant agreement no. 222943) and by
   investment for the future NeurATRIS: Infrastructure de recherche
   translationnelle pour les biotherapies en Neurosciences
   (ANR-11-INBS-0011). Additional support was provided by ANR-10-LBX-0087
   IEC and ANR-10-IDEX-0001-02 PSL* grants. A Durr, A Brice, V Damotte, I
   Rebeix and B Fontaine were supported by IHU grant ANR-10-IAIHU-06. L
   Cleret de Langavant was supported by an AP-HP/CEA interface contract.
   The funders had no role in study design, data collection and analysis,
   the decision to publish, or preparation of the manuscript.
CR Arning L, 2013, NEUROGENETICS, V14, P171, DOI 10.1007/s10048-013-0365-x
   Aziz NA, 2009, NEUROLOGY, V73, P1280, DOI 10.1212/WNL.0b013e3181bd1121
   Becanovic K, 2015, NAT NEUROSCI, V18, P807, DOI 10.1038/nn.4014
   Biglan KM, 2016, JAMA NEUROL, V73, P102, DOI 10.1001/jamaneurol.2015.2736
   BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361
   Brandt J, 1996, NEUROLOGY, V46, P527, DOI 10.1212/WNL.46.2.527
   Cardebat D, ACTA MED BELGICA, V90, P207
   Charvin D, 2005, P NATL ACAD SCI USA, V102, P12218, DOI 10.1073/pnas.0502698102
   Charvin D, 2008, NEUROBIOL DIS, V29, P22, DOI 10.1016/j.nbd.2007.07.028
   Chen JY, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00114
   Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589
   Choi ML, 2014, NEUROBIOL DIS, V66, P19, DOI 10.1016/j.nbd.2014.02.004
   Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024
   Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028
   Corvol JC, 2011, ANN NEUROL, V69, P111, DOI 10.1002/ana.22155
   Epping EA, 2016, AM J PSYCHIAT, V173, P184, DOI 10.1176/appi.ajp.2015.14121551
   Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067
   Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96
   Gennatas ED, 2012, NEUROLOGY, V78, P1663, DOI 10.1212/WNL.0b013e3182574fa1
   Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572
   Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461
   Gusella JF, 2014, MOVEMENT DISORD, V29, P1359, DOI 10.1002/mds.26001
   Harbo HF, 2009, EUR J NEUROL, V16, P777, DOI 10.1111/j.1468-1331.2009.02646.x
   KIEBURTZ K, 1994, J MED GENET, V31, P872, DOI 10.1136/jmg.31.11.872
   Kieburtz K, 1996, MOVEMENT DISORD, V11, P136
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992
   Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683
   Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804
   Mura T, 2014, J NEUROL NEUROSUR PS, V85, P363, DOI 10.1136/jnnp-2013-305078
   Naes T, 2001, J CHEMOMETR, V15, P413
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Pavese N, 2010, NEUROBIOL DIS, V37, P356, DOI 10.1016/j.nbd.2009.10.015
   Proust-Lima C, 2013, BRIT J MATH STAT PSY, V66, P470, DOI 10.1111/bmsp.12000
   Ramos EM, 2013, NEUROGENETICS, V14, P173, DOI 10.1007/s10048-013-0364-y
   Rosenblatt A, 2012, MOVEMENT DISORD, V27, P272, DOI 10.1002/mds.24024
   Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3
   Schacht JP, 2016, PHARMACOGENOMICS J, V16, P430, DOI 10.1038/tpj.2016.43
   Schwab LC, 2015, EXPERT REV NEUROTHER, V15, P445, DOI 10.1586/14737175.2015.1025383
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7
   Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X
   Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007
   TURJANSKI N, 1995, BRAIN, V118, P689, DOI 10.1093/brain/118.3.689
   Vinther-Jensen T, 2016, CLIN GENET, V89, P320, DOI 10.1111/cge.12628
   Vivot A, 2015, MOL PSYCHIATR, V20, P1173, DOI 10.1038/mp.2015.62
   Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369
   Vuono R, 2015, BRAIN, V138, P1907, DOI 10.1093/brain/awv107
   Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101
   Williams-Gray CH, 2008, BRAIN, V131, P397, DOI 10.1093/brain/awm313
   Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c
   Wolf RC, 2013, EXP NEUROL, V247, P39, DOI 10.1016/j.expneurol.2013.03.022
   Wu K, 2012, BRAIN, V135, P2449, DOI 10.1093/brain/aws157
   Zielonka D, 2013, PARKINSONISM RELAT D, V19, P192, DOI 10.1016/j.parkreldis.2012.09.012
NR 56
TC 4
Z9 4
U1 2
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 22
PY 2016
VL 11
IS 9
AR e0161106
DI 10.1371/journal.pone.0161106
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW8GO
UT WOS:000383893200005
PM 27657697
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Piulachs, X
   Alemany, R
   Guillen, M
AF Piulachs, Xavier
   Alemany, Ramon
   Guillen, Montserrat
TI Joint Modelling of Survival and Emergency Medical Care Usage in Spanish
   Insureds Aged 65+
SO PLOS ONE
LA English
DT Article
ID LONGITUDINAL DATA; PROSTATE-CANCER; ERROR; TOOL
AB Background
   We study the longevity and medical resource usage of a large sample of insureds aged 65 years or older drawn from a large health insurance dataset. Yearly counts of each subject's emergency room and ambulance service use and hospital admissions are made. Occurrence of mortality is also monitored. The study aims to capture the simultaneous dependence between their demand for healthcare and survival.
   Methods
   We demonstrate the benefits of taking a joint approach to modelling longitudinal and survival processes by using a large dataset from a Spanish medical mutual company. This contains historical insurance information for 39,137 policyholders aged 65+ (39.5% men and 60.5% women) across the eight-year window of the study. The joint model proposed incorporates information on longitudinal demand for care in a weighted cumulative effect that places greater emphasis on more recent than on past service demand.
   Results
   A strong significant and positive relationship between the exponentially weighted demand for emergency, ambulance and hospital services is found with risk of death (alpha = 1.462, p < 0.001). Alternative weighting specifications are tested, but in all cases they show that a joint approach indicates a close connection between health care demand and time-todeath. Additionally, the model allows us to predict individual survival curves dynamically as new information on demand for services becomes known.
   Conclusions
   The joint model fitted demonstrates the utility of analysing demand for medical services and survival simultaneously. Likewise, it allows the personalized prediction of survival in advanced age subjects.
C1 [Piulachs, Xavier; Alemany, Ramon; Guillen, Montserrat] Univ Barcelona, Dept Econometr, Riskctr IREA, Barcelona, Spain.
RP Guillen, M (reprint author), Univ Barcelona, Dept Econometr, Riskctr IREA, Barcelona, Spain.
EM mguillen@ub.edu
RI Leira, Ramon Alemany/N-9694-2013; Guillen, Montserrat/E-1407-2011
OI Guillen, Montserrat/0000-0002-2644-6268
FU Spanish Ministry of Economy and Competitiveness/FEDER
   [ECO2013-48326-C2-1-P]
FX MG thanks ICREA Academia program. All authors were supported by the
   Spanish Ministry of Economy and Competitiveness/FEDER
   ECO2013-48326-C2-1-P. The funders had no role in study design,
   datacollection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abrahamowicz M, 2012, STAT MED, V31, P1014, DOI 10.1002/sim.4343
   Barrett J, 2015, J R STAT SOC B, V77, P131, DOI 10.1111/rssb.12060
   Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525
   Cameron KA, 2010, J WOMENS HEALTH, V19, P1643, DOI 10.1089/jwh.2009.1701
   COX DR, 1972, J R STAT SOC B, V34, P187
   Dendukuri N, 2004, J AM GERIATR SOC, V52, P290, DOI 10.1111/j.1532-5415.2004.52073.x
   Faucett CL, 1996, STAT MED, V15, P1663, DOI 10.1002/(SICI)1097-0258(19960815)15:15<1663::AID-SIM294>3.0.CO;2-1
   Hauptmann M, 2000, BIOMETRICS, V56, P1105, DOI 10.1111/j.0006-341X.2000.01105.x
   Henderson R, 2000, Biostatistics, V1, P465, DOI 10.1093/biostatistics/1.4.465
   Hogan J W, 1998, Stat Methods Med Res, V7, P28
   Hsieh F, 2006, BIOMETRICS, V62, P1037, DOI 10.1111/j.1541-0420.2006.00570.x
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Proust-Lima C, 2009, BIOSTATISTICS, V10, P535, DOI 10.1093/biostatistics/kxp009
   R Core Team, 2015, R LANG ENV STAT COMP
   Rizopoulos D., 2014, PREPRINT
   Rizopoulos D, 2011, BIOMETRICS, V67, P819, DOI 10.1111/j.1541-0420.2010.01546.x
   Rizopoulos JM, 2010, J STAT SOFT, V35
   Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015
   Sweeting MJ, 2011, BIOMETRICAL J, V53, P750, DOI 10.1002/bimj.201100052
   TSIATIS AA, 1995, J AM STAT ASSOC, V90, P27, DOI 10.2307/2291126
   Verbeke G, 2000, LINEAR MIXED MODELS
   Wulfsohn MS, 1997, BIOMETRICS, V53, P330, DOI 10.2307/2533118
   Yu MG, 2008, J AM STAT ASSOC, V103, P178, DOI 10.1198/016214507000000400
NR 23
TC 1
Z9 1
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 13
PY 2016
VL 11
IS 4
AR e0153234
DI 10.1371/journal.pone.0153234
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ3UC
UT WOS:000374131200063
PM 27073868
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Franco-Pedroso, J
   Ramos, D
   Gonzalez-Rodriguez, J
AF Franco-Pedroso, Javier
   Ramos, Daniel
   Gonzalez-Rodriguez, Joaquin
TI Gaussian Mixture Models of Between-Source Variation for Likelihood Ratio
   Computation from Multivariate Data
SO PLOS ONE
LA English
DT Article
ID ALGORITHM
AB In forensic science, trace evidence found at a crime scene and on suspect has to be evaluated from the measurements performed on them, usually in the form of multivariate data (for example, several chemical compound or physical characteristics). In order to assess the strength of that evidence, the likelihood ratio framework is being increasingly adopted. Several methods have been derived in order to obtain likelihood ratios directly from univariate or multivariate data by modelling both the variation appearing between observations (or features) coming from the same source (within-source variation) and that appearing between observations coming from different sources (between-source variation). In the widely used multivariate kernel likelihood-ratio, the within-source distribution is assumed to be normally distributed and constant among different sources and the between-source variation is modelled through a kernel density function (KDF). In order to better fit the observed distribution of the between-source variation, this paper presents a different approach in which a Gaussian mixture model (GMM) is used instead of a KDF. As it will be shown, this approach provides better-calibrated likelihood ratios as measured by the log-likelihood ratio cost (C-llr) in experiments performed on freely available forensic datasets involving different trace evidences: inks, glass fragments and car paints.
C1 [Franco-Pedroso, Javier; Ramos, Daniel; Gonzalez-Rodriguez, Joaquin] Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain.
RP Franco-Pedroso, J (reprint author), Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain.
EM javier.franco@uam.es
FU Ministerio de Economia y Competitividad (ES) [TEC2012-37585-C02-01]
FX JFP recieved funding from "Ministerio de Economia y Competitividad (ES)"
   (http://www.mineco.gob.es/) through the project "CMC-V2:
   Caracterizacion, Modelado y Compensacion de Variabilidad en la Senal de
   Voz", with grant number TEC2012-37585-C02-01. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahuja RK, 2001, OPER RES, V49, P784, DOI 10.1287/opre.49.5.784.10601
   Aitken C.G.G., 2004, STAT EVALUATION EVID
   Aitken CGG, 2004, J ROY STAT SOC C-APP, V53, P109, DOI 10.1046/j.0035-9254.2003.05271.x
   AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Bishop C., 2006, PATTERN RECOGNITION
   Bolck A, 2009, FORENSIC SCI INT, V191, P42, DOI 10.1016/j.forsciint.2009.06.006
   Borgstrom BJ, 2013, INT CONF ACOUST SPEE, P7693, DOI 10.1109/ICASSP.2013.6639160
   Brummer N, 2006, COMPUT SPEECH LANG, V20, P230, DOI 10.1016/j.csl.2005.08.001
   Campbell WM, 2006, IEEE SIGNAL PROC LET, V13, P308, DOI 10.1109/LSP.2006.870086
   Cook R, 1998, SCI JUSTICE, V38, P231, DOI 10.1016/S1355-0306(98)72117-3
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019
   Gonzalez-Rodriguez J, 2007, IEEE T AUDIO SPEECH, V15, P2104, DOI 10.1109/TASL.2007.902747
   Jain AK, 2006, IEEE T INF FOREN SEC, V1, P125, DOI 10.1109/TIFS.2006.873653
   Ketchen DJ, 1996, STRATEGIC MANAGE J, V17, P441, DOI 10.1002/(SICI)1097-0266(199606)17:6<441::AID-SMJ819>3.0.CO;2-G
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Li P, 2012, IEEE T PATTERN ANAL, V34, P144, DOI 10.1109/TPAMI.2011.104
   MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P281, DOI DOI 10.1234/12345678
   McLachlan G. J., 1988, APPL STAT
   Ramos D, 2013, J FORENSIC SCI, V58, P1503, DOI 10.1111/1556-4029.12233
   Ramos D, 2013, FORENSIC SCI INT, V230, P156, DOI 10.1016/j.forsciint.2013.04.014
   Rose P, 2015, P 40 ICASSP INT C AC, P4819
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
   Sizov A, 2014, LECT NOTES COMPUT SC, V8621, P464, DOI 10.1007/978-3-662-44415-3_47
   Turk M. A., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P586, DOI 10.1109/CVPR.1991.139758
   van Leeuwen DA, 2007, SPEAKER CLASSIFICATI, V4343, P330, DOI [10.1007/978-3-540-74200-519, DOI 10.1007/978-3-540-74200-519]
   Zadora G, 2014, STATISTICAL ANALYSIS IN FORENSIC SCIENCE: EVIDENTIAL VALUE OF MULTIVARIATE PHYSICOCHEMICAL DATA, P1, DOI 10.1002/9781118763155
   Zadrozny B., 2002, P 8 ACM SIGKDD INT C, P694, DOI DOI 10.1007/S10994-013-5343-X
NR 28
TC 5
Z9 5
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2016
VL 11
IS 2
AR e0149958
DI 10.1371/journal.pone.0149958
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF3VL
UT WOS:000371276100193
PM 26901680
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kuhelj, A
   de Groot, M
   Blejec, A
   Virant-Doberlet, M
AF Kuhelj, Anka
   de Groot, Maarten
   Blejec, Andrej
   Virant-Doberlet, Meta
TI The Effect of Timing of Female Vibrational Reply on Male Signalling and
   Searching Behaviour in the Leafhopper Aphrodes makarovi
SO PLOS ONE
LA English
DT Article
ID BINOTATA SPECIES COMPLEX; AUSTRALIAN BUSH-CRICKET; VIBRATORY
   COMMUNICATION; ACOUSTIC COMMUNICATION; REPRODUCTIVE ISOLATION;
   TREEHOPPERS HEMIPTERA; MATE RECOGNITION; HOMOPTERA; SONG; SEX
AB Sexual communication in animals often involves duetting characterized by a coordinated reciprocal exchange of acoustic signals. We used playback experiments to study the role of timing of a female reply in the species-specific duet structure in the leafhopper Aphrodes makarovi (Hemiptera: Cicadellidae). In leafhoppers, mate recognition and location is mediated exclusively by species-and sex-specific substrate-borne vibrational signals and a female signal emitted in reply to male advertisement calls is essential for recognition and successful location of the female. In A. makarovi, males have to initiate each exchange of vibrational signals between partners, and in a duet the beginning of a female reply overlaps the end of the male advertisement call. Results of playback treatments in which female replies were delayed and did not overlap with the male call revealed that in order to trigger an appropriate behavioural response of the male, female reply has to appear in a period less than 400 ms after the end of the initiating male call. Results also suggest that males are not able to detect a female reply while calling, since female reply that did not continue after the end of male call triggered male behaviour similar to behaviour observed in the absence of female reply. Together, our results show that vibrational duets are tightly coordinated and that the species-specific duet structure plays an important role in mate recognition in location processes.
C1 [Kuhelj, Anka; de Groot, Maarten; Blejec, Andrej; Virant-Doberlet, Meta] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia.
RP Virant-Doberlet, M (reprint author), Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia.
EM meta.virant@nib.si
RI Virant-Doberlet, Meta/G-9251-2019; Blejec, Andrej/M-5215-2019
OI Virant-Doberlet, Meta/0000-0001-7510-2392; Blejec,
   Andrej/0000-0001-7484-6031; Kuhelj, Anka/0000-0002-8164-2843; de Groot,
   Maarten/0000-0002-5721-6676
FU Slovenian National Research Agency [J1-2181, P1-0255];  [1000-11-310197]
FX Funding provided by PhD Fellowship: 1000-11-310197; Slovenian National
   Research Agency; http://www.arrs.gov.si/sl/; AK, research grant:
   J1-2181; Slovenian National Research Agency; http://www.arrs.gov.si/sl/;
   MVD and Research Programme: P1-0255; Slovenian National Research Agency;
   http://www.arrs.gov.si/sl/; AB & MVD. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ABBOTT JC, 1993, J INSECT BEHAV, V6, P467, DOI 10.1007/BF01049526
   Bailey WJ, 2000, ANIM BEHAV, V59, P361, DOI 10.1006/anbe.1999.1325
   Bailey WJ, 2004, J EXP BIOL, V207, P803, DOI 10.1242/jeb.00840
   Bailey WJ, 2003, PHYSIOL ENTOMOL, V28, P157, DOI 10.1046/j.1365-3032.2003.00337.x
   Barbosa F, 2014, STUDYING VIBRATIONAL, P147
   BARTH FG, 1988, OECOLOGIA, V77, P194, DOI 10.1007/BF00379186
   Bluemel JK, 2014, SYST ENTOMOL, V39, P304, DOI 10.1111/syen.12056
   Boumans L, 2015, J ETHOL, V33, P87, DOI 10.1007/s10164-015-0423-y
   Cocroft RB, 2006, ETHOLOGY, V112, P779, DOI 10.1111/j.1439-0310.2006.01226.x
   Cocroft R. B., 2014, STUDYING VIBRATIONAL, P249, DOI 10.1007/978-3-662-43607-3_13
   Cocroft R. B., 2014, STUDYING VIBRATIONAL, P3
   Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2
   Cokl A, 2007, BEHAV PROCESS, V75, P40, DOI 10.1016/j.beproc.2007.01.003
   Cokl A, 2006, CONT T ENT, P71
   Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674
   Davidian M, 1995, NONLINEAR MODELS REP
   de Groot M, 2012, J INSECT BEHAV, V25, P419, DOI 10.1007/s10905-011-9304-6
   de Groot M, 2011, CENT EUR J BIOL, V6, P756, DOI 10.2478/s11535-011-0056-2
   De Luca PA, 2011, ETHOLOGY, V117, P440, DOI 10.1111/j.1439-0310.2011.01893.x
   Derlink M, 2014, THESIS U LJUBLJANA
   Derlink M, 2014, ANIM BEHAV, V90, P181, DOI 10.1016/j.anbehav.2014.01.023
   DEVRIJER PWF, 1984, NETH J ZOOL, V34, P388, DOI 10.1163/002829684X00218
   DEWINTER AJ, 1990, BIOL J LINN SOC, V40, P191, DOI 10.1111/j.1095-8312.1990.tb01975.x
   Dietrich CH, 2004, SYST ENTOMOL, V29, P455, DOI 10.1111/j.0307-6970.2004.00250.x
   DOBLER S, 1994, J COMP PHYSIOL A, V175, P67, DOI 10.1007/BF00217437
   Emerson SB, 1999, BRAIN BEHAV EVOLUT, V53, P187, DOI 10.1159/000006594
   Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510
   Hall ML, 2009, ADV STUD BEHAV, V40, P67, DOI 10.1016/S0065-3454(09)40003-2
   Hall ML, 2004, BEHAV ECOL SOCIOBIOL, V55, P415, DOI 10.1007/s00265-003-0741-x
   Heller K.-G., 1990, P130
   HELLER KG, 1986, BEHAV ECOL SOCIOBIOL, V18, P189, DOI 10.1007/BF00290822
   HENNIG RM, 1994, J EXP BIOL, V187, P45
   Henry CS, 2006, BEHAV ECOL SOCIOBIOL, V61, P39, DOI 10.1007/s00265-006-0235-8
   Henry CS, 2013, BIOL REV, V88, P787, DOI 10.1111/brv.12027
   Henry CS, 2009, J INSECT BEHAV, V22, P289, DOI 10.1007/s10905-009-9174-3
   Hill PSM, 2008, VIBRATIONAL COMMUNIC
   Hochberg Y., 1987, MULTIPLE COMP PROCED
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   Hoy R, 2002, NATURE, V418, P831, DOI 10.1038/418831a
   HUNT RE, 1991, BEHAV ECOL SOCIOBIOL, V28, P315, DOI 10.1007/BF00164380
   HUNT RE, 1992, J INSECT BEHAV, V5, P1, DOI 10.1007/BF01049154
   Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784
   Kokko H, 2007, EVOLUTION, V61, P1162, DOI 10.1111/j.1558-5646.2007.00090.x
   Kuhelj A, 2015, THESIS U LJUBLJANA
   Kuhelj A, 2015, BEHAV ECOL SOCIOBIOL, V69, P815, DOI 10.1007/s00265-015-1898-9
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lakes-Harlan R., 2014, STUDYING VIBRATIONAL, P277
   Legendre F, 2012, ANIM BEHAV, V83, P361, DOI 10.1016/j.anbehav.2011.11.003
   Mazzoni V, 2009, ENTOMOL EXP APPL, V133, P174, DOI 10.1111/j.1570-7458.2009.00911.x
   Mazzoni V, 2009, B ENTOMOL RES, V99, P401, DOI 10.1017/S0007485308006408
   McNett GD, 2010, BEHAV ECOL SOCIOBIOL, V64, P2043, DOI 10.1007/s00265-010-1018-9
   MICHELSEN A, 1982, BEHAV ECOL SOCIOBIOL, V11, P269, DOI 10.1007/BF00299304
   Ossiannilsson F, 1949, OPUSC ENTOMOL S, V3, P1
   Percy DM, 2006, INVERTEBR SYST, V20, P431, DOI 10.1071/IS05057
   Polajnar J, 2014, BEHAV PROCESS, V107, P68, DOI 10.1016/j.beproc.2014.07.013
   Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919
   Pringle J. W. S., 1957, Proceedings of the Linnean Society of London, V167, P144
   R Development Core Team, 2015, LANG ENV STAT COMP
   ROBINSON D, 1986, PHYSIOL ENTOMOL, V11, P317, DOI 10.1111/j.1365-3032.1986.tb00419.x
   Robinson DJ, 2002, ADV INSECT PHYSIOL, V29, P151, DOI 10.1016/S0065-2806(02)29003-7
   Rodriguez RL, 2006, ETHOLOGY, V112, P1231, DOI 10.1111/j.1439-0310.2006.01285.x
   Rodriguez RL, 2004, EVOLUTION, V58, P571, DOI 10.1111/j.0014-3820.2004.tb01679.x
   Rohde B, 2013, ANN ENTOMOL SOC AM, V106, P392, DOI 10.1603/AN12150
   RUPPRECHT R, 1975, J INSECT PHYSIOL, V21, P305, DOI 10.1016/0022-1910(75)90026-8
   Stewart KW, 2006, CONT T ENT, P179
   Stumpner A, 2001, J INSECT BEHAV, V14, P511, DOI 10.1023/A:1011176106943
   Tishechkin D. Yu., 2000, Russian Entomological Journal, V9, P1
   Tishechkin D. Yu., 2007, Russian Entomological Journal, V16, P39
   Todt D, 2000, ADV STUD BEHAV, V29, P247, DOI 10.1016/S0065-3454(08)60107-2
   Uhl G, 2011, SPIDER BEHAV FLEXIBI, P128
   Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001
   Virant-Doberlet M., 2014, STUDYING VIBRATIONAL, P93, DOI 10.1007/978-3-662-43607-3_7
   Virant-Doberlet M, 2011, MOL ECOL, V20, P2204, DOI 10.1111/j.1365-294X.2011.05038.x
   Virant-Doberlet M, 2006, CONT T ENT, P81
   Wade MJ, 2003, MATING SYSTEMS MATIN
   Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002
   ZIMMERMANN U, 1989, J COMP PHYSIOL A, V164, P621, DOI 10.1007/BF00614504
   Zorovic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026843
NR 78
TC 8
Z9 8
U1 2
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 21
PY 2015
VL 10
IS 10
AR e0139020
DI 10.1371/journal.pone.0139020
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CU0ZM
UT WOS:000363248400017
PM 26488472
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hayden, KM
   Lutz, MW
   Kuchibhatla, M
   Germain, C
   Plassman, BL
AF Hayden, Kathleen M.
   Lutz, Michael W.
   Kuchibhatla, Maragatha
   Germain, Cassandra
   Plassman, Brenda L.
TI Effect of APOE and CD33 on Cognitive Decline
SO PLOS ONE
LA English
DT Article
ID APOLIPOPROTEIN-E EPSILON-4; GENOME-WIDE ASSOCIATION; ALZHEIMER-DISEASE;
   IDENTIFIES VARIANTS; COMMON VARIANTS; RISK; DEMENTIA; IMPAIRMENT;
   GENOTYPE; HEALTH
AB Objective
   An Alzheimer's disease (AD) diagnosis is preceded by a long period of cognitive decline. We previously demonstrated increased risk of decline among individuals possessing one or more APOE epsilon 4 alleles together with a family history of AD. The objective of this study is to investigate the possibility that such an increased risk might be due to AD risk genes with small effects in combination with APOE.
   Methods
   Participants in the Health and Retirement Study (HRS) over the age of 65, who contributed DNA, and had two or more evaluations with an abbreviated version of the modified Telephone Interview for Cognitive Status (TICS-m) were eligible for the study (n = 7451). A genetic risk score (g-score) was derived using AD risk genes' meta-analyses data, assigning risk according to the number of risk alleles and summed over all the risk genes. Trajectories of cognitive function were modeled in four groups of Caucasian participants with and without one or more APOE epsilon 4 alleles and either a high or low g-score: APOE epsilon 4-/low g-score; APOE epsilon 4-/high g-score; APOE epsilon 4+/low g-score; and APOE epsilon 4+/high g-score. Post hoc analyses evaluated interactions between individual genes and APOE.
   Results
   Individuals in the APOE epsilon 4+/high g-score group exhibited the greatest cognitive decline over time (p<.0001). This risk appeared to be greater than the sum of the effects of either high g-score or APOE epsilon 4 alone. When gene interactions were individually tested with APOE, a statistically significant interaction with CD33 was discovered (p = 0.04) although the interaction was no longer significant when adjusted for multiple comparisons.
   Conclusions
   Individuals with multiple AD risk genes in addition to having one or more APOE epsilon 4 alleles are at greater risk of cognitive decline than individuals with either APOE epsilon 4 or a high genetic risk score. Among those with one or more APOE epsilon 4 alleles, having one or more copies of the CD33 C (risk) allele may further increase the risk of cognitive decline.
C1 [Hayden, Kathleen M.; Germain, Cassandra; Plassman, Brenda L.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA.
   [Hayden, Kathleen M.; Lutz, Michael W.; Plassman, Brenda L.] Duke Univ, Med Ctr, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA.
   [Lutz, Michael W.; Plassman, Brenda L.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA.
   [Kuchibhatla, Maragatha] Duke Univ, Med Ctr, Dept Biostat, Durham, NC USA.
RP Hayden, KM (reprint author), Wake Forest Sch Med, Div Publ Hlth Sci, Dept Social Sci & Hlth Policy, Winston Salem, NC 27157 USA.
EM khayden@wakehealth.edu
RI ; Germain, Cassandra/C-7185-2016
OI Lutz, Michael/0000-0001-8809-5574; Germain,
   Cassandra/0000-0003-4712-0969
FU National Institute on Aging [R01AG042633]
FX This work was supported funded by the National Institute on Aging, grant
   # R01AG042633 (http://www.nia.nih.gov/) to KMH, MWL, MK, CG, and BLP.
   The funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934
   Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435
   Brandt J., 1988, NEUROPSY NEUROPSY BE, V1, P111, DOI DOI 10.1159/000264678
   Carrasquillo MM, 2015, NEUROBIOL AGING, V36, P60, DOI 10.1016/j.neurobiolaging.2014.07.042
   DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330
   Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014
   Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440
   Hayden KM, 2009, ARCH NEUROL-CHICAGO, V66, P1378, DOI 10.1001/archneurol.2009.237
   Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803
   Hu N, 2014, NEUROSCI LETT, V563, P51, DOI 10.1016/j.neulet.2014.01.004
   Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6
   Jiang T, 2014, MOL NEUROBIOL, V49, P529, DOI 10.1007/s12035-013-8536-1
   JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742
   Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277
   Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439
   Manly JJ, 2011, ARCH NEUROL-CHICAGO, V68, P607, DOI 10.1001/archneurol.2011.88
   Marden JR, 2014, BRAIN BEHAV, V4, P687, DOI 10.1002/brb3.248
   McArdle JJ, 2007, PSYCHOL AGING, V22, P525, DOI 10.1037/0882-7974.22.3.525
   Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801
   Ofstedal MB, 2005, DOCUMENTATION COGNIT
   Qiu CX, 2003, NEUROLOGY, V61, P655, DOI 10.1212/WNL.61.5.655
   Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973
   Rodriguez-Rodriguez E, 2013, J NEURAL TRANSM, V120, P807, DOI 10.1007/s00702-012-0920-x
   The Mixed Procedure, 1992, SAS STAT SOFTW CHANG
   Verhaaren BFJ, 2013, BIOL PSYCHIAT, V73, P429, DOI 10.1016/j.biopsych.2012.04.009
   Zhang CA, 2014, NEUROBIOL AGING, V35, DOI [10.1016/j.neurobiolaging.2013.12.021, 10.1016/j.neurobiolaging.2013.08.013]
NR 30
TC 6
Z9 7
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 23
PY 2015
VL 10
IS 6
AR e0130419
DI 10.1371/journal.pone.0130419
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL4DD
UT WOS:000356901900041
PM 26102276
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Buchner, H
   Rehfuess, EA
AF Buchner, Hannes
   Rehfuess, Eva A.
TI Cooking and Season as Risk Factors for Acute Lower Respiratory
   Infections in African Children: A Cross-Sectional Multi-Country Analysis
SO PLOS ONE
LA English
DT Article
ID INDOOR AIR-POLLUTION; SOLID-FUEL USE; DEVELOPING-COUNTRIES; PNEUMONIA;
   DISEASE; STOVES; IMPROVEMENT; XUANWEI; BURDEN
AB Background
   Acute lower respiratory infections (ALRI) are a leading cause of death among African children under five. A significant proportion of these are attributable to household air pollution from solid fuel use.
   Methods
   We assessed the relationship between cooking practices and ALRI in pooled datasets of Demographic and Health Surveys conducted between 2000 and 2011 in countries of sub-Saharan Africa. The impacts of main cooking fuel, cooking location and stove ventilation were examined in 18 (n = 56,437), 9 (n = 23,139) and 6 countries (n = 14,561) respectively. We used a causal diagram and multivariable logistic mixed models to assess the influence of covariates at individual, regional and national levels.
   Results
   Main cooking fuel had a statistically significant impact on ALRI risk (p<0.0001), with season acting as an effect modifier (p = 0.034). During the rainy season, relative to clean fuels, the odds of suffering from ALRI were raised for kerosene (OR 1.64; CI: 0.99, 2.71), coal and charcoal (OR 1.54; CI: 1.21, 1.97), wood (OR 1.20; CI: 0.95, 1.51) and lower-grade biomass fuels (OR 1.49; CI: 0.93, 2.35). In contrast, during the dry season the corresponding odds were reduced for kerosene (OR 1.23; CI: 0.77, 1.95), coal and charcoal (OR 1.35; CI: 1.06, 1.72) and lower-grade biomass fuels (OR 1.07; CI: 0.69, 1.66) but increased for wood (OR 1.32; CI: 1.04, 1.66). Cooking location also emerged as a season-dependent statistically significant (p = 0.0070) determinant of ALRI, in particular cooking indoors without a separate kitchen during the rainy season (OR 1.80; CI: 1.30, 2.50). Due to infrequent use in Africa we could, however, not demonstrate an effect of stove ventilation.
   Conclusions
   We found differential and season-dependent risks for different types of solid fuels and kerosene as well as cooking location on child ALRI. Future household air pollution studies should consider potential effect modification of cooking fuel by season.
C1 [Buchner, Hannes; Rehfuess, Eva A.] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany.
RP Buchner, H (reprint author), Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany.
EM buchner@staburo.de
FU Munich Center of Health Sciences
FX This work was supported by the Munich Center of Health Sciences
   (http://www.en.mc-health.uni-muenchen.de/profil/index.html).
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Boerma JT, 1996, B WORLD HEALTH ORGAN, V74, P209
   Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987
   Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078
   Central Intelligence Agency (CIA), 2012, WORLD FACTBOOK
   Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55
   Chengappa C, 2007, ENERGY SUSTAIN DEV, V11, P33, DOI DOI 10.1016/S0973-0826(08)60398-1
   Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529
   Fenske N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078692
   Fitzmaurice G, 2004, APPL LONGITUDINAL AN
   Haspil-Corgan TA, 2004, ANN EMERG MED, V44, pS37, DOI 10.1016/j.annemergmed.2004.07.121
   Institute for Health Metrics and Evaluation, 2013, GBD HEAT MAP
   Joffe M, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-1
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826
   LANATA CF, 1994, INT J EPIDEMIOL, V23, P827, DOI 10.1093/ije/23.4.827
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Markovitz AR, 2012, INT J EPIDEMIOL, V41, P504, DOI 10.1093/ije/dyr194
   Masera OR, 2000, WORLD DEV, V28, P2083, DOI 10.1016/S0305-750X(00)00076-0
   Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473
   Mishra V, 2005, POPUL ENVIRON, V26, P375, DOI 10.1007/s1111-005-0005-y
   Mishra V, 2003, INT J EPIDEMIOL, V32, P847, DOI 10.1093/ije/dyg240
   Mueller V, 2011, INT J EPIDEMIOL, V40, P1643, DOI 10.1093/ije/dyr150
   OrcMacro International Inc, 2008, DEM HLTH SURV
   Paynter S, 2013, EPIDEMIOL INFECT, V141, P1328, DOI 10.1017/S0950268812001379
   Rehfuess E, 2006, ENVIRON HEALTH PERSP, V114, P373, DOI 10.1289/ehp.8603
   Rehfuess EA, 2009, J EPIDEMIOL COMMUN H, V63, P887, DOI 10.1136/jech.2008.082685
   Rehfuess EA, IMPACTS INT IN PRESS
   Rehfuess EA, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-13
   Rehfuess EA, 2014, ENVIRON HEALTH PERSP, V122, P120, DOI 10.1289/ehp.1306639
   Rehfuess EA, 2010, ENVIRON RES, V110, P725, DOI 10.1016/j.envres.2010.07.006
   Rutstein Shea O., 2004, DHS COMP REPORTS
   Sinton JE, 2004, ENERGY SUSTAIN DEV, V8, P33, DOI DOI 10.1016/S0973-0826(08)60465-2
   Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356
   Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5
   UN Habitat (United Nations Human Settlements Programme), 2004, URB IND GUID MON HAB
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA, V138
   Wichmann J., 2006, Southern African Journal of Epidemiology & Infection, V21, P48
NR 39
TC 9
Z9 9
U1 1
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 4
PY 2015
VL 10
IS 6
AR e0128933
DI 10.1371/journal.pone.0128933
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ7TC
UT WOS:000355701600078
PM 26042802
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Henschell, MA
   Webster, CR
   Flaspohler, DJ
   Fortin, CR
AF Henschell, Max A.
   Webster, Christopher R.
   Flaspohler, David J.
   Fortin, Chad R.
TI Influence of Plant Community Composition on Biomass Production in
   Planted Grasslands
SO PLOS ONE
LA English
DT Article
ID FLORISTIC QUALITY ASSESSMENT; SPECIES COMPOSITION; CONSUMERS GUIDE;
   DIVERSITY; BIODIVERSITY; SWITCHGRASS; CONSERVATION; BIOENERGY; INVASION;
   INDEXES
AB United States energy policy mandates increased use of renewable fuels. Restoring grasslands could contribute to a portion of this requirement through biomass harvest for bioenergy use. We investigated which plant community characteristics are associated with differences in biomass yield from a range of realistic native prairie plantings (n = 11; i.e., conservation planting, restoration, and wildlife cover). Our primary goal was to understand whether patterns in plant community composition and the Floristic Quality Index (FQI) were related to productivity as evidenced by dormant season biomass yield. FQI is an objective measure of how closely a plant community represents that of a pre-European settlement community. Our research was conducted in planted fields of native tallgrass prairie species, and provided a gradient in floristic quality index, species richness, species diversity, and species evenness in south-central Wisconsin during 2008 and 2009. We used a network of 15 randomly located 1 m(2) plots within each field to characterize the plant community and estimate biomass yield by clipping the plots at the end of each growing season. While plant community composition and diversity varied significantly by planting type, biomass yield did not vary significantly among planting types (ANOVA; P > 0.05). Biomass yield was positively correlated with plant community evenness, richness, C4 grass cover, and floristic quality index, but negatively correlated with plant species diversity in our multi-season multiple linear mixed effects models. Concordantly, plots with biomass yield in the lowest quartile (biomass yield <3500 kh/ha) had 8% lower plant community evenness and 9% lower FQI scores than those in the upper quartile (biomass yield > 5800 kh/ha). Our results suggest that promoting the establishment of fields with high species evenness and floristic quality may increase biomass yield, while simultaneously supporting biodiversity.
C1 [Henschell, Max A.; Webster, Christopher R.; Flaspohler, David J.; Fortin, Chad R.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.
RP Henschell, MA (reprint author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.
EM henschell@wisc.edu
FU National Science Foundation Materials Use: Science, Engineering, and
   Society [0524872]; Wisconsin Focus on Energy [08-13]
FX This work was funded by the National Science Foundation (www.nsf.gov)
   Materials Use: Science, Engineering, and Society grant #0524872 and from
   the Wisconsin Focus on Energy (https://focusonenergy.com) grant # 08-13.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adler PR, 2006, AGRON J, V98, P1518, DOI 10.2134/agronj2005.0351
   Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1
   Baer SG, 2002, ECOL APPL, V12, P1688, DOI 10.1890/1051-0761(2002)012[1688:CIESAF]2.0.CO;2
   Bernthal TW, 2003, DEV FLORISTIC QUALIT, P22
   BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268
   Burnham KP, 2004, MODEL SELECTION MULT
   CAMARGO JA, 1992, B ENVIRON CONTAM TOX, V48, P428
   Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104
   Chalcraft DR, 2009, BIODIVERS CONSERV, V18, P91, DOI 10.1007/s10531-008-9457-6
   CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x
   Clarke KR, 2006, PRIMER V6 USER MANUA
   Cohen MJ, 2004, ECOL APPL, V14, P784, DOI 10.1890/02-5378
   Di Virgilio N, 2007, FIELD CROP RES, V101, P232, DOI 10.1016/j.fcr.2006.11.009
   Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x
   Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8
   Garlock RJ, 2012, BIOMASS BIOENERG, V37, P49, DOI 10.1016/j.biombioe.2011.12.036
   Grace J. B., 2002, ANAL ECOLOGICAL COMM
   Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123
   Henry M., 2001, Oikos, V92, P291
   Herman KD, 1997, NAT AREA J, V17, P265
   Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103
   Johnson MVV, 2010, BIOENERG RES, V3, P353, DOI 10.1007/s12155-010-9094-2
   Jungers JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061209
   Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lee D, 2013, GCB BIOENERGY, V5, P6, DOI 10.1111/j.1757-1707.2012.01177.x
   Liebman M, 2013, RENEW AGR FOOD SYST, V28, P115, DOI 10.1017/S1742170512000300
   MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380
   Mitchell R, 2008, BIOFUEL BIOPROD BIOR, V2, P530, DOI 10.1002/bbb.106
   Monti A, 2009, BIOMASS BIOENERG, V33, P841, DOI 10.1016/j.biombioe.2009.01.006
   Mushet DM, 2002, WETLANDS, V22, P126, DOI 10.1672/0277-5212(2002)022[0126:FQAOON]2.0.CO;2
   Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x
   Paine LK, 1996, BIOMASS BIOENERG, V10, P231, DOI 10.1016/0961-9534(95)00072-0
   Peet RK, 1998, FLEXIBLE MULTIPURPOS, P63
   R Core Development Team, 2013, R LANG ENV STAT COMP
   Robertson BA, 2013, BIOENERG RES, V6, P311, DOI 10.1007/s12155-012-9258-3
   Robertson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016941
   Roscher C, 2009, ACTA OECOL, V35, P206, DOI 10.1016/j.actao.2008.10.003
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
   Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749
   Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x
   Swink F., 1979, PLANTS CHICAGO REGIO
   Taft JB, 2006, BIOL CONSERV, V131, P42, DOI 10.1016/j.biocom.2006.02.006
   Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300
   Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391
   Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306
   Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x
   U. S. Energy Information Administration. Monthly Energy Review February 2015, 2015, DOEEIA0035 OFF EN ST, P224
   van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102
   Webster CR, 2010, BIOFUELS-UK, V1, P451, DOI 10.4155/BFS.10.18
   Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111
   White R.P., 2000, GRASSLAND ECOSYSTEMS
   Wilsey BJ, 2011, PERSPECT PLANT ECOL, V13, P265, DOI 10.1016/j.ppees.2011.07.002
   Yurkonis KA, 2005, J ECOL, V93, P1053, DOI 10.1111/j.1365-2745.2005.01029.x
   Zar J.H., 2010, BIOSTATISTICAL ANAL
NR 55
TC 4
Z9 4
U1 0
U2 36
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 27
PY 2015
VL 10
IS 5
AR e0125758
DI 10.1371/journal.pone.0125758
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ0RO
UT WOS:000355185600030
PM 26018412
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hum, RJ
   Verguet, S
   Cheng, YL
   McGahan, AM
   Jha, P
AF Hum, Ryan J.
   Verguet, Stephane
   Cheng, Yu-Ling
   McGahan, Anita M.
   Jha, Prabhat
TI Are Global and Regional Improvements in Life Expectancy and in Child,
   Adult and Senior Survival Slowing?
SO PLOS ONE
LA English
DT Article
ID MORTALITY; COUNTRIES; PROGRESS; HEALTH; TRENDS; INCOME; LIMITS
AB Improvements in life expectancy have been considerable over the past hundred years. Forecasters have taken to applying historical trends under an assumption of continuing improvements in life expectancy in the future. A linear mixed effects model was used to estimate the trends in global and regional rates of improvements in life expectancy, child, adult, and senior survival, in 166 countries between 1950 and 2010. Global improvements in life expectancy, including both child and adult survival rates, decelerated significantly over the study period. Overall life expectancy gains were estimated to have declined from 5.9 to 4.0 months per year for a mean deceleration of -0.07 months/year(2); annual child survival gains declined from 4.4 to 1.6 deaths averted per 1000 for a mean deceleration of -0.06 deaths/1000/year(2); adult survival gains were estimated to decline from 4.8 to 3.7 deaths averted per 1000 per year for a mean deceleration of -0.08 deaths/1000/year(2). Senior survival gains however increased from 2.4 to 4.2 deaths averted per 1000 per year for an acceleration of 0.03 deaths/1000/year(2). Regional variation in the four measures was substantial. The rates of global improvements in life expectancy, child survival, and adult survival have declined since 1950 despite an increase in the rate of improvements among seniors. We postulate that low-cost innovation, related to the last half-century progress in health-primarily devoted to children and middle age, is reaping diminishing returns on its investments. Trends are uneven across regions and measures, which may be due in part to the state of epidemiological transition between countries and regions and disparities in the diffusion of innovation, accessible only in high-income countries where life expectancy is already highest.
C1 [Hum, Ryan J.; Cheng, Yu-Ling] Univ Toronto, Ctr Global Engn, Toronto, ON, Canada.
   [Hum, Ryan J.; Cheng, Yu-Ling] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [Verguet, Stephane] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [McGahan, Anita M.] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada.
   [McGahan, Anita M.] Univ Toronto, Munk Sch Global Affairs, Toronto, ON, Canada.
   [Jha, Prabhat] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada.
RP Hum, RJ (reprint author), Univ Toronto, Ctr Global Engn, Toronto, ON, Canada.
EM ryan.hum@mail.utoronto.ca
FU Ontario Graduate Scholarship program; Bill and Melinda Gates Foundation;
   Social Sciences and Humanities Research Council [435-2012-0102]; Disease
   Control Priorities 3; Ontario Graduate Scholarship program; Bill and
   Melinda Gates Foundation; Social Sciences and Humanities Research
   Council [435-2012-0102]; Disease Control Priorities 3
FX RJH was funded through the Ontario Graduate Scholarship program. SV was
   funded through the Bill and Melinda Gates Foundation through the Disease
   Control Priorities Network grant to the University of Washington. AMM
   was funded through the Social Sciences and Humanities Research Council
   Grant #435-2012-0102. PJ was funded through the Disease Control
   Priorities 3. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2013, WORLD POPULATION PRO
   ASHTON B, 1984, POPUL DEV REV, V10, P613, DOI 10.2307/1973284
   Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005
   Bloom DE, 2007, P NATL ACAD SCI USA, V104, P16044, DOI 10.1073/pnas.0702012104
   Bongaarts J, 2006, POPUL DEV REV, V32, P605, DOI 10.1111/j.1728-4457.2006.00144.x
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Cohen B, 2011, INT DIFFERENCES MORT
   Collier P, 2004, OXFORD ECON PAP, V56, P563, DOI 10.1093/oep/gpf064
   Croghan TW, 2006, MILBANK Q, V84, P333, DOI 10.1111/j.1468-0009.2006.00450.x
   FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304
   Hill K, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001303.1002, DOI 10.1371/JOURNAL.PMED.1001303.1002]
   Hum RJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00051
   Jamison DT, 2013, GLOBAL PROBLEMS, SMART SOLUTIONS: COSTS AND BENEFITS, P390
   Jamison DT, 2013, HOW MUCH HAVE GLOBAL PROBLEMS COST THE WORLD?: A SCORECARD FROM 1900 TO 2050, P207
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lee R., 2003, MORTALITY FORECASTS, DOI [10.1038/35015561, DOI 10.1038/35015561]
   LIKER JK, 1985, SOC SCI RES, V14, P80, DOI 10.1016/0049-089X(85)90013-4
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8
   Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516
   Masquelier B, 2014, POP STUD-J DEMOG, V68, P161, DOI 10.1080/00324728.2013.856458
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   McMichael AJ, 2004, LANCET, V363, P1155, DOI 10.1016/S0140-6736(04)15902-3
   Muennig P, 2010, HEALTH AFFAIR, P10
   Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675
   OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414
   Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078
   Raftery AE, 2013, DEMOGRAPHY, V50, P777, DOI 10.1007/s13524-012-0193-x
   Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9
   Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1
   Steenland K, 2004, EPIDEMIOLOGY, V15, P63, DOI 10.1097/01.ede.0000100287.45004.e7
   United Nations Population Division, 2013, WORKING PAPER NO ESA
   Vallin J, 2009, POPUL DEV REV, V35, P159, DOI 10.1111/j.1728-4457.2009.00264.x
   Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984
   Verguet S, 2014, LANCET GLOB HEALTH, V2, pE698, DOI 10.1016/S2214-109X(14)70316-X
   Verguet S, 2014, HEALTH POLICY PLANN, V29, P151, DOI 10.1093/heapol/czs143
   Verguet S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002814
   Verguet S, 2013, HEALTH POLICY, V109, P137, DOI 10.1016/j.healthpol.2012.09.013
   White KM, 2002, POPUL DEV REV, V28, P59, DOI 10.1111/j.1728-4457.2002.00059.x
   Wilmoth JR, 2003, POPUL DEV REV, V29, P239
   Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366
   Woolf SH, 2013, U S HEALTH IN INTERN
   World Health Organization, 1996, AD HOC COMMITTEE ON
   World Health Organization, 2010, UNAIDS GLOBAL REPORT, DOI [10.1189/jlb.0811394, DOI 10.1189/JLB.0811394]
   Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5
NR 46
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 18
PY 2015
VL 10
IS 5
AR e0124479
DI 10.1371/journal.pone.0124479
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CI7BG
UT WOS:000354917300008
PM 25992949
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Grant, EM
   Young, DR
   Wu, TT
AF Grant, Edward M.
   Young, Deborah Rohm
   Wu, Tong Tong
TI Predictors for Physical Activity in Adolescent Girls Using Statistical
   Shrinkage Techniques for Hierarchical Longitudinal Mixed Effects Models
SO PLOS ONE
LA English
DT Article
ID SCHOOL; MULTILEVEL; BLACK; TRIAL; DEPRESSION; ENJOYMENT; CHILDREN; SCALE
AB We examined associations among longitudinal, multilevel variables and girls' physical activity to determine the important predictors for physical activity change at different adolescent ages. The Trial of Activity for Adolescent Girls 2 study (Maryland) contributed participants from 8th (2009) to 11th grade (2011) (n=561). Questionnaires were used to obtain demographic, and psychosocial information (individual-and social-level variables); height, weight, and triceps skinfold to assess body composition; interviews and surveys for school-level data; and self-report for neighborhood-level variables. Moderate to vigorous physical activity minutes were assessed from accelerometers. A doubly regularized linear mixed effects model was used for the longitudinal multilevel data to identify the most important covariates for physical activity. Three fixed effects at the individual level and one random effect at the school level were chosen from an initial total of 66 variables, consisting of 47 fixed effects and 19 random effects variables, in additional to the time effect. Self-management strategies, perceived barriers, and social support from friends were the three selected fixed effects, and whether intramural or interscholastic programs were offered in middle school was the selected random effect. Psychosocial factors and friend support, plus a school's physical activity environment, affect adolescent girl's moderate to vigorous physical activity longitudinally.
C1 [Grant, Edward M.; Wu, Tong Tong] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.
   [Young, Deborah Rohm] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA.
RP Young, DR (reprint author), Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA.
EM Deborah.r.young@kp.org
FU National Heart, Lung, and Blood Institute at the National Institutes of
   Health [R01 HL094572, HL119058]
FX This work was supported by the National Heart, Lung, and Blood Institute
   at the National Institutes of Health (Grants R01 HL094572 and HL119058
   to DRY). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Bandura A., 1986, SOCIAL FDN THOUGHT A
   Barr-Anderson DJ, 2008, RES Q EXERCISE SPORT, V79, P18, DOI 10.5641/193250308X13086753542735
   Birnbaum AS, 2005, AM J HEALTH BEHAV, V29, P250, DOI 10.5993/AJHB.29.3.6
   Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e
   Centers for Disease C Prevention, 2000, 2000 CDC GROWTH CHAR
   Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10
   Duncan SC, 2007, ANN BEHAV MED, V33, P80, DOI 10.1207/s15324796abm3301_9
   Elder JP, 2007, HEALTH EDUC RES, V22, P155, DOI 10.1093/her/cyl059
   Evenson KR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-28
   GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017
   Goodman RM, 1997, HLTH BEHAV HLTH ED T
   Hearst MO, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-8
   Heitzler CD, 2010, AM J HEALTH BEHAV, V34, P593
   Kelly EB, 2010, J PHYS ACT HEALTH, V7, P184, DOI 10.1123/jpah.7.2.184
   Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LANGE N, 1989, J AM STAT ASSOC, V84, P241, DOI 10.2307/2289869
   Loftin M, 2007, Int J Body Compos Res, V5, P1
   Lytle LA, 2009, ANN BEHAV MED, V38, P124, DOI 10.1007/s12160-009-9127-2
   MARSH HW, 1994, J SPORT EXERCISE PSY, V16, P43, DOI 10.1123/jsep.16.1.43
   McCambridge TM, 2006, PEDIATRICS, V117, P1834, DOI 10.1542/peds.2006-0472
   Mckay CM, 2007, PEDIATRICS, V119, pS84, DOI 10.1542/peds.2006-2089M
   MCKENZIE TL, 1992, J TEACH PHYS EDUC, V11, P195
   Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9
   Motl RW, 2000, PREV MED, V31, P584, DOI 10.1106/pmed.2000.0735
   Motl RW, 2003, MED SCI SPORT EXER, V35, P128, DOI 10.1249/01.MSS.0000043478.38705
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40
   Pate RR, 2009, J ADOLESCENT HEALTH, V44, P275, DOI [10.1016/j.jadohealth.2008.07.003, 10.1016/j.adohealth.2008.07.003]
   Patnode CD, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-79
   Perry CK, 2012, J PRIM PREV, V33, P111, DOI 10.1007/s10935-012-0270-3
   Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72
   RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606
   Raghunathan T, 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186
   Rushovich BR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-20
   Saelens BE, 2000, BEHAV THER, V31, P365, DOI 10.1016/S0005-7894(00)80020-9
   Sallis J. F, 1999, PHYS ACTIVITY BEHAV
   Sallis JF, 2000, MED SCI SPORT EXER, V32, P963
   Sallis JF, 2002, PEDIATR EXERC SCI, V14, P30, DOI 10.1123/pes.14.1.30
   Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5
   Schmitz KH, 2002, PREV MED, V34, P266, DOI 10.1006/pmed.2001.0982
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
   Scott MM, 2007, J URBAN HEALTH, V84, P346, DOI 10.1007/s11524-007-9179-1
   Skinner BF, 1953, SCI HLTH BEHAV
   Stevens J, 2005, CONTEMP CLIN TRIALS, V26, P223, DOI 10.1016/j.cct.2004.12.011
   STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6
   Taylor WC, 2002, PEDIATR EXERC SCI, V14, P418
   Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI [10.1249/01.MSS.0000074670.03001.98, 10.1249/01.MSS.0000113666.98463.B0]
   Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
   Wang S, 2010, U MICHIGAN WORKING P
   Webber LS, 2008, AM J PREV MED, V34, P173, DOI 10.1016/j.amepre.2007.11.018
   Young D, 2014, J PHYS ACT HEALTH, V11, P950, DOI 10.1123/jpah.2012-0192
NR 51
TC 2
Z9 2
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 30
PY 2015
VL 10
IS 4
AR e0125431
DI 10.1371/journal.pone.0125431
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH0MA
UT WOS:000353713100090
PM 25928064
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ricker, M
   Ramirez, VMP
   von Rosen, D
AF Ricker, Martin
   Pena Ramirez, Victor M.
   von Rosen, Dietrich
TI A New Method to Compare Statistical Tree Growth Curves: The PL-GMANOVA
   Model and Its Application with Dendrochronological Data
SO PLOS ONE
LA English
DT Article
AB Growth curves are monotonically increasing functions that measure repeatedly the same subjects over time. The classical growth curve model in the statistical literature is the Generalized Multivariate Analysis of Variance (GMANOVA) model. In order to model the tree trunk radius (r) over time (t) of trees on different sites, GMANOVA is combined here with the adapted PL regression model Q=A.T+E, where for b not equal 0 : Q=Ei[-b.r] - Ei[-b.r] and for b=0 : Q=Ln[r/r(1)], A = initial relative growth to be estimated, T=t-t(1), and E is an error term for each tree and time point. Furthermore, Ei[-b.r] = integral (Exp[b.r]/r)dr, b = -1/TPR, with TPR being the turning point radius in a sigmoid curve, and r(1) at t(1) is an estimated calibrating time-radius point. Advantages of the approach are that growth rates can be compared among growth curves with different turning point radiuses and different starting points, hidden outliers are easily detectable, the method is statistically robust, and heteroscedasticity of the residuals among time points is allowed. The model was implemented with dendrochronological data of 235 Pinus montezumae trees on ten Mexican volcano sites to calculate comparison intervals for the estimated initial relative growth (A) over cap. One site (at the Popocatepetl volcano) stood out, with (A) over cap being 3.9 times the value of the site with the slowest-growing trees. Calculating variance components for the initial relative growth, 34% of the growth variation was found among sites, 31% among trees, and 35% over time. Without the Popocatepetl site, the numbers changed to 7%, 42%, and 51%. Further explanation of differences in growth would need to focus on factors that vary within sites and over time.
C1 [Ricker, Martin] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City, DF, Mexico.
   [Pena Ramirez, Victor M.] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico.
   [von Rosen, Dietrich] Swedish Univ Agr Sci, Dept Energy & Technol, Uppsala, Sweden.
RP Ricker, M (reprint author), Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City, DF, Mexico.
EM mricker@ib.unam.mx
CR Belsley D. A., 1991, CONDITIONING DIAGNOS
   Burkhart H. E, 2012, MODELING FOREST TREE
   CONOVER WJ, 1980, PRACTICAL NONPARAMET
   DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359
   Demidenko E, 2004, MIXED MODELS THEORY
   Duncan T. E., 2006, INTRO LATENT VARIABL
   Enders W., 2010, APPL ECONOMETRIC TIM
   Fisher RA., 1921, ANN APPL BIOL, V7, P367, DOI [10.1111/j.1744-7348.1921.tb05524.x, DOI 10.1111/J.1744-7348.1921.TB05524.X]
   Fitzmaurice G. M., 2011, APPL LONGITUDINAL AN
   FLIGNER MA, 1981, J AM STAT ASSOC, V76, P162, DOI 10.2307/2287062
   GABRIEL KR, 1978, J AM STAT ASSOC, V73, P724, DOI 10.2307/2286265
   Golub G.H., 1996, MATRIX COMPUTATIONS
   HUI SL, 1984, BIOMETRICS, V40, P691, DOI 10.2307/2530912
   Hunt R, 1982, PLANT GROWTH CURVES
   Jeffrey A., 1995, HDB MATH FORMULAS IN
   KHATRI CG, 1966, ANN I STAT MATH, V18, P75, DOI 10.1007/BF02869518
   Kiviste A, 2002, FUNCIONES CRECIMIENT
   Kollo T., 2005, ADV MULTIVARIATE STA
   Kshirsagar A. M., 1995, GROWTH CURVES
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014
   LISKI EP, 1985, COMMUN STAT-SIMUL C, V14, P13, DOI 10.1080/03610918508812423
   Littell R. C., 2006, SAS MIXED MODELS
   Maddala G. S., 2009, INTRO ECONOMETRICS
   Miller Jr R. G., 1981, SIMULTANEOUS STAT IN
   Muller K. E., 2006, LINEAR MODEL THEORY
   Pan J.-X., 2002, GROWTH CURVE MODELS
   Pena Ramirez VM, 2013, THESIS U NACL AUTONO
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   POTTHOFF RF, 1964, BIOMETRIKA, V51, P313
   Ricker M, 2004, FOREST SCI, V50, P213
   Ricker M, 2007, CAN J FOREST RES, V37, P977, DOI 10.1139/X06-304
   Rohlf FJ, 2012, STAT TABLES
   Ryan TP, 2009, MODERN REGRESSION AN
   Sokal R. R., 2012, BIOMETRY
   Speer J.H., 2010, FUNDAMENTALS TREE RI
   Srivastava MS, 1999, STAT TEXTB MONOG, V159, P547
   Srivastava MS, 2002, METHODS MULTIVARIATE
   Stroup W. W., 2013, GEN LINEAR MIXED MOD
   Timm NH, 2002, UNIVARIATE MULTIVARI
   Verbeke G, 2000, LINEAR MIXED MODELS
   Vonesh E, 1997, LINEAR NONLINEAR MOD
   VONROSEN D, 1995, ANN I STAT MATH, V47, P129, DOI 10.1007/BF00773417
   VONROSEN D, 1991, COMMUN STAT THEORY, V20, P2791, DOI 10.1080/03610929108830668
   Weerahandi S., 2004, GEN INFERENCE REPEAT
   Weiskittel AR, 2011, FOREST GROWTH AND YIELD MODELING, P1, DOI 10.1002/9781119998518
   Wenk G, 1990, WALDERTRAGSLEHRE
NR 47
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 17
PY 2014
VL 9
IS 11
AR e112396
DI 10.1371/journal.pone.0112396
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT8BL
UT WOS:000345158700043
PM 25402427
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bompard, L
   Xu, S
   Styner, M
   Paniagua, B
   Ahn, M
   Yuan, Y
   Jewells, V
   Gao, W
   Shen, DG
   Zhu, HT
   Lin, WL
AF Bompard, Lucile
   Xu, Shun
   Styner, Martin
   Paniagua, Beatriz
   Ahn, Mihye
   Yuan, Ying
   Jewells, Valerie
   Gao, Wei
   Shen, Dinggang
   Zhu, Hongtu
   Lin, Weili
TI Multivariate Longitudinal Shape Analysis of Human Lateral Ventricles
   during the First Twenty-Four Months of Life
SO PLOS ONE
LA English
DT Article
ID BRAIN-DEVELOPMENT; PRETERM INFANTS; NEONATAL BRAIN; AUTISM; MRI;
   SCHIZOPHRENIA; CHILDREN; VOLUME; SEGMENTATION; REGISTRATION
AB Background: Little is known about the temporospatial shape characteristics of human lateral ventricles (LVs) during the first two years of life. This study aimed to delineate the morphological growth characteristics of LVs during early infancy using longitudinally acquired MR images in normal healthy infants.
   Methods: 24 healthy infants were MR imaged starting from 2 weeks old every 3 months during the first and every 6 months during the second year. Bilateral LVs were segmented and longitudinal morphological and shape analysis were conducted using longitudinal mixed effect models.
   Results: A significant bilateral ventricular volume increase (p<0.0001) is observed in year one (Left: 126 +/- 51% and Right: 145 +/- 62%), followed by a significant reduction (p<0.02) during the second year of life (Left: -24 +/- 27% and Right: -20 +/- 18%) despite the continuing increase of intracranial volume. Morphological analysis reveals that the ventricular growth is spatially non-uniform, and that the most significant growth occurs during the first 6 months. The first 3 months of life exhibit a significant (p<0.01) bilateral lengthening of the anterior lateral ventricle and a significant increase of radius (p<0.01) and area (p<0.01) at the posterior portion of the ventricle. Shape analysis shows that the horns exhibit a faster growth rate than the mid-body. Finally, bilateral significant age effects (p<0.01) are observed for the growth of LVs whereas gender effects are more subtle and significant effects (p<0.01) only present at the left anterior and posterior horns. More importantly, both the age and gender effects are growth directionally dependent.
   Conclusions: We have demonstrated the temporospatial shape growth characteristics of human LVs during the first two years of life using a unique longitudinal MR data set. A temporally and spatially non-uniform growth pattern was reported. These normative results could provide invaluable information to discern abnormal growth patterns in patients with neurodevelopmental disorders.
C1 [Bompard, Lucile; Gao, Wei; Shen, Dinggang; Zhu, Hongtu; Lin, Weili] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27599 USA.
   [Xu, Shun; Styner, Martin; Paniagua, Beatriz] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA.
   [Styner, Martin; Paniagua, Beatriz] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA.
   [Ahn, Mihye; Zhu, Hongtu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA.
   [Yuan, Ying] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA.
   [Jewells, Valerie; Gao, Wei; Shen, Dinggang; Lin, Weili] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA.
RP Lin, WL (reprint author), Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27599 USA.
EM weili_lin@med.unc.edu
OI Ahn, Mihye/0000-0002-0388-7036
FU National Institutes of Health (NIH) [R01NS055754, RR025747-01,
   P01CA142538-01, MH086633, EB005149-01]
FX This work was supported in part by grants from the National Institutes
   of Health (NIH): R01NS055754, RR025747-01, P01CA142538-01, MH086633 and
   EB005149-01. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Achiron R, 1997, OBSTET GYNECOL, V89, P233, DOI 10.1016/S0029-7844(96)00506-6
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bookstein F L, 1997, Med Image Anal, V1, P225
   Bouix S, 2005, NEUROIMAGE, V25, P1077, DOI 10.1016/j.neuroimage.2004.12.051
   BRECHBUHLER C, 1995, COMPUT VIS IMAGE UND, V61, P154, DOI 10.1006/cviu.1995.1013
   COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004
   Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337
   Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016
   Davies RH, 2002, IEEE T MED IMAGING, V21, P525, DOI 10.1109/TMI.2002.1009388
   Davis BC, 2010, INT J COMPUT VISION, V90, P255, DOI 10.1007/s11263-010-0367-1
   DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409
   Fletcher PT, 2004, IEEE T MED IMAGING, V23, P995, DOI 10.1109/TMI.2004.831793
   Frangou S, 1997, AM J PSYCHIAT, V154, P1424
   Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106
   Gilmore JH, 2010, AM J PSYCHIAT, V167, P1083, DOI 10.1176/appi.ajp.2010.09101492
   Gilmore JH, 2008, BIOL PSYCHIAT, V64, P1069, DOI 10.1016/j.biopsych.2008.07.031
   Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366
   Hazlett HC, 2012, AM J PSYCHIAT, V169, P601, DOI 10.1176/appi.ajp.2012.11091425
   Ichihashi K, 2002, EARLY HUM DEV, V68, P55
   Kelemen A, 1998, 3 DIMENSIONAL MODEL, P87
   Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lawrie SM, 1998, BRIT J PSYCHIAT, V172, P110, DOI 10.1192/bjp.172.2.110
   Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001
   LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900
   Lyall AE, 2012, EARLY HUM DEV, V88, P691, DOI 10.1016/j.earlhumdev.2012.02.003
   Munsell BC, 2008, IEEE T PATTERN ANAL, V30, P2023, DOI 10.1109/TPAMI.2007.70841
   Nestor SM, 2008, BRAIN, V131, P2443, DOI 10.1093/brain/awn146
   Paniagua B, 2013, P SOC PHOTO-OPT INST, V8672
   PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012
   PIVEN J, 1995, AM J PSYCHIAT, V152, P1145
   Pizer SM, 1999, IEEE T MED IMAGING, V18, P851, DOI 10.1109/42.811263
   Prassopoulos P, 1996, J CHILD NEUROL, V11, P197, DOI 10.1177/088307389601100306
   REISS AL, 1995, NAT GENET, V11, P331, DOI 10.1038/ng1195-331
   Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763
   Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464
   SALIBA E, 1990, ARCH DIS CHILD, V65, P1029, DOI 10.1136/adc.65.10_Spec_No.1029
   SHAH P S, 1992, Indian Pediatrics, V29, P439
   Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819
   Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066
   Shun Xu, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563011
   Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698
   Styner M, 2005, P NATL ACAD SCI USA, V102, P4872, DOI 10.1073/pnas.0501117102
   Styner Martin, 2006, Insight J, P242
   Styner M, 2007, I S BIOMED IMAGING, P1192, DOI 10.1109/ISBI.2007.357071
   Team R.C.R, 2013, LANG ENV STAT COMP
   Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16
   Wu GR, 2010, LECT NOTES COMPUT SC, V6362, P618
   Yuan Ying, 2013, Inf Process Med Imaging, V23, P220, DOI 10.1007/978-3-642-38868-2_19
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
   ZIPURSKY RB, 1990, PSYCHIAT RES-NEUROIM, V35, P71, DOI 10.1016/S0165-1781(06)80009-0
NR 51
TC 5
Z9 5
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 29
PY 2014
VL 9
IS 9
AR e108306
DI 10.1371/journal.pone.0108306
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU6XR
UT WOS:000345745400064
PM 25265017
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shiffman, D
   Pare, G
   Oberbauer, R
   Louie, JZ
   Rowland, CM
   Devlin, JJ
   Mann, JF
   McQueen, MJ
AF Shiffman, Dov
   Pare, Guillaume
   Oberbauer, Rainer
   Louie, Judy Z.
   Rowland, Charles M.
   Devlin, James J.
   Mann, Johannes F.
   McQueen, Matthew J.
TI A Gene Variant in CERS2 Is Associated with Rate of Increase in
   Albuminuria in Patients with Diabetes from ONTARGET and TRANSCEND
SO PLOS ONE
LA English
DT Article
ID CERAMIDE SYNTHASE 2; HIGH-RISK PATIENTS; TELMISARTAN; DISEASE;
   INTOLERANT; RAMIPRIL; EVENTS; TRIALS; LOCI
AB Although albuminuria and subsequent advanced stage chronic kidney disease are common among patients with diabetes, the rate of increase in albuminuria varies among patients. Since genetic variants associated with estimated glomerular filtration rate (eGFR) were identified in cross sectional studies, we asked whether these variants were also associated with rate of increase in albuminuria among patients with diabetes from ONTARGET and TRANSCEND-randomized controlled trials of ramipril, telmisartan, both, or placebo. For 16 genetic variants associated with eGFR at a genome-wide level, we evaluated the association with annual rate of increase in albuminuria estimated from urine albumin: creatinine ratio (uACR). One of the variants (rs267734) was associated with rate of increase in albuminuria. The annual rate of increase in albuminuria among risk homozygotes (69% of the study population) was 11.3% (95%CI; 7.5% to 15.3%), compared with 5.0% (95% CI; 3.3% to 6.8%) for heterozygotes (27% of the population), and 1.7% (95% CI; -1.7% to 5.3%) for non-risk homozygotes (4% of the population); P = 0.0015 for the difference between annual rates in the three genotype groups. These estimates were adjusted for age, sex, ethnicity, and principal component of genetic heterogeneity. Among patients without albuminuria at baseline (uACR<30 mg/g), each risk allele was associated with 50% increased risk of incident albuminuria (OR = 1.50; 95% CI 1.15 to 1.95; P = 0.003) after further adjustment for traditional risk factors including baseline uACR and eGFR. The rs267734 variant is in almost perfect linkage-disequilibrium (r(2) = 0.94) with rs267738, a single nucleotide polymorphism encoding a glutamic acid to alanine change at position 115 of the ceramide synthase 2 (CERS2) encoded protein. However, it is unknown whether CERS2 function influences albuminuria. In conclusion, we found that rs267734 in CERS2 is associated with rate of increase in albuminuria among patients with diabetes and elevated risk of cardiovascular disease.
C1 [Shiffman, Dov; Louie, Judy Z.; Rowland, Charles M.; Devlin, James J.] Celera, Alameda, CA 94502 USA.
   [Pare, Guillaume; McQueen, Matthew J.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.
   [Pare, Guillaume; McQueen, Matthew J.] McMaster Univ, Hamilton, ON, Canada.
   [Oberbauer, Rainer] KH Elisabethinen, Dept Nephrol, Linz, Austria.
   [Oberbauer, Rainer] Med Univ Vienna, Dept Nephrol, Vienna, Austria.
   [Mann, Johannes F.] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany.
RP Shiffman, D (reprint author), Celera, Alameda, CA 94502 USA.
EM dov.shiffman@celera.com
RI Pare, Guillaume/T-9631-2018
OI Pare, Guillaume/0000-0002-6795-4760
FU European Community [241544]; Celera; Boehringer Ingelheim
FX The research leading to these results has received funding from the
   European Community's Seventh Framework Programme under the grant
   agreement n o 241544. Funding for ONTARGET and TRANSCEND Studies:
   Boehringer Ingelheim. The funders had no role in study design, data
   collection and analysis, decision to publish. Co-authors DS, JZL, CMR,
   and JJD are employed by Celera. Celera provided support in the form of
   salaries for authors DS, JZL, CMR, and JJD, but did not have any
   additional role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. The specific
   roles of these authors are articulated in the 'author contributions'
   section.
CR Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x
   Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292
   Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Deshmukh HA, 2013, DIABETIC MED, V30, P1230, DOI 10.1111/dme.12211
   Ellis JW, 2012, HUM MOL GENET, V21, P3293, DOI 10.1093/hmg/dds138
   Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825
   Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359
   Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971
   Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200
   Mann JFE, 2003, J AM SOC NEPHROL, V14, P641, DOI 10.1097/01.ASN.0000051594.21922.99
   Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610
   Pinheiro J, 2012, NLME LINEAR NONLINEA, V3, P1
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620
   Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674
   Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020
   U. S. Renal Data System, 2012, USRDS 2012 ANN DAT R
   Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793
   Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8
   Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317
NR 24
TC 14
Z9 14
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 19
PY 2014
VL 9
IS 9
AR e106631
DI 10.1371/journal.pone.0106631
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ0RY
UT WOS:000342491600010
PM 25238615
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Heuer, A
   Rubner, O
AF Heuer, Andreas
   Rubner, Oliver
TI Optimizing the Prediction Process: From Statistical Concepts to the Case
   Study of Soccer
SO PLOS ONE
LA English
DT Article
ID FOOTBALL; MODEL; PERFORMANCE; GOALS
AB 3 We present a systematic approach for prediction purposes based on panel data, involving information about different interacting subjects and different times (here: two). The corresponding bivariate regression problem can be solved analytically for the final statistical estimation error. Furthermore, this expression is simplified for the special case that the subjects do not change their properties between the last measurement and the prediction period. This statistical framework is applied to the prediction of soccer matches, based on information from the previous and the present season. It is determined how well the outcome of soccer matches can be predicted theoretically. This optimum limit is compared with the actual quality of the prediction, taking the German premier league as an example. As a key step for the actual prediction process one has to identify appropriate observables which reflect the strength of the individual teams as close as possible. A criterion to distinguish different observables is presented. Surprisingly, chances for goals turn out to be much better suited than the goals themselves to characterize the strength of a team. Routes towards further improvement of the prediction are indicated. Finally, two specific applications are discussed.
C1 [Heuer, Andreas; Rubner, Oliver] WWU Muenster, Inst Phys Chem, Munster, Germany.
   [Heuer, Andreas; Rubner, Oliver] WWU Muenster, Ctr Nonlinear Sci CeNoS, Munster, Germany.
RP Heuer, A (reprint author), WWU Muenster, Inst Phys Chem, Munster, Germany.
EM andheuer@uni-muenster.de
FU Deutsche Forschungsgemeinschaft; Open Access Publication Fund of
   University of Muenster
FX The authors acknowledge support by Deutsche Forschungsgemeinschaft and
   Open Access Publication Fund of University of Muenster. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ambrey CL, 2014, ECON LETT, V123, P131, DOI 10.1016/j.econlet.2014.01.031
   Andersson P, 2005, INT J FORECASTING, V21, P565, DOI 10.1016/j.ijforecast.2005.03.004
   Bittner E, 2009, EUR PHYS J B, V67, P459, DOI 10.1140/epjb/e2008-00396-1
   Bittner E, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/58002
   Constantinou AC, 2012, KNOWL-BASED SYST, V36, P322, DOI 10.1016/j.knosys.2012.07.008
   Dixon MJ, 1998, J ROY STAT SOC D-STA, V47, P523, DOI 10.1111/1467-9884.00152
   Dixon MJ, 1997, J R STAT SOC C-APPL, V46, P265, DOI 10.1111/1467-9876.00065
   Forrest D, 2000, INT J FORECASTING, V16, P317, DOI 10.1016/S0169-2070(00)00050-9
   Freedman D, 2007, BAYES LINEAR STAT TH
   Goddard J, 2005, INT J FORECASTING, V21, P331, DOI 10.1016/j.ijforecast.2004.08.002
   Goddard J, 2004, J FORECASTING, V23, P51, DOI 10.1002/for.877
   Goldstein M, 2005, STAT MODELS THEORY P
   Heuer A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38007
   Heuer A, 2009, EUR PHYS J B, V67, P445, DOI 10.1140/epjb/e2009-00024-8
   Heuer A, 2012, PERFEKTE TIIPP STAT
   Heuer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047678
   Hvattum LM, 2010, INT J FORECASTING, V26, P460, DOI 10.1016/j.ijforecast.2009.10.002
   Judge TA, 2008, J APPL PSYCHOL, V93, P849, DOI 10.1037/0021-9010.93.4.849
   Koning RH, 2000, J ROY STAT SOC D-STA, V49, P419, DOI 10.1111/1467-9884.00244
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lee A, 1997, CHANCE, V10, P15
   Maher M, 1982, STAT NEERL, V36, P109, DOI DOI 10.1111/j.1467-9574.1982.tb00782.x
   Rue H, 2000, J ROY STAT SOC D-STA, V49, P399, DOI 10.1111/1467-9884.00243
   Schnitzlein DD, 2014, J POPUL ECON, V27, P69, DOI 10.1007/s00148-013-0468-6
   Sire C, 2009, EUR PHYS J B, V67, P473, DOI 10.1140/epjb/e2008-00405-5
   Song C, 2007, INT J FORECASTING, V23, P405, DOI 10.1016/j.ijforecast.2007.05.003
   Woolridge JM, 2002, ECONOMETRIC ANAL CRO
NR 27
TC 3
Z9 3
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 8
PY 2014
VL 9
IS 9
AR e104647
DI 10.1371/journal.pone.0104647
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO4JX
UT WOS:000341304700010
PM 25198501
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gracitelli, CPB
   Tatham, AJ
   Zangwill, LM
   Weinreb, RN
   Liu, T
   Medeiros, FA
AF Gracitelli, Carolina P. B.
   Tatham, Andrew J.
   Zangwill, Linda M.
   Weinreb, Robert N.
   Liu, Ting
   Medeiros, Felipe A.
TI Estimated Rates of Retinal Ganglion Cell Loss in Glaucomatous Eyes with
   and without Optic Disc Hemorrhages
SO PLOS ONE
LA English
DT Article
ID OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; NERVE-FIBER LAYER;
   VISUAL-FIELD LOSS; RANDOM-EFFECTS MODELS; OCULAR HYPERTENSION; AFRICAN
   DESCENT; BARBADOS EYE; PROGRESSION; POPULATION
AB Purpose: To evaluate whether optic disc hemorrhages are associated with faster rates of estimated retinal ganglion cell (RGC) loss in glaucoma.
   Methods: A longitudinal observational cohort study of 222 eyes of 122 patients with glaucoma recruited from the Diagnostic Innovations Glaucoma Study (DIGS) followed for an average of 3.74 +/- 0.85 years. All subjects had optical coherence tomography and standard automated perimetry during follow up. Optic disc hemorrhages were detected by masked evaluation of stereophotographs. Rates of change in estimated numbers of RGCs were determined using a previously described method. A random coefficients model was used to investigate the relationship between disc hemorrhages and rates of change in estimated RGC counts over time.
   Results: 19 eyes of 18 subjects had at least one disc hemorrhage during follow up. At baseline, average estimated RGC counts in eyes with and without disc hemorrhages were 677,994 cells and 682,021 cells, respectively (P = 0.929). Eyes with optic disc hemorrhages during follow-up had significantly faster rates of estimated RGC loss than eyes without disc hemorrhages (22,233 cells/year versus 10,704 cells/year, P = 0.020). The effect of disc hemorrhages on the rates of estimated RGC loss remained significant after adjusting for confounding variables.
   Conclusion: Eyes with disc hemorrhages showed faster rates of RGC loss compared to eyes without disc hemorrhages. These results provide further evidence that disc hemorrhages should be considered as an indicator of increased risk for faster neural loss in glaucoma.
C1 [Gracitelli, Carolina P. B.; Tatham, Andrew J.; Zangwill, Linda M.; Weinreb, Robert N.; Liu, Ting; Medeiros, Felipe A.] Univ Calif San Diego, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA.
   [Gracitelli, Carolina P. B.; Tatham, Andrew J.; Zangwill, Linda M.; Weinreb, Robert N.; Liu, Ting; Medeiros, Felipe A.] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA.
   [Gracitelli, Carolina P. B.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Tatham, Andrew J.] Univ Edinburgh, Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland.
   [Tatham, Andrew J.] Univ Edinburgh, Dept Ophthalmol, Edinburgh, Midlothian, Scotland.
RP Medeiros, FA (reprint author), Univ Calif San Diego, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA.
EM fmedeiros@glaucoma.ucsd.edu
FU National Institutes of Health/National Eye Institute [EY021818, EY11008,
   EY14267, EY019869, P30EY022589]; Research to Prevent Blindness (New
   York, N.Y.); Brazilian National Research Council-CAPES [12309-13-3];
   Alcon; Allergan; Pfizer; Merck; Santen
FX This work was supported in part by National Institutes of
   Health/National Eye Institute grants EY021818 (F.A.M.), EY11008
   (L.M.Z.), EY14267 (L.M.Z.), EY019869 (L.M.Z.), and core grant
   P30EY022589; an unrestricted grant from Research to Prevent Blindness
   (New York, N.Y.); Brazilian National Research Council-CAPES grant
   12309-13-3 (CPBG); grants for participants' glaucoma medications from
   Alcon, Allergan, Pfizer, Merck, and Santen. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR AIRAKSINEN PJ, 1983, ACTA OPHTHALMOL, V61, P186
   BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9
   Beckett LA, 2004, STAT MED, V23, P231, DOI 10.1002/sim.1712
   Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031
   Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022
   Cedrone C, 2012, J GLAUCOMA, V21, P1, DOI 10.1097/IJG.0b013e3182027796
   De Moraes CG, 2013, ACTA OPHTHALMOL, V91, pe86, DOI 10.1111/j.1755-3768.2012.02577.x
   De Moraes CGV, 2009, INVEST OPHTH VIS SCI, V50, P4727, DOI 10.1167/iovs.09-3446
   de Voogd S, 2005, OPHTHALMOLOGY, V112, P1487, DOI 10.1016/j.ophtha.2005.04.018
   Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3
   Fieuws S, 2007, STAT METHODS MED RES, V16, P387, DOI 10.1177/0962280206075305
   Gunvant P, 2005, J GLAUCOMA, V14, P20, DOI 10.1097/01.ijg.0000146367.43872.ea
   Harwerth RS, 2010, PROG RETIN EYE RES, V29, P249, DOI 10.1016/j.preteyeres.2010.02.001
   Ishida K, 2000, AM J OPHTHALMOL, V129, P707, DOI 10.1016/S0002-9394(00)00441-4
   Jeoung JW, 2008, OPHTHALMOLOGY, V115, P2132, DOI 10.1016/j.ophtha.2008.08.024
   Jonas JB, 2002, INVEST OPHTH VIS SCI, V43, P2956
   Jonas JB, 2002, OPHTHALMOLOGY, V109, P2078, DOI 10.1016/S0161-6420(02)01237-X
   JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012
   Kim SH, 2006, OPHTHALMOLOGY, V113, P598, DOI 10.1016/j.ophtha.2005.12.018
   KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Law SK, 2001, AM J OPHTHALMOL, V132, P411, DOI 10.1016/S0002-9394(01)01009-1
   Leske MC, 2007, OPHTHALMOLOGY, V114, P1058, DOI 10.1016/j.ophtha.2006.08.051
   Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48
   Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89
   Liou SY, 2001, AM J OPHTHALMOL, V132, P618, DOI 10.1016/S0002-9394(01)01238-7
   Medeiros FA, 2005, ARCH OPHTHALMOL-CHIC, V123, P1351, DOI 10.1001/archopht.123.10.1351
   Medeiros FA, 2008, OPHTHALMOLOGY, V115, P1340, DOI 10.1016/j.ophtha.2007.11.008
   Medeiros FA, 2012, AM J OPHTHALMOL, V154, P814, DOI 10.1016/j.ajo.2012.04.022
   Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345
   Medeiros FA, 2012, ARCH OPHTHALMOL-CHIC, V130, P1107, DOI 10.1001/archophthalmol.2012.827
   Medeiros FA, 2010, OPHTHALMOLOGY, V117, P2061, DOI 10.1016/j.ophtha.2010.02.015
   Medeiros FA, 2009, AM J OPHTHALMOL, V148, P155, DOI 10.1016/j.ajo.2009.01.021
   MIKELBERG FS, 1989, OPHTHALMOLOGY, V96, P1325
   Mukesh BN, 2002, OPHTHALMOLOGY, V109, P1047, DOI 10.1016/S0161-6420(02)01040-0
   Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58
   Radcliffe NM, 2008, AM J OPHTHALMOL, V146, P735, DOI 10.1016/j.ajo.2008.06.018
   Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187
   Siegner SW, 1996, OPHTHALMOLOGY, V103, P1014, DOI 10.1016/S0161-6420(96)30572-1
   Sonnsjo B, 2002, PROG RETIN EYE RES, V21, P35, DOI 10.1016/S1350-9462(01)00019-2
   Varma R, 2012, AM J OPHTHALMOL, V154, P315, DOI 10.1016/j.ajo.2012.02.014
   Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192
NR 42
TC 17
Z9 17
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 26
PY 2014
VL 9
IS 8
AR e105611
DI 10.1371/journal.pone.0105611
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO4JK
UT WOS:000341303200040
PM 25157619
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mubarqui, RL
   Perez, RC
   Kladt, RA
   Lopez, JLZ
   Parker, A
   Seck, MT
   Sall, B
   Bouyer, J
AF Mubarqui, Ruben Leal
   Perez, Rene Cano
   Kladt, Roberto Angulo
   Lopez, Jose Luis Zavala
   Parker, Andrew
   Seck, Momar Talla
   Sall, Baba
   Bouyer, Jeremy
TI The Smart Aerial Release Machine, a Universal System for Applying the
   Sterile Insect Technique
SO PLOS ONE
LA English
DT Article
ID TSETSE-FLIES; PALPALIS-GAMBIENSIS; MATING PERFORMANCE; DIPTERA;
   GLOSSINIDAE; ZANZIBAR; SENEGAL; MODELS; UNGUJA; ISLAND
AB Background: Beyond insecticides, alternative methods to control insect pests for agriculture and vectors of diseases are needed. Management strategies involving the mass-release of living control agents have been developed, including genetic control with sterile insects and biological control with parasitoids, for which aerial release of insects is often required. Aerial release in genetic control programmes often involves the use of chilled sterile insects, which can improve dispersal, survival and competitiveness of sterile males. Currently available means of aerially releasing chilled fruit flies are however insufficiently precise to ensure homogeneous distribution at low release rates and no device is available for tsetse.
   Methodology/Principal Findings: Here we present the smart aerial release machine, a new design by the Mubarqui Company, based on the use of vibrating conveyors. The machine is controlled through Bluetooth by a tablet with Android Operating System including a completely automatic guidance and navigation system (MaxNav software). The tablet is also connected to an online relational database facilitating the preparation of flight schedules and automatic storage of flight reports. The new machine was compared with a conveyor release machine in Mexico using two fruit flies species (Anastrepha ludens and Ceratitis capitata) and we obtained better dispersal homogeneity (% of positive traps, p<0.001) for both species and better recapture rates for Anastrepha ludens (p<0.001), especially at low release densities (<1500 per ha). We also demonstrated that the machine can replace paper boxes for aerial release of tsetse in Senegal.
   Conclusions/Significance: This technology limits damages to insects and allows a large range of release rates from 10 flies/km(2) for tsetse flies up to 600 000 flies/km(2) for fruit flies. The potential of this machine to release other species like mosquitoes is discussed. Plans and operating of the machine are provided to allow its use worldwide.
C1 [Mubarqui, Ruben Leal; Perez, Rene Cano; Kladt, Roberto Angulo] Serv Aereos Biol & Forest Mubarqui, Cuidad Victoria, Mexico.
   [Lopez, Jose Luis Zavala] Programa Moscamed, Tapachula, Mexico.
   [Parker, Andrew] Int Atom Energy Agcy FAO IAEA, Joint Food & Agr Org, Insect Pest Control Lab, Programme Nucl Tech Food & Agr, Vienna, Austria.
   [Seck, Momar Talla; Bouyer, Jeremy] Inst Senegalais Rech Agricoles, Lab Natl Elevage & Rech Vet, Dakar, Hann, Senegal.
   [Sall, Baba] Direct Serv Vet, Dakar, Senegal.
   [Bouyer, Jeremy] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France.
   [Bouyer, Jeremy] INRA, Unite Mixte Rech 1309, Montpellier, France.
RP Bouyer, J (reprint author), Inst Senegalais Rech Agricoles, Lab Natl Elevage & Rech Vet, Dakar, Hann, Senegal.
EM bouyer@cirad.fr
FU Mubarqui Company; International Atomic Energy Agency
FX The work was funded by the Mubarqui Company and the International Atomic
   Energy Agency. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Arredondo J, 2013, EFECTO TIEMPO HIPOXI
   Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9
   Bates D., 2011, LME4 LINEAR MIXED EE
   BAUER B, 1984, REV ELEV MED VET PAY, V37, P9
   Bjelis M, 2011, J APPL ENTOMOL, V137, P154
   Bouyer J, 2008, MED VET ENTOMOL, V22, P140, DOI 10.1111/j.1365-2915.2008.00727.x
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bouyer J, 2010, J MED ENTOMOL, V47, P543
   Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040
   Burnham K. P, 2002, MODEL SELECTION MULT
   CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251
   Day MF, 2012, INSECT PATHOLOGY ADV, V1, P29
   Dicko AH, 2014, P NATL ACAD IN PRESS
   Diggle PJ, 1994, ANAL LONGITUDINAL DA
   Enkerlin W, 2007, GUIDANCE PACKING SHI
   Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16
   Gutierrez Ruelas JM, 2012, SITUACION ACTUAL MOS
   HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Leal Mubarqui R, 2005, MANUAL OPERACION MET
   Liedo P, 2007, FLA ENTOMOL, V90, P33, DOI 10.1653/0015-4040(2007)90[33:IMPOMS]2.0.CO;2
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Mutika GN, 2013, ENTOMOL EXP APPL, V146, P177, DOI 10.1111/j.1570-7458.2012.01305.x
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   R Core Team, 2014, R LANG ENV STAT COMP
   Rayaisse JB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001491
   Rull J., 1996, FRUIT FLY PESTS WORL, P561
   SCHWARZ AJ, 1985, FLA ENTOMOL, V68, P467, DOI 10.2307/3495135
   Tan LT, 2011, J APPL ENTOMOL, P126
   Tween G., 2007, P229, DOI 10.1007/978-1-4020-6059-5_21
   Villasenor A, 2000, CURRENT PROGR MEDFLY, P361
   Vreysen M.J.B., 2007, AREA WIDE CONTROL IN
   Vreysen MJB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002857
   Vreysen MJB, 2013, J INVERTEBR PATHOL, V112, pS15, DOI 10.1016/j.jip.2012.07.026
   Vreysen MJB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000907
   Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123
   Zavala JL, 2014, 9 INT S FRUIT FLIES
NR 37
TC 7
Z9 7
U1 0
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 18
PY 2014
VL 9
IS 7
AR e103077
DI 10.1371/journal.pone.0103077
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM1OC
UT WOS:000339615200110
PM 25036274
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Vazquez-Alcocer, A
   Garzon-Cortes, DL
   Sanchez-Casas, RM
AF Vazquez-Alcocer, Alan
   Ladislao Garzon-Cortes, Daniel
   Maria Sanchez-Casas, Rosa
TI LADES: A Software for Constructing and Analyzing Longitudinal Designs in
   Biomedical Research
SO PLOS ONE
LA English
DT Article
ID POWER ANALYSIS; MODELS
AB One of the most important steps in biomedical longitudinal studies is choosing a good experimental design that can provide high accuracy in the analysis of results with a minimum sample size. Several methods for constructing efficient longitudinal designs have been developed based on power analysis and the statistical model used for analyzing the final results. However, development of this technology is not available to practitioners through user-friendly software. In this paper we introduce LADES (Longitudinal Analysis and Design of Experiments Software) as an alternative and easy-to-use tool for conducting longitudinal analysis and constructing efficient longitudinal designs. LADES incorporates methods for creating cost-efficient longitudinal designs, unequal longitudinal designs, and simple longitudinal designs. In addition, LADES includes different methods for analyzing longitudinal data such as linear mixed models, generalized estimating equations, among others. A study of European eels is reanalyzed in order to show LADES capabilities. Three treatments contained in three aquariums with five eels each were analyzed. Data were collected from 0 up to the 12th week post treatment for all the eels (complete design). The response under evaluation is sperm volume. A linear mixed model was fitted to the results using LADES. The complete design had a power of 88.7% using 15 eels. With LADES we propose the use of an unequal design with only 14 eels and 89.5% efficiency. LADES was developed as a powerful and simple tool to promote the use of statistical methods for analyzing and creating longitudinal experiments in biomedical research.
C1 [Vazquez-Alcocer, Alan] Ctr Invest Matemat, Guanajuato, Mexico.
   [Ladislao Garzon-Cortes, Daniel; Maria Sanchez-Casas, Rosa] Univ Autonoma Nuevo Leon, Fac Med Vet & Zootecn, Escobedo, Nuevo Leon, Mexico.
   [Ladislao Garzon-Cortes, Daniel; Maria Sanchez-Casas, Rosa] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico.
RP Vazquez-Alcocer, A (reprint author), Ctr Invest Matemat, Guanajuato, Mexico.
EM alan.vazquez@cimat.mx
OI SANCHEZ CASAS, ROSA MARIA/0000-0002-2626-7227
FU Centro de Investigacion en Matematicas; Facultad de Medicina Veterinaria
   y Zootecnia; Centro de investigacion y Desarrollo en Ciencias de la
   Salud of the Universidad Autonoma de Nuevo Leon
FX This work was funded with internal funding of the Centro de
   Investigacion en Matematicas, the Facultad de Medicina Veterinaria y
   Zootecnia and the Centro de investigacion y Desarrollo en Ciencias de la
   Salud of the Universidad Autonoma de Nuevo Leon. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR A FIELD, 1998, BRIT J MATH STAT PSY, V51, P367
   Arnau J, 2010, PERCEPT MOTOR SKILL, V110, P547, DOI 10.2466/PMS.110.2.547-566
   Asturiano JF, 2006, THERIOGENOLOGY, V66, P1012, DOI 10.1016/j.theriogenology.2006.02.041
   Atkinson AC, 1992, OPTIMUM EXPT DESIGNS
   Cohen J, 1988, STAT POWER ANAL BEHA
   De Jong K, 2010, PSYCHOTHER RES, V20, P273, DOI 10.1080/10503300903376320
   Dell Ralph B, 2002, ILAR J, V43, P207
   Diggle P., 1994, OXFORD STAT SCI SERI
   Festing Michael F W, 2002, ILAR J, V43, P244
   Gromping U, 2014, J STAT SOFTW, V56, P1
   HELMS RW, 1992, STAT MED, V11, P1889, DOI 10.1002/sim.4780111411
   Hintze J, 2013, PASS 12
   Hojsgaard S., 2006, J STAT SOFTW, V15, P1
   Huang WZ, 2005, J R STAT SOC B, V67, P135, DOI 10.1111/j.1467-9868.2005.00492.x
   La Rosa PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052078
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267
   PETERMAN RM, 1990, CAN J FISH AQUAT SCI, V47, P2, DOI 10.1139/f90-001
   Pinheiro JC, 2009, STAT COMPUTING
   Pinheiro Jose C., 2013, NLME LINEAR NONLINEA
   R Core Team, 2013, R LANG ENV STAT COMP
   Raudenbush ea SW, 2011, OPTIMAL DESIGN SOFTW
   Reboussin BA, 2002, J ROY STAT SOC C-APP, V51, P69, DOI 10.1111/1467-9876.04742
   Reich NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035564
   Roy A, 2007, BIOMETRICS, V63, P699, DOI 10.1111/j.1541-0420.2007.00769.x
   Stegmaier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055723
   Verbeke G, 2009, SPRINGER SER STAT, P1
   Wheeler B., 2011, ALGDESIGN ALGORITHMI
   WHEELER RE, 1974, TECHNOMETRICS, V16, P193, DOI 10.2307/1267939
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734
   Zuur A., 2009, MIXED EFFECTS MODELS
NR 32
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 1
PY 2014
VL 9
IS 7
AR e100570
DI 10.1371/journal.pone.0100570
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM1UX
UT WOS:000339635000029
PM 24983945
OA DOAJ Gold, Green Accepted, Green Published
DA 2019-07-16
ER

PT J
AU Thomas, R
   Hubbard, AE
   McHale, CM
   Zhang, LP
   Rappaport, SM
   Lan, Q
   Rothman, N
   Vermeulen, R
   Guyton, KZ
   Jinot, J
   Sonawane, BR
   Smith, MT
AF Thomas, Reuben
   Hubbard, Alan E.
   McHale, Cliona M.
   Zhang, Luoping
   Rappaport, Stephen M.
   Lan, Qing
   Rothman, Nathaniel
   Vermeulen, Roel
   Guyton, Kathryn Z.
   Jinot, Jennifer
   Sonawane, Babasaheb R.
   Smith, Martyn T.
TI Characterization of Changes in Gene Expression and Biochemical Pathways
   at Low Levels of Benzene Exposure
SO PLOS ONE
LA English
DT Article
ID PRINCIPAL COMPONENT ANALYSIS; ACUTE MYELOID-LEUKEMIA; TESTING
   ASSOCIATION; VARIABLE IMPORTANCE; LONGITUDINAL DATA; BONE-MARROW;
   METABOLISM; IDENTIFICATION; PHENOL; KEGG
AB Benzene, a ubiquitous environmental pollutant, causes acute myeloid leukemia (AML). Recently, through transcriptome profiling of peripheral blood mononuclear cells (PBMC), we reported dose-dependent effects of benzene exposure on gene expression and biochemical pathways in 83 workers exposed across four airborne concentration ranges (from < 1 ppm to > 10 ppm) compared with 42 subjects with non-workplace ambient exposure levels. Here, we further characterize these dose-dependent effects with continuous benzene exposure in all 125 study subjects. We estimated air benzene exposure levels in the 42 environmentally-exposed subjects from their unmetabolized urinary benzene levels. We used a novel nonparametric, data-adaptive model selection method to estimate the change with dose in the expression of each gene. We describe non-parametric approaches to model pathway responses and used these to estimate the dose responses of the AML pathway and 4 other pathways of interest. The response patterns of majority of genes as captured by mean estimates of the first and second principal components of the dose-response for the five pathways and the profiles of 6 AML pathway response-representative genes (identified by clustering) exhibited similar apparent supra-linear responses. Responses at or below 0.1 ppm benzene were observed for altered expression of AML pathway genes and CYP2E1. Together, these data show that benzene alters disease-relevant pathways and genes in a dose-dependent manner, with effects apparent at doses as low as 100 ppb in air. Studies with extensive exposure assessment of subjects exposed in the low-dose range between 10 ppb and 1 ppm are needed to confirm these findings.
C1 [Thomas, Reuben; Hubbard, Alan E.; McHale, Cliona M.; Zhang, Luoping; Rappaport, Stephen M.; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Superfund Res Program, Berkeley, CA 94704 USA.
   [Lan, Qing; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD USA.
   [Guyton, Kathryn Z.; Jinot, Jennifer; Sonawane, Babasaheb R.] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Washington, DC 20460 USA.
   [Vermeulen, Roel] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.
RP Thomas, R (reprint author), Univ Calif Berkeley, Sch Publ Hlth, Superfund Res Program, Berkeley, CA 94704 USA.
EM reuben.thomas@berkeley.edu
RI Vermeulen, Roel/F-8037-2011
OI Vermeulen, Roel/0000-0003-4082-8163
FU National Institutes of Health, National Institute of Environmental
   Health Sciences [R01ES01896, P42 ES004705]; Environment Protection
   Agency [EP-11-001398]
FX Original data generated through funding from National Institutes of
   Health grants R01ES01896 and P42 ES004705 from the National Institute of
   Environmental Health Sciences with additional statistical analyses being
   funded in part by Environment Protection Agency contract number
   EP-11-001398. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR ANDREWS LS, 1979, LIFE SCI, V25, P567, DOI 10.1016/0024-3205(79)90550-2
   Bates D, 2008, IME4 LINEAR MIXED EF
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bolen CR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-258
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1023/A:1018054314350
   Chen X, 2008, BIOINFORMATICS, V24, P2474, DOI 10.1093/bioinformatics/btn458
   Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090
   Cleveland W, 1991, PACIFIC GROVE CH LOC, P309
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Gelman A, 2010, ARM DATA ANAL USING
   Gill RD, 2001, ANN STAT, V29, P1785
   Goeman JJ, 2005, BIOINFORMATICS, V21, P1950, DOI 10.1093/bioinformatics/bti267
   Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382
   Haykin S, 1999, NEURAL NETWORKS COMP
   Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428
   Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   Khalade A, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-31
   Kim S, 2006, CARCINOGENESIS, V27, P772, DOI 10.1093/carcin/bgi297
   KOOP DR, 1989, TOXICOL APPL PHARM, V98, P278, DOI 10.1016/0041-008X(89)90233-0
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lan Q, 2006, SCIENCE, V312, P998
   Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443
   Lorsbach RB, 2001, INT J HEMATOL, V74, P258, DOI 10.1007/BF02982058
   Ma S, 2009, BIOINFORMATICS, V25, P882, DOI 10.1093/bioinformatics/btp085
   McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297
   McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546
   Metzeler KH, 2012, BLOOD, V120, P2118, DOI 10.1182/blood-2012-02-411827
   Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677
   Nedelcheva V, 1999, ARCH TOXICOL, V73, P33, DOI 10.1007/s002040050583
   Pollard KS, 2010, HOPACH HIERARCHICAL, P2100
   Polley E, 2010, SUPERLEARNER SUPER L
   Powley MW, 2000, J BIOCHEM MOL TOXIC, V14, P303, DOI 10.1002/1099-0461(2000)14:6<303::AID-JBT2>3.0.CO;2-8
   Powley MW, 2002, INHAL TOXICOL, V14, P569, DOI 10.1080/08958370290084502
   Qu QS, 2002, AM J IND MED, V42, P275, DOI 10.1002/ajim.10121
   Rappaport SM, 2005, CHEM-BIOL INTERACT, V153, P103, DOI 10.1016/j.cbi.2005.03.014
   Rappaport SM, 2002, J CHROMATOGR B, V778, P367, DOI 10.1016/S0378-4347(01)00457-1
   Rappaport SM, 2009, ENVIRON HEALTH PERSP, V117, P946, DOI 10.1289/ehp.0800510
   Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1
   SAMMETT D, 1979, J TOXICOL ENV HEALTH, V5, P785, DOI 10.1080/15287397909529789
   Sheets PL, 2004, J BIOCHEM MOL TOXIC, V18, P92, DOI 10.1002/jbt.20010
   Silva FPG, 2003, ONCOGENE, V22, P538, DOI 10.1038/sj.onc.1206141
   Smith MT, 2011, CHEMICOBIOLOGICAL IN
   Steffen B, 2005, CRIT REV ONCOL HEMAT, V56, P195, DOI 10.1016/j.critrevonc.2004.10.012
   Steinmaus C, 2008, OCCUP ENVIRON MED, V65, P371, DOI 10.1136/oem.2007.036913
   Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25
   Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307
   SUBRAHMANYAM VV, 1991, FREE RADICAL RES COM, V15, P285, DOI 10.3109/10715769109105224
   SUBRAHMANYAM VV, 1990, TOXICOLOGY, V62, P107, DOI 10.1016/0300-483X(90)90035-F
   team RDc, 2004, R LANG ENV STAT COMP
   Thomas R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r44
   van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309
   van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9
   VANDOORNKHOSROV.SB, 2003, HEMATOL J, V4, P31
   Vermeulen R, 2004, ANN OCCUP HYG, V48, P105, DOI 10.1093/annhyg/meh005
   Vlaanderen J, 2010, ENVIRON HEALTH PERSP, V118, P526, DOI 10.1289/ehp.0901127
   Wotton S, 2002, CANCER RES, V62, P7181
   Zhang LP, 2010, CHEM-BIOL INTERACT, V184, P86, DOI 10.1016/j.cbi.2009.12.011
NR 63
TC 27
Z9 27
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 1
PY 2014
VL 9
IS 5
AR e91828
DI 10.1371/journal.pone.0091828
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG6EE
UT WOS:000335510600005
PM 24786086
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Xiao, Q
   Moore, SC
   Boca, SM
   Matthews, CE
   Rothman, N
   Stolzenberg-Solomon, RZ
   Sinha, R
   Cross, AJ
   Sampson, JN
AF Xiao, Qian
   Moore, Steven C.
   Boca, Simina M.
   Matthews, Charles E.
   Rothman, Nathaniel
   Stolzenberg-Solomon, Rachael Z.
   Sinha, Rashmi
   Cross, Amanda J.
   Sampson, Joshua N.
TI Sources of Variability in Metabolite Measurements from Urinary Samples
SO PLOS ONE
LA English
DT Article
ID CHRONIC-FATIGUE-SYNDROME; CORTISOL METABOLITES; PREMENOPAUSAL WOMEN;
   DIURNAL EXCRETION; PROFILES; RISK; METABOLOMICS; REPRODUCIBILITY;
   DISEASE; SYSTEMS
AB Background: The application of metabolomics in epidemiological studies would potentially allow researchers to identify biomarkers associated with exposures and diseases. However, within-individual variability of metabolite levels caused by temporal variation of metabolites, together with technical variability introduced by laboratory procedures, may reduce the study power to detect such associations. We assessed the sources of variability of metabolites from urine samples and the implications for designing epidemiologic studies.
   Methods: We measured 539 metabolites in urine samples from the Navy Colon Adenoma Study using liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectroscopy (GC-MS). The study collected 2-3 samples per person from 17 male subjects (age 38-70) over 2-10 days. We estimated between-individual, within-individual, and technical variability and calculated expected study power with a specific focus on large case-control and nested case-control studies.
   Results: Overall technical reliability was high (median intraclass correlation = 0.92), and for 72% of the metabolites, the majority of total variance can be attributed to between-individual variability. Age, gender and body mass index explained only a small proportion of the total metabolite variability. For a relative risk (comparing upper and lower quartiles of "usual" levels) of 1.5, we estimated that a study with 500, 1,000, and 5,000 individuals could detect 1.0%, 4.5% and 75% of the metabolite associations.
   Conclusions: The use of metabolomics in urine samples from epidemiological studies would require large sample sizes to detect associations with moderate effect sizes.
C1 [Xiao, Qian; Moore, Steven C.; Matthews, Charles E.; Stolzenberg-Solomon, Rachael Z.; Sinha, Rashmi] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA.
   [Boca, Simina M.; Sampson, Joshua N.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA.
   [Rothman, Nathaniel] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA.
   [Cross, Amanda J.] Univ London Imperial Coll Sci Technol & Med, London, England.
RP Xiao, Q (reprint author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA.
EM qian.xiao@nih.gov
RI Moore, Steven/D-8760-2016; Stolzenberg-Solomon, Rachael/Y-9280-2018
OI Moore, Steven/0000-0002-8169-1661; Stolzenberg-Solomon,
   Rachael/0000-0003-3698-7006; Boca, Simina/0000-0002-1400-3398; matthews,
   charles/0000-0001-8037-3103
FU National Institutes of Health, National Cancer Institute, Department of
   Health and Human Services
FX This research was supported by the Intramural Research Program of the
   National Institutes of Health, National Cancer Institute, Department of
   Health and Human Services. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR CAGNACCI A, 1992, J CLIN ENDOCR METAB, V75, P447, DOI 10.1210/jc.75.2.447
   Eliassen AH, 2009, CANCER EPIDEM BIOMAR, V18, P2860, DOI 10.1158/1055-9965.EPI-09-0591
   Ellis JK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-61
   Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h
   Fenske M, 2006, J PSYCHOSOM RES, V60, P627, DOI 10.1016/j.jpsychores.2005.07.008
   Floegel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021103
   Frederiksen H, 2013, ENVIRON SCI TECHNOL, V47, P958, DOI 10.1021/es303640b
   Gika HG, 2008, J CHROMATOGR B, V871, P299, DOI 10.1016/j.jchromb.2008.05.048
   Helen GS, 2012, CANCER EPIDEM BIOMAR, V21, P1105, DOI 10.1158/1055-9965.EPI-12-0236
   Jerjes WK, 2006, J PSYCHOSOM RES, V60, P145, DOI 10.1016/j.jpsychores.2005.07.008
   Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Li Z, 2010, J EXPO SCI ENV EPID, V20, P526, DOI 10.1038/jes.2009.41
   Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094
   Moore SC, 2014, METABOLOMICS, V10, P259, DOI 10.1007/s11306-013-0574-1
   Neri LM, 2013, LEUKEMIA
   Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047
   Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1
   ROSNER B, 1992, AM J EPIDEMIOL, V136, P1400, DOI 10.1093/oxfordjournals.aje.a116453
   Rothman N, 2011, MOL EPIDEMIOLOGY PRI
   Sampson JN, 2013, CANCER EPIDEM BIOMAR, V22, P631, DOI 10.1158/1055-9965.EPI-12-1109
   Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005
   Sinha R, 1999, CANCER RES, V59, P4320
   Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059
   Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133
   Wallace M, 2010, HUM REPROD, V25, P949, DOI 10.1093/humrep/deq011
   Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307
   Wust S., 2000, NOISE HEALTH, V2, P79
   Xu XH, 2012, NEUROSCI BULL, V28, P641, DOI 10.1007/s12264-012-1272-0
NR 29
TC 11
Z9 12
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 1
PY 2014
VL 9
IS 5
AR e95749
DI 10.1371/journal.pone.0095749
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG6EE
UT WOS:000335510600051
PM 24788433
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zeng, P
   Zhao, Y
   Zhang, LW
   Huang, SP
   Chen, F
AF Zeng, Ping
   Zhao, Yang
   Zhang, Liwei
   Huang, Shuiping
   Chen, Feng
TI Rare Variants Detection with Kernel Machine Learning Based on Likelihood
   Ratio Test
SO PLOS ONE
LA English
DT Article
ID LINEAR MIXED MODELS; QUANTITATIVE TRAITS; DISEASE ASSOCIATION; GENOMIC
   SIMILARITY; COMMON DISEASES; GENETIC PATHWAY; COMPONENTS; REGRESSION;
   SUSCEPTIBILITY; INFORMATION
AB This paper mainly utilizes likelihood-based tests to detect rare variants associated with a continuous phenotype under the framework of kernel machine learning. Both the likelihood ratio test (LRT) and the restricted likelihood ratio test (ReLRT) are investigated. The relationship between the kernel machine learning and the mixed effects model is discussed. By using the eigenvalue representation of LRT and ReLRT, their exact finite sample distributions are obtained in a simulation manner. Numerical studies are performed to evaluate the performance of the proposed approaches under the contexts of standard mixed effects model and kernel machine learning. The results have shown that the LRT and ReLRT can control the type I error correctly at the given alpha level. The LRT and ReLRT consistently outperform the SKAT, regardless of the sample size and the proportion of the negative causal rare variants, and suffer from fewer power reductions compared to the SKAT when both positive and negative effects of rare variants are present. The LRT and ReLRT performed under the context of kernel machine learning have slightly higher powers than those performed under the context of standard mixed effects model. We use the Genetic Analysis Workshop 17 exome sequencing SNP data as an illustrative example. Some interesting results are observed from the analysis. Finally, we give the discussion.
C1 [Zeng, Ping; Zhao, Yang; Zhang, Liwei; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.
   [Zeng, Ping; Huang, Shuiping] Xuzhou Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Xuzhou, Jiangsu, Peoples R China.
RP Chen, F (reprint author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.
EM fengchen@njmu.edu.cn
OI Zeng, Ping/0000-0003-2710-3440
FU National Natural Science Foundation of China [81072389, 81373102];
   Research Found for the Doctoral Program of Higher Education of China
   [20113234110002]; Natural Science Foundation of the Jiangsu Higher
   Education Institutions of China [10KJA330034]; College Philosophy and
   Social Science Foundation from Education Department of Jiangsu Province
   of China [2013SJB790059, 2013SJD790032]; Research Foundation from Xuzhou
   Medical College [2012KJ02]; Research and Innovation Project for College
   Graduates of Jiangsu Province of China [CXLX13_574]; Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD)
FX This work was supported by National Natural Science Foundation of China
   (No. 81072389, 81373102), Research Found for the Doctoral Program of
   Higher Education of China (No. 20113234110002), Key Grant of Natural
   Science Foundation of the Jiangsu Higher Education Institutions of China
   (No. 10KJA330034), College Philosophy and Social Science Foundation from
   Education Department of Jiangsu Province of China (No. 2013SJB790059,
   2013SJD790032), Research Foundation from Xuzhou Medical College (No.
   2012KJ02), Research and Innovation Project for College Graduates of
   Jiangsu Province of China (No. CXLX13_574), and the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Almasy Laura, 2011, BMC Proc, V5 Suppl 9, pS2, DOI 10.1186/1753-6561-5-S9-S2
   Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421
   Bacanu SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042530
   Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867
   Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609
   Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136
   Bowes J, 2010, HUM GENET, V128, P627, DOI 10.1007/s00439-010-0889-1
   Chen Z, 2003, BIOMETRICS, V59, P762, DOI 10.1111/j.0006-341X.2003.00089.x
   Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779
   Claeskens G, 2004, J ROY STAT SOC B, V66, P909, DOI 10.1111/j.1467-9868.2004.05421.x
   CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913
   Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x
   Cristianini N., 2000, INTRO SUPPORT VECTOR
   Davies R. B, 1980, J R STAT SOC C, V29, P323, DOI DOI 10.2307/2346911
   Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025
   Feng T, 2010, HUM GENET, V128, P269, DOI 10.1007/s00439-010-0849-9
   Ghosh Saurabh, 2011, BMC Proc, V5 Suppl 9, pS1, DOI 10.1186/1753-6561-5-S9-S1
   Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285
   Greven S, 2008, J COMPUT GRAPH STAT, V17, P870, DOI 10.1198/106186008X386599
   Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437
   Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704
   HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796
   HARVILLE DA, 1974, BIOMETRIKA, V61, P383, DOI 10.2307/2334370
   Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677
   Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289
   KIMELDORF G, 1971, J MATH ANAL APPL, V33, P82, DOI 10.1016/0022-247X(71)90184-3
   Kuo BS, 1999, ECONOMET THEOR, V15, P24
   Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014
   Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007
   Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481
   Liang KY, 1996, J ROY STAT SOC B MET, V58, P785
   Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309
   Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156
   Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x
   Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292
   Liu H, 2009, COMPUT STAT DATA AN, V53, P853, DOI 10.1016/j.csda.2008.11.025
   Madsen B.E., 2009, PLOS GENET, V5
   Mallick BK, 2005, J R STAT SOC B, V67, P219, DOI 10.1111/j.1467-9868.2005.00498.x
   Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3
   Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003
   Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728
   PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545
   Peng G, 2013, P NATL ACAD SCI USA, V110, P3985, DOI 10.1073/pnas.1222158110
   Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272
   R Core Team, 2013, R LANG ENV STAT COMP
   Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984
   Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118
   Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305
   Schaid DJ, 2010, HUM HERED, V70, P109, DOI 10.1159/000312641
   Schaid DJ, 2010, HUM HERED, V70, P132, DOI 10.1159/000312643
   Scheipl F, 2008, COMPUT STAT DATA AN, V52, P3283, DOI 10.1016/j.csda.2007.10.022
   Scholkopf B., 2001, LEARNING KERNELS SUP
   SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471
   Shawe-Taylor J., 2004, KERNEL METHODS PATTE
   Smith G, 2013, ANN CLIN BIOCHEM, V50, P83, DOI 10.1258/acb.2012.012103
   STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455
   Verbeke G, 2003, BIOMETRICS, V59, P254, DOI 10.1111/1541-0420.00032
   Verbeke G, 2009, SPRINGER SER STAT, P1
   Wahba G, 1990, SPLINE MODELS OBSERV
   Wahba G., 1999, ADV KERNEL METHODS S, V6, P69
   Wu MC, 2013, GENET EPIDEMIOL, V37, P267, DOI 10.1002/gepi.21715
   Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029
   Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002
   Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608
   Yu L, 2013, HUM GENET, V132, P285, DOI 10.1007/s00439-012-1249-0
   Zhan HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044173
   Zuo LJ, 2013, J HUM GENET, V58, P178, DOI 10.1038/jhg.2012.153
NR 69
TC 2
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 27
PY 2014
VL 9
IS 3
AR e93355
DI 10.1371/journal.pone.0093355
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE0SW
UT WOS:000333677500112
PM 24675868
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Eckel, SP
   Linn, WS
   Berhane, K
   Rappaport, EB
   Salam, MT
   Zhang, Y
   Gilliland, FD
AF Eckel, Sandrah P.
   Linn, William S.
   Berhane, Kiros
   Rappaport, Edward B.
   Salam, Muhammad T.
   Zhang, Yue
   Gilliland, Frank D.
TI Estimation of Parameters in the Two-Compartment Model for Exhaled Nitric
   Oxide
SO PLOS ONE
LA English
DT Article
ID EXTENDED NO ANALYSIS; EXCHANGE PARAMETERS; ASTHMA; ALVEOLAR; CHILDREN;
   SYNTHASE; SCHOOLCHILDREN; POPULATION; DIFFUSION; POLLUTION
AB The fractional concentration of exhaled nitric oxide (FeNO) is a biomarker of airway inflammation that is being increasingly considered in clinical, occupational, and epidemiological applications ranging from asthma management to the detection of air pollution health effects. FeNO depends strongly on exhalation flow rate. This dependency has allowed for the development of mathematical models whose parameters quantify airway and alveolar compartment contributions to FeNO. Numerous methods have been proposed to estimate these parameters using FeNO measured at multiple flow rates. These methods-which allow for non-invasive assessment of localized airway inflammation-have the potential to provide important insights on inflammatory mechanisms. However, different estimation methods produce different results and a serious barrier to progress in this field is the lack of a single recommended method. With the goal of resolving this methodological problem, we have developed a unifying framework in which to present a comprehensive set of existing and novel statistical methods for estimating parameters in the simple two-compartment model. We compared statistical properties of the estimators in simulation studies and investigated model fit and parameter estimate sensitivity across methods using data from 1507 schoolchildren from the Southern California Children's Health Study, one of the largest multiple flow FeNO studies to date. We recommend a novel nonlinear least squares model with natural log transformation on both sides that produced estimators with good properties, satisfied model assumptions, and fit the Children's Health Study data well.
C1 [Eckel, Sandrah P.; Linn, William S.; Berhane, Kiros; Rappaport, Edward B.; Salam, Muhammad T.; Gilliland, Frank D.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.
   [Zhang, Yue] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.
RP Eckel, SP (reprint author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.
EM eckel@usc.edu
OI Salam, Muhammad/0000-0002-3565-8916
FU National Heart, Lung and Blood Institute [5R01HL61768, 5R01HL76647];
   Southern California Environmental Health Sciences Center [5P30ES007048];
   National Institute of Environmental Health Sciences; Children's
   Environmental Health Center [5P01ES009581, R826708-01, RD831861-01];
   National Institute of Environmental Health Sciences and the
   Environmental Protection Agency; National Institute of Environmental
   Health Sciences [5P01ES011627]; James H. Zumberge Research and
   Innovation Fund; Hastings Foundation
FX This work was supported by the National Heart, Lung and Blood Institute
   (grants 5R01HL61768 and 5R01HL76647); the Southern California
   Environmental Health Sciences Center (grant 5P30ES007048) funded by the
   National Institute of Environmental Health Sciences; the Children's
   Environmental Health Center (grants 5P01ES009581, R826708-01 and
   RD831861-01) funded by the National Institute of Environmental Health
   Sciences and the Environmental Protection Agency; the National Institute
   of Environmental Health Sciences (grant 5P01ES011627); the James H.
   Zumberge Research and Innovation Fund, and the Hastings Foundation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ATS/ERS, 2008, AM J RESP CRIT CARE, V171, P912, DOI DOI 10.1164/RCCM.200406-710ST.PUBMED:15817806
   Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090
   Bastain TM, 2010, EUR RESP J
   Bates DM, 1988, NONLINEAR REGRESSION
   Bates DM, 1992, STAT MODELS S
   Berhane K, 2011, EUR RESPIR J, V37, P1029, DOI 10.1183/09031936.00081410
   Breton CV, 2011, AM J RESP CRIT CARE, V184, P191, DOI 10.1164/rccm.201012-2029OC
   Condorelli P, 2007, J APPL PHYSIOL, V102, P417, DOI 10.1152/japplphysiol.00533.2006
   Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697
   Davidian M, 1995, NONLINEAR MODELS REP
   Dennis J., 1981, ACM T MATH SOFTWARE, V7, P367
   Eckel SP, 2013, OCCUP ENVIRON MED, V70, P519, DOI 10.1136/oemed-2013-101458
   Eckel SP, 2011, ENV HLTH PERSPECT
   Eco Medics AG, 2006, ANAL CLD 88 SERIES O
   FIELLER EC, 1957, BIOMETRIKA, V44, P470, DOI 10.1093/biomet/44.3-4.470
   Garcia-Rio F, 2011, J ASTHMA, V48, P329, DOI 10.3109/02770903.2011.565847
   GAY DM, 1981, SIAM J SCI STAT COMP, V2, P186, DOI 10.1137/0902016
   Gelb AF, 2010, THORAX, V65, P619, DOI 10.1136/thx.2009.132696
   George SC, 2004, J APPL PHYSIOL, V96, P831, DOI 10.1152/japplphysiol.00950.2003
   George SC, 2008, J APPL PHYSIOL, V104, P909, DOI 10.1152/japplphysiol.00111.2008
   Hogman M, 2000, RESP MED, V94, P985, DOI 10.1053/rmed.2000.0872
   Hogman M, 1997, ACTA PHYSIOL SCAND, V159, P345, DOI 10.1046/j.1365-201X.1997.00101.x
   Hogman M, 2002, RESP MED, V96, P24, DOI 10.1053/rmed.2001.1204
   Hogman M, 2007, J BREATH RES, V1, DOI 10.1088/1752-7155/1/2/024001
   Hogman M, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/4/047103
   Hogman M, 2009, CLIN PHYSIOL FUNCT I, V29, P18, DOI 10.1111/j.1475-097X.2008.00831.x
   Keen C, 2011, RESP MED, V105, P1476, DOI 10.1016/j.rmed.2011.04.004
   Kerckx Y, 2008, J APPL PHYSIOL, V104, P918, DOI 10.1152/japplphysiol.01032.2007
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lehouck A, 2010, RESP MED, V104, P1020, DOI 10.1016/j.rmed.2010.01.001
   Linn WS, 2009, J EXPO SCI ENV EPID, V19, P674, DOI 10.1038/jes.2008.64
   Linn WS, 2009, PEDIATR PULM, V44, P1033, DOI 10.1002/ppul.21101
   Linn WS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-28
   Linn WS, 2013, PEDIAT PULMONOL
   Mahut B, 2010, ALLERGY, V65, P636, DOI 10.1111/j.1398-9995.2009.02221.x
   Malinovschi A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-92
   Pietropaoli AP, 1999, J APPL PHYSIOL, V87, P1532
   Puckett JL, 2010, PEDIATR PULM, V45, P174, DOI 10.1002/ppul.21172
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Rodway G W, 2009, Chron Respir Dis, V6, P19, DOI 10.1177/1479972308095936
   Rosa MJ, 2011, PEDIATR PULM, V46, P83, DOI 10.1002/ppul.21328
   Rottier BL, 2005, J APPL PHYSIOL, V99, P378, DOI 10.1152/japplphysiol.00163.2005
   Roy K, 2007, EUR RESPIR J, V29, P651, DOI 10.1183/09031936.00149706
   Salam MT, 2011, ALLERGY, V66, P412, DOI 10.1111/j.1398-9995.2010.02492.x
   Salam MT, 2012, J ALLERGY CLIN IMMUN, V129, P232, DOI 10.1016/j.jaci.2011.09.037
   SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709
   Shorter JH, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037108
   Silkoff PE, 2000, AM J RESP CRIT CARE, V161, P1218, DOI 10.1164/ajrccm.161.4.9903111
   Silkoff PE, 1997, AM J RESP CRIT CARE, V155, P260, DOI 10.1164/ajrccm.155.1.9001322
   Suresh V, 2008, J APPL PHYSIOL, V104, P1743, DOI 10.1152/japplphysiol.01355.2007
   Tsoukias NM, 1998, J APPL PHYSIOL, V85, P653
   Verbanck S, 2012, EUR RESPIR J, V39, P1258, DOI 10.1183/09031936.00105611
NR 52
TC 14
Z9 14
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 17
PY 2014
VL 9
IS 1
AR e85471
DI 10.1371/journal.pone.0085471
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 297EA
UT WOS:000330237000037
PM 24465571
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rose, S
   Frye, RE
   Slattery, J
   Wynne, R
   Tippett, M
   Pavliv, O
   Melnyk, S
   James, SJ
AF Rose, Shannon
   Frye, Richard E.
   Slattery, John
   Wynne, Rebecca
   Tippett, Marie
   Pavliv, Oleksandra
   Melnyk, Stepan
   James, S. Jill
TI Oxidative Stress Induces Mitochondrial Dysfunction in a Subset of Autism
   Lymphoblastoid Cell Lines in a Well-Matched Case Control Cohort
SO PLOS ONE
LA English
DT Article
ID SPARE RESPIRATORY CAPACITY; NECROSIS-FACTOR-ALPHA; COULOMETRIC
   ELECTROCHEMICAL DETECTION; COMPLEX-I; SPECTRUM DISORDERS;
   PARKINSONS-DISEASE; METHYL MERCURY; CYTOCHROME-C; CHILDREN; GLUTATHIONE
AB There is increasing recognition that mitochondrial dysfunction is associated with the autism spectrum disorders. However, little attention has been given to the etiology of mitochondrial dysfunction or how mitochondrial abnormalities might interact with other physiological disturbances associated with autism, such as oxidative stress. In the current study we used respirometry to examine reserve capacity, a measure of the mitochondrial ability to respond to physiological stress, in lymphoblastoid cell lines (LCLs) derived from children with autistic disorder (AD) as well as age and gender-matched control LCLs. We demonstrate, for the first time, that LCLs derived from children with AD have an abnormal mitochondrial reserve capacity before and after exposure to increasingly higher concentrations of 2,3-dimethoxy-1,4-napthoquinone (DMNQ), an agent that increases intracellular reactive oxygen species (ROS). Specifically, the AD LCLs exhibit a higher reserve capacity at baseline and a sharper depletion of reserve capacity when ROS exposure is increased, as compared to control LCLs. Detailed investigation indicated that reserve capacity abnormalities seen in AD LCLs were the result of higher ATP-linked respiration and maximal respiratory capacity at baseline combined with a marked increase in proton leak respiration as ROS was increased. We further demonstrate that these reserve capacity abnormalities are driven by a subgroup of eight (32%) of 25 AD LCLs. Additional investigation of this subgroup of AD LCLs with reserve capacity abnormalities revealed that it demonstrated a greater reliance on glycolysis and on uncoupling protein 2 to regulate oxidative stress at the inner mitochondria membrane. This study suggests that a significant subgroup of AD children may have alterations in mitochondrial function which could render them more vulnerable to a pro-oxidant microenvironment derived from intrinsic and extrinsic sources of ROS such as immune activation and pro-oxidant environmental toxicants. These findings are consistent with the notion that AD is caused by a combination of genetic and environmental factors.
C1 [Rose, Shannon; Frye, Richard E.; Slattery, John; Wynne, Rebecca; Tippett, Marie; Pavliv, Oleksandra; Melnyk, Stepan; James, S. Jill] Arkansas Childrens Hosp, Res Inst, Dept Pediat, Little Rock, AR 72202 USA.
RP Frye, RE (reprint author), Arkansas Childrens Hosp, Res Inst, Dept Pediat, 800 Marshall St, Little Rock, AR 72202 USA.
EM REFrye@uams.edu
OI Rose, Shannon/0000-0003-0595-4367
FU National Institute for Child Health and Development; Arkansas
   Biosciences Institute; Jane Botsford Johnson Foundation
FX This research was funded by the National Institute for Child Health and
   Development (SJJ), the Arkansas Biosciences Institute (REF, SJJ), and
   the Jane Botsford Johnson Foundation (REF). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anderberg MR, 1973, CLUSTER ANAL APPL
   Anitha A, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-12
   [Anonymous], 2009, MMWR SURVEILL SUMM, V58, P1
   APA, 1994, DIAGN STAT MAN MENT
   Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P840, DOI 10.1016/j.bbi.2010.09.002
   Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035
   BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891
   Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x
   Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503
   Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010
   Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015
   Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001
   Evangeliou A, 2003, J CHILD NEUROL, V18, P113, DOI 10.1177/08830738030180020501
   FernandezCheca JC, 1997, AM J PHYSIOL-GASTR L, V273, pG7
   FOWLER BA, 1977, EXP MOL PATHOL, V27, P403, DOI 10.1016/0014-4800(77)90010-7
   Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143
   Frye RE, 2012, N AM J MED SCI, V5, P141, DOI DOI 10.7156/V5I3P141
   Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530
   Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507
   Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006
   Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706
   Goyer RA, 1997, ANNU REV NUTR, V17, P37, DOI 10.1146/annurev.nutr.17.1.37
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Gu F, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.68
   Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76
   Hill BG, 2010, BIOCHEM J, V424, P99
   Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198
   Hiura TS, 2000, J IMMUNOL, V165, P2703, DOI 10.4049/jimmunol.165.5.2703
   James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366
   James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926
   Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485
   Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577
   Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9
   Melnyk S, 2000, CLIN CHEM, V46, P265
   Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7
   Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385
   Nickles D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-477
   Oh JH, 2013, J HUM GENET, V58, P16, DOI 10.1038/jhg.2012.123
   Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007
   Pourahmad J, 2001, ADV EXP MED BIOL, V500, P249
   Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61
   Rose Shannon, 2012, Autism Res Treat, V2012, P986519, DOI 10.1155/2012/986519
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200
   Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002
   Shenker BJ, 1999, TOXICOL APPL PHARM, V157, P23, DOI 10.1006/taap.1999.8652
   Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x
   STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1
   STUBBS EG, 1977, J AUTISM CHILD SCHIZ, V7, P49, DOI 10.1007/BF01531114
   Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F
   Vali S, 2007, NEUROSCIENCE, V149, P917, DOI 10.1016/j.neuroscience.2007.08.028
   Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06
   Ward J.H., 1963, J AM STAT SOC, V77, P841
   Wong PW, 2001, J NEUROCHEM, V76, P450, DOI 10.1046/j.1471-4159.2001.00022.x
   Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007
   YAMANO T, 1995, ARCH ENVIRON CON TOX, V28, P1, DOI 10.1007/BF00213961
NR 59
TC 57
Z9 58
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 8
PY 2014
VL 9
IS 1
AR e85436
DI 10.1371/journal.pone.0085436
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 291WL
UT WOS:000329862500249
PM 24416410
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Park, SY
   Baek, S
   Kim, S
   Yoon, SY
   Kwon, HS
   Chang, YS
   Cho, YS
   Jang, AS
   Park, JW
   Nahm, DH
   Yoon, HJ
   Cho, SH
   Cho, YJ
   Choi, B
   Moon, HB
   Kim, TB
AF Park, So Young
   Baek, Seunghee
   Kim, Sujeong
   Yoon, Sun-young
   Kwon, Hyouk-Soo
   Chang, Yoon-Seok
   Cho, You Sook
   Jang, An-Soo
   Park, Jung Won
   Nahm, Dong-Ho
   Yoon, Ho-Joo
   Cho, Sang-Heon
   Cho, Young-Joo
   Choi, ByoungWhui
   Moon, Hee-Bom
   Kim, Tae-Bum
CA COREA Study Grp
TI Clinical Significance of Asthma Clusters by Longitudinal Analysis in
   Korean Asthma Cohort
SO PLOS ONE
LA English
DT Article
ID QUALITY-OF-LIFE; ADULT ASTHMA; PHENOTYPES; IDENTIFICATION; PERCEPTION;
   SEVERITY; DYSPNEA
AB Background: We have previously identified four distinct groups of asthma patients in Korean cohorts using cluster analysis: (A) smoking asthma, (B) severe obstructive asthma, (C) early-onset atopic asthma, and (D) late-onset mild asthma.
   Methods and Results: A longitudinal analysis of each cluster in a Korean adult asthma cohort was performed to investigate the clinical significance of asthma clusters over 12 months. Cluster A showed relatively high asthma control test (ACT) scores but relatively low FEV1 scores, despite a high percentage of systemic corticosteroid use. Cluster B had the lowest mean FEV1, ACT, and the quality of life questionnaire for adult Korean asthmatics (QLQAKA) scores throughout the year, even though the percentage of systemic corticosteroid use was the highest among the four clusters. Cluster C was ranked second in terms of FEV1, with the second lowest percentage of systemic corticosteroid use, and showed a marked improvement in subjective symptoms over time. Cluster D consistently showed the highest FEV1, the lowest systemic corticosteroid use, and had high ACT and QLQAKA scores.
   Conclusion: Our asthma clusters had clinical significance with consistency among clusters over 12 months. These distinctive phenotypes may be useful in classifying asthma in real practice.
C1 [Park, So Young; Kim, Sujeong; Yoon, Sun-young; Kwon, Hyouk-Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum] Univ Ulsan, Coll Med, Asan Med Ctr, Div Allergy & Clin Immunol,Dept Internal Med, Seoul, South Korea.
   [Baek, Seunghee] Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea.
   [Chang, Yoon-Seok; Cho, Sang-Heon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.
   [Jang, An-Soo] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon, South Korea.
   [Park, Jung Won] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Nahm, Dong-Ho] Ajou Univ, Coll Med, Dept Internal Med, Suwon 441749, South Korea.
   [Yoon, Ho-Joo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea.
   [Cho, Young-Joo] Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Choi, ByoungWhui] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea.
RP Kim, TB (reprint author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Allergy & Clin Immunol,Dept Internal Med, Seoul, South Korea.
EM allergy@medimail.co.kr
RI Chang, Yoon-Seok/J-5628-2012
OI Chang, Yoon-Seok/0000-0003-3157-0447; Cho, You Sook/0000-0001-8767-2667
FU Korea Healthcare Technology R&D Project, Ministry of Health and Welfare,
   Republic of Korea [A102065, HI13C0776]
FX This study was supported by a grant of the Korea Healthcare Technology
   R&D Project, Ministry of Health and Welfare, Republic of Korea (grant
   no. A102065 & HI13C0776). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X
   BALL GH, 1967, BEHAV SCI, V12, P153, DOI 10.1002/bs.3830120210
   Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707
   Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E
   Green RH, 2007, CURR OPIN ALLERGY CL, V7, P43, DOI 10.1097/ACI.0b013e3280118a32
   Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-17540C
   Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x
   JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76
   Kim TB, 2013, EUR RESPIR J, V41, P1308, DOI 10.1183/09031936.00100811
   Kim TB, 2009, ANN ALLERG ASTHMA IM, V103, P311, DOI 10.1016/S1081-1206(10)60530-3
   Kim TB, 2012, EUR RESP J
   Kleis S, 2007, RESP MED, V101, P1426, DOI 10.1016/j.rmed.2007.01.019
   Kwon HS, 2008, J KOREAN MED SCI, V23, P621, DOI 10.3346/jkms.2008.23.4.621
   Lai CKW, 2011, RESPIROLOGY, V16, P688, DOI 10.1111/j.1440-1843.2011.01954.x
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lenfant C, 2002, GLOBAL STRATEGY ASTH
   Miller MK, 2005, J ALLERGY CLIN IMMUN, V116, P990, DOI 10.1016/j.jaci.2005.08.018
   Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC
   Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008
   Polosa R, 2012, EUR RESP J
   Veen JCCMI, 1998, AM J RESP CRIT CARE, V158, P1134, DOI 10.1164/ajrccm.158.4.9710087
   Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8
   ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248
NR 23
TC 9
Z9 9
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2013
VL 8
IS 12
AR e83540
DI 10.1371/journal.pone.0083540
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 284NF
UT WOS:000329325200081
PM 24391784
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Fjaer, S
   Bo, L
   Lundervold, A
   Myhr, KM
   Pavlin, T
   Torkildsen, O
   Wergeland, S
AF Fjaer, Sveinung
   Bo, Lars
   Lundervold, Arvid
   Myhr, Kjell-Morten
   Pavlin, Tina
   Torkildsen, Oivind
   Wergeland, Stig
TI Deep Gray Matter Demyelination Detected by Magnetization Transfer Ratio
   in the Cuprizone Model
SO PLOS ONE
LA English
DT Article
ID PROGRESSIVE MULTIPLE-SCLEROSIS; CORTICAL LESION DETECTION; WHITE-MATTER;
   TRANSFER MRI; GREY-MATTER; MS; BRAIN; REMYELINATION; PATHOLOGY
AB In multiple sclerosis (MS), the correlation between lesion load on conventional magnetic resonance imaging (MRI) and clinical disability is weak. This clinico-radiological paradox might partly be due to the low sensitivity of conventional MRI to detect gray matter demyelination. Magnetization transfer ratio (MTR) has previously been shown to detect white matter demyelination in mice. In this study, we investigated whether MTR can detect gray matter demyelination in cuprizone exposed mice. A total of 54 female C57BL/6 mice were split into one control group () and eight cuprizone exposed groups (N-S = 6). The mice were exposed to 0.2% (w/w) cuprizone for up to six weeks. MTR images were obtained at a 7 Tesla Bruker MR-scanner before cuprizone exposure, weekly for six weeks during cuprizone exposure, and once two weeks after termination of cuprizone exposure. Immunohistochemistry staining for myelin (anti-Proteolopid Protein) and oligodendrocytes (anti-Neurite Outgrowth Inhibitor Protein A) was obtained after each weekly scanning. Rates of MTR change and correlations between MTR values and histological findings were calculated in five brain regions. In the corpus callosum and the deep gray matter a significant rate of MTR value decrease was found, 0.96% per week (p<.0001) and 0.39% per week (p<.0001) respectively. The MTR values correlated to myelin loss as evaluated by immunohistochemistry (Corpus callosum: R-2 = (.)43, p<0001. Deep gray matter: R-2 = .21, p<.001), but did not correlate to oligodendrocyte density. Significant results were not found in the cerebellum, the olfactory bulb or the cerebral cortex. This study shows that MTR can be used to detect demyelination in the deep gray matter, which is of particular interest for imaging of patients with MS, as deep gray matter demyelination is common in MS, and is not easily detected on conventional clinical MRI.
C1 [Fjaer, Sveinung; Bo, Lars; Myhr, Kjell-Morten; Torkildsen, Oivind; Wergeland, Stig] Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway.
   [Fjaer, Sveinung; Bo, Lars; Myhr, Kjell-Morten; Torkildsen, Oivind; Wergeland, Stig] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway.
   [Lundervold, Arvid] Univ Bergen, Neuroinformat & Image Anal Lab, Dept Biomed, Bergen, Norway.
   [Pavlin, Tina] Univ Bergen, Mol Imaging Ctr, Dept Biomed, Bergen, Norway.
   [Lundervold, Arvid; Pavlin, Tina] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway.
RP Fjaer, S (reprint author), Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway.
EM sveinung@fjaer.com
RI Torkildsen, Oivind/A-1606-2008; Myhr, Kjell-Morten/H-1528-2018
OI Torkildsen, Oivind/0000-0001-5294-2866; Myhr,
   Kjell-Morten/0000-0002-0980-510X
CR Agosta F, 2006, BRAIN, V129, P2620, DOI 10.1093/brain/aw1208
   Aharoni R, 2012, EXPT NEUROLOGY
   Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003
   Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051
   Cercignani M, 2001, AM J NEURORADIOL, V22, P952
   Chen JTH, 2013, NEUROLOGY, V80, P246, DOI 10.1212/WNL.0b013e31827deb99
   Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926
   Dehmeshki J, 2003, J NEUROL, V250, P67, DOI 10.1007/s00415-003-0955-x
   Deloire-Grassin MSA, 2000, J NEUROL SCI, V178, P10, DOI 10.1016/S0022-510X(00)00331-2
   Dousset V, 1998, NEUROLOGY, V51, P1150, DOI 10.1212/WNL.51.4.1150
   DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968
   Filippi M, 1998, J NEUROL SCI, V159, P162, DOI 10.1016/S0022-510X(98)00162-2
   FILIPPI M, 1995, NEUROLOGY, V45, P478, DOI 10.1212/WNL.45.3.478
   Filippi M, 1999, NEUROLOGY, V52, P588, DOI 10.1212/WNL.52.3.588
   Filippi M, 2013, NEUROLOGY
   Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1
   Geurts JJG, 2008, J NEUROL, V255, P183, DOI 10.1007/s00415-008-0620-5
   Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450
   Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005
   Hackmack K, 2012, J NEUROL, V259, P2151, DOI 10.1007/s00415-012-6475-9
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972
   Minagar A, 2013, NEUROLOGY, V80, P210, DOI 10.1212/WNL.0b013e31827b910b
   Nijeholt GJLA, 2001, BRAIN, V124, P154, DOI 10.1093/brain/124.1.154
   Rausch M, 2009, MULT SCLER, V15, P16, DOI 10.1177/1352458508096006
   Rocca MA, 1999, AM J NEURORADIOL, V20, P821
   Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0
   Sharma J, 2006, J NEUROIMAGING, V16, P302, DOI 10.1111/j.1552-6569.2006.00054.x
   Thiessen JD, 2013, NMR BIOMED, V26, P1562, DOI 10.1002/nbm.2992
   Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441
   Vrenken H, 2007, MULT SCLER, V13, P708, DOI 10.1177/1352458506075521
   Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569
   Wergeland S, 2012, APMIS, V120, P648, DOI 10.1111/j.1600-0463.2012.02882.x
   Wergeland S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026262
   Wilhelm MJ, 2012, P NATL ACAD SCI USA, V109, P9605, DOI 10.1073/pnas.1115107109
   Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3
NR 36
TC 26
Z9 26
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 30
PY 2013
VL 8
IS 12
AR e84162
DI 10.1371/journal.pone.0084162
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 282SX
UT WOS:000329194700094
PM 24386344
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nogueira, LM
   Sampson, JN
   Chu, LW
   Yu, K
   Andriole, G
   Church, T
   Stanczyk, FZ
   Koshiol, J
   Hsing, AW
AF Nogueira, Leticia M.
   Sampson, Joshua N.
   Chu, Lisa W.
   Yu, Kai
   Andriole, Gerald
   Church, Timothy
   Stanczyk, Frank Z.
   Koshiol, Jill
   Hsing, Ann W.
TI Individual Variations in Serum Melatonin Levels through Time:
   Implications for Epidemiologic Studies
SO PLOS ONE
LA English
DT Article
ID BREAST-CANCER RISK; NIGHT-SHIFT WORK; URINARY 6-SULFATOXYMELATONIN
   LEVELS; LIFE-STYLE FACTORS; LIGHT-AT-NIGHT; SLEEP DURATION; CIRCADIAN
   DISRUPTION; PROSTATE-CANCER; NURSES HEALTH; POSTMENOPAUSAL WOMEN
AB Melatonin, a marker for the circadian rhythm with serum levels peaking between 2AM and 5AM, is hypothesized to possess anti-cancer properties, making it a mechanistic candidate for the probable carcinogenic effect of circadian rhythm disruption. In order to weigh epidemiologic evidence on the association of melatonin with cancer, we must first understand the laboratory and biological sources of variability in melatonin levels measured in samples. Participants for this methodological study were men enrolled in the Prostate Lung Colorectal and Ovarian Cancer Screening Trial (PLCO). We measured serum melatonin levels over a five year period in 97 individuals to test if melatonin levels are steady over time. The Pearson correlation coefficient between two measures separated by 1 year was 0.87, while the correlation between two measures separated by 5 years was to 0.70. In an additional cross-sectional study of 292 individuals, we used Analysis of Variance to identify differences in melatonin levels between different lifestyle and environmental characteristics. Serum melatonin levels were slightly higher in samples collected from 130 individuals during the winter, (6.36 +/- 0.59 pg/ml) than in samples collected from 119 individuals during the summer (4.83 +/- 0.62 pg/ml). Serum melatonin levels were lowest in current smokers (3.02 +/- 1.25 pg/ml, p = 0.007) compared to never (6.66 +/- 0.66 pg/ml) and former (5.59 +/- 0.50 pg/ml) smokers whereas BMI did not significantly affect serum melatonin levels in this study. In conclusion, the high 5 year correlation of melatonin levels implies that single measurements may be used to detect population level associations between melatonin and risk of cancer. Furthermore, our results reiterate the need to record season of sample collection, and individual characteristics in order to maximize study power and prevent confounding.
C1 [Nogueira, Leticia M.; Sampson, Joshua N.; Yu, Kai; Koshiol, Jill] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.
   [Chu, Lisa W.; Hsing, Ann W.] Canc Prevent Inst Calif, Fremont, CA USA.
   [Andriole, Gerald] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA.
   [Church, Timothy] Univ Minnesota, Sch Publ Hlth, Dept Environm Hlth Sci, Minneapolis, MN USA.
   [Stanczyk, Frank Z.] Univ So Calif, Keck Sch Med, Dept Obstet Gynecol & Prevent Med, Los Angeles, CA 90033 USA.
RP Nogueira, LM (reprint author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.
EM leticia.nogueira@nih.gov
RI Nogueira, Leticia/J-2547-2019
OI Church, Timothy R./0000-0003-3292-5035
FU Division of Cancer Epidemiology and Genetics; Division of Cancer
   Prevention, National Cancer Institute, National Institutes of Health,
   Department of Health and Human Services
FX This research was supported by the Intramural Research Program of the
   Division of Cancer Epidemiology and Genetics and contracts from the
   Division of Cancer Prevention, National Cancer Institute, National
   Institutes of Health, Department of Health and Human Services. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ahmad S, 2009, ANAL BIOCHEM, V394, P237, DOI 10.1016/j.ab.2009.07.029
   Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002
   ARENDT J, 1985, J CLIN ENDOCR METAB, V60, P1166, DOI 10.1210/jcem-60-6-1166
   Band PR, 1996, AM J EPIDEMIOL, V143, P137
   BECKFRIIS J, 1984, PSYCHONEUROENDOCRINO, V9, P261, DOI 10.1016/0306-4530(84)90005-2
   Benloucif S, 2005, J BIOL RHYTHM, V20, P178, DOI 10.1177/0748730404273983
   Bhatti P, 2013, OCCUP ENVIRON MED, V70, P231, DOI 10.1136/oemed-2012-101146
   Bhatti P, 2012, AM J EPIDEMIOL, V176, P760, DOI 10.1093/aje/kws311
   Black A, 2009, PROSTATE CANC SCREEN, P361
   Bracci M, 2013, J BIOL REG HOMEOS AG, V27, P267
   Brainard GC, 2001, J NEUROSCI, V21, P6405
   Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31
   Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557
   Davis S, 2001, AM J EPIDEMIOL, V154, P591, DOI 10.1093/aje/154.7.591
   Erren TC, 2008, NATURWISSENSCHAFTEN, V95, P367, DOI 10.1007/s00114-007-0335-y
   Erren TC, 2013, INT J CANCER, V133, P2010, DOI 10.1002/ijc.28212
   Erren TC, 2013, AM J EPIDEMIOL, V177, P1020, DOI 10.1093/aje/kwt056
   Erren Thomas C, 2010, Epidemiol Perspect Innov, V7, P11, DOI 10.1186/1742-5573-7-11
   Erren TC, 2010, NEUROENDOCRINOL LETT, V31, P1
   FERNANDEZ B, 1990, J STEROID BIOCHEM, V35, P257, DOI 10.1016/0022-4731(90)90282-W
   FERRIER IN, 1982, CLIN ENDOCRINOL, V17, P181, DOI 10.1111/j.1365-2265.1982.tb01577.x
   Fideleff HL, 2006, J PINEAL RES, V40, P214, DOI 10.1111/j.1600-079X.2005.00301.x
   Forman JP, 2010, J HYPERTENS, V28, P446, DOI 10.1097/HJH.0b013e3283340c16
   Fritschi L, 2013, BRIT J CANCER, V109, P2472, DOI 10.1038/bjc.2013.544
   Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277
   Graham C, 1998, J PINEAL RES, V24, P230, DOI 10.1111/j.1600-079X.1998.tb00538.x
   Grundy A, 2013, OCCUP ENV MED
   Grundy A, 2013, CANCER EPIDEMIOL, V37, P606, DOI 10.1016/j.canep.2013.04.006
   Hansen J, 2006, CANCER CAUSE CONTROL, V17, P531, DOI 10.1007/s10552-005-9006-5
   Hansen J, 2001, JNCI-J NATL CANCER I, V93, P1513, DOI 10.1093/jnci/93.20.1513
   Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013
   Hansen J, 2012, OCCUP ENVIRON MED, V69, P551, DOI 10.1136/oemed-2011-100240
   Hansen J, 2012, EUR J CANCER, V48, P1722, DOI 10.1016/j.ejca.2011.07.005
   Hattori A, 2013, OBESITY, V21, P856, DOI 10.1002/oby.20313
   Haus EL, 2013, SLEEP MED REV, V17, P273, DOI 10.1016/j.smrv.2012.08.003
   Higuchi S, 2011, J PHYSIOL ANTHROPOL, V30, P251, DOI 10.2114/jpa2.30.251
   Hill SM, 2011, J MAMMARY GLAND BIOL, V16, P235, DOI 10.1007/s10911-011-9222-4
   HONMA KI, 1992, AM J PHYSIOL, V262, pR885
   Hsing AW, 2010, CANCER EPIDEM BIOMAR, V19, P932, DOI 10.1158/1055-9965.EPI-10-0004
   ILLNEROVA H, 1985, BRAIN RES, V328, P186, DOI 10.1016/0006-8993(85)91342-3
   Jia YJ, 2013, CANCER EPIDEMIOL, V37, P197, DOI 10.1016/j.canep.2013.01.005
   Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684
   Kedrosky P, 2011, WORLD POPULATION DIS
   KENNAWAY DJ, 1986, ACTA ENDOCRINOL-COP, V113, P450, DOI 10.1530/acta.0.1130450
   KIVELA A, 1988, ACTA PHYSIOL SCAND, V132, P321, DOI 10.1111/j.1748-1716.1988.tb08335.x
   Kloog I, 2009, CHRONOBIOL INT, V26, P108, DOI 10.1080/07420520802694020
   Knutsson A, 2013, SCAND J WORK ENV HEA, V39, P170, DOI 10.5271/sjweh.3323
   Kubo T, 2011, INT J UROL, V18, P206, DOI 10.1111/j.1442-2042.2010.02714.x
   Kubo T, 2006, AM J EPIDEMIOL, V164, P549, DOI 10.1093/aje/kwj232
   Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Leppaluoto Juhani, 2004, Int J Circumpolar Health, V63 Suppl 2, P161
   Levallois P, 2001, AM J EPIDEMIOL, V154, P601, DOI 10.1093/aje/154.7.601
   LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030
   Lie JAS, 2006, CANCER CAUSE CONTROL, V17, P39, DOI 10.1007/s10552-005-3639-2
   Lie JAS, 2011, AM J EPIDEMIOL, V173, P1272, DOI 10.1093/aje/kwr014
   Mahlberg R, 2006, PSYCHONEUROENDOCRINO, V31, P634, DOI 10.1016/j.psyneuen.2006.01.009
   Mantele S, 2012, PLOS ONE, V7
   Mediavilla MD, 2010, CURR MED CHEM, V17, P4462
   Megdal SP, 2005, EUR J CANCER, V41, P2023, DOI 10.1016/j.ejca.2005.05.010
   Menegaux F, 2012, ARCH MAL PROF ENVIRO, V73, P547, DOI 10.1016/j.admp.2012.03.009
   Mirick DK, 2008, CANCER EPIDEM BIOMAR, V17, P3306, DOI 10.1158/1055-9965.EPI-08-0605
   Morera AL, 2006, J PINEAL RES, V41, P279, DOI 10.1111/j.1600-079X.2006.00365.x
   O'Leary ES, 2006, AM J EPIDEMIOL, V164, P358, DOI 10.1093/aje/kwj211
   Ostrowska Z BB, 1996, ENDOCR REGUL, V30, P19
   Ozguner F, 2005, TOXICOL IND HEALTH, V21, P21, DOI 10.1191/0748233705th211oa
   Parent M-E, 2012, AM J EPIDEMIOLOGY
   Parent ME, 2012, AM J EPIDEMIOL, V176, P751, DOI 10.1093/aje/kws318
   Patel D, 2006, OCCUP MED-OXFORD, V56, P433, DOI 10.1093/occmed/kq1078
   Pesch B, 2010, SCAND J WORK ENV HEA, V36, P134, DOI 10.5271/sjweh.2890
   Pronk A, 2010, AM J EPIDEMIOL, V171, P953, DOI 10.1093/aje/kwq029
   Reiter Russel J., 2007, Critical Reviews in Oncogenesis, V13, P303
   SAVITZ DA, 1994, EPIDEMIOLOGY, V5, P550
   Schernhammer ES, 2006, J PINEAL RES, V40, P116, DOI 10.1111/j.1600-079X.2005.00285.x
   Schernhammer ES, 2006, EPIDEMIOLOGY, V17, P108, DOI 10.1097/01.ede.0000190539.03500.c1
   Schernhammer ES, 2005, J NATL CANCER I, V97, P1084, DOI 10.1093/jnci/dji190
   Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563
   Schernhammer ES, 2003, J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825
   Schernhammer ES, 2008, J NATL CANCER I, V100, P898, DOI 10.1093/jnci/djn171
   Schernhammer ES, 2010, CANCER EPIDEM BIOMAR, V19, P729, DOI 10.1158/1055-9965.EPI-09-1229
   Schernhammer ES, 2009, CANCER EPIDEM BIOMAR, V18, P74, DOI 10.1158/1055-9965.EPI-08-0637
   Stevens RG, 2000, EPIDEMIOLOGY, V11, P660, DOI 10.1097/00001648-200011000-00008
   Stevens RG, 2006, CANCER CAUSE CONTROL, V17, P501, DOI 10.1007/s10552-005-9001-x
   Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178
   Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490
   STOKKAN KA, 1994, J PINEAL RES, V16, P33, DOI 10.1111/j.1600-079X.1994.tb00079.x
   Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X
   Travis RC, 2004, JNCI-J NATL CANCER I, V96, P475, DOI 10.1093/jnci/djh077
   Travis RC, 2003, CANCER EPIDEM BIOMAR, V12, P806
   Tynes T, 1996, CANCER CAUSE CONTROL, V7, P197, DOI 10.1007/BF00051295
   Ursing C, 2005, EUR J CLIN PHARMACOL, V61, P197, DOI 10.1007/s00228-005-0908-7
   Villeneuve S, 2011, AM J IND MED, V54, P499, DOI 10.1002/ajim.20952
   Viswanathan AN, 2009, CANCER LETT, V281, P1, DOI 10.1016/j.canlet.2008.11.002
   Wada K, 2013, ANN EPIDEMIOL, V23, P60, DOI 10.1016/j.annepidem.2012.11.003
   Wang F, 2013, ANN ONCOLOGY
   WIRZJUSTICE A, 1979, PSYCHIAT RES, V1, P53, DOI 10.1016/0165-1781(79)90028-3
   Wu AH, 2008, CARCINOGENESIS, V29, P1244, DOI 10.1093/carcin/bgn100
   Youngstedt SD, 2002, ENVIRON RES, V89, P201, DOI 10.1006/enrs.2002.4370
NR 98
TC 13
Z9 14
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 23
PY 2013
VL 8
IS 12
AR e83208
DI 10.1371/journal.pone.0083208
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 278IG
UT WOS:000328882000069
PM 24376664
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Garcia, Y
   Callaway, RM
   Diaconu, A
   Montesinos, D
AF Garcia, Yedra
   Callaway, Ragan M.
   Diaconu, Alecu
   Montesinos, Daniel
TI Invasive and Non-Invasive Congeners Show Similar Trait Shifts between
   Their Same Native and Non-Native Ranges
SO PLOS ONE
LA English
DT Article
ID STARTHISTLE CENTAUREA-SOLSTITIALIS; ALIEN PLANTS; SEED SIZE; GROWTH;
   EVOLUTION; IMPACTS; DETERMINANTS; METAANALYSIS; POPULATIONS; RESISTANCE
AB Differences in morphological or ecological traits expressed by exotic species between their native and non-native ranges are often interpreted as evidence for adaptation to new conditions in the non-native ranges. In turn this adaptation is often hypothesized to contribute to the successful invasion of these species. There is good evidence for rapid evolution by many exotic invasives, but the extent to which these evolutionary changes actually drive invasiveness is unclear. One approach to resolving the relationship between adaptive responses and successful invasion is to compare traits between populations from the native and non-native ranges for both exotic invaders and congeners that are exotic but not invasive. We compared a suite of morphological traits that are commonly tested in the literature in the context of invasion for three very closely related species of Centaurea, all of which are sympatric in the same native and non-native ranges in Europe and North America. Of these, C. solstitialis is highly invasive whereas C. calcitrapa and C. sulphurea are not. For all three species, plants from non-native populations showed similar shifts in key traits that have been identified in other studies as important putative adaptive responses to post-introduction invasion. For example, for all three species plants from populations in non-native ranges were (i) larger and (ii) produced seeds that germinated at higher rates. In fact, the non-invasive C. calcitrapa showed the strongest trait shift between ranges. Centaurea solstitialis was the only species for which plants from the non-native range increased allocation to defensive spines, and allocated proportionally less resources to reproduction, patterns contrary to what would be predicted by theory and other empirical studies to enhance invasion. Our results suggest caution when interpreting the commonly observed increase in size and reproductive capacity as factors that cause exotics to become invaders.
C1 [Garcia, Yedra; Montesinos, Daniel] Univ Coimbra, Ctr Funct Ecol, Coimbra, Portugal.
   [Callaway, Ragan M.; Montesinos, Daniel] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.
   [Diaconu, Alecu] Inst Biol Res Iasi, Biol Control Lab, Iasi, Romania.
   [Montesinos, Daniel] UV, CSIC, Ctr Invest Desertificac CIDE, GV, Valencia, Spain.
RP Garcia, Y (reprint author), Univ Coimbra, Ctr Funct Ecol, Coimbra, Portugal.
EM yedragg@gmail.com
RI Garcia, Yedra/M-2167-2019; Montesinos, Daniel/A-9070-2012; DIACONU,
   Alecu/A-9299-2011
OI Garcia, Yedra/0000-0003-3373-1355; Montesinos,
   Daniel/0000-0003-2893-0878; 
FU NSF-DEB [0614406]; NSF EPSCoR; Spanish Micinn [2008-0662]; Portuguese
   FCT [SFRH/BPD/72595/2010]; Marie Curie Career Integration Grant
FX RMC was funded by NSF-DEB 0614406 and thanks NSF EPSCoR; DM was funded
   by the Spanish Micinn (2008-0662), by the Portuguese FCT
   (SFRH/BPD/72595/2010), and by a Marie Curie Career Integration Grant
   (FP7-321909); YG was funded by DM's MC-CIG (FP7-321909). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147
   Barbe GD, 1989, NOXIOUS WEEDS CALIFO
   Bastlova-Hanzelyova D, 2001, PLANT INVASIONS: SPECIES ECOLOGY AND ECOSYSTEM MANAGEMENT, P33
   Bennett JR, 2013, BIOL INVASIONS, V15, P707, DOI 10.1007/s10530-012-0320-z
   BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425
   Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z
   Buckley YM, 2003, ECOLOGY, V84, P1434, DOI 10.1890/0012-9658(2003)084[1434:AIBAGS]2.0.CO;2
   Burns JH, 2004, DIVERS DISTRIB, V10, P387, DOI 10.1111/j.1366-9516.2004.00105.x
   Cadotte MW, 2006, ECOSCIENCE, V13, P388, DOI 10.2980/i1195-6860-13-3-388.1
   Callaway RM, 2011, ECOLOGY, V92, P2208, DOI 10.1890/11-0518.1
   Castro SA, 2005, DIVERS DISTRIB, V11, P183, DOI 10.1111/j.1366-9516.2005.00145.x
   Cronk Q. C. B., 1995, PLANT INVADERS THREA
   Crooks Jeffrey A., 1999, Population and Community Biology Series, V24, P103
   Daehler CC, 1997, OECOLOGIA, V110, P99, DOI 10.1007/s004420050138
   Daehler CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004462
   DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2
   Dlugosch KM, 2013, G3-GENES GENOM GENET, V3, P359, DOI 10.1534/g3.112.003871
   Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043
   Elton C. S., 1958, ECOLOGY INVASIONS AN
   Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108
   Garcia-Jacas N, 2006, ANN BOT-LONDON, V98, P741, DOI 10.1093/aob/mcl157
   Gerlach J, 1997, P CALIF WEED SCI SOC, V49, P136
   Gerlach JD, 2003, ECOL APPL, V13, P167, DOI 10.1890/1051-0761(2003)013[0167:TLHCOI]2.0.CO;2
   Graebner RC, 2012, PLANT ECOL, V213, P545, DOI 10.1007/s11258-012-0020-x
   Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995
   Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x
   Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.1365-2745.2004.00953.x
   Hierro JL, 2009, OIKOS, V118, P529, DOI 10.1111/j.1600-0706.2009.17283.x
   HOBBS RJ, 1995, CONSERV BIOL, V9, P761, DOI 10.1046/j.1523-1739.1995.09040761.x
   Jakobs G, 2004, DIVERS DISTRIB, V10, P11, DOI 10.1111/j.1472-4642.2004.00052.x
   Kelly M, 1996, P CAL EX PEST PLANT, P61
   Knapp S, 2012, ECOL LETT, V15, P696, DOI 10.1111/j.1461-0248.2012.01787.x
   Kudoh H, 2007, ECOL RES, V22, P869, DOI 10.1007/s11284-007-0417-5
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lambrinos JG, 2002, ECOLOGY, V83, P518, DOI 10.1890/0012-9658(2002)083[0518:TVISOC]2.0.CO;2
   Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x
   LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K
   Maddox DM, 1996, CAN J BOT, V74, P262, DOI 10.1139/b96-031
   MADDOX DM, 1985, WEED SCI, V33, P315, DOI 10.1017/S0043174500082357
   Maron JL, 2004, ECOLOGY, V85, P3243, DOI 10.1890/04-0297
   Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027
   Milbau A, 2008, CONSERV BIOL, V22, P308, DOI 10.1111/j-1523-1739.2007.00877.x
   Montesinos D, 2012, AM NAT, V180, P529, DOI 10.1086/667585
   Muth NZ, 2006, AM J BOT, V93, P188, DOI 10.3732/ajb.93.2.188
   Nijs I, 2004, WEED TECHNOL, V18, P1240, DOI 10.1614/0890-037X(2004)018[1240:NMFAAP]2.0.CO;2
   Penuelas J, 2010, GLOBAL CHANGE BIOL, V16, P2171, DOI 10.1111/j.1365-2486.2009.02054.x
   Pitcairn MJ, 2002, WEED TECHNOL, V16, P452, DOI 10.1614/0890-037X(2002)016[0452:PSCCSG]2.0.CO;2
   Pysek P, 2003, OECOLOGIA, V135, P122, DOI 10.1007/s00442-002-1170-7
   Pysek Petr, 2007, V193, P97
   R Core Team, 2012, R LANG ENV STAT COMP
   Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768
   Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1
   ROBBINS W. W., 1940, CALIFORNIA AGRIC EXP STA BULL, V637, P1
   Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2
   Siemann E, 2001, ECOL LETT, V4, P514, DOI 10.1046/j.1461-0248.2001.00274.x
   Sun M, 1997, CAN J BOT, V75, P1470, DOI 10.1139/b97-861
   Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x
   te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277
   Thebaud C, 1996, ECOLOGY, V77, P791, DOI 10.2307/2265502
   Thomsen CD, 1993, CALIF AGR, V47, P36
   van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x
   van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x
   Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x
   Widmer TL, 2007, WEED SCI, V55, P465, DOI 10.1614/WS-06-211R.1
   Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0
   Willis AJ, 1999, OECOLOGIA, V120, P632, DOI 10.1007/s004420050899
NR 66
TC 14
Z9 14
U1 0
U2 64
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 17
PY 2013
VL 8
IS 12
AR e82281
DI 10.1371/journal.pone.0082281
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 276GT
UT WOS:000328737700009
PM 24358163
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ciaranello, AL
   Morris, BL
   Walensky, RP
   Weinstein, MC
   Ayaya, S
   Doherty, K
   Leroy, V
   Hou, TG
   Desmonde, S
   Lu, ZG
   Noubary, F
   Patel, K
   Ramirez-Avila, L
   Losina, E
   Seage, GR
   Freedberg, KA
AF Ciaranello, Andrea L.
   Morris, Bethany L.
   Walensky, Rochelle P.
   Weinstein, Milton C.
   Ayaya, Samuel
   Doherty, Kathleen
   Leroy, Valeriane
   Hou, Taige
   Desmonde, Sophie
   Lu, Zhigang
   Noubary, Farzad
   Patel, Kunjal
   Ramirez-Avila, Lynn
   Losina, Elena
   Seage, George R., III
   Freedberg, Kenneth A.
TI Validation and Calibration of a Computer Simulation Model of Pediatric
   HIV Infection
SO PLOS ONE
LA English
DT Article
ID RESOURCE-LIMITED SETTINGS; TO-CHILD TRANSMISSION; COST-EFFECTIVENESS
   ANALYSIS; ANTIRETROVIRAL THERAPY; COTE-DIVOIRE; COTRIMOXAZOLE
   PROPHYLAXIS; DISEASE PROGRESSION; ECONOMIC-EVALUATION; AFRICAN INFANTS;
   VIRUS-INFECTION
AB Background: Computer simulation models can project long-term patient outcomes and inform health policy. We internally validated and then calibrated a model of HIV disease in children before initiation of antiretroviral therapy to provide a framework against which to compare the impact of pediatric HIV treatment strategies.
   Methods: We developed a patient-level (Monte Carlo) model of HIV progression among untreated children <5 years of age, using the Cost-Effectiveness of Preventing AIDS Complications model framework: the CEPAC-Pediatric model. We populated the model with data on opportunistic infection and mortality risks from the International Epidemiologic Database to Evaluate AIDS (IeDEA), with mean CD4% at birth (42%) and mean CD4% decline (1.4%/month) from the Women and Infants' Transmission Study (WITS). We internally validated the model by varying WITS-derived CD4% data, comparing the corresponding model-generated survival curves to empirical survival curves from IeDEA, and identifying best-fitting parameter sets as those with a root-mean square error (RMSE) <0.01. We then calibrated the model to other African settings by systematically varying immunologic and HIV mortality-related input parameters. Model-generated survival curves for children aged 0-60 months were compared, again using RMSE, to UNAIDS data from >1,300 untreated, HIV-infected African children.
   Results: In internal validation analyses, model-generated survival curves fit IeDEA data well; modeled and observed survival at 16 months of age were 91.2% and 91.1%, respectively. RMSE varied widely with variations in CD4% parameters; the best fitting parameter set (RMSE = 0.00423) resulted when CD4% was 45% at birth and declined by 6%/month (ages 0-3 months) and 0.3%/month (ages > 3 months). In calibration analyses, increases in IeDEA-derived mortality risks were necessary to fit UNAIDS survival data.
   Conclusions: The CEPAC-Pediatric model performed well in internal validation analyses. Increases in modeled mortality risks required to match UNAIDS data highlight the importance of pre-enrollment mortality in many pediatric cohort studies.
C1 [Ciaranello, Andrea L.; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.
   [Morris, Bethany L.; Walensky, Rochelle P.; Doherty, Kathleen; Hou, Taige; Lu, Zhigang; Noubary, Farzad; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA.
   [Ciaranello, Andrea L.; Walensky, Rochelle P.; Ramirez-Avila, Lynn; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA.
   [Ciaranello, Andrea L.; Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA.
   [Losina, Elena] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.
   [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.
   [Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA.
   [Weinstein, Milton C.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.
   [Patel, Kunjal; Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Ayaya, Samuel] Moi Univ, Dept Child Hlth & Pediat, Eldoret, Kenya.
   [Leroy, Valeriane; Desmonde, Sophie] Univ Bordeaux 2, Inst Sante Publ & Dev, INSERM, U897, F-33076 Bordeaux, France.
   [Ramirez-Avila, Lynn] Childrens Hosp, Boston, MA 02115 USA.
   [Ramirez-Avila, Lynn] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
   [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA.
   [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
RP Ciaranello, AL (reprint author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.
EM aciaranello@partners.org
RI , Leroy/F-8129-2013; Desmonde, Sophie/E-4748-2019
OI , Leroy/0000-0003-3542-8616; Desmonde, Sophie/0000-0001-9372-2819;
   Losina, ELENA/0000-0002-3424-0892; Walensky, Rochelle
   P./0000-0002-8795-379X
FU National Institutes of Health (International Maternal Pediatric
   Adolescent AIDS Clinical Trials Group (IMPAACT); National Institute of
   Allergy and Infectious Diseases [K01 AI078754, K24 AI062476, R01
   AI058736, R01 AI093269, U01 AI069911, U01AI09919]; Harvard Center for
   AIDS Research; Elizabeth Glaser Pediatric AIDS Foundation; March of
   Dimes Foundation; Massachusetts General Hospital Executive Committee on
   Research; National Institute of Allergy and Infectious Diseases (NIAID)
   [U01 AI068632]; Eunice Kennedy Shriver National Institute of Child
   Health and Human Development (NICHD); National Institute of Mental
   Health (NIMH) [AI068632]; Statistical and Data Analysis Center at
   Harvard School of Public Health, under the National Institute of Allergy
   and Infectious Diseases [5 U01 AI41110, 1 U01 AI068616]; National
   Institute of Allergy and Infectious Diseases (NIAID); NICHD
   International and Domestic Pediatric and Maternal HIV Clinical Trials
   Network; NICHD [N01-DK-9-001/HHSN267200800001C]
FX This work was supported by the National Institutes of Health
   (International Maternal Pediatric Adolescent AIDS Clinical Trials Group
   (IMPAACT); National Institute of Allergy and Infectious Diseases,
   through K01 AI078754, K24 AI062476, R01 AI058736, R01 AI093269 (RPW),
   U01 AI069911, U01AI09919 (IeDEA West Africa); the Harvard Center for
   AIDS Research); the Elizabeth Glaser Pediatric AIDS Foundation, the
   March of Dimes Foundation, and the Massachusetts General Hospital
   Executive Committee on Research. Overall support for IMPAACT was
   provided by the National Institute of Allergy and Infectious Diseases
   (NIAID) [U01 AI068632], the Eunice Kennedy Shriver National Institute of
   Child Health and Human Development (NICHD), and the National Institute
   of Mental Health (NIMH) [AI068632]. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the NIH. This work was supported by the Statistical
   and Data Analysis Center at Harvard School of Public Health, under the
   National Institute of Allergy and Infectious Diseases cooperative
   agreement #5 U01 AI41110 with the Pediatric AIDS Clinical Trials Group
   (PACTG) and #1 U01 AI068616 with the IMPAACT Group. Support of the sites
   was provided by the National Institute of Allergy and Infectious
   Diseases (NIAID) and the NICHD International and Domestic Pediatric and
   Maternal HIV Clinical Trials Network funded by NICHD (contract number
   N01-DK-9-001/HHSN267200800001C). Sophie Desmonde is a fellow of the
   Ecole des Hautes Etudes en Sante Publique (EHESP), Rennes, France. The
   funders had no role in study design, data analysis, interpretation of
   results, or decision to publish.
CR Adhikari M, 2006, INDIAN PEDIATR, V43, P804
   Bagenda D, 2006, PEDIATRICS, V117, P729, DOI 10.1542/peds.2005-2699
   Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510
   Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248
   Chearskul S, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e25
   CIARANELLO A, 2011, INCIDENCE WHO STAGE
   Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858
   Ciaranello AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001156
   Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59
   Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224
   Ciaranello AL, 2011, AIDS, V25, P479, DOI 10.1097/QAD.0b013e3283428cbe
   Desmonde S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-182
   Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012
   Egger M, 2008, LANCET, V371, P1558, DOI 10.1016/S0140-6736(08)60669-8
   Ferrand RA, 2007, CLIN INFECT DIS, V44, P874, DOI 10.1086/511873
   Foca M, 2006, PEDIATRICS, V118, P146, DOI 10.1542/peds.2005-0294
   Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108
   FRYBACK DG, 2006, JNCI MONOGRAPHS, V36, P11
   Gibb DM, 2008, AIDS, V22, P97
   Goldhaber-Fiebert JD, 2010, VALUE HEALTH, V13, P667, DOI 10.1111/j.1524-4733.2010.00698.x
   Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247
   Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7
   Hunink M, 2003, DECISION MAKING HLTH
   Hussey GD, 1998, S AFR MED J, V88, P554
   Johri Mira, 2011, Cost Eff Resour Alloc, V9, P3, DOI 10.1186/1478-7547-9-3
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Marston M, 2011, INT J EPIDEMIOL, V40, P385, DOI 10.1093/ije/dyq255
   MCINTYRE JA, 2005, ADDITION SHORT COURS
   Menzies NA, 2009, PEDIATR INFECT DIS J, V28, P819, DOI 10.1097/INF.0b013e3181a3954b
   Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2
   Munyagwa M, 2012, TROP MED INT HEALTH, V17, P836, DOI 10.1111/j.1365-3156.2012.03000.x
   *NAT I ALL INF DIS, 2012, INT EP DAT EV AIDS
   *NAT TECHN INF, 2010, WOM INF TRANS STUD W
   Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7
   Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5
   Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088
   Prendergast A, 2008, FUTURE HIV THER, V2, P201
   Prendergast A, 2008, AIDS, V22, P1333, DOI 10.1097/QAD.0b013e32830437df
   Robberstad B, 2010, JAIDS-J ACQ IMM DEF, V55, P397, DOI 10.1097/QAI.0b013e3181eef4d3
   Ryan M, 2008, AIDS, V22, P749, DOI 10.1097/QAD.0b013e3282f43519
   Rydzak CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012647
   Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100
   Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984
   Schneider K, 2011, AIDS, V25, P1143, DOI 10.1097/QAD.0b013e3283466fab
   Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9
   Sheon AR, 1996, J WOMENS HEALTH, V5, P69
   Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586
   Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56
   STOUT NK, 2009, PHARMACOECONOMICS, V27, P13
   *UNAIDS CHILD SURV, 2010, SURV CHILDR HIV INF
   United Nations, 2009, WORLD POP PROSP 2008
   Vanni T, 2011, PHARMACOECONOMICS, V29, P35, DOI 10.2165/11584600-000000000-00000
   Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971
   Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138
   Walker AS, 2006, JAIDS-J ACQ IMM DEF, V42, P637, DOI 10.1097/01.qai.0000226334.34717.dc
   Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253
   World Health Organization, 2010, ANT THER HIV INF INF
   Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6
NR 58
TC 10
Z9 10
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 13
PY 2013
VL 8
IS 12
AR UNSP e83389
DI 10.1371/journal.pone.0083389
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 276FP
UT WOS:000328734200082
PM 24349503
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Mosley, JD
   Van Driest, SL
   Larkin, EK
   Weeke, PE
   Witte, JS
   Wells, QS
   Karnes, JH
   Guo, Y
   Bastarache, L
   Olson, LM
   McCarty, CA
   Pacheco, JA
   Jarvik, GP
   Carrell, DS
   Larson, EB
   Crosslin, DR
   Kullo, IJ
   Tromp, G
   Kuivaniemi, H
   Carey, DJ
   Ritchie, MD
   Denny, JC
   Roden, DM
AF Mosley, Jonathan D.
   Van Driest, Sara L.
   Larkin, Emma K.
   Weeke, Peter E.
   Witte, John S.
   Wells, Quinn S.
   Karnes, Jason H.
   Guo, Yan
   Bastarache, Lisa
   Olson, Lana M.
   McCarty, Catherine A.
   Pacheco, Jennifer A.
   Jarvik, Gail P.
   Carrell, David S.
   Larson, Eric B.
   Crosslin, David R.
   Kullo, Iftikhar J.
   Tromp, Gerard
   Kuivaniemi, Helena
   Carey, David J.
   Ritchie, Marylyn D.
   Denny, Josh C.
   Roden, Dan M.
TI Mechanistic Phenotypes: An Aggregative Phenotyping Strategy to Identify
   Disease Mechanisms Using GWAS Data
SO PLOS ONE
LA English
DT Article
ID ELECTRONIC MEDICAL-RECORDS; GENOMIC INSTABILITY; EMERGE NETWORK; CANCER;
   SUSCEPTIBILITY; ASSOCIATION; RISK; IDENTIFICATION; HERITABILITY;
   HALLMARKS
AB A single mutation can alter cellular and global homeostatic mechanisms and give rise to multiple clinical diseases. We hypothesized that these disease mechanisms could be identified using low minor allele frequency (MAF < 0.1) non-synonymous SNPs (nsSNPs) associated with "mechanistic phenotypes'', comprised of collections of related diagnoses. We studied two mechanistic phenotypes: (1) thrombosis, evaluated in a population of 1,655 African Americans; and (2) four groupings of cancer diagnoses, evaluated in 3,009 white European Americans. We tested associations between nsSNPs represented on GWAS platforms and mechanistic phenotypes ascertained from electronic medical records (EMRs), and sought enrichment in functional ontologies across the top-ranked associations. We used a two-step analytic approach whereby nsSNPs were first sorted by the strength of their association with a phenotype. We tested associations using two reverse genetic models and standard additive and recessive models. In the second step, we employed a hypothesis-free ontological enrichment analysis using the sorted nsSNPs to identify functional mechanisms underlying the diagnoses comprising the mechanistic phenotypes. The thrombosis phenotype was solely associated with ontologies related to blood coagulation (Fisher's p = 0.0001, FDR p = 0.03), driven by the F5, P2RY12 and F2RL2 genes. For the cancer phenotypes, the reverse genetics models were enriched in DNA repair functions (p = 261025, FDR p = 0.03) (POLG/FANCI, SLX4/FANCP, XRCC1, BRCA1, FANCA, CHD1L) while the additive model showed enrichment related to chromatid segregation (p = 461026, FDR p = 0.005) (KIF25, PINX1). We were able to replicate nsSNP associations for POLG/FANCI, BRCA1, FANCA and CHD1L in independent data sets. Mechanism-oriented phenotyping using collections of EMR-derived diagnoses can elucidate fundamental disease mechanisms.
C1 [Mosley, Jonathan D.; Larkin, Emma K.; Weeke, Peter E.; Wells, Quinn S.; Karnes, Jason H.; Denny, Josh C.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN 37203 USA.
   [Van Driest, Sara L.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA.
   [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
   [Bastarache, Lisa; Denny, Josh C.] Vanderbilt Univ, Nashville, TN 37235 USA.
   [Guo, Yan] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA.
   [Olson, Lana M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA.
   [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA.
   [Pacheco, Jennifer A.] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Jarvik, Gail P.; Crosslin, David R.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA.
   [Jarvik, Gail P.; Crosslin, David R.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   [Carrell, David S.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA.
   [Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA.
   [Tromp, Gerard; Kuivaniemi, Helena; Carey, David J.] Geisinger Hlth Syst, Sigfried & Janet Weis Ctr Res, Danville, PA USA.
   [Ritchie, Marylyn D.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
RP Roden, DM (reprint author), Vanderbilt Univ, Dept Med, Nashville, TN 37203 USA.
EM dan.roden@vanderbilt.edu
RI Tromp, Gerard/B-2677-2017; Kuivaniemi, Helena/Q-8178-2019; Wells,
   Quinn/D-2686-2014; Jarvik, Gail/N-6476-2014; Tromp, Gerard/P-3014-2019
OI Tromp, Gerard/0000-0002-7761-0806; Kuivaniemi,
   Helena/0000-0001-5753-8766; Wells, Quinn/0000-0003-3899-0313; Jarvik,
   Gail/0000-0002-6710-8708; Tromp, Gerard/0000-0002-7761-0806; Pacheco,
   Jennifer/0000-0001-8021-5818; Denny, Josh/0000-0002-3049-7332; McCarty,
   Catherine/0000-0003-1089-0142; Mosley, Jonathan/0000-0001-6421-2887
FU VUMC Clinical Pharmacology Training grant [T32 GM07569]; electronic
   MEdical Records and GEnomics (eMERGE) Network [U01-HG-04603,
   1U02HG004608-01, 5U01HG006389-02, UO1HG006375, U01-HG04599,
   U01-HG004609, U01HG006382]; ARRA grant [RC2 GM092618, R01 LM 010685];
   Vanderbilt CTSA grant from NCATS/NIH [UL1 TR000445]; NIH [P30DK072488,
   R01DK088231, R01DK091601]; Pennsylvania Commonwealth Universal Research
   Enhancement Program; Ben Franklin Technology Development Fund of PA;
   Geisinger Clinical Research Fund; American Heart Association
FX This work was supported by the VUMC Clinical Pharmacology Training grant
   (T32 GM07569), the electronic MEdical Records and GEnomics (eMERGE)
   Network U01-HG-04603 (Vanderbilt), 1U02HG004608-01 and 5U01HG006389-02
   (Marshfield/EIRH), UO1HG006375 (Group Health/University of Washington),
   U01-HG04599 (Mayo Clinic), U01-HG004609 (Northwestern University),
   U01HG006382 (Geisinger), an ARRA grant RC2 GM092618, R01 LM 010685, and
   the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH. At Geisinger the
   work was supported by NIH (P30DK072488, R01DK088231 and R01DK091601),
   Pennsylvania Commonwealth Universal Research Enhancement Program, the
   Ben Franklin Technology Development Fund of PA, the Geisinger Clinical
   Research Fund, and a Grant-In-Aid from the American Heart Association.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864
   Cerhan JR, 2012, CANCER EPIDEM BIOMAR, V21, P1799, DOI 10.1158/1055-9965.EPI-12-0696
   Chan THM, 2012, HEPATOLOGY, V55, P491, DOI 10.1002/hep.24709
   Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013
   Cookson WOCM, 1999, BRIT MED BULL, V55, P358, DOI 10.1258/0007142991902420
   Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x
   Cramer TJ, 2012, THROMB HAEMOSTASIS, V107, P15, DOI 10.1160/TH11-06-0431
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126
   Eyfjord JE, 2005, MUTAT RES-FUND MOL M, V592, P18, DOI 10.1016/j.mrfmmm.2005.05.010
   Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029
   FITZMAURICE GM, 1993, BIOMETRIKA, V80, P141, DOI 10.1093/biomet/80.1.141
   Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968
   Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Jenkins RB, 2012, NAT GENET, V44, P1122, DOI 10.1038/ng.2388
   Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283
   Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798
   Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257
   Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372
   Manis JP, 2007, NEW ENGL J MED, V357, P2426, DOI 10.1056/NEJMp0707712
   Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494
   McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13
   Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858
   Okamoto S, 1998, CYTOGENET CELL GENET, V83, P25, DOI 10.1159/000015159
   Pritchard JK, 2000, GENETICS, V155, P945
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Yang Q, 2012, J PROBAB STAT, DOI 10.1155/2012/652569
   Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89
   Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607
   Shah NH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002827
   Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1
   Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034
   Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949
   Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7
   Yonekawa T, 2012, MOL CELL BIOL, V32, P1387, DOI 10.1128/MCB.05641-11
NR 39
TC 10
Z9 10
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 12
PY 2013
VL 8
IS 12
AR e81503
DI 10.1371/journal.pone.0081503
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 276EU
UT WOS:000328731800020
PM 24349080
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Clavel, J
   Poulet, N
   Porcher, E
   Blanchet, S
   Grenouillet, G
   Pavoine, S
   Biton, A
   Seon-Massin, N
   Argillier, C
   Daufresne, M
   Teillac-Deschamps, P
   Julliard, R
AF Clavel, Joanne
   Poulet, Nicolas
   Porcher, Emmanuelle
   Blanchet, Simon
   Grenouillet, Gael
   Pavoine, Sandrine
   Biton, Anne
   Seon-Massin, Nirmala
   Argillier, Christine
   Daufresne, Martin
   Teillac-Deschamps, Pauline
   Julliard, Romain
TI A New Freshwater Biodiversity Indicator Based on Fish Community
   Assemblages
SO PLOS ONE
LA English
DT Article
ID FUNCTIONAL DIVERSITY; CLIMATE-CHANGE; BIRD COMMUNITIES; EFFECTS MODELS;
   FOOD WEBS; LAND-USE; STREAM; INDEX; ORIGINALITY; SIMILARITY
AB Biodiversity has reached a critical state. In this context, stakeholders need indicators that both provide a synthetic view of the state of biodiversity and can be used as communication tools. Using river fishes as model, we developed community indicators that aim at integrating various components of biodiversity including interactions between species and ultimately the processes influencing ecosystem functions. We developed indices at the species level based on (i) the concept of specialization directly linked to the niche theory and (ii) the concept of originality measuring the overall degree of differences between a species and all other species in the same clade. Five major types of originality indices, based on phylogeny, habitat-linked and diet-linked morphology, life history traits, and ecological niche were analyzed. In a second step, we tested the relationship between all biodiversity indices and land use as a proxy of human pressures. Fish communities showed no significant temporal trend for most of these indices, but both originality indices based on diet-and habitat-linked morphology showed a significant increase through time. From a spatial point of view, all indices clearly singled out Corsica Island as having higher average originality and specialization. Finally, we observed that the originality index based on niche traits might be used as an informative biodiversity indicator because we showed it is sensitive to different land use classes along a landscape artificialization gradient. Moreover, its response remained unchanged over two other land use classifications at the global scale and also at the regional scale.
C1 [Clavel, Joanne] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.
   [Clavel, Joanne; Porcher, Emmanuelle; Pavoine, Sandrine; Teillac-Deschamps, Pauline; Julliard, Romain] Univ Paris 06, Dept Ecol & Gest Biodivers, Unite Mixte Rech 7204, Paris, France.
   [Clavel, Joanne; Porcher, Emmanuelle; Pavoine, Sandrine; Teillac-Deschamps, Pauline; Julliard, Romain] Museum Natl Hist Nat, CNRS, Paris, France.
   [Poulet, Nicolas] Off Natl Eau & Milieux Aquat, Dept Ecohydraul, Toulouse, France.
   [Poulet, Nicolas] Inst Mecan Fluides Toulouse, Toulouse, France.
   [Poulet, Nicolas] Inst Natl Rech Sci & Technol Environm & Agr, Toulouse, France.
   [Blanchet, Simon] CNRS, Unite Rech 2936, Stn Ecol Expt, Moulis, France.
   [Blanchet, Simon; Grenouillet, Gael] Univ Toulouse 3, Unite Mixte Rech 5174, Dept Evolut & Divers Biol, F-31062 Toulouse, France.
   [Blanchet, Simon; Grenouillet, Gael] Ecole Natl Format Agron, CNRS, Toulouse, France.
   [Pavoine, Sandrine] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Biton, Anne] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.
   [Seon-Massin, Nirmala] Off Natl Eau & Milieux Aquat, Dept Act Sci & Tech, Vincennes, France.
   [Argillier, Christine; Daufresne, Martin] Off Natl Eau & Milieux Aquat, Unite Rech HYAX, Dept Eaux Hydroecol, Aix En Provence, France.
   [Argillier, Christine; Daufresne, Martin] Inst Natl Rech Sci & Technol Environm & Agr, Aix En Provence, France.
RP Clavel, J (reprint author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.
EM joanne.clavel@gmail.com
RI Blanchet, Simon/D-4850-2013; Grenouillet, Gael/E-6518-2019
OI Blanchet, Simon/0000-0002-3843-589X; Porcher,
   Emmanuelle/0000-0002-9264-8239
FU "Departement Evolution et Diversite Biologique" (EDB) is part of the
   "Laboratoire d'Excellence" (LABEX) [ANR-10-LABX-41]; ONEMA - Officie
   National des Eaux et des Milieux Aquatiques
FX "Departement Evolution et Diversite Biologique" (EDB) is part of the
   "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41),
   ONEMA - Officie National des Eaux et des Milieux Aquatiques." Both
   funders (EDB and ONEMA) had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Baker ME, 2013, FRESHW SCI, V32, P489, DOI 10.1899/12-142.1
   Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x
   Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281
   BERG LS, 1965, FISHES USSR ADJACENT, V1
   Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106
   Blum MGB, 2006, PLOS GENET, V2, P1138, DOI 10.1371/journal.pgen.0020122
   Bohning-Gaese K, 1999, EVOL ECOL RES, V1, P347
   Bossard M., 2000, CORINE LAND COVER TE
   Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x
   Buisson L, 2009, DIVERS DISTRIB, V15, P613, DOI 10.1111/j.1472-4642.2009.00565.x
   Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512
   Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148
   CEN, 2003, 140112003 CEN EN EUR
   Chessel D, 2004, R NEWS, V4, P5, DOI DOI 10.HTTP://DX.D0I.0RG/10.2307/3780087
   Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216
   de Bello F, 2010, BIOL CONSERV, V143, P9, DOI 10.1016/j.biocon.2009.04.022
   Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x
   Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x
   Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x
   Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2
   DUBOIS A, 2009, COMMISSARIAT GEN DEV, V18, P1
   Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950
   Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x
   Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772
   Froese R, 2000, FISHBASE 2000 CONCEP
   Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x
   Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046
   Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296
   Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x
   Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272
   Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x
   Kottelat M, 2007, HDB EUROPEAN FRESH W
   Labropoulou M, 1998, ENVIRON BIOL FISH, V51, P309, DOI 10.1023/A:1007445112309
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LENAT D R, 1988, Journal of the North American Benthological Society, V7, P222, DOI 10.2307/1467422
   Leps J, 2006, PRESLIA, V78, P481
   LEVREL H, 2007, SELECTING INDICATORS, P1
   LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014
   Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746
   Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x
   MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505
   MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009
   Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006
   Mace GM, 2005, NATURE, V434, P32, DOI 10.1038/434032a
   Marzin A, 2013, HYDROBIOLOGIA, V704, P375, DOI 10.1007/s10750-012-1254-2
   Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x
   *MILL, 2005, EC ASS SYNTH BIOD
   Mouillot D, 2008, BIOL CONSERV, V141, P1569, DOI 10.1016/j.biocon.2008.04.002
   Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x
   Oberdorff T, 2001, FRESHWATER BIOL, V46, P399, DOI 10.1046/j.1365-2427.2001.00669.x
   Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x
   Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x
   Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x
   PINHEIRO J, 2012, R LANG ENV STAT COMP
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Poulet N, 2011, J FISH BIOL, V79, P1436, DOI 10.1111/j.1095-8649.2011.03084.x
   Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x
   RAHEL FJ, 1991, T AM FISH SOC, V120, P319, DOI 10.1577/1548-8659(1991)120<0319:FAAHGI>2.3.CO;2
   RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1
   Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x
   Reyjol Y, 2007, GLOBAL ECOL BIOGEOGR, V16, P65, DOI 10.1111/j.1466-822x.2006.00264.x
   Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6
   Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1
   Schleuter D, 2012, GLOBAL ECOL BIOGEOGR, V21, P1083, DOI 10.1111/j.1466-8238.2012.00763.x
   SIBBING FA, 2001, REV FISH BIOL FISHER, V10, P383
   Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8
   TACHET H, 1984, INTRO ETUDE MACROINV
   Wang LZ, 2003, CAN J FISH AQUAT SCI, V60, P491, DOI 10.1139/F03-043
   Zalewski M., 1990, P89
NR 69
TC 4
Z9 5
U1 0
U2 80
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 22
PY 2013
VL 8
IS 11
AR UNSP e80968
DI 10.1371/journal.pone.0080968
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259QP
UT WOS:000327541700040
PM 24278356
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mons, U
   Raum, E
   Kramer, HU
   Ruter, G
   Rothenbacher, D
   Rosemann, T
   Szecsenyi, J
   Brenner, H
AF Mons, Ute
   Raum, Elke
   Kraemer, Heike U.
   Rueter, Gernot
   Rothenbacher, Dietrich
   Rosemann, Thomas
   Szecsenyi, Joachim
   Brenner, Hermann
TI Effectiveness of a Supportive Telephone Counseling Intervention in Type
   2 Diabetes Patients: Randomized Controlled Study
SO PLOS ONE
LA English
DT Article
ID QUALITY IMPROVEMENT STRATEGIES; IMPROVING PRIMARY-CARE; GLYCEMIC
   CONTROL; CHRONIC ILLNESS; MELLITUS; RISK; MANAGEMENT; PREVALENCE;
   REGRESSION; DISEASE
AB Objectives: This randomized controlled trial investigated whether a patient-centered supportive counseling intervention comprising monthly telephone-based counseling sessions by practice nurses over 12 months improved diabetes-related medical and psycho-social outcomes above usual care in type 2 diabetes patients with poor glycemic control at baseline (HbA(1c) >7.5%) in a primary care setting.
   Research Design: Patients were individually randomized into intervention (n = 103) and usual care group (n = 101). The primary outcome was change in HbA(1c)-concentration after 12 and 18 months. Secondary outcomes were lipid levels, blood pressure, health-related quality of life and symptoms of depression. Follow-up-measurements were carried out after 6, 12 and 18 months to assess potential immediate and maintained effects of the intervention. For the multivariate analysis, hierarchical linear models were computed for each outcome to assess within-group changes in outcomes over time and between-group differences in patterns of change.
   Results: HbA(1c) (in %) decreased significantly from baseline to 12-month follow-up measurement both in the intervention (-0.44) and the usual care group (-0.51), but there was no significant between-group intervention effect. Significant improvements in the intervention group along with significant between-group differences were seen for health-related quality of life and, transiently, for systolic blood pressure and depression.
   Conclusions: Although we found no beneficial effect of the supportive telephone counseling in terms of a reduction of HbA1c above usual care, our findings suggest some beneficial effects on cardiovascular risk factors, quality of life and depression. Continuous efforts might be needed to sustain improvements in patient outcomes.
C1 [Mons, Ute; Raum, Elke; Kraemer, Heike U.; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.
   [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.
   [Rosemann, Thomas] Univ Zurich Hosp, Dept Gen Practice & Hlth Serv Res, CH-8091 Zurich, Switzerland.
   [Szecsenyi, Joachim] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.
RP Mons, U (reprint author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.
EM u.mons@dkfz.de
RI Brenner, Hermann/B-4627-2017
OI Brenner, Hermann/0000-0002-6129-1572; Rothenbacher,
   Dietrich/0000-0002-3563-2791
FU German Federal Ministry of Education and Research [01GX0746]
FX This study was supported by a grant of the German Federal Ministry of
   Education and Research (01GX0746). The funding body had no role in the
   study design, the collection, analysis or interpretation of the data,
   the writing of the manuscript, or on the decision to submit the paper
   for publication.
CR BLOMQVIST N, 1987, J CLIN PERIODONTOL, V14, P34, DOI 10.1111/j.1600-051X.1987.tb01510.x
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909
   BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147
   Digenio AG, 2009, ANN INTERN MED, V150, P255, DOI 10.7326/0003-4819-150-4-200902170-00006
   Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04
   Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28
   Gotz K, 2012, GMS PSYCHOSOC MED, V9
   Heidemann C, 2013, BUNDESGESUNDHEITSBLA, V56, P668, DOI 10.1007/s00103-012-1662-5
   KIRKMAN MS, 1994, DIABETES CARE, V17, P840, DOI 10.2337/diacare.17.8.840
   Koster I, 2012, DEUT MED WOCHENSCHR, V137, P1013, DOI 10.1055/s-0032-1304891
   Kramer HU, 2012, AM J MANAG CARE, V18, P362
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9
   Pimouguet C, 2011, CAN MED ASSOC J, V183, pE115, DOI 10.1503/cmaj.091786
   RENDERS CM, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001481
   Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9
   Seitz P, 2011, DIABETES OBES METAB, V13, P479, DOI 10.1111/j.1463-1326.2010.01347.x
   Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   SHEIKH J I, 1986, Clinical Gerontologist, V5, P165
   Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427
   Sox HC, 2010, MED CARE, V48, pS7, DOI 10.1097/MLR.0b013e3181da3709
   Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2
   Stock SAK, 2006, DIABETIC MED, V23, P299, DOI 10.1111/j.1464-5491.2005.01779.x
   Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004
   Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2
   Vrijhoef HJM, 2002, INT J NURS STUD, V39, P441, DOI 10.1016/S0020-7489(01)00046-3
   Ware J. E., 1995, SCORE SF 12 PHYS MEN
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   WEINBERER M, 1995, J GEN INTERN MED, V10, P59, DOI 10.1007/BF02600227
   Woollard J, 2003, J CARDIOVASC RISK, V10, P31, DOI [10.1097/00043798-200302000-00007, 10.1097/01.hjr.0000050718.61003.30]
NR 32
TC 12
Z9 12
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 30
PY 2013
VL 8
IS 10
AR e77954
DI 10.1371/journal.pone.0077954
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 243RL
UT WOS:000326334500081
PM 24205043
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Then, C
   Wahl, S
   Kirchhofer, A
   Grallert, H
   Krug, S
   Kastenmuller, G
   Romisch-Margl, W
   Claussnitzer, M
   Illig, T
   Heier, M
   Meisinger, C
   Adamski, J
   Thorand, B
   Huth, C
   Peters, A
   Prehn, C
   Heukamp, I
   Laumen, H
   Lechner, A
   Hauner, H
   Seissler, J
AF Then, Cornelia
   Wahl, Simone
   Kirchhofer, Anna
   Grallert, Harald
   Krug, Susanne
   Kastenmueller, Gabi
   Roemisch-Margl, Werner
   Claussnitzer, Melina
   Illig, Thomas
   Heier, Margit
   Meisinger, Christa
   Adamski, Jerzy
   Thorand, Barbara
   Huth, Cornelia
   Peters, Annette
   Prehn, Cornelia
   Heukamp, Ina
   Laumen, Helmut
   Lechner, Andreas
   Hauner, Hans
   Seissler, Jochen
TI Plasma Metabolomics Reveal Alterations of Sphingo- and
   Glycerophospholipid Levels in Non-Diabetic Carriers of the Transcription
   Factor 7-Like 2 Polymorphism rs7903146
SO PLOS ONE
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; TCF7L2 GENE; INSULIN-SECRETION;
   ADIPOSE-TISSUE; RISK; ASSOCIATION; ACID; METABOLISM; INCREASES; VARIANTS
AB Aims/Hypothesis: Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene have been shown to display a powerful association with type 2 diabetes. The aim of the present study was to evaluate metabolic alterations in carriers of a common TCF7L2 risk variant.
   Methods: Seventeen non-diabetic subjects carrying the T risk allele at the rs7903146 TCF7L2 locus and 24 subjects carrying no risk allele were submitted to intravenous glucose tolerance test and euglycemic-hyperinsulinemic clamp. Plasma samples were analysed for concentrations of 163 metabolites through targeted mass spectrometry.
   Results: TCF7L2 risk allele carriers had a reduced first-phase insulin response and normal insulin sensitivity. Under fasting conditions, carriers of TCF7L2 rs7903146 exhibited a non-significant increase of plasma sphingomyelins (SMs), phosphatidylcholines (PCs) and lysophosphatidylcholines (lysoPCs) species. A significant genotype effect was detected in response to challenge tests in 6 SMs (C16:0, C16:1, C18:0, C18:1, C24:0, C24:1), 5 hydroxy-SMs (C14:1, C16:1, C22:1, C22:2, C24:1), 4 lysoPCs (C14:0, C16:0, C16:1, C17:0), 3 diacyl-PCs (C28:1, C36:6, C40:4) and 4 long-chain acyl-alkyl-PCs (C40:2, C40:5, C44:5, C44:6).
   Discussion: Plasma metabolomic profiling identified alterations of phospholipid metabolism in response to challenge tests in subjects with TCF7L2 rs7903146 genotype. This may reflect a genotype-mediated link to early metabolic abnormalities prior to the development of disturbed glucose tolerance.
C1 [Then, Cornelia; Kirchhofer, Anna; Heukamp, Ina; Lechner, Andreas; Seissler, Jochen] Klinikum Univ Munchen, Med Klin & Poliklin 4, Diabet Zentrum, Munich, Germany.
   [Then, Cornelia; Grallert, Harald; Lechner, Andreas; Seissler, Jochen] Univ Munich, Clin Cooperat Grp Diabet, Munich, Germany.
   [Then, Cornelia; Grallert, Harald; Krug, Susanne; Claussnitzer, Melina; Laumen, Helmut; Lechner, Andreas; Hauner, Hans; Seissler, Jochen] Helmholtz Zentrum Munchen, Munich, Germany.
   [Wahl, Simone; Grallert, Harald] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany.
   [Krug, Susanne; Claussnitzer, Melina; Laumen, Helmut; Hauner, Hans] Tech Univ Munich, Else Kroener Fresenius Ctr Nutr Med, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany.
   [Krug, Susanne; Claussnitzer, Melina; Laumen, Helmut; Hauner, Hans] Tech Univ Munich, Clin Cooperat Grp Nutrigen & Type Diabet 2, D-80290 Munich, Germany.
   [Kastenmueller, Gabi; Roemisch-Margl, Werner] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.
   [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany.
   [Heier, Margit; Meisinger, Christa; Thorand, Barbara; Huth, Cornelia; Peters, Annette] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.
   [Thorand, Barbara; Huth, Cornelia] German Ctr Diabet Res DZD, Neuherberg, Germany.
   [Adamski, Jerzy; Prehn, Cornelia] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany.
RP Seissler, J (reprint author), Klinikum Univ Munchen, Med Klin & Poliklin 4, Diabet Zentrum, Campus Innenstadt, Munich, Germany.
EM jochen.seissler@med.uni-muenchen.de
RI Thorand, Barbara/B-5349-2014; Laumen, Helmut/M-5140-2013; Meisinger,
   Christine/B-5358-2014; Grallert, Harald/B-3424-2013; Huth,
   Cornelia/B-5350-2014; Peters, Annette/A-6117-2011
OI Thorand, Barbara/0000-0002-8416-6440; Laumen,
   Helmut/0000-0002-5885-5242; Huth, Cornelia/0000-0003-2421-433X; Peters,
   Annette/0000-0001-6645-0985; Kastenmuller, Gabi/0000-0002-2368-7322;
   Prehn, Cornelia/0000-0002-1274-4715; Meisinger,
   Christa/0000-0002-9026-6544
FU Helmholtz Zentrum Munchen-National Research Center for Environmental
   Health; German Federal Ministry of Education and Science, Research and
   Technology; State of Bavaria; Virtual Diabetes Institute (Helmholtz
   Zentrum Munchen); Clinical Cooperation Group LMU
   (Ludwig-Maximilians-Universitat Munchen - Helmholtz Zentrum Muenchen);
   Clinical Cooperation Group TU (Else Kroner-Fresenius-Center for
   Nutritional Medicine, Technische Universitat Munchen - Helmholtz Zentrum
   Munchen); German Center for Diabetes Research (DZD e.V.)
FX The KORA research platform studies were initiated and financed by the
   Helmholtz Zentrum Munchen-National Research Center for Environmental
   Health, which is funded by the German Federal Ministry of Education and
   Science, Research and Technology and by the State of Bavaria. The study
   was supported by a research grant from the Virtual Diabetes Institute
   (Helmholtz Zentrum Munchen), the Clinical Cooperation Group LMU
   (Ludwig-Maximilians-Universitat Munchen - Helmholtz Zentrum Muenchen),
   the Clinical Cooperation Group TU (Else Kroner-Fresenius-Center for
   Nutritional Medicine, Technische Universitat Munchen - Helmholtz Zentrum
   Munchen) and in part by the German Center for Diabetes Research (DZD
   e.V.). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alibegovic AC, 2010, DIABETES, V59, P836, DOI 10.2337/db09-0918
   [Anonymous], HORM METAB RES, V43, P355, DOI [10.1055/s-0031-1275270, DOI 10.1055/S-0031-1275270.PUBMED:21448848]
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053
   Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867
   Chen XY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-25
   Dohi T, 2012, CLIN CHIM ACTA, V413, P207, DOI 10.1016/j.cca.2011.09.027
   Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234
   Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495
   Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883
   Gault CR, 2010, ADV EXP MED BIOL, V688, P1
   Gonzalez-Sanchez JL, 2008, DIABETOLOGIA, V51, P1993, DOI 10.1007/s00125-008-1129-2
   Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x
   Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787
   Huo TG, 2009, J PHARMACEUT BIOMED, V49, P976, DOI 10.1016/j.jpba.2009.01.008
   Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507
   Ip W, 2012, AM J PHYSIOL-ENDOC M, V303, pE1166, DOI 10.1152/ajpendo.00249.2012
   Ishida-Oku M, 2010, ISLETS, V2, P274, DOI 10.4161/islets.2.5.12728
   Kaminska D, 2012, DIABETES, V61, P2807, DOI 10.2337/db12-0239
   Kouglas P, 2006, MED SCI MONITOR, V12, pRA5
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11
   Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JC130706
   Marzi C, 2007, HORM METAB RES, V39, P46, DOI 10.1055/s-2007-957345
   Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646
   Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383
   Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140
   Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002
   Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051
   Pietilainen KH, 2006, J CLIN ENDOCR METAB, V91, P2776, DOI 10.1210/jc.2005-2848
   Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x
   Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x
   Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4
   Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330
   Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6
   Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50
   Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847
   Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953
   Villareal DT, 2010, DIABETES, V59, P479, DOI 10.2337/db09-1169
   Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609
   Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307
   Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43
   Xu FG, 2013, J CLIN ENDOCR METAB, V98, pE1060, DOI 10.1210/jc.2012-4132
   Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176
   Yea K, 2009, J BIOL CHEM, V284, P33833, DOI 10.1074/jbc.M109.024869
   Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z
   Zhang Y, 2009, APOPTOSIS, V14, P878, DOI 10.1007/s10495-009-0364-4
   Zhu C, 2011, TALANTA, V85, P1711, DOI 10.1016/j.talanta.2011.05.036
NR 48
TC 17
Z9 17
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 24
PY 2013
VL 8
IS 10
AR e78430
DI 10.1371/journal.pone.0078430
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 241FR
UT WOS:000326152300060
PM 24205231
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kuramoto, L
   Cragg, J
   Nandhagopal, R
   Mak, E
   Sossi, V
   de la Fuente-Fernandez, R
   Stoessl, AJ
   Schulzer, M
AF Kuramoto, Lisa
   Cragg, Jacquelyn
   Nandhagopal, Ramachandiran
   Mak, Edwin
   Sossi, Vesna
   de la Fuente-Fernandez, Raul
   Stoessl, A. Jon
   Schulzer, Michael
TI The Nature of Progression in Parkinson's Disease: An Application of
   Non-Linear, Multivariate, Longitudinal Random Effects Modelling
SO PLOS ONE
LA English
DT Article
ID COMPENSATORY CHANGES; IMPACT
AB Background: To date, statistical methods that take into account fully the non-linear, longitudinal and multivariate aspects of clinical data have not been applied to the study of progression in Parkinson's disease (PD). In this paper, we demonstrate the usefulness of such methodology for studying the temporal and spatial aspects of the progression of PD. Extending this methodology further, we also explore the presymptomatic course of this disease.
   Methods: Longitudinal Positron Emission Tomography (PET) measurements were collected on 78 PD patients, from 4 subregions on each side of the brain, using 3 different radiotracers. Non-linear, multivariate, longitudinal random effects modelling was applied to analyze and interpret these data.
   Results: The data showed a non-linear decline in PET measurements, which we modelled successfully by an exponential function depending on two patient-related covariates duration since symptom onset and age at symptom onset. We found that the degree of damage was significantly greater in the posterior putamen than in the anterior putamen throughout the disease. We also found that over the course of the illness, the difference between the less affected and more affected sides of the brain decreased in the anterior putamen. Younger patients had significantly poorer measurements than older patients at the time of symptom onset suggesting more effective compensatory mechanisms delaying the onset of symptoms. Cautious extrapolation showed that disease onset had occurred some 8 to 17 years prior to symptom onset.
   Conclusions: Our model provides important biological insights into the pathogenesis of PD, as well as its preclinical aspects. Our methodology can be applied widely to study many other chronic progressive diseases.
C1 [Kuramoto, Lisa; Schulzer, Michael] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada.
   [Cragg, Jacquelyn; Nandhagopal, Ramachandiran; Mak, Edwin; de la Fuente-Fernandez, Raul; Stoessl, A. Jon; Schulzer, Michael] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V5Z 1M9, Canada.
   [Sossi, Vesna] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada.
RP Kuramoto, L (reprint author), Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada.
EM lisa.kuramoto@ubc.ca
RI Stoessl, A Jon/J-9661-2015
OI Stoessl, A Jon/0000-0002-9778-7246; Ramachandiran,
   Nandhagopal/0000-0002-2379-0055
FU Canadian Institutes of Health Research; Michael Smith Foundation for
   Health Research; Canada Research Chairs; James A. Moore Chair in
   Parkinson's Research; Pacific Parkinson's Research Institute
FX The authors gratefully acknowledge financial support from the Canadian
   Institutes of Health Research for funding operating costs of studies and
   infrastructure (PET, statistics), the Michael Smith Foundation for
   Health Research for infrastructure support (imaging, statistics) and
   salary support (VS), Canada Research Chairs for salary support (AJS),
   James A. Moore Chair in Parkinson's Research for salary support (RFF),
   and the Pacific Parkinson's Research Institute for infrastructure
   support for research operations. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams Jr, 2005, BRAIN, V128, P2777, DOI 10.1093/brain/awh607
   Armitage P, 1998, ENCY BIOSTATISTICS C, P1125
   Au WL, 2005, MOL BRAIN RES, V134, P24, DOI 10.1016/j.molbrainres.2004.09.028
   Brent RP, 1973, ALGORITHMS MINIMIZAT
   Brooks DJ, 2003, EXP NEUROL, V184, pS68, DOI 10.1016/j.expneurol.2003.08.008
   Bruck A, 2006, MOVEMENT DISORD, V21, P958, DOI 10.1002/mds.20855
   Davidian M, 1995, NONLINEAR MODELS REP
   de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284
   Draper N. R., 1998, APPL REGRESSION ANAL
   Fahn S, 2004, NEW ENGL J MED, V351, P2498
   Fleiss J, 2003, STAT METHODS RATES P
   Hilker R, 2005, ARCH NEUROL-CHICAGO, V62, P378, DOI 10.1001/archneur.62.3.378
   Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3
   Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lee CS, 2004, ARCH NEUROL-CHICAGO, V61, P1920, DOI 10.1001/archneur.61.12.1920
   Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4
   LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087
   Marshall G, 2006, STAT MED, V25, P2817, DOI 10.1002/sim.2361
   Morrish PK, 1998, J NEUROL NEUROSUR PS, V64, P314, DOI 10.1136/jnnp.64.3.314
   Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585
   Nandhagopal R, 2008, NEUROLOGY, V70, P1478, DOI 10.1212/01.wnl.0000310432.92489.90
   Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209
   Nandhagopal R, 2011, BRAIN, V134, P3290, DOI 10.1093/brain/awr233
   R Development Core Team, 2006, R LANG ENV STAT COMP
   Ratkowsky DA, 1990, HDB NONLINEAR REGRES
   Rubenstein LM, 1997, PHARMACOECONOMICS, V12, P486, DOI 10.2165/00019053-199712040-00006
   Scheife RT, 2000, AM J HEALTH-SYST PH, V57, P953, DOI 10.1093/ajhp/57.10.953
   Schwarz J, 2004, J NUCL MED, V45, P1694
   SPINKS TJ, 1992, PHYS MED BIOL, V37, P1637, DOI 10.1088/0031-9155/37/8/002
NR 30
TC 15
Z9 15
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 18
PY 2013
VL 8
IS 10
AR e76595
DI 10.1371/journal.pone.0076595
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 239MM
UT WOS:000326029300038
PM 24204641
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cheng, KF
   Chen, JH
AF Cheng, Kuang-Fu
   Chen, Jin-Hua
TI Detecting Rare Variants in Case-Parents Association Studies
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; GENOTYPE RELATIVE RISKS; LINKAGE
   DISEQUILIBRIUM; COMMON VARIANTS; HDL CHOLESTEROL; CANDIDATE-GENE;
   PLASMA-LEVELS; DISEASE; SUSCEPTIBILITY; HAPLOTYPES
AB Despite the success of genome-wide association studies (GWASs) in detecting common variants (minor allele frequency >= 0.05) many suggested that rare variants also contribute to the genetic architecture of diseases. Recently, researchers demonstrated that rare variants can show a strong stratification which may not be corrected by using existing methods. In this paper, we focus on a case-parents study and consider methods for testing group-wise association between multiple rare (and common) variants in a gene region and a disease. All tests depend on the numbers of transmitted mutant alleles from parents to their diseased children across variants and hence they are robust to the effect of population stratification. We use extensive simulation studies to compare the performance of four competing tests: the largest single-variant transmission disequilibrium test (TDT), multivariable test, combined TDT, and a likelihood ratio test based on a random-effects model. We find that the likelihood ratio test is most powerful in a wide range of settings and there is no negative impact to its power performance when common variants are also included in the analysis. If deleterious and protective variants are simultaneously analyzed, the likelihood ratio test was generally insensitive to the effect directionality, unless the effects are extremely inconsistent in one direction.
C1 [Cheng, Kuang-Fu; Chen, Jin-Hua] Taipei Med Univ, Ctr Biostat, Taipei, Taiwan.
   [Cheng, Kuang-Fu; Chen, Jin-Hua] Taipei Med Univ, Dept Epidemiol, Taipei, Taiwan.
   [Cheng, Kuang-Fu] Natl Cent Univ, Grad Inst Stat, Chungli 32054, Taiwan.
RP Cheng, KF (reprint author), Taipei Med Univ, Ctr Biostat, Taipei, Taiwan.
EM Kfcheng@tmu.edu.tw
FU National Science Council, Taiwan [NSC100-2118-M-039-001-MY3]
FX This research was supported in part by the National Science Council,
   Taiwan (NSC100-2118-M-039-001-MY3). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471
   Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733
   Bird TD, 2005, NEW ENGL J MED, V352, P862, DOI 10.1056/NEJMp058027
   Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136
   Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090
   Brunham LR, 2006, ANNU REV NUTR, V26, P105, DOI 10.1146/annurev.nutr.26.061505.111214
   Chen JH, 2011, STAT MED, V30, P291, DOI 10.1002/sim.4092
   Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779
   Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103
   Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870
   Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71
   Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628
   Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024
   Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]
   Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782
   Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384
   Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a
   Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957
   Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074
   Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39
   Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005
   Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272
   Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984
   Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305
   SCHAID DJ, 1993, AM J HUM GENET, V53, P1114
   Scherag A, 2002, HUM HERED, V54, P210, DOI 10.1159/000070666
   Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010
   Shi M, 2007, AM J HUM GENET, V81, P53, DOI 10.1086/518670
   Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973
   Slatter TL, 2008, CLIN GENET, V73, P179, DOI 10.1111/j.1399-0004.2007.00940.x
   Smith DJ, 2002, HUM MOL GENET, V11, P2455, DOI 10.1093/hmg/11.20.2455
   SPIELMAN RS, 1993, AM J HUM GENET, V52, P506
   Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714
   Spirin V, 2007, AM J HUM GENET, V81, P1298, DOI 10.1086/522497
   Sun FZ, 1999, AM J EPIDEMIOL, V150, P97
   Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174
   Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029
   Zhang ZG, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-65
   Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031134
NR 41
TC 2
Z9 2
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2013
VL 8
IS 9
AR e74310
DI 10.1371/journal.pone.0074310
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 228VP
UT WOS:000325220000007
PM 24086332
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Brander, SM
   Connon, RE
   He, GC
   Hobbs, JA
   Smalling, KL
   Teh, SJ
   White, JW
   Werner, I
   Denison, MS
   Cherr, GN
AF Brander, Susanne M.
   Connon, Richard E.
   He, Guochun
   Hobbs, James A.
   Smalling, Kelly L.
   Teh, Swee J.
   White, J. Wilson
   Werner, Inge
   Denison, Michael S.
   Cherr, Gary N.
TI From 'Omics to Otoliths: Responses of an Estuarine Fish to Endocrine
   Disrupting Compounds across Biological Scales
SO PLOS ONE
LA English
DT Article
ID DEPENDENT SEX DETERMINATION; MINNOW PIMEPHALES-PROMELAS; MEDAKA
   ORYZIAS-LATIPES; IN-VITRO; HYPOMESUS-TRANSPACIFICUS; POPULATION-LEVEL;
   MENIDIA-MENIDIA; GENE-EXPRESSION; TREATMENT-PLANT; DELTA SMELT
AB Endocrine disrupting chemicals (EDCs) cause physiological abnormalities and population decline in fishes. However, few studies have linked environmental EDC exposures with responses at multiple tiers of the biological hierarchy, including population-level effects. To this end, we undertook a four-tiered investigation in the impacted San Francisco Bay estuary with the Mississippi silverside (Menidia audens), a small pelagic fish. This approach demonstrated links between different EDC sources and fish responses at different levels of biological organization. First we determined that water from a study site primarily impacted by ranch run-off had only estrogenic activity in vitro, while water sampled from a site receiving a combination of urban, limited ranch run-off, and treated wastewater effluent had both estrogenic and androgenic activity. Secondly, at the molecular level we found that fish had higher mRNA levels for estrogen-responsive genes at the site where only estrogenic activity was detected but relatively lower expression levels where both estrogenic and androgenic EDCs were detected. Thirdly, at the organism level, males at the site exposed to both estrogens and androgens had significantly lower mean gonadal somatic indices, significantly higher incidence of severe testicular necrosis and altered somatic growth relative to the site where only estrogens were detected. Finally, at the population level, the sex ratio was significantly skewed towards males at the site with measured androgenic and estrogenic activity. Our results suggest that mixtures of androgenic and estrogenic EDCs have antagonistic and potentially additive effects depending on the biological scale being assessed, and that mixtures containing androgens and estrogens may produce unexpected effects. In summary, evaluating EDC response at multiple tiers is necessary to determine the source of disruption (lowest scale, i.e. cell line) and what the ecological impact will be (largest scale, i.e. sex ratio).
C1 [Brander, Susanne M.; Cherr, Gary N.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.
   [Brander, Susanne M.; He, Guochun; Denison, Michael S.; Cherr, Gary N.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.
   [Brander, Susanne M.; White, J. Wilson] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.
   [Connon, Richard E.; Teh, Swee J.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA.
   [Hobbs, James A.] Univ Calif Davis, Dept Wildlife Fisheries & Conservat Biol, Davis, CA 95616 USA.
   [Smalling, Kelly L.] US Geol Survey, Sacramento, CA USA.
   [Werner, Inge] Eawag Ecole Polytech Fed Lausanne, Swiss Ctr Appl Ecotoxicol, Dubendorf, Switzerland.
   [Cherr, Gary N.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
RP Brander, SM (reprint author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.
EM branders@uncw.edu
OI Smalling, Kelly/0000-0002-1214-4920
FU Delta Science [R/SF-27, SCI-05-C111]; National Science Foundation
   [GK-12, 0841297]; Sacramento Regional County Sanitation District;
   Interagency Ecological Program, Sacramento, California [4600008070];
   National Institutes of Environmental Health Sciences [P42-ES004699];
   California Department of Fish and Wildlife [E1183010]
FX This work was supported by grants from Delta Science (Pre-Doctoral
   Fellowship R/SF-27 to SMB and grant no. SCI-05-C111), the National
   Science Foundation (GK-12 Pre-Doctoral Fellowship to SMB, grant no.
   0841297), the Sacramento Regional County Sanitation District, and the
   Interagency Ecological Program, Sacramento, California (Contract No.
   4600008070 to IW), a Superfund Research Grant from the National
   Institutes of Environmental Health Sciences (P42-ES004699 to M.
   Denison), and continuing funding from the California Department of Fish
   and Wildlife (Contract No. E1183010 to REC and SMB). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adams RG, 2007, ENVIRON SCI TECHNOL, V41, P1317, DOI 10.1021/es0621593
   Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200
   Anderson SL, 2006, MAR ENVIRON RES, V62, pS317, DOI 10.1016/j.marvenvres.2006.04.011
   Ankley GT, 2008, AQUAT TOXICOL, V88, P69, DOI 10.1016/j.aquatox.2008.03.005
   Ankley GT, 2010, AQUAT TOXICOL, V99, P389, DOI 10.1016/j.aquatox.2010.05.020
   Banks JE, 2010, RISK ANAL, V30, P175, DOI 10.1111/j.1539-6924.2009.01349.x
   BARKMAN RC, 1987, J FISH BIOL, V31, P683, DOI 10.1111/j.1095-8649.1987.tb05271.x
   Blazer VS, 2002, FISH PHYSIOL BIOCHEM, V26, P85, DOI 10.1023/A:1023332216713
   Bogers R, 2006, AQUAT TOXICOL, V80, P119, DOI 10.1016/j.aquatox.2006.07.020
   Brander SM, 2012, ENV TOXICOLOGY CHEM
   Brander SM, 2013, MONITORING WATER QUALITY: POLLUTION ASSESSMENT, ANALYSIS, AND REMEDIATION, P103, DOI 10.1016/B978-0-444-59395-5.00005-4
   Brander SM, 2012, ECOTOXICOLOGY, V21, P1272, DOI 10.1007/s10646-012-0879-2
   Brander SM, 2009, ENVIRON TOXICOL CHEM, V28, P1493, DOI 10.1897/08-374.1
   Braun AM, 2003, BIOL REPROD, V69, P1642, DOI 10.1095/biolreprod.103.015479
   BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926
   Chang H, 2011, WATER RES, V45, P732, DOI 10.1016/j.watres.2010.08.046
   Clements William H., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P113, DOI 10.1023/A:1009927612391
   Connon RE, 2011, AQUAT TOXICOL, V105, P369, DOI 10.1016/j.aquatox.2011.07.002
   CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577
   CONOVER DO, 1990, SCIENCE, V250, P1556, DOI 10.1126/science.250.4987.1556
   Crago J, 2011, CHEMOSPHERE, V82, P1669, DOI 10.1016/j.chemosphere.2010.11.011
   Dang ZC, 2011, TOXICOL LETT, V202, P36, DOI 10.1016/j.toxlet.2011.01.016
   Denslow Nancy, 2007, P255, DOI 10.1007/978-1-4020-6235-3_10
   Doyle MA, 2011, J ENV MONITORING, V13
   Duffy TA, 2010, J EXP ZOOL PART A, V313A, P421, DOI 10.1002/jez.612
   Duffy TA, 2009, MAR ECOL PROG SER, V380, P245, DOI 10.3354/meps07928
   Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048
   Filby AL, 2007, ENVIRON HEALTH PERSP, V115, P1704, DOI 10.1289/ehp.10443
   Giudice BD, 2010, ENVIRON TOXICOL CHEM, V30, P2220
   Green M.R., 2012, MOL CLONING LAB MANU
   Gurney WSC, 2006, ENVIRON HEALTH PERSP, V114, P122, DOI 10.1289/ehp.8064
   Gutjahr-Gobell RE, 2006, ECOTOX ENVIRON SAFE, V63, P244, DOI 10.1016/j.ecoenv.2005.05.017
   Harris CA, 2011, ENV HLTH PERSPECT, V119
   Heinze G, 2003, COMPUT METH PROG BIO, V71, P181, DOI 10.1016/S0169-2607(02)00088-3
   Hladik ML, 2008, B ENVIRON CONTAM TOX, V80, P139, DOI 10.1007/s00128-007-9332-2
   Hobbs JA, 2007, FISH B-NOAA, V105, P30
   Houtman CJ, 2004, ENVIRON TOXICOL CHEM, V23, P32, DOI 10.1897/02-544
   Houtman CJ, 2007, ENVIRON TOXICOL CHEM, V26, P898, DOI 10.1897/06-326R.1
   HUBBS C, 1976, COPEIA, P386
   Jeffries MKS, 2011, AQUAT TOXICOL, V105, P189, DOI 10.1016/j.aquatox.2011.04.008
   Johnson R, 2009, OECD GUIDAN IN PRESS
   KENNEDY WJ, 1971, ANN MATH STAT, V42, P1273, DOI 10.1214/aoms/1177693240
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104
   Knapp R, 2010, BIOL LETT, V7, P150
   Kolodziej EP, 2003, ENVIRON TOXICOL CHEM, V22, P2622, DOI 10.1897/03-42
   Kuivila K., 2008, SAN FRANCISCO ESTUAR, V6
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LEDREAN Y, 1995, MOL CELL ENDOCRINOL, V109, P27, DOI 10.1016/0303-7207(95)03482-M
   Leon A, 2007, AQUAT TOXICOL, V82, P195, DOI 10.1016/j.aquatox.2007.02.012
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI 10.1897/1551-5028(2001)020<0297:EPOCDI>2.0.CO;2
   MIDDAUGH DP, 1992, COPEIA, P53
   Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1
   Moyle PB, 2002, INLAND FISHES CALIFO
   NICHOLS FH, 1986, SCIENCE, V231, P567, DOI 10.1126/science.231.4738.567
   Nimrod AC, 1998, AQUAT TOXICOL, V44, P141, DOI 10.1016/S0166-445X(98)00062-9
   O'Rear T. A., 2009, TRENDS FISH POPULATI
   Orton F, 2009, ENVIRON SCI TECHNOL, V43, P2144, DOI 10.1021/es8028928
   Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   Pottinger TG, 2010, ENVIRON INT, V37, P158
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Rempel MA, 2008, INT REV CEL MOL BIO, P207
   Rempel MA, 2006, AQUAT TOXICOL, V77, P241, DOI 10.1016/j.aquatox.2005.12.007
   Rogers JM, 2000, IN VITRO MOL TOXICOL, V13, P67
   Rose WL, 2005, ENVIRON TOXICOL CHEM, V24, P2612, DOI 10.1897/04-516R.1
   Sanchez W, 2011, ENVIRON INT, V37, P1342, DOI 10.1016/j.envint.2011.06.002
   Scholz NL, 2012, BIOSCIENCE, V62, P428, DOI 10.1525/bio.2012.62.4.13
   Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008
   Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099
   Seki M, 2006, ENVIRON TOXICOL CHEM, V25, P2742, DOI 10.1897/05-647R.1
   Singh PB, 2008, CHEMOSPHERE, V72, P422, DOI 10.1016/j.chemosphere.2008.02.026
   Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207
   Tamura H, 2006, BIOORGAN MED CHEM, V14, P7160, DOI 10.1016/j.bmc.2006.06.064
   Thomas P, 2011, P ROYAL SOC B
   Tilton F, 2002, AQUAT TOXICOL, V61, P211, DOI 10.1016/S0166-445X(02)00058-9
   Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y
   Velasco-Santamaria YM, 2010, MAR ENVIRON RES, V69, pS67, DOI 10.1016/j.marenvres.2009.09.009
   Yamahira K, 2003, COPEIA, P155, DOI 10.1643/0045-8511(2003)003[0155:IVITDS]2.0.CO;2
   Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1
NR 80
TC 25
Z9 26
U1 0
U2 54
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 25
PY 2013
VL 8
IS 9
AR e74251
DI 10.1371/journal.pone.0074251
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 228VC
UT WOS:000325218700019
PM 24086325
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ljungberg, JK
   Hansson, P
   Andres, P
   Josefsson, M
   Nilsson, LG
AF Ljungberg, Jessica K.
   Hansson, Patrik
   Andres, Pilar
   Josefsson, Maria
   Nilsson, Lars-Goran
TI A Longitudinal Study of Memory Advantages in Bilinguals
SO PLOS ONE
LA English
DT Article
ID COGNITIVE RESERVE; EPISODIC MEMORY; PROSPECTIVE COHORT; EXECUTIVE
   CONTROL; OLDER-ADULTS; BRAIN; RETRIEVAL; ATTENTION; TASK; FLUENCY
AB Typically, studies of cognitive advantages in bilinguals have been conducted previously by using executive and inhibitory tasks (e.g. Simon task) and applying cross-sectional designs. This study longitudinally investigated bilingual advantages on episodic memory recall, verbal letter and categorical fluency during the trajectory of life. Monolingual and bilingual participants (n= 178) between 35-70 years at baseline were drawn from the Betula Prospective Cohort Study of aging, memory, and health. Results showed that bilinguals outperformed monolinguals at the first testing session and across time both in episodic memory recall and in letter fluency. No interaction with age was found indicating that the rate of change across ages was similar for bilinguals and monolinguals. As predicted and in line with studies applying cross-sectional designs, no advantages associated with bilingualism were found in the categorical fluency task. The results are discussed in the light of successful aging.
C1 [Ljungberg, Jessica K.; Hansson, Patrik] Umea Univ, Dept Psychol, S-90187 Umea, Sweden.
   [Ljungberg, Jessica K.] Cardiff Univ, Sch Psychol, Cardiff, Wales.
   [Andres, Pilar] Univ Balearic Isl, Dept Psychol, Palma De Mallorca, Spain.
   [Nilsson, Lars-Goran] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden.
   [Josefsson, Maria] Umea Univ, Umea Sch Business & Econ, Dept Stat, Umea, Sweden.
RP Ljungberg, JK (reprint author), Umea Univ, Dept Psychol, S-90187 Umea, Sweden.
EM jessica.korningljungberg@psy.umu.se
RI Andres Benito, Pilar/G-3411-2011
OI Josefsson, Maria/0000-0002-1812-3581
FU Bank of Sweden Tercentenary Foundation [1988-0082:17, J2001-0682];
   Swedish Council for Planning and Coordination of Research [D1988-0092,
   D1989-0115, D1990-0074, D1991-0258, D1992-0143, D1997-0756, D1997-1841,
   D1999-0739, B1999-474]; Swedish Council for Research in the Humanities
   and Social Sciences [F377/1988-2000]; Swedish Council for Social
   Research [1988-1990: 88-0082, 311/1991-2000]; Swedish Research Council
   [345-2003-3883, 315-2004-6977, 421-2011-1782]; Swedish Council for
   Working Life and Social Research [2211-0505]; Spanish Ministry of
   Science and Innovation [PSI2010-21609-C02-02]
FX The Betula Study is supported by the Bank of Sweden Tercentenary
   Foundation (grant number 1988-0082:17, J2001-0682); Swedish Council for
   Planning and Coordination of Research (grant number D1988-0092,
   D1989-0115, D1990-0074, D1991-0258, D1992-0143, D1997-0756, D1997-1841,
   D1999-0739, B1999-474); Swedish Council for Research in the Humanities
   and Social Sciences (grant number F377/1988-2000); Swedish Council for
   Social Research (grant number 1988-1990: 88-0082, 311/1991-2000); and
   the Swedish Research Council (grant number 345-2003-3883,
   315-2004-6977). Jessica K. Ljungberg is supported by grants from the
   Swedish Research Council (421-2011-1782) and the Swedish Council for
   Working Life and Social Research (2211-0505) and Pilar Andres is
   supported by a grant from the Spanish Ministry of Science and Innovation
   (PSI2010-21609-C02-02). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abutalebi J., 2001, BILING-LANG COGN, V4, P179, DOI DOI 10.1017/S136672890100027X
   Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003
   Aiken LS, 1991, MULTIPLE REGRESSION
   Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078
   Baltes P. B., 2005, CAMBRIDGE HDB AGE AG, P47
   Bates D, 2011, IME4 LINEAR MIXED EF
   Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x
   Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290
   Bialystok E, 2009, PSYCHOL SCI, V3, P89
   Bialystok E, 2008, J EXP PSYCHOL LEARN, V34, P859, DOI 10.1037/0278-7393.34.4.859
   Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001
   Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013
   Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001
   Craik FIM, 2010, NEUROLOGY, V75, P1726, DOI 10.1212/WNL.0b013e3181fc2a1c
   De Bleser R, 2003, J NEUROLINGUIST, V16, P439, DOI 10.1016/S0911-6044(03)00022-8
   Depue BE, 2012, NEUROSCI BIOBEHAV R, V36, P1382, DOI 10.1016/j.neubiorev.2012.02.012
   Emmorey K, 2008, PSYCHOL SCI, V19, P1201, DOI 10.1111/j.1467-9280.2008.02224.x
   Erickson IK, 2009, BRIT J SPORT MED, V43, P22
   Fernandes MA, 2007, CAN J EXP PSYCHOL, V61, P128, DOI 10.1037/cjep2007014
   Finkel D, 2009, PSYCHOL AGING, V3, P563
   Green D. W., 1998, BILING-LANG COGN, V1, P67, DOI [10.1017/S1366728998000133, DOI 10.1017/S1366728998000133]
   Grogan A, 2009, CEREB CORTEX, V19, P2690, DOI 10.1093/cercor/bhp023
   Hernandez M, 2010, BILING-LANG COGN, V13, P315, DOI 10.1017/S1366728909990010
   Hertzog C., 2009, SCI AM MIND, V20, P24, DOI [10.1038/scientificamericanmind0709-24, DOI 10.1038/SCIENTIFICAMERICANMIND0709-24]
   Josefsson M, 2012, J AM GERIATR SOC, V60, P2308, DOI 10.1111/jgs.12000
   Kroll FJ, 2008, ACTA PSYCHOL, V128, P416
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Luo L, 2010, COGNITION, V114, P29, DOI 10.1016/j.cognition.2009.08.014
   MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1
   Morton J. B., BILINGUAL A IN PRESS
   Morton JB, 2007, DEVELOPMENTAL SCI, V10, P719, DOI 10.1111/j.1467-7687.2007.00623.x
   Nilsson LG, 2009, NEUROBIOL AGING, V30, P521, DOI 10.1016/j.neurobiolaging.2008.11.013
   Nilsson LG, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.107.s179.5.x
   Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633
   Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026
   Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005
   Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002
   Park DC, 2007, J GERONTOL B-PSYCHOL, V62, P45, DOI 10.1093/geronb/62.special_issue_1.45
   Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Rodriguez-Fornells A, 2005, J COGNITIVE NEUROSCI, V17, P422, DOI 10.1162/0898929053279559
   Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3
   Ronnlund M., 2006, BALTIC J PSYCHOL, V7, P6
   Salthouse TA, 2006, PERSPECT PSYCHOL SCI, V1, P68, DOI 10.1111/j.1745-6916.2006.00005.x
   SCHAIE KW, 1994, AM PSYCHOL, V49, P304, DOI 10.1037/0003-066X.49.4.304
   Schroeder SR, 2012, J COGN PSYCHOL, V24, P591, DOI 10.1080/20445911.2012.669367
   Schweizer TA, 2012, CORTEX, V48, P991, DOI 10.1016/j.cortex.2011.04.009
   SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0
   SNOW RE, 1984, ADV PSYCHOL HUMAN IN, P47
   Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004
   Tao L., 2011, FRONT PSYCHOL, V2, P1, DOI DOI 10.3389/FPSYG.2011.00123
   Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264
   Wechsler D., 1981, WECHSLER ADULT INTEL
   Wodniecka Z, 2010, INT J BILING EDUC BI, V13, P575, DOI 10.1080/13670050.2010.488287
   Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864
NR 55
TC 35
Z9 35
U1 1
U2 50
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 4
PY 2013
VL 8
IS 9
AR e73029
DI 10.1371/journal.pone.0073029
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 219OE
UT WOS:000324515600058
PM 24023803
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Taylor-Robinson, DC
   Smyth, R
   Diggle, PJ
   Whitehead, M
AF Taylor-Robinson, David C.
   Smyth, Rosalind
   Diggle, Peter J.
   Whitehead, Margaret
TI A Longitudinal Study of the Impact of Social Deprivation and Disease
   Severity on Employment Status in the UK Cystic Fibrosis Population
SO PLOS ONE
LA English
DT Article
ID MACROLEVEL CONTEXTS; HEALTH INEQUALITIES; CHRONICALLY ILL; WORK
   DISABILITY; ADULTS; EPIDEMIOLOGY; CHALLENGES; MORTALITY; POLICIES;
   CHANCES
AB Background: People with Cystic Fibrosis (CF) in the UK and elsewhere are increasingly surviving into adulthood, yet there is little research on the employment consequences of having CF. We investigated, for the first time in a UK-wide cohort, longitudinal employment status, and its association with deprivation, disease severity, and time in hospital.
   Methods: We did a longitudinal registry study of adults with CF in the UK aged 20 to 40 (3458 people with 15,572 observations between 1996 and 2010), using mixed effects models.
   Results: Around 50% of adults with CF were in employment. Male sex, higher lung function and body mass index, and less time in hospital were associated with improved employment chances. All other things being equal, being in the most deprived quintile was associated with a reduction of employment prevalence of 17.6 percentage points compared to the prevalence in the least deprived quintile. Having poor lung function was associated with a reduced employment prevalence of 7.2 percentage points compared to the prevalence for people with relatively good lung function. Acting synergistically, deprivation modifies the effect of lung function on employment chances - poor lung function in the least deprived group was associated with a 3 percentage point reduction in employment chances, while poor lung function in the most deprived quintile was associated with a 7.7 point reduction in employment chances.
   Conclusions: Greater deprivation, disease severity, and time in hospital are all associated with employment chances in adults with CF. Furthermore, our analysis suggests that deprivation amplifies the harmful association of disease severity on employment. Future studies should focus on understanding and mitigating the barriers to employment faced by people with CF.
C1 [Taylor-Robinson, David C.; Whitehead, Margaret] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.
   [Smyth, Rosalind] UCL, Inst Child Hlth, London, England.
   [Diggle, Peter J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.
RP Taylor-Robinson, DC (reprint author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.
EM dctr@liv.ac.uk
OI Diggle, Peter/0000-0003-3521-5020
FU MRC [G0802448]; Medical Research Council [G0802448]
FX DTR is supported by an MRC Population Health Scientist Fellowship
   (G0802448). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adler AI, 2008, DIABETES CARE, V31, P1789, DOI 10.2337/dc08-0466
   [Anonymous], 2013, LANCET RESP MED, V1, P121, DOI 10.1016/S2213-2600(13)70002-X
   Bambra C, 2010, J EPIDEMIOL COMMUN H, V64, P284, DOI 10.1136/jech.2008.082743
   Bambra C, 2009, PREV MED, V48, P454, DOI 10.1016/j.ypmed.2008.12.018
   Barr HL SA, 2011, BMJ
   Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285
   Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6
   BRITTON JR, 1989, BRIT MED J, V298, P483, DOI 10.1136/bmj.298.6672.483
   Burker EJ, 2004, PEDIATR PULM, V38, P413, DOI 10.1002/ppul.20090
   Cystic Fibrosis Trust, 2011, UK CF REG ANN DAT RE
   Cystic Fibrosis Trust, 2011, UK CF REG
   Diderichsen F, 2001, SOCIAL ORIGINS DISPA
   Diggle PJ, 2002, ANAL LONGITUDINAL DA
   Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506
   Edwards J, 2010, DISABIL SOC, V25, P441, DOI 10.1080/09687591003755831
   Frangolias DD, 2003, AM J RESP CRIT CARE, V167, P150, DOI 10.1164/rccm.2202053
   GILLEN M, 1995, AM J RESP CRIT CARE, V152, P153, DOI 10.1164/ajrccm.152.1.7599815
   Grimes DA, 2008, OBSTET GYNECOL, V111, P423, DOI 10.1097/01.AOG.0000297304.32187.5d
   Hastie T. J., 1990, GEN ADDITIVE MODELS
   Havermans T, 2009, J CYST FIBROS, V8, P218, DOI 10.1016/j.jcf.2009.03.002
   Hogg M, 2007, J CYST FIBROS, V6, P223, DOI 10.1016/j.jcf2006.10.004
   Holland P, 2011, INT J HEALTH SERV, V41, P415, DOI 10.2190/HS.41.3.b
   Holland P, 2011, INT J HEALTH SERV, V41, P395, DOI 10.2190/HS.41.3.a
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Marmot Michael, 2010, FAIR SOC HLTH LIVES
   Mehta G, 2004, J ROY SOC MED, V97, P60
   O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333
   Rosenfeld M, 2005, TASK FORCE EVALUATE
   Saldana PS, 2012, WORK, V42, P185, DOI 10.3233/WOR-2012-1353
   Sawicki GS, 2009, J CYST FIBROS, V8, P91, DOI 10.1016/j.jcf.2008.09.007
   Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100
   Semple MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022425
   Taylor-Robinson D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4818
   WALTERS S, 1993, BRIT MED J, V306, P549, DOI 10.1136/bmj.306.6877.549
NR 34
TC 13
Z9 13
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 23
PY 2013
VL 8
IS 8
AR e73322
DI 10.1371/journal.pone.0073322
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 217ZW
UT WOS:000324403200046
PM 24009747
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Keller, J
   Rulseh, AM
   Komarek, A
   Latnerova, I
   Rusina, R
   Brozova, H
   Vymazal, J
AF Keller, Jiri
   Rulseh, Aaron M.
   Komarek, Arnost
   Latnerova, Iva
   Rusina, Robert
   Brozova, Hana
   Vymazal, Josef
TI New Non-Linear Color Look-Up Table for Visualization of Brain Fractional
   Anisotropy Based on Normative Measurements - Principals and First
   Clinical Use
SO PLOS ONE
LA English
DT Article
ID VOXEL-BASED MORPHOMETRY; DIFFUSION; REGION; TRACT
AB Fractional anisotropy (FA) is the most commonly used quantitative measure of diffusion in the brain. Changes in FA have been reported in many neurological disorders, but the implementation of diffusion tensor imaging (DTI) in daily clinical practice remains challenging. We propose a novel color look-up table (LUT) based on normative data as a tool for screening FA changes. FA was calculated for 76 healthy volunteers using 12 motion-probing gradient directions (MPG), a subset of 59 subjects was additionally scanned using 30 MPG. Population means and 95% prediction intervals for FA in the corpus callosum, frontal gray matter, thalamus and basal ganglia were used to create the LUT. Unique colors were assigned to inflection points with continuous ramps between them. Clinical use was demonstrated on 17 multiple system atrophy (MSA) patients compared to 13 patients with Parkinson disease (PD) and 17 healthy subjects. Four blinded radiologists classified subjects as MSA/non-MSA. Using only the LUT, high sensitivity (80%) and specificity (84%) were achieved in differentiating MSA subjects from PD subjects and controls. The LUTs generated from 12 and 30 MPG were comparable and accentuate FA abnormalities.
C1 [Keller, Jiri] Charles Univ Prague, Fac Med 3, Dept Neurol, Prague, Czech Republic.
   [Keller, Jiri; Rulseh, Aaron M.; Latnerova, Iva; Vymazal, Josef] Na Homolce Hosp, Dept Radiol, Prague, Czech Republic.
   [Komarek, Arnost] Charles Univ Prague, Fac Math & Phys, Dept Probabil & Math Stat, Prague, Czech Republic.
   [Rusina, Robert] Thomayer Hosp, Dept Neurol, Prague, Czech Republic.
   [Rusina, Robert; Brozova, Hana] Fac Med 1, Dept Neurol, Prague, Czech Republic.
   [Rusina, Robert; Brozova, Hana] Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic.
   [Rusina, Robert; Brozova, Hana] Gen Univ Hosp Prague, Prague, Czech Republic.
RP Keller, J (reprint author), Charles Univ Prague, Fac Med 3, Dept Neurol, Prague, Czech Republic.
EM keller.public+plosone@gmail.com
RI Komarek, Arnost/A-5534-2012; Rulseh, Aaron/D-3924-2015
OI Komarek, Arnost/0000-0001-8778-3762; Keller, Jiri/0000-0002-6799-7840;
   Rulseh, Aaron/0000-0002-8332-4419
FU Interni grantova agentura Ministerstva zdravotnictvi (IGA MZCR)
   [NT11328, NT12094]; Research Project Charles University in Prague;
   PRVOUK P34; Research Goal MSM [0021620849]
FX This study was supported by grants Interni grantova agentura
   Ministerstva zdravotnictvi (IGA MZCR) NT11328, NT12094, Research Project
   Charles University in Prague, PRVOUK P34, and Research Goal MSM
   0021620849. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Bates D. M., 2011, LME4 LINEAR MIXED EF
   Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004
   Bozzali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048079
   Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525
   Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044
   Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019
   Harrison DM, 2011, NEUROLOGY, V76, P179, DOI 10.1212/WNL.0b013e318206ca61
   Ibrahim I, 2009, NEUROENDOCRINOL LETT, V30, P39
   Jolapara M, 2010, NEURORADIOLOGY
   Keller J, 2010, ISMRM ESMRMB JOINT A
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Llufriu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037167
   Mitelman SA, 2009, SCHIZOPHR RES, V114, P144, DOI 10.1016/j.schres.2009.07.021
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J
   Palmer SL, 2002, AM J NEURORADIOL, V23, P1088
   Peters BD, 2010, J PSYCHIATR RES, V44, P993, DOI 10.1016/j.jpsychires.2010.05.003
   Preti MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035856
   R Development Core Team, 2009, R LANG ENV STAT COMP
   Rasband W. S, 1997, IMAGEJ
   Rulseh AM, 2013, J MAGN RESON IMAGING, V38, P1103, DOI 10.1002/jmri.24065
   Sharma KR, 2012, JOURNAL OF NEUROIMAG
   Shiga K, 2005, J NEUROL, V252, P589, DOI 10.1007/s00415-005-0708-0
   Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021
   Taoka T, 2007, NEUROIMAGE, V37, P387, DOI 10.1016/j.neuroimage.2007.05.028
   Tha KK, 2010, RADIOLOGY, V255, P563, DOI 10.1148/radiol.10090988
   Van Camp N, 2012, NEUROBIOL AGING, V33, P945, DOI 10.1016/j.neurobiolaging.2010.07.001
   Weiss Kenneth L, 2002, Radiographics, V22, pe3
   WEISS KL, 1987, AM J ROENTGENOL, V149, P825, DOI 10.2214/ajr.149.4.825
   Xu JS, 2010, NEUROPSYCHOPHARMACOL, V35, P1541, DOI 10.1038/npp.2010.25
   Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045476
NR 32
TC 1
Z9 1
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 22
PY 2013
VL 8
IS 8
AR e71431
DI 10.1371/journal.pone.0071431
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 218ZA
UT WOS:000324470700016
PM 23990954
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhang, ZY
   Hong, Y
   Gao, J
   Xiao, SJ
   Ma, JW
   Zhang, WC
   Ren, J
   Huang, LS
AF Zhang, Zhiyan
   Hong, Yuan
   Gao, Jun
   Xiao, Shijun
   Ma, Junwu
   Zhang, Wanchang
   Ren, Jun
   Huang, Lusheng
TI Genome-Wide Association Study Reveals Constant and Specific Loci for
   Hematological Traits at Three Time Stages in a White Duroc x Erhualian
   F-2 Resource Population
SO PLOS ONE
LA English
DT Article
ID BLOOD-CELL; LONGITUDINAL DATA; MIXED-MODEL; COAT COLOR; PARAMETERS;
   CHROMOSOME; PLATELET; SWINE; HERITABILITY; CONSORTIUM
AB Hematological traits are important indicators of immune function and have been commonly examined as biomarkers of disease and disease severity in humans. Pig is an ideal biomedical model for human diseases due to its high degree of similarity with human physiological characteristics. Here, we conducted genome-wide association studies (GWAS) for 18 hematological traits at three growth stages (days 18, 46 and 240) in a White Duroc x Erhualian F-2 intercross. In total, we identified 38 genome-wide significant regions containing 185 genome-wide significant SNPs by single-marker GWAS or LONG-GWAS. The significant regions are distributed on pig chromosomes (SSC) 1, 4, 5, 7, 8, 10, 11, 12, 13, 17 and 18, and most of significant SNPs reside on SSC7 and SSC8. Of the 38 significant regions, 7 show constant effects on hematological traits across the whole life stages, and 6 regions have time-specific effects on the measured traits at early or late stages. The most prominent locus is the genomic region between 32.36 and 84.49 Mb on SSC8 that is associated with multiple erythroid traits. The KIT gene in this region appears to be a promising candidate gene. The findings improve our understanding of the genetic architecture of hematological traits in pigs. Further investigations are warranted to characterize the responsible gene(s) and causal variant(s) especially for the major loci on SSC7 and SSC8.
C1 [Ren, Jun] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.
   Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China.
RP Ren, J (reprint author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.
EM renjunjxau@hotmail.com; lushenghuang@hotmail.com
RI Ren, Jun/H-9793-2019
FU Program for Innovative Research Team of the Ministry of Agriculture of
   China; Program for Changjiang Scholars and Innovative Research Team in
   University [IRT1136]
FX This work was supported by the Program for Innovative Research Team of
   the Ministry of Agriculture of China and Program for Changjiang Scholars
   and Innovative Research Team in University (IRT1136). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614
   Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308
   BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284
   Cho IC, 2011, ANIM GENET, V42, P621, DOI 10.1111/j.1365-2052.2011.02204.x
   Druet T, 2011, GENETICS, V188, P409, DOI 10.1534/genetics.111.127720
   Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431
   Dupuis J, 1999, GENETICS, V151, P373
   EDFORSLILJA I, 1994, VET IMMUNOL IMMUNOP, V40, P1, DOI 10.1016/0165-2427(94)90011-6
   Eding H, 2001, J ANIM BREED GENET, V118, P141, DOI 10.1046/j.1439-0388.2001.00290.x
   Escribano L, 1998, LEUKEMIA LYMPHOMA, V30, P459, DOI 10.3109/10428199809057558
   Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735
   Fesus L, 2005, J ANIM BREED GENET, V122, P127, DOI 10.1111/j.1439-0388.2005.00504.x
   Furlotte NA, 2012, GENET EPIDEMIOL, V36, P463, DOI 10.1002/gepi.21640
   Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466
   Garner C, 2000, BLOOD, V95, P342
   Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x
   HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796
   Hayes BJ, 2008, J ANIM SCI, V86, P2089, DOI 10.2527/jas.2007-0733
   Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946
   JACKSON IJ, 1994, PIGM CELL RES, V7, P73, DOI 10.1111/j.1600-0749.1994.tb00024.x
   Johansson A, 2005, ANIM GENET, V36, P288, DOI 10.1111/j.1365-2052.2005.01320.x
   Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531
   Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Luo WZ, 2012, INT J BIOL SCI, V8, P870, DOI 10.7150/ijbs.4027
   Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015
   Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003
   Sakurai M, 1996, MAMM GENOME, V7, P397, DOI 10.1007/BF03035316
   Sartelet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002581
   Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467
   Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234
   TULLIS JL, 1952, BLOOD, V7, P891
   Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105
   Wang JY, 2013, ANIM GENET, V44, P34, DOI 10.1111/j.1365-2052.2012.02366.x
   Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608
   Yang S, 2009, ANIM GENET, V40, P273, DOI 10.1111/j.1365-2052.2008.01830.x
   Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702
   Zou ZZ, 2008, MAMM GENOME, V19, P640, DOI 10.1007/s00335-008-9142-9
NR 40
TC 12
Z9 18
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2013
VL 8
IS 5
AR e63665
DI 10.1371/journal.pone.0063665
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 146RJ
UT WOS:000319107900052
PM 23691082
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kurahashi, I
   Fujita, Y
   Arao, T
   Kurata, T
   Koh, Y
   Sakai, K
   Matsumoto, K
   Tanioka, M
   Takeda, K
   Takiguchi, Y
   Yamamoto, N
   Tsuya, A
   Matsubara, N
   Mukai, H
   Minami, H
   Chayahara, N
   Yamanaka, Y
   Miwa, K
   Takahashi, S
   Takahashi, S
   Nakagawa, K
   Nishio, K
AF Kurahashi, Issei
   Fujita, Yoshihiko
   Arao, Tokuzo
   Kurata, Takayasu
   Koh, Yasuhiro
   Sakai, Kazuko
   Matsumoto, Koji
   Tanioka, Maki
   Takeda, Koji
   Takiguchi, Yuichi
   Yamamoto, Nobuyuki
   Tsuya, Asuka
   Matsubara, Nobuaki
   Mukai, Hirofumi
   Minami, Hironobu
   Chayahara, Naoko
   Yamanaka, Yasuhiro
   Miwa, Keisuke
   Takahashi, Shin
   Takahashi, Shunji
   Nakagawa, Kazuhiko
   Nishio, Kazuto
TI A Microarray-Based Gene Expression Analysis to Identify Diagnostic
   Biomarkers for Unknown Primary Cancer
SO PLOS ONE
LA English
DT Article
ID EPITHELIAL-MESENCHYMAL TRANSITION; DEPENDENT PROTEIN-KINASE; PHASE-II
   TRIAL; MOLECULAR CLASSIFICATION; PRIMARY SITE; HEPATOCELLULAR-CARCINOMA;
   COLORECTAL-CARCINOMA; RIBOSOMAL BIOGENESIS; RESEARCH-NETWORK; CELL
   APOPTOSIS
AB Background: The biological basis for cancer of unknown primary (CUP) at the molecular level remains largely unknown, with no evidence of whether a common biological entity exists. Here, we assessed the possibility of identifying a common diagnostic biomarker for CUP using a microarray gene expression analysis.
   Methods: Tumor mRNA samples from 60 patients with CUP were analyzed using the Affymetrix U133A Plus 2.0 GeneChip and were normalized by asinh (hyperbolic arc sine) transformation to construct a mean gene-expression profile specific to CUP. A gene-expression profile specific to non-CUP group was constructed using publicly available raw microarray datasets. The t-tests were performed to compare the CUP with non-CUP groups and the top 59 CUP specific genes with the highest fold change were selected (p-value<0.001).
   Results: Among the 44 genes that were up-regulated in the CUP group, 6 genes for ribosomal proteins were identified. Two of these genes (RPS7 and RPL11) are known to be involved in the Mdm2-p53 pathway. We also identified several genes related to metastasis and apoptosis, suggesting a biological attribute of CUP.
   Conclusions: The protein products of the up-regulated and down-regulated genes identified in this study may be clinically useful as unique biomarkers for CUP.
C1 [Kurahashi, Issei] Univ Tokyo, Dept Planning Informat & Management, Tokyo, Japan.
   [Fujita, Yoshihiko; Arao, Tokuzo; Sakai, Kazuko; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan.
   [Kurata, Takayasu; Nakagawa, Kazuhiko] Kinki Univ, Sch Med, Dept Med Oncol, Osaka 589, Japan.
   [Koh, Yasuhiro] Shizuoka Canc Ctr, Res Inst, Div Drug Discovery & Dev, Shizuoka, Japan.
   [Matsumoto, Koji; Tanioka, Maki] Hyogo Canc Ctr, Div Med Oncol, Akashi, Hyogo, Japan.
   [Takeda, Koji; Tsuya, Asuka] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan.
   [Takiguchi, Yuichi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chiba, Japan.
   [Yamamoto, Nobuyuki] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan.
   [Matsubara, Nobuaki; Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Hematol & Oncol, Chiba, Japan.
   [Minami, Hironobu; Chayahara, Naoko] Kobe Univ, Grad Sch Med, Div Med Oncol Hematol, Kobe, Hyogo 657, Japan.
   [Yamanaka, Yasuhiro] Tochigi Canc Ctr, Dept Med Oncol, Utsunomiya, Tochigi, Japan.
   [Miwa, Keisuke] Saitama Med Univ, Dept Med Oncol, Ctr Comprehens Canc, Int Med Ctr, Saitama, Japan.
   [Takahashi, Shin] Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.
   [Takahashi, Shunji] Canc Inst Hosp, Div Med Oncol, Tokyo, Japan.
RP Nishio, K (reprint author), Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan.
EM knishio@med.kindai.ac.jp
OI Tanioka, Maki/0000-0002-6558-2246
FU Ministry of Health, Labour and Welfare
FX This work was supported by the grant-in-aid for Scientific Research from
   the Ministry of Health, Labour and Welfare. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ABBRUZZESE JL, 1995, J CLIN ONCOL, V13, P2094, DOI 10.1200/JCO.1995.13.8.2094
   ABBRUZZESE JL, 1994, J CLIN ONCOL, V12, P1272, DOI 10.1200/JCO.1994.12.6.1272
   Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100
   Anderberg MR, 1973, CLUSTER ANAL APPL
   Bandres E, 2004, ONCOL REP, V12, P287
   Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8
   Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895
   de Marval PM, 2011, CANCER PREV RES, V4, P851, DOI 10.1158/1940-6207.CAPR-10-0360
   Dennis JL, 2005, CLIN CANCER RES, V11, P3766, DOI 10.1158/1078-0432.CCR-04-2236
   Durbin B, 2003, BIOINFORMATICS, V19, P1360, DOI 10.1093/bioinformatics/btg178
   Fu ZY, 2011, BIOMED PHARMACOTHER, V65, P163, DOI 10.1016/j.biopha.2011.02.004
   Giordano TJ, 2001, AM J PATHOL, V159, P1231, DOI 10.1016/S0002-9440(10)62509-6
   Greco FA, 2002, J CLIN ONCOL, V20, P1651, DOI 10.1200/JCO.20.6.1651
   Hainsworth JD, 2007, J CLIN ONCOL, V25, P1747, DOI 10.1200/JCO.2006.09.3047
   Hastie T, 2009, ELEMENT STAT LEARNIN
   Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96
   Iurisci I, 2009, ANTICANCER RES, V29, P403
   Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040
   Jiffar T, 2011, ONCOGENE, V30, P3163, DOI 10.1038/onc.2011.39
   Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209
   Kurahashi I, 2007, J JAPAN STAT SOC, V36, P147
   Kwee TC, 2009, EUR RADIOL, V19, P731, DOI 10.1007/s00330-008-1194-4
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557
   Macha MA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-655
   Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9
   Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003
   Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027
   Mao P, 2011, J BIOL CHEM, V286, P19381, DOI 10.1074/jbc.M111.218040
   Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185
   Melle C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003767
   Park Jong Sun, 2011, BMC Res Notes, V4, P56, DOI 10.1186/1756-0500-4-56
   Pavlidis N, 2003, EUR J CANCER, V39, P1990, DOI 10.1016/S0959-8049(03)00547-1
   Pimiento JM, 2007, AM J SURG, V194, P7
   Pimiento JM, 2007, AM J SURG, V194, P833, DOI 10.1016/j.amjsurg.2007.08.039
   Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167
   Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398
   Rodnina MV, 2009, CURR OPIN CELL BIOL, V21, P435, DOI 10.1016/j.ceb.2009.01.023
   Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015
   Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7
   Schneider BJ, 2007, CANCER-AM CANCER SOC, V110, P770, DOI 10.1002/cncr.22857
   Shedden KA, 2003, AM J PATHOL, V163, P1985, DOI 10.1016/S0002-9440(10)63557-2
   Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022
   Sokol JP, 2005, BREAST CANCER RES, V7, pR844, DOI 10.1186/bcr1312
   Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898
   STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393
   Su AI, 2001, CANCER RES, V61, P7388
   Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442
   Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451
   Tothill RW, 2005, CANCER RES, V65, P4031, DOI 10.1158/0008-5472.CAN-04-3617
   Um JH, 2004, J PHARMACOL EXP THER, V311, P1062, DOI 10.1124/jpet.104.070938
   Varadhachary GR, 2008, LANCET ONCOL, V9, P596, DOI 10.1016/S1470-2045(08)70151-7
   Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275
   Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014
NR 56
TC 11
Z9 11
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 9
PY 2013
VL 8
IS 5
AR e63249
DI 10.1371/journal.pone.0063249
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 155HD
UT WOS:000319737700050
PM 23671674
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wiria, AE
   Hamid, F
   Wammes, LJ
   Kaisar, MMM
   May, L
   Prasetyani, MA
   Wahyuni, S
   Djuardi, Y
   Ariawan, I
   Wibowo, H
   Lell, B
   Sauerwein, R
   Brice, GT
   Sutanto, I
   van Lieshout, L
   de Craen, AJM
   van Ree, R
   Verweij, JJ
   Tsonaka, R
   Houwing-Duistermaat, JJ
   Luty, AJF
   Sartono, E
   Supali, T
   Yazdanbakhsh, M
AF Wiria, Aprilianto E.
   Hamid, Firdaus
   Wammes, Linda J.
   Kaisar, Maria M. M.
   May, Linda
   Prasetyani, Margaretta A.
   Wahyuni, Sitti
   Djuardi, Yenny
   Ariawan, Iwan
   Wibowo, Heri
   Lell, Bertrand
   Sauerwein, Robert
   Brice, Gary T.
   Sutanto, Inge
   van Lieshout, Lisette
   de Craen, Anton J. M.
   van Ree, Ronald
   Verweij, Jaco J.
   Tsonaka, Roula
   Houwing-Duistermaat, Jeanine J.
   Luty, Adrian J. F.
   Sartono, Erliyani
   Supali, Taniawati
   Yazdanbakhsh, Maria
TI The Effect of Three-Monthly Albendazole Treatment on Malarial
   Parasitemia and Allergy: A Household-Based Cluster-Randomized,
   Double-Blind, Placebo-Controlled Trial
SO PLOS ONE
LA English
DT Article
ID TRANSMITTED HELMINTH INFECTIONS; PLASMODIUM-FALCIPARUM INFECTION;
   ANTHELMINTIC TREATMENT; PRESCHOOL-CHILDREN; RESEARCH AGENDA; DISEASES;
   ATOPY; SUSCEPTIBILITY; ELIMINATION; PREVALENCE
AB Background: Helminth infections are proposed to have immunomodulatory activities affecting health outcomes either detrimentally or beneficially. We evaluated the effects of albendazole treatment, every three months for 21 months, on STH, malarial parasitemia and allergy.
   Methods and Findings: A household-based cluster-randomized, double-blind, placebo-controlled trial was conducted in an area in Indonesia endemic for STH. Using computer-aided block randomization, 481 households (2022 subjects) and 473 households (1982 subjects) were assigned to receive placebo and albendazole, respectively, every three months. The treatment code was concealed from trial investigators and participants. Malarial parasitemia and malaria-like symptoms were assessed in participants older than four years of age while skin prick test (SPT) to allergens as well as reported symptoms of allergy in children aged 5-15 years. The general impact of treatment on STH prevalence and body mass index (BMI) was evaluated. Primary outcomes were prevalence of malarial parasitemia and SPT to any allergen. Analysis was by intention to treat. At 9 and 21 months post-treatment 80.8% and 80.1% of the study subjects were retained, respectively. The intensive treatment regiment resulted in a reduction in the prevalence of STH by 48% in albendazole and 9% in placebo group. Albendazole treatment led to a transient increase in malarial parasitemia at 6 months post treatment (OR 4.16(1.35-12.80)) and no statistically significant increase in SPT reactivity (OR 1.18(0.74-1.86) at 9 months or 1.37 (0.93-2.01) 21 months). No effect of anthelminthic treatment was found on BMI, reported malaria-like-and allergy symptoms. No adverse effects were reported.
   Conclusions: The study indicates that intensive community treatment of 3 monthly albendazole administration for 21 months over two years leads to a reduction in STH. This degree of reduction appears safewithout any increased risk of malaria or allergies.
C1 [Wiria, Aprilianto E.; Kaisar, Maria M. M.; Prasetyani, Margaretta A.; Djuardi, Yenny; Wibowo, Heri; Sutanto, Inge; Supali, Taniawati] Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia.
   [Wiria, Aprilianto E.; Hamid, Firdaus; Wammes, Linda J.; Kaisar, Maria M. M.; May, Linda; Prasetyani, Margaretta A.; Djuardi, Yenny; van Lieshout, Lisette; Verweij, Jaco J.; Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands.
   [Hamid, Firdaus] Hasanuddin Univ, Fac Med, Dept Microbiol, Makassar, Indonesia.
   [Wahyuni, Sitti] Hasanuddin Univ, Fac Med, Dept Parasitol, Makassar, Indonesia.
   [Ariawan, Iwan] Univ Indonesia, Sch Publ Hlth, Dept Biostat, Jakarta, Indonesia.
   [Lell, Bertrand] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.
   [Lell, Bertrand] Univ Tubingen, Inst Trop Med, Dept Parasitol, Tubingen, Germany.
   [Sauerwein, Robert; Luty, Adrian J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.
   [Brice, Gary T.] Naval Med Res Unit 2, Jakarta, Indonesia.
   [de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.
   [van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands.
   [van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands.
   [Tsonaka, Roula; Houwing-Duistermaat, Jeanine J.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands.
RP Supali, T (reprint author), Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia.
EM taniawati@yahoo.com; M.Yazdanbakhsh@lumc.nl
RI Sauerwein, Robert/C-8519-2013; Hamid, Firdaus/M-6862-2017
OI Hamid, Firdaus/0000-0003-1788-0836; Luty, Adrian/0000-0001-8830-3425;
   Yazdanbakhsh, Maria/0000-0002-7666-1441
FU Royal Netherlands Academy of Arts and Science (KNAW) [KNAW-05-PP-35];
   European Commission [INCO-CT-2006-031714, INCO-CT-2006-032436, Glofal
   FP6-2003-FOOD-2-B]; Prof. Dr. P.C. Flu Foundation
FX This study was funded by The Royal Netherlands Academy of Arts and
   Science (KNAW), Ref.KNAW-05-PP-35, European Commission contracts
   INCO-CT-2006-031714 and INCO-CT-2006-032436, Glofal FP6-2003-FOOD-2-B,
   and the Prof. Dr. P.C. Flu Foundation. No funding bodies had any role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798
   Alderman H, 2006, BRIT MED J, V333, P122, DOI 10.1136/bmj.38877.393530.7C
   Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992
   Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100
   Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4
   Brutus L, 2007, AM J TROP MED HYG, V77, P1091, DOI 10.4269/ajtmh.2007.77.1091
   Cooper PJ, 2006, LANCET, V367, P1598, DOI 10.1016/S0140-6736(06)68697-2
   Dickson R, 2000, BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697
   Djuardi Y, 2011, PARASITOLOGY, V138, P1508, DOI 10.1017/S0031182011000588
   Elyazar IRF, 2011, ADV PARASIT, V74, P41, DOI 10.1016/B978-0-12-385897-9.00002-1
   Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x
   Feary J, 2011, ALLERGY, V66, P569, DOI 10.1111/j.1398-9995.2010.02512.x
   Flohr C, 2010, CLIN EXP ALLERGY, V40, P131, DOI 10.1111/j.1365-2222.2009.03346.x
   Flohr C, 2009, CLIN EXP ALLERGY, V39, P20, DOI 10.1111/j.1365-2222.2008.03134.x
   Hamid F, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-83
   Harijanto Paul N, 2010, Acta Med Indones, V42, P51
   Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937
   Kirwan P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-277
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lau S, 2006, LANCET, V367, P1556, DOI 10.1016/S0140-6736(06)68670-4
   Lustigman S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001582
   Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183
   Mpairwe H, 2011, PEDIAT ALLERG IMM-UK, V22, P305, DOI 10.1111/j.1399-3038.2010.01122.x
   Nacher M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-259
   Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549
   Specht S, 2007, LANCET, V369, P446, DOI 10.1016/S0140-6736(07)60210-4
   Szefler SJ, 2008, J ALLERGY CLIN IMMUN, V121, P614, DOI 10.1016/j.jaci.2007.11.033
   Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5
   Utzinger J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001646
   Webb EL, 2011, LANCET, V377, P52, DOI 10.1016/S0140-6736(10)61457-2
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA
   Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77
   World Health Organization, 2010, GUID TREATM MAL
NR 33
TC 35
Z9 35
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2013
VL 8
IS 3
AR e57899
DI 10.1371/journal.pone.0057899
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 125SR
UT WOS:000317562100017
PM 23526959
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yan, FR
   Huang, Y
   Liu, JL
   Lu, T
   Lin, JG
AF Yan, Fang-Rong
   Huang, Yuan
   Liu, Jun-Lin
   Lu, Tao
   Lin, Jin-Guan
TI Bayesian Inference for Generalized Linear Mixed Model Based on the
   Multivariate t Distribution in Population Pharmacokinetic Study
SO PLOS ONE
LA English
DT Article
ID LONGITUDINAL DATA; INDIVIDUALIZATION
AB This article provides a fully Bayesian approach for modeling of single-dose and complete pharmacokinetic data in a population pharmacokinetic (PK) model. To overcome the impact of outliers and the difficulty of computation, a generalized linear model is chosen with the hypothesis that the errors follow a multivariate Student t distribution which is a heavy-tailed distribution. The aim of this study is to investigate and implement the performance of the multivariate t distribution to analyze population pharmacokinetic data. Bayesian predictive inferences and the Metropolis-Hastings algorithm schemes are used to process the intractable posterior integration. The precision and accuracy of the proposed model are illustrated by the simulating data and a real example of theophylline data.
C1 [Yan, Fang-Rong; Lin, Jin-Guan] Southeast Univ, Dept Math, Nanjing, Jiangsu, Peoples R China.
   [Yan, Fang-Rong; Huang, Yuan; Liu, Jun-Lin; Lu, Tao] China Pharmaceut Univ, Dept Math, Nanjing, Jiangsu, Peoples R China.
   [Yan, Fang-Rong; Huang, Yuan; Liu, Jun-Lin; Lu, Tao] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.
   [Lu, Tao] China Pharmaceut Univ, Lab Mol Design & Drug Discovery, Nanjing, Jiangsu, Peoples R China.
RP Yan, FR (reprint author), Southeast Univ, Dept Math, Nanjing, Jiangsu, Peoples R China.
EM f.r.yan@163.com; lut163@163.com; jglin@seu.edu.cn
FU NSFC [81130068, 1117165]; NSFCJS [BK2011058]; Fundamental Research Funds
   for the Central Universities [JKQ2011032]
FX The work of Fang-Rong Yan, Yuan Huang, Jun-Lin Liu and Tao Lu was funded
   by NSFC (Program No.81130068) and the Fundamental Research Funds for the
   Central Universities (Program No.JKQ2011032). Jin-Guan Lin's work was
   supported by NSFC (Program No.1117165) and NSFCJS (Program
   No.BK2011058). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adeline S, 2006, STAT DATA ANAL, V51, P1562
   Chib S, 1999, STAT COMPUT, V9, P17, DOI 10.1023/A:1008853808677
   Davidian M, 1995, STAT MED, V15, P1462
   Debasis K, 1998, J STAT PLAN INFER, V70, P317
   Ette EI, 2004, ANN PHARMACOTHER, V38, P2136, DOI 10.1345/aph.1E260
   Ette EI, 2004, ANN PHARMACOTHER, V38, P1907, DOI 10.1345/aph.1E259
   Fong YY, 2010, BIOSTATISTICS, V11, P397, DOI 10.1093/biostatistics/kxp053
   Geweke J., 1993, J APPL ECONOMET, V8, P19
   Gimenez O, 2010, ECOLOGY, V91, P951, DOI 10.1890/09-1903.1
   Gomez E, 1998, COMMUN STAT-THEOR M, V27, P589, DOI 10.1080/03610929808832115
   James WT, 2009, COMPUT METH PROG BIO, V96, P49
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Liu I, 2007, STAT MED, V28, P412
   Natarajan R, 2000, J AM STAT ASSOC, V95, P227, DOI 10.2307/2669540
   Robert V., 1994, International Journal of Bio-Medical Computing, V36, P153, DOI 10.1016/0020-7101(94)90109-0
   Salway R, 2008, BIOMETRICS, V64, P620, DOI 10.1111/j.1541-0420.2007.00897.x
   SHEINER LB, 1982, J PHARM SCI, V71, P1344, DOI 10.1002/jps.2600711209
   UPTON RA, 1982, J PHARMACOKINET BIOP, V10, P123, DOI 10.1007/BF01062330
   VONESH EF, 1992, STAT MED, V11, P1929, DOI 10.1002/sim.4780111413
   WADE JR, 1993, J PHARMACOKINET BIOP, V21, P209, DOI 10.1007/BF01059771
   Wakefield J, 1996, J PHARMACOKINET BIOP, V24, P103, DOI 10.1007/BF02353512
   Wakefield J, 2004, NONLINEAR REGRESSION, P119
   Wakefield J, 1991, J R STAT SOC C, V43, P201
   Wang JX, 2005, PHARM STAT, V4, P59, DOI 10.1002/pst.154
   WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023
NR 25
TC 0
Z9 0
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 8
PY 2013
VL 8
IS 3
AR e58369
DI 10.1371/journal.pone.0058369
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 140TZ
UT WOS:000318679900063
PM 23520504
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Takata, Y
   Shu, XO
   Gao, YT
   Li, HL
   Zhang, XL
   Gao, J
   Cai, H
   Yang, G
   Xiang, YB
   Zheng, W
AF Takata, Yumie
   Shu, Xiao-Ou
   Gao, Yu-Tang
   Li, Honglan
   Zhang, Xianglan
   Gao, Jing
   Cai, Hui
   Yang, Gong
   Xiang, Yong-Bing
   Zheng, Wei
TI Red Meat and Poultry Intakes and Risk of Total and Cause-Specific
   Mortality: Results from Cohort Studies of Chinese Adults in Shanghai
SO PLOS ONE
LA English
DT Article
ID CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; LUNG-CANCER;
   CONSUMPTION; STROKE; MEN; REPRODUCIBILITY; TESTOSTERONE; ASSOCIATIONS;
   VALIDITY
AB Most previous studies of meat intake and total or cause-specific mortality were conducted in North America, whereas studies in other areas have been limited and reported inconsistent results. This study investigated the association of red meat or poultry intake with risk of total and cause-specific mortality, including cancer and cardiovascular disease (CVD), in two large population-based prospective cohort studies of 134,290 Chinese adult women and men in Shanghai. Meat intakes were assessed through validated food frequency questionnaires administered in person at baseline. Vital status and dates and causes of deaths were ascertained through annual linkage to the Shanghai Vital Statistics Registry and Shanghai Cancer Registry databases and home visits every 2-3 years. Cox regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of death associated with quintiles of meat intake. During 803,265 person-years of follow up for women and 334,281 person-years of follow up for men, a total of 4,210 deaths in women and 2,733 deaths in men accrued. The median intakes of red meat were 43 g/day among women and 54 g/day among men, and pork constituted at least 95% of total meat intake for both women and men. Red meat intake was associated with increased total mortality among men, but not among women; the HR (95% CI) comparing the highest with the lowest quintiles were 1.18 (1.02-1.35) and 0.92 (0.82-1.03), respectively. This sex difference was statistically significant (P = 0.01). Red meat intake was associated with increased risk of ischemic heart disease mortality (HR = 1.41, 95% CI = 1.05-1.89) and with decreased risk of hemorrhagic stroke mortality (HR = 0.62, 95% CI = 0.45-0.87). There were suggestive inverse associations of poultry intake with risk of total and all-CVD mortality among men, but not among women. Further investigations are needed to elucidate the sex-specific associations between red meat intake and mortality.
C1 [Takata, Yumie; Shu, Xiao-Ou; Zhang, Xianglan; Cai, Hui; Yang, Gong; Zheng, Wei] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA.
   [Gao, Yu-Tang; Li, Honglan; Gao, Jing; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China.
RP Shu, XO (reprint author), Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA.
EM xiao-ou.shu@vanderbilt.edu
FU National Cancer Institute [R37CA070867, R01 CA082729]; National Heart,
   Lung, and Blood Institute [R0 1HL095931]
FX This work was funded by National Cancer Institute grants (R37CA070867,
   PI: WZ; R01 CA082729, PI: XOS) and the National Heart, Lung, and Blood
   Institute (R0 1HL095931, PI: XZ). The funders had no role in study
   design, data
CR Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165
   Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9
   Choi JS, 2007, ATHEROSCLEROSIS, V192, P445, DOI 10.1016/j.atherosclerosis.2007.03.006
   Silva EOD, 2009, ARCH INTERN MED, V169, P1538, DOI 10.1001/archinternmed.2009.278
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Du SF, 2000, J NUTR, V130, P193
   Fang Jing, 2006, J Immigr Minor Health, V8, P387, DOI 10.1007/s10903-006-9009-7
   Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s
   He K, 2003, BRIT MED J, V327, P777, DOI 10.1136/bmj.327.7418.777
   Hyde Z, 2012, CANCER EPIDEM BIOMAR, V21, P1319, DOI 10.1158/1055-9965.EPI-12-0129
   *INT AG RES CANC, 2004, IARC MON EV CARC RIS, V83
   Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841
   Iso H, 2001, CIRCULATION, V103, P856, DOI 10.1161/01.CIR.103.6.856
   Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L
   Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977
   Mirvish SS, 2002, J NUTR, V132, p3526S, DOI 10.1093/jn/132.11.3526S
   Nagao M, 2012, EUR J CLIN NUTR, V66, P687, DOI 10.1038/ejcn.2012.6
   Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287
   REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542
   Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151
   Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738
   Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6
   Skog KI, 1998, FOOD CHEM TOXICOL, V36, P879, DOI 10.1016/S0278-6915(98)00061-1
   Sugimura T, 1990, Princess Takamatsu Symp, V21, P279
   Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190
   Villegas R, 2007, BRIT J NUTR, V97, P993, DOI 10.1017/S0007114507669189
   Warlow CP, 1998, LANCET S3, V352, P1
   World Health Organization, 1977, INT CLASS DIS 9 VERS
   Yang WS, 2012, ANN ONCOL, V23, P3163, DOI 10.1093/annonc/mds207
   Yang Y, 2002, CHINA FOOD COMPOSITI
   Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322
NR 35
TC 40
Z9 42
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2013
VL 8
IS 2
AR e56963
DI 10.1371/journal.pone.0056963
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 113IC
UT WOS:000316658800054
PM 23451121
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Warrington, NM
   Wu, YY
   Pennell, CE
   Marsh, JA
   Beilin, LJ
   Palmer, LJ
   Lye, SJ
   Briollais, L
AF Warrington, Nicole M.
   Wu, Yan Yan
   Pennell, Craig E.
   Marsh, Julie A.
   Beilin, Lawrence J.
   Palmer, Lyle J.
   Lye, Stephen J.
   Briollais, Laurent
TI Modelling BMI Trajectories in Children for Genetic Association Studies
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; QUALITY-OF-LIFE; OBESE
   CHILDREN; FTO GENE; WAIST CIRCUMFERENCE; COMMON VARIANTS; ADULT OBESITY;
   CHILDHOOD; LOCI
AB Background: The timing of associations between common genetic variants and changes in growth patterns over childhood provide insight into the development of obesity in later life. To address this question, it is important to define appropriate statistical models to allow for the detection of genetic effects influencing longitudinal childhood growth.
   Methods and Results: Children from The Western Australian Pregnancy Cohort (Raine; n = 1,506) Study were genotyped at 17 genetic loci shown to be associated with childhood obesity (FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, ETV5, SEC16B, LYPLAL1, TFAP2B, MTCH2, BCDIN3D, NRXN3, SH2B1, MRSA) and an obesity-risk-allele-score was calculated as the total number of 'risk alleles' possessed by each individual. To determine the statistical method that fits these data and has the ability to detect genetic differences in BMI growth profile, four methods were investigated: linear mixed effects model, linear mixed effects model with skew-t random errors, semi-parametric linear mixed models and a non-linear mixed effects model. Of the four methods, the semi-parametric linear mixed model method was the most efficient for modelling childhood growth to detect modest genetic effects in this cohort. Using this method, three of the 17 loci were significantly associated with BMI intercept or trajectory in females and four in males. Additionally, the obesity-risk-allele score was associated with increased average BMI (female: beta = 0.0049, P = 0.0181; male: beta = 0.0071, P = 0.0001) and rate of growth (female: beta = 0.0012, P = 0.0006; male: beta = 0.0008, P = 0.0068) throughout childhood.
   Conclusions: Using statistical models appropriate to detect genetic variants, variations in adult obesity genes were associated with childhood growth. There were also differences between males and females. This study provides evidence of genetic effects that may identify individuals early in life that are more likely to rapidly increase their BMI through childhood, which provides some insight into the biology of childhood growth.
C1 [Warrington, Nicole M.; Pennell, Craig E.; Marsh, Julie A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia.
   [Warrington, Nicole M.; Wu, Yan Yan; Palmer, Lyle J.; Lye, Stephen J.; Briollais, Laurent] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.
   [Beilin, Lawrence J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia.
   [Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada.
RP Briollais, L (reprint author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.
EM laurent@lunenfeld.ca
RI Palmer, Lyle John/K-3196-2014; Lye, Stephen J/E-7269-2013; Briollais,
   Laurent/A-2941-2013; Wu, Yanyan/H-1356-2017; Palmer, Lyle
   John/N-1948-2019; Study, Raine/G-9547-2015; Warrington,
   Nicole/P-4868-2014; Pennell, Craig/C-5190-2011
OI Palmer, Lyle John/0000-0002-1628-3055; Lye, Stephen
   J/0000-0002-3305-4406; Wu, Yanyan/0000-0003-1553-1392; Palmer, Lyle
   John/0000-0002-1628-3055; Warrington, Nicole/0000-0003-4195-775X;
   Pennell, Craig/0000-0002-0937-6165; Marsh, Julie/0000-0001-8984-6907
FU University of Western Australia (UWA); Raine Medical Research
   Foundation; UWA Faculty of Medicine; Dentistry and Health Sciences;
   Telethon Institute for Child Health Research, Curtin University; Women
   and Infants Research Foundation; National Health and Medical Research
   Council of Australia [403981, 003209]; Canadian Institutes of Health
   Research [MOP-82893]; Australian Postgraduate Award from Australian
   Government of Innovation, Industry, Science and Research; Raine Study
   PhD Top-Up Scholarship
FX The following institutions provide funding for Core Management of the
   Raine Study: The University of Western Australia (UWA), Raine Medical
   Research Foundation, UWA Faculty of Medicine, Dentistry and Health
   Sciences, The Telethon Institute for Child Health Research, Curtin
   University and Women and Infants Research Foundation. This study was
   supported by project grants from the National Health and Medical
   Research Council of Australia (Grant ID 403981 and ID 003209;
   http://www.nhmrc.gov.au/) and the Canadian Institutes of Health Research
   (Grant ID MOP-82893; http://www.cihr-irsc.gc.ca/e/193.html). Ms.
   Warrington is funded by an Australian Postgraduate Award from the
   Australian Government of Innovation, Industry, Science and Research and
   a Raine Study PhD Top-Up Scholarship. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Azzalini A, 1999, J ROY STAT SOC B, V61, P579, DOI 10.1111/1467-9868.00194
   Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227
   Bradford NF, 2009, PRIMARY CARE, V36, P319, DOI 10.1016/j.pop.2009.01.002
   Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156
   Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775
   Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115
   Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292
   den Hoed M, 2010, DIABETES, V59, P2980, DOI 10.2337/db10-0370
   DIETZ WH, 1994, AM J CLIN NUTR, V59, P955
   Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048
   DONNELLY CA, 1995, J AM STAT ASSOC, V90, P984, DOI 10.2307/2291334
   Efron B, 1994, INTRO BOOTSTRAP
   Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284
   Evans S, 1996, EARLY HUM DEV, V45, P203, DOI 10.1016/0378-3782(96)01728-8
   Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18
   Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634
   GASSER T, 1984, ANN HUM BIOL, V11, P397, DOI 10.1080/03014468400007311
   GOLDSTEIN H, 1986, ANN HUM BIOL, V13, P129, DOI 10.1080/03014468600008271
   Griffiths LJ, 2010, INT J PEDIATR OBES, V5, P282, DOI 10.3109/17477160903473697
   Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504
   Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434
   Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539
   Hinney A, 2009, OBESITY FACTS, V2, P3, DOI 10.1159/000200020
   Huang RC, 2006, INT J OBES RES
   Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.1080/10618600.1996.10474713
   Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0
   Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4
   Jiao H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-51
   Kindblom JM, 2009, DIABETES, V58, P867, DOI 10.2337/db08-0606
   Lachos VH, 2010, STAT SINICA, V20, P303
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lawlor DA, 2005, ARCH DIS CHILD, V90, P692, DOI 10.1136/adc.2004.062919
   Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508
   Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179
   Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140
   Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927
   Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301
   Milani S, 1989, Acta Paediatr Scand Suppl, V350, P95
   NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H
   Parsons TJ, 1999, INT J OBESITY, V23, pS1
   Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303
   PREECE MA, 1978, ANN HUM BIOL, V5, P1, DOI 10.1080/03014467800002601
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   RICE JA, 1991, J ROY STAT SOC B MET, V53, P233
   Sawyer MG, 2006, AMBUL PEDIATR, V6, P306, DOI 10.1016/j.ambp.2006.08.005
   Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115
   SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014
   Song PXK, 2007, STAT SINICA, V17, P929
   Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686
   Srinivasan SR, 2006, HYPERTENSION, V48, P33, DOI 10.1161/01.HYP.0000226410.11198.f4
   Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238
   Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274
   Tsiros MD, 2009, INT J OBESITY, V33, P387, DOI 10.1038/ijo.2009.42
   Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939
   Wardle J, 2008, AM J CLIN NUTR, V87, P398
   Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287
   Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864
   Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159
NR 58
TC 20
Z9 20
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 17
PY 2013
VL 8
IS 1
AR e53897
DI 10.1371/journal.pone.0053897
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 073JI
UT WOS:000313738900025
PM 23349760
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Amieva, H
   Meillon, C
   Helmer, C
   Barberger-Gateau, P
   Dartigues, JF
AF Amieva, Helene
   Meillon, Celine
   Helmer, Catherine
   Barberger-Gateau, Pascale
   Dartigues, Jean Francois
TI Ginkgo Biloba Extract and Long-Term Cognitive Decline: A 20-Year
   Follow-Up Population-Based Study
SO PLOS ONE
LA English
DT Article
ID PRECLINICAL ALZHEIMERS-DISEASE; PLACEBO-CONTROLLED TRIAL; EGB 761(R);
   BENZODIAZEPINE USE; RANDOMIZED-TRIAL; VITAMIN-E; DEMENTIA; PREVENTION;
   SUPPLEMENTATION; IMPAIRMENT
AB Background: Numerous studies have looked at the potential benefits of various nootropic drugs such as Ginkgo biloba extract (EGb761 (R); Tanakan (R)) and piracetam (Nootropyl (R)) on age-related cognitive decline often leading to inconclusive results due to small sample sizes or insufficient follow-up duration. The present study assesses the association between intake of EGb761 (R) and cognitive function of elderly adults over a 20-year period.
   Methods and Findings: The data were gathered from the prospective community-based cohort study 'Paquid'. Within the study sample of 3612 non-demented participants aged 65 and over at baseline, three groups were compared: 589 subjects reporting use of EGb761 (R) at at least one of the ten assessment visits, 149 subjects reporting use of piracetam at one of the assessment visits and 2874 subjects not reporting use of either EGb761 (R) or piracetam. Decline on MMSE, verbal fluency and visual memory over the 20-year follow-up was analysed with a multivariate mixed linear effects model. A significant difference in MMSE decline over the 20-year follow-up was observed in the EGb761 (R) and piracetam treatment groups compared to the 'neither treatment' group. These effects were in opposite directions: the EGb761 (R) group declined less rapidly than the 'neither treatment' group, whereas the piracetam group declined more rapidly (beta = -0.6). Regarding verbal fluency and visual memory, no difference was observed between the EGb761 (R) group and the 'neither treatment' group (respectively, beta = 0.21 and beta = -0.03), whereas the piracetam group declined more rapidly (respectively, beta = -1.40 and beta = -0.44). When comparing the EGb761 (R) and piracetam groups directly, a different decline was observed for the three tests (respectively beta = -1.07, beta = -1.61 and beta = -0.41).
   Conclusion: Cognitive decline in a non-demented elderly population was lower in subjects who reported using EGb761 (R) than in those who did not. This effect may be a specific medication effect of EGb761 (R), since it was not observed for another nootropic medication, piracetam.
C1 [Amieva, Helene; Meillon, Celine; Helmer, Catherine; Barberger-Gateau, Pascale; Dartigues, Jean Francois] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.
   [Amieva, Helene] Univ Bordeaux, Dept Psychol, Bordeaux, France.
RP Amieva, H (reprint author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.
EM helene.amieva@isped.u-bordeaux2.fr
RI Amieva, Helene/E-4850-2014; HELMER, Catherine/I-6581-2015
OI HELMER, Catherine/0000-0002-5169-7421
FU ARMA (Bordeaux); Caisse Nationale d'Assurance Maladie des Travailleurs
   Salaries (CNAMTS); Conseil General de la Dordogne; Conseil General de la
   Gironde; Conseil Regional d'Aquitaine; Fondation de France; France
   Alzheimer (Paris); GIS Longevite; Institut National de la Sante et de la
   Recherche Medicale (INSERM); Mutuelle Generale de l'Education Nationale
   (MGEN); Mutualite Sociale Agricole (MSA); NOVARTIS Pharma (France); SCOR
   Insurance (France)
FX Funding: The PAQUID study was supported by ARMA (Bordeaux); Caisse
   Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS);
   Conseil General de la Dordogne; Conseil General de la Gironde; Conseil
   Regional d'Aquitaine; Fondation de France; France Alzheimer (Paris); GIS
   Longevite; Institut National de la Sante et de la Recherche Medicale
   (INSERM); Mutuelle Generale de l'Education Nationale (MGEN); Mutualite
   Sociale Agricole (MSA); NOVARTIS Pharma (France); SCOR Insurance
   (France). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abdel-Kader R, 2007, PHARMACOL RES, V56, P493, DOI 10.1016/j.phrs.2007.09.011
   American Psychiatric Association, 1987, DIAGN STAT MAN MENT
   Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509
   Andrieu S, 2003, J GERONTOL A-BIOL, V58, P372
   Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520
   BENTON A, 1965, MANUEL APPL TEST RET
   Bierman EJM, 2007, INT J GERIATR PSYCH, V22, P1194, DOI 10.1002/gps.1811
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853
   Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b
   Dartigues JF, 2007, J AM GERIATR SOC, V55, P395, DOI 10.1111/j.1532-5415.2007.01084.x
   Dartigues JF, 1997, THERAPIE, V52, P503
   DARTIGUES JF, 1992, NEUROEPIDEMIOLOGY, V11, P14, DOI 10.1159/000110955
   DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683
   Dodge HH, 2008, NEUROLOGY, V70, P1809, DOI 10.1212/01.wnl.0000303814.13509.db
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Galasko DR, 2012, ARCH NEUROL
   Grodstein F, 2007, ARCH INTERN MED, V167, P2184, DOI 10.1001/archinte.167.20.2184
   HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009
   Herrschaft H, 2012, J PSYCHIATR RES, V46, P716, DOI 10.1016/j.jpsychires.2012.03.003
   Howieson DB, 2008, J INT NEUROPSYCH SOC, V14, P192, DOI 10.1017/S1355617708080375
   Ihl R, 2010, J NEUROL SCI, V299, P184, DOI 10.1016/j.jns.2010.08.033
   ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467
   Janssen IM, 2010, WIEN MED WOCHENSCHR, V160, P539, DOI 10.1007/s10354-010-0844-8
   Jia X, 2008, J HUM NUTR DIET, V21, P317, DOI 10.1111/j.1365-277X.2008.00887.x
   Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462
   Kehr J, 2012, INT PSYCHOGERIATR, V24, pS25, DOI 10.1017/S1041610212000567
   Kesse-Guyot E, 2011, AM J CLIN NUTR, V94, P892, DOI 10.3945/ajcn.110.007815
   KOLTRINGER P, 1995, CLIN HEMORHEOL, V15, P649
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Leoutsakos JMS, 2012, INT J GERIATR PSYCH, V27, P364, DOI 10.1002/gps.2723
   Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Meinert CL, 2008, ALZHEIMERS DEMENT, V4, pS7, DOI 10.1016/j.jalz.2007.10.007
   Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009
   Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223
   Rosler M, 1998, J NEURAL TRANSM-SUPP, P211
   Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704
   Schneider Lon S., 2005, Current Alzheimer Research, V2, P541, DOI 10.2174/156720505774932287
   Schneider LS, 2012, LANCET NEUROL, V11, P836, DOI 10.1016/S1474-4422(12)70212-0
   Small BJ, 2007, CORTEX, V43, P826, DOI 10.1016/S0010-9452(08)70682-8
   Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com
   Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7
   van Vliet P, 2009, EXP GERONTOL, V44, P112, DOI 10.1016/j.exger.2008.05.004
   Vellas B, 2012, LANCET NEUROL, V11, P851, DOI 10.1016/S1474-4422(12)70206-5
   Weinmann S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-14
   Williams B, 2004, NEUROBIOL AGING, V25, P955, DOI 10.1016/j.neurobiolaging.2003.10.008
   Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20
   Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006
   Yaffe K, 2004, NEUROLOGY, V63, P1705
   Yoshitake T, 2010, BRIT J PHARMACOL, V159, P659, DOI 10.1111/j.1476-5381.2009.00580.x
   Zandi PP, 2005, ARCH GEN PSYCHIAT, V62, P217, DOI 10.1001/archpsyc.62.2.217
NR 55
TC 38
Z9 45
U1 0
U2 34
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 11
PY 2013
VL 8
IS 1
AR e52755
DI 10.1371/journal.pone.0052755
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 086RY
UT WOS:000314705800024
PM 23326356
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Powell, DJ
   Schlotz, W
AF Powell, Daniel J.
   Schlotz, Wolff
TI Daily Life Stress and the Cortisol Awakening Response: Testing the
   Anticipation Hypothesis
SO PLOS ONE
LA English
DT Article
ID CHRONIC-FATIGUE-SYNDROME; INFLAMMATORY MARKERS; PSYCHOSOCIAL STRESS;
   WORK OVERLOAD; ASSOCIATIONS; WOMEN; GLUCOCORTICOIDS; COVARIANCE;
   SECRETION; SYMPTOMS
AB The cortisol awakening response (CAR) is a distinct facet of the circadian cortisol rhythm associated with various health conditions and risk factors. It has repeatedly been suggested that the CAR could be a result of the anticipated demands of the upcoming day (stress anticipation) and could support coping with daily life stress. In a sample of 23 healthy participants CARs were assessed on two consecutive days by measures of salivary cortisol upon awakening (S1) and 30 and 45 minutes later, which were aggregated to the area under the curve increase (AUCI). Stress anticipation was assessed immediately after awakening. On the same days, daily life stress and distress were assessed six times per day based on a quasi-randomized design using handheld computers. Associations were tested by day using regression analysis and standard multilevel/mixed effects models for longitudinal data. The CAR AUCI moderated the effect of daily life stress on distress; higher CAR increases were associated with attenuated distress responses to daily life stress on both days (day 1: p = .039; day 2: p = .004) adjusted for age, gender, sleep quality, time of awakening and oral contraceptive use. Lagged-effects and redundancy models showed that this effect was not due to prior-day CAR increases but specific for same day CARs. On day 2, associations between daily life stress and distress were stronger when individuals showed a higher S1 cortisol level, but this effect was similar for S1 on day 1, and the day 2 effect of S1 became non-significant when S1 on day 1 was controlled. No associations were found between stress anticipation and CARs. Findings indicate that the CAR increase is associated with successful coping with same-day daily life stress.
C1 [Powell, Daniel J.; Schlotz, Wolff] Univ Southampton, Fac Social & Human Sci, Southampton, Hants, England.
   [Schlotz, Wolff] Univ Regensburg, Inst Psychol, D-8400 Regensburg, Germany.
RP Schlotz, W (reprint author), Univ Southampton, Fac Social & Human Sci, Southampton, Hants, England.
EM wolff.schlotz@ur.de
OI Powell, Daniel/0000-0003-4995-6057; Schlotz, Wolff/0000-0003-2356-7766
FU School of Psychology, University of Southampton; German Research
   Foundation (DFG)
FX This study was financially supported by the School of Psychology,
   University of Southampton. Publication of this work was supported by the
   German Research Foundation (DFG) within the funding programme Open
   Access Publishing. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adam EK, 2006, P NATL ACAD SCI USA, V103, P17058, DOI 10.1073/pnas.060503103
   Adam EK, 2010, PSYCHONEUROENDOCRINO, V35, P921, DOI 10.1016/j.psyneuen.2009.12.007
   Asparouhov T, 2009, STRUCT EQU MODELING, V16, P297
   Bengtsson I, 2010, METABOLISM, V59, P1012, DOI 10.1016/j.metabol.2009.10.024
   Bohmelt AH, 2005, PSYCHOSOM MED, V67, P288, DOI 10.1097/01.psy.0000157064.72831.ba
   Bruehl H, 2009, PSYCHONEUROENDOCRINO, V34, P815, DOI 10.1016/j.psyneuen.2008.12.010
   Bryk A. S., 1992, HIERARCHICAL LINEAR
   Buchanan TW, 2004, BIOL PSYCHIAT, V56, P651, DOI 10.1016/j.biopsych.2004.08.014
   Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004
   Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011
   CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98
   Costanzo ES, 2012, HEALTH PSYCHOL, V31, P360, DOI 10.1037/a0027018
   CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297
   DeSantis AS, 2012, PSYCHONEUROENDOCRINO, V37, P1009, DOI 10.1016/j.psyneuen.2011.11.009
   DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S
   Edwards S, 2003, PSYCHOSOM MED, V65, P320, DOI 10.1097/01.PSY.0000033123.70631.8E
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014
   Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536
   Hedeker D., 2006, LONGITUDINAL DATA AN
   Hellhammer J, 2007, PSYCHONEUROENDOCRINO, V32, P80, DOI 10.1016/j.psyneuen.2006.10.005
   Henckens MJAG, 2010, J NEUROSCI, V30, P12725, DOI 10.1523/JNEUROSCI.3112-10.2010
   Het S, 2007, BEHAV NEUROSCI, V121, P11, DOI 10.1037/0735-7044.121.1.11
   Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Inslicht SS, 2011, BIOL PSYCHIAT, V70, P1055, DOI 10.1016/j.biopsych.2011.06.030
   Kern S, 2011, PSYCHONEUROENDOCRINO, V36, P1505, DOI 10.1016/j.psyneuen.2011.04.004
   Kunz-Ebrecht SR, 2004, PSYCHONEUROENDOCRINO, V29, P516, DOI 10.1016/S0306-4530(03)00072-6
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Long J. Scott., 1997, REGRESSION MODELS CA
   Mikolajczak M, 2010, PSYCHONEUROENDOCRINO, V35, P752, DOI 10.1016/j.psyneuen.2009.11.003
   MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25
   Nater UM, 2008, J CLIN ENDOCR METAB, V93, P703, DOI 10.1210/jc.2007-1747
   Powell D, 2009, THESIS U SOUTHAMPTON
   Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7
   Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4
   Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI
   Roberts ADL, 2004, BRIT J PSYCHIAT, V184, P136, DOI 10.1192/bjp.184.2.136
   Rohleder N, 2007, PERS SOC PSYCHOL B, V33, P69, DOI 10.1177/0146167206293986
   Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55
   Schlotz W, 2004, PSYCHOSOM MED, V66, P207, DOI 10.1097/01.psy.0000116715.78238.56
   Schlotz W., 2011, HDB RES METHODS STUD, P193
   Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658
   Schulz P, 1998, STRESS MEDICINE, V14, P91, DOI 10.1002/(SICI)1099-1700(199804)14:2<91::AID-SMI765>3.0.CO;2-S
   Sheng YY, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00034
   Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415
   Singer JD, 2003, APPL LONGITUDINAL DA
   Stalder T, 2010, PSYCHONEUROENDOCRINO, V35, P209, DOI 10.1016/j.psyneuen.2009.06.006
   Steptoe A, 2004, INT J OBESITY, V28, P1168, DOI 10.1038/sj.ijo.0802715
   Stetler C, 2004, PSYCHONEUROENDOCRINO, V29, P1250, DOI 10.1016/j.psyneuen.2004.03.003
   Thorn L, 2006, PSYCHONEUROENDOCRINO, V31, P1009, DOI 10.1016/j.psyneuen.2006.05.012
   Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008
   Wirtz PH, 2007, PSYCHONEUROENDOCRINO, V32, P430, DOI 10.1016/j.psyneuen.2007.02.006
   Wolf OT, 2005, PSYCHONEUROENDOCRINO, V30, P101, DOI 10.1016/j.psyneuen.2004.05.001
   Zoccola PM, 2011, PSYCHONEUROENDOCRINO, V36, P592, DOI 10.1016/j.psyneuen.2010.10.004
NR 55
TC 31
Z9 31
U1 1
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2012
VL 7
IS 12
AR e52067
DI 10.1371/journal.pone.0052067
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 060RA
UT WOS:000312794500082
PM 23284871
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Jaud, T
   Dragon, AC
   Garcia, JV
   Guinet, C
AF Jaud, Thomas
   Dragon, Anne-Cecile
   Garcia, Jade Vacquie
   Guinet, Christophe
TI Relationship between Chlorophyll a Concentration, Light Attenuation and
   Diving Depth of the Southern Elephant Seal Mirounga leonina
SO PLOS ONE
LA English
DT Article
ID OCEANOGRAPHIC CONDITIONS; FORAGING STRATEGIES; KERGUELEN ISLANDS; CASE-1
   WATERS; OCEAN; BEHAVIOR; TEMPERATURE; MOVEMENTS; PREDATOR; MODELS
AB Recently, a number of Antarctic marine environmental studies have used oceanographic parameters collected from instrumented top predators for ecological and physical information. Phytoplankton concentration is generally quantified through active measurement of chlorophyll fluorescence. In this study, light absorption coefficient (K-0.75) was used as an indicator of phytoplankton concentration. This measurement, easy to obtain and requiring low electric power, allows for assessing of the fine scale horizontal structuring of phytoplankton. As part of this study, Southern elephant seals (SES) were simultaneously equipped with a fluorometer and a light logger. Along the SES tracks, variations in K-0.75 were strongly correlated with chlorophyll, a concentration measured by the fluorometer within the euphotic layer. With regards to SES foraging behaviour, bottom depth of the seal's dive was highly dependent on light intensity at 150 m, indicating that the vertical distribution of SES's prey such as myctophids is tightly related to light level. Therefore, change in phytoplankton concentration may not only have a direct effect on SES's prey abundance but may also determine their vertical accessibility with likely consequences on SES foraging efficiency.
C1 [Jaud, Thomas; Dragon, Anne-Cecile; Garcia, Jade Vacquie; Guinet, Christophe] Ctr Biol Chize, Marine Predator Dept, Villiers En Bois, France.
RP Jaud, T (reprint author), Ctr Biol Chize, Marine Predator Dept, Villiers En Bois, France.
EM jaud.thomas@gmail.com
FU Centre National d'Etudes Spatiale; Total Foundation; Agence Nationale de
   la Recherche though the Program ANR-VMC- IPSOS SEAL
FX Funding came from the Centre National d'Etudes Spatiale, the Total
   Foundation and the Agence Nationale de la Recherche though the Program
   ANR-VMC- IPSOS SEAL. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alvain S, 2005, DEEP-SEA RES PT I, V52, P1989, DOI 10.1016/j.dsr.2005.06.015
   Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109
   Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005
   Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560
   BATTY RS, 1990, MAR BIOL, V107, P383, DOI 10.1007/BF01313419
   Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104
   Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4
   Boehlert GW, 2001, J ATMOS OCEAN TECH, V18, P1882, DOI 10.1175/1520-0426(2001)018<1882:APESUI>2.0.CO;2
   Boehme L, 2009, OCEAN SCI
   BOYD IL, 1991, POLAR BIOL, V11, P259, DOI 10.1007/BF00238460
   Bradshaw CJA, 2004, ICES J MAR SCI, V61, P1014, DOI 10.1016/j.icesjms.2004.07.012
   Bricaud A, 1998, J GEOPHYS RES-OCEANS, V103, P31033, DOI 10.1029/98JC02712
   Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015
   Catul V, 2011, REV FISH BIOL FISHER, V21, P339, DOI 10.1007/s11160-010-9176-4
   Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105
   Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673
   Croxall J, 1985, J ANIM ECOL, P1
   Dragon AC, 2012, HORIZONTAL AREA REST
   Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498
   Dragon AC, 2010, PROG OCEANOGR, V87, P61, DOI 10.1016/j.pocean.2010.09.025
   Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437
   Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529
   GORDON HR, 1989, LIMNOL OCEANOGR, V34, P1389, DOI 10.4319/lo.1989.34.8.1389
   Gould J, 2006, WEATHER, V61, P17, DOI [10.1256/wea.56.05, DOI 10.1256/WEA.56.05]
   Hense I, 2000, J MARINE SYST, V27, P235, DOI 10.1016/S0924-7963(00)00070-1
   Hooker SK, 2003, DEEP-SEA RES PT I, V50, P927, DOI 10.1016/S0967-0637(03)00055-4
   Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753
   Hulley PA, 1981, RESULTS RES CRUISES
   ICHIYE T, 1967, PURE APPL GEOPHYS, V67, P143, DOI 10.1007/BF00880572
   Kahru M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030430
   Kirk J. T., 1994, LIGHT PHOTOSYNTHESIS
   Klatt O, 2007, J ATMOS OCEAN TECH, V24, P1301, DOI 10.1175/JTECH2026.1
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Levy M, 2008, LECT NOTES PHYS, V744, P219, DOI 10.1007/978-3-540-75215-8_9
   Lewis R, 2006, P R SOC B, V273, P2901, DOI 10.1098/rspb.2006.3642
   Liu SH, 2003, J PLANKTON RES, V25, P1069, DOI 10.1093/plankt/25.9.1069
   Loots C, 2007, POLAR BIOL, V30, P951, DOI 10.1007/s00300-007-0253-7
   Lydersen C, 2004, J MARINE SYST, V46, P99, DOI 10.1016/j.jmarsys.2003.11.019
   MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580
   McConnell BJ, 1996, CAN J ZOOL, V74, P1485, DOI 10.1139/z96-163
   NELSON DM, 1991, LIMNOL OCEANOGR, V36, P1650, DOI 10.4319/lo.1991.36.8.1650
   Rasmus KE, 2004, DEEP-SEA RES PT II, V51, P2583, DOI 10.1016/j.dsr2.2001.01.004
   Roquet F, 2011, J ATMOSPHERIC OCEANI
   Roquet F, 2009, J MARINE SYST, V78, P377, DOI 10.1016/j.jmarsys.2008.11.017
   Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187
   [Team RDC Computing RFfS], 2009, COMP RFFS
   Teo SLH, 2009, AQUAT BIOL, V5, P195, DOI 10.3354/ab00152
   Weimerskirch H, 1999, BIOL CONSERV, V87, P273, DOI 10.1016/S0006-3207(98)00039-1
   Xing X, 2011, LIMNOLOGY OCEA UNPUB
NR 49
TC 22
Z9 23
U1 0
U2 45
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 17
PY 2012
VL 7
IS 10
AR e47444
DI 10.1371/journal.pone.0047444
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 038AF
UT WOS:000311146900062
PM 23082166
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Otte, WM
   Dijkhuizen, RM
   van Meer, MPA
   van der Hel, WS
   Verlinde, SAMW
   van Nieuwenhuizen, O
   Viergever, MA
   Stam, CJ
   Braun, KPJ
AF Otte, Willem M.
   Dijkhuizen, Rick M.
   van Meer, Maurits P. A.
   van der Hel, Wilhelmina S.
   Verlinde, Suzanne A. M. W.
   van Nieuwenhuizen, Onno
   Viergever, Max A.
   Stam, Cornelis J.
   Braun, Kees P. J.
TI Characterization of Functional and Structural Integrity in Experimental
   Focal Epilepsy: Reduced Network Efficiency Coincides with White Matter
   Changes
SO PLOS ONE
LA English
DT Article
ID TEMPORAL-LOBE EPILEPSY; GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD
   NETWORKS; SUBJECT DIFFUSION DATA; TETANUS TOXIN; SPATIAL STATISTICS;
   STATUS EPILEPTICUS; VOXELWISE ANALYSIS; RAT MODEL; MRI DATA
AB Background: Although focal epilepsies are increasingly recognized to affect multiple and remote neural systems, the underlying spatiotemporal pattern and the relationships between recurrent spontaneous seizures, global functional connectivity, and structural integrity remain largely unknown.
   Methodology/Principal Findings: Here we utilized serial resting-state functional MRI, graph-theoretical analysis of complex brain networks and diffusion tensor imaging to characterize the evolution of global network topology, functional connectivity and structural changes in the interictal brain in relation to focal epilepsy in a rat model. Epileptic networks exhibited a more regular functional topology than controls, indicated by a significant increase in shortest path length and clustering coefficient. Interhemispheric functional connectivity in epileptic brains decreased, while intrahemispheric functional connectivity increased. Widespread reductions of fractional anisotropy were found in white matter regions not restricted to the vicinity of the epileptic focus, including the corpus callosum.
   Conclusions/Significance: Our longitudinal study on the pathogenesis of network dynamics in epileptic brains reveals that, despite the locality of the epileptogenic area, epileptic brains differ in their global network topology, connectivity and structural integrity from healthy brains.
C1 [Otte, Willem M.; van Meer, Maurits P. A.; van der Hel, Wilhelmina S.; Verlinde, Suzanne A. M. W.; van Nieuwenhuizen, Onno; Braun, Kees P. J.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.
   [Otte, Willem M.; Dijkhuizen, Rick M.; van Meer, Maurits P. A.; Viergever, Max A.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.
   [Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands.
RP Otte, WM (reprint author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.
EM wim@invivonmr.uu.nl
RI Otte, Willem M./J-6140-2019; Viergever, Max A/J-1215-2014; Otte,
   Willem/I-1228-2013
OI Otte, Willem M./0000-0003-1511-6834; Otte, Willem/0000-0003-1511-6834;
   Dijkhuizen, Rick/0000-0002-4623-4078
FU Dutch National Epilepsy Fund (NEF) [08-10]; Utrecht University's High
   Potential program
FX This research was supported by the Dutch National Epilepsy Fund (NEF nr.
   08-10) and Utrecht University's High Potential program. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582
   Barkmeier DT, 2009, CLIN EEG NEUROSCI, V40, P234, DOI 10.1177/155005940904000405
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432
   Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa
   Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5
   Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291
   BRENER K, 1991, EUR J NEUROSCI, V3, P47, DOI 10.1111/j.1460-9568.1991.tb00810.x
   Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575
   CENDES F, 1995, NEUROLOGY, V45, P2058, DOI 10.1212/WNL.45.11.2058
   Chavez M, 2006, CHAOS, V16, DOI 10.1063/1.2180467
   Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701
   Coan AC, 2009, NEUROLOGY, V73, P834, DOI 10.1212/WNL.0b013e3181b783dd
   Duncan J, 2009, CURR OPIN NEUROL, V22, P179, DOI 10.1097/WCO.0b013e328328f260
   Dupont S, 2000, BRAIN, V123, P1722, DOI 10.1093/brain/123.8.1722
   Fabene PF, 2003, NEUROIMAGE, V18, P375, DOI 10.1016/S1053-8119(02)00025-3
   Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x
   Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5
   Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106
   Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104
   Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013
   Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.1080/10618600.1996.10474713
   ITO BM, 1988, NEUROLOGY, V38, P924, DOI 10.1212/WNL.38.6.924
   Jansons KM, 2003, LECT NOTES COMPUT SC, V2732, P672
   Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008
   Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543
   Jones R. H., 1993, LONGITUDINAL DATA SE
   Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125
   Klein S, 2009, IEEE T MED IMAGING
   Koepp MJ, 2005, LANCET NEUROL, V4, P42, DOI 10.1016/S1474-4422(04)00965-2
   Kotloski R, 2002, PROG BRAIN RES, V135, P95
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701
   Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525
   LOUIS ED, 1990, ELECTROEN CLIN NEURO, V75, P548, DOI 10.1016/0013-4694(90)90141-6
   Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315
   Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54
   Marsh ED, 2006, EPILEPSIA, V47, P1999, DOI 10.1111/j.1528-1167.2006.00894.x
   Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103
   Mirsattari SM, 2004, ARCH NEUROL-CHICAGO, V61, P1254, DOI 10.1001/archneur.61.8.1254
   Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105
   MORRELL F, 1989, J CLIN NEUROPHYSIOL, V6, P227, DOI 10.1097/00004691-198907000-00002
   Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784
   Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004
   Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra
   Nilsen KE, 2006, EPILEPSIA, V47, P1169, DOI 10.1111/j.1528-1167.2006.00540.x
   Nilsen KE, 2005, EPILEPSIA, V46, P179, DOI 10.1111/j.0013-9580.2005.26004.x
   Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103
   Otte WM, 2012, EPILEPSIA, P1
   Paxinos G., 2007, RAT BRAIN STEREOTAXI
   Percha B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031909
   Pinheiro J, 2007, R PACKAGE VERSION, V3, P57
   Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002
   Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001
   Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010
   RUBINOV M, 2009, NEUROIMAGE
   Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112
   Siek J, 2002, BOOST GRAPH LIB USER, P112
   Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698
   Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062
   Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x
   Stam CJ, 2012, CLIN NEUROPHYSIOL
   Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3
   Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x
   Sutula TP, 2003, CURR OPIN NEUROL, V16, P189, DOI 10.1097/01.wco.0000063770.15877.bc
   TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207
   Vaessen M.J., 2011, CEREB CORTEX
   van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124
   van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010
   Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550
   Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f
   Wang K, 2010, NMR BIOMED
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Williams KA, 2010, MAGN RESON IMAGING, V28, P995, DOI 10.1016/j.mri.2010.03.007
NR 76
TC 36
Z9 36
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 12
PY 2012
VL 7
IS 7
AR e39078
DI 10.1371/journal.pone.0039078
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 973NH
UT WOS:000306366400008
PM 22808026
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Godderis, L
   Thomas, R
   Hubbard, AE
   Tabish, AM
   Hoet, P
   Zhang, LP
   Smith, MT
   Veulemans, H
   McHale, CM
AF Godderis, Lode
   Thomas, Reuben
   Hubbard, Alan E.
   Tabish, Ali M.
   Hoet, Peter
   Zhang, Luoping
   Smith, Martyn T.
   Veulemans, Hendrik
   McHale, Cliona M.
TI Effect of Chemical Mutagens and Carcinogens on Gene Expression Profiles
   in Human TK6 Cells
SO PLOS ONE
LA English
DT Article
ID CANCER-RISK-ESTIMATION; NONGENOTOXIC CARCINOGENS; EXPOSED WORKERS; COMET
   ASSAY; P53 STATUS; GENOTOXICITY; RADIATION; STYRENE; LINES; MOUSE
AB Characterization of toxicogenomic signatures of carcinogen exposure holds significant promise for mechanistic and predictive toxicology. In vitro transcriptomic studies allow the comparison of the response to chemicals with diverse mode of actions under controlled experimental conditions. We conducted an in vitro study in TK6 cells to characterize gene expression signatures of exposure to 15 genotoxic carcinogens frequently used in European industries. We also examined the dose-responsive changes in gene expression, and perturbation of biochemical pathways in response to these carcinogens. TK6 cells were exposed at 3 dose levels for 24 h with and without S9 human metabolic mix. Since S9 had an impact on gene expression (885 genes), we analyzed the gene expression data from cells cultures incubated with S9 and without S9 independently. The ribosome pathway was affected by all chemical-dose combinations. However in general, no similar gene expression was observed among carcinogens. Further, pathways, i.e. cell cycle, DNA repair mechanisms, RNA degradation, that were common within sets of chemical-dose combination were suggested by clustergram. Linear trends in dose-response of gene expression were observed for Trichloroethylene, Benz[a]anthracene, Epichlorohydrin, Benzene, and Hydroquinone. The significantly altered genes were involved in the regulation of (anti-) apoptosis, maintenance of cell survival, tumor necrosis factor-related pathways and immune response, in agreement with several other studies. Similarly in S9+ cultures, Benz[a]pyrene, Styrene and Trichloroethylene each modified over 1000 genes at high concentrations. Our findings expand our understanding of the transcriptomic response to genotoxic carcinogens, revealing the alteration of diverse sets of genes and pathways involved in cellular homeostasis and cell cycle control.
C1 [Godderis, Lode; Tabish, Ali M.; Hoet, Peter; Veulemans, Hendrik] Katholieke Univ Leuven, Louvain, Belgium.
   [Godderis, Lode] Idewe, External Serv Prevent & Protect Work, Heverlee, Belgium.
   [Thomas, Reuben; Zhang, Luoping; Smith, Martyn T.; McHale, Cliona M.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.
   [Hubbard, Alan E.] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA.
RP Godderis, L (reprint author), Katholieke Univ Leuven, Louvain, Belgium.
EM Lode.Godderis@med.kuleuven.be
RI Hoet, Peter/H-9987-2013
OI Hoet, Peter/0000-0002-0292-6603; Godderis, Lode/0000-0003-4764-8835
FU Research Fund K.U. Leuven
FX This project could only be realized thanks to the financing by Research
   Fund K.U. Leuven. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1
   Alexa A, 2007, GENE SET ENRICHMENT
   Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2
   Andersen ME, 2010, TOXICOL SCI, V118, P716, DOI 10.1093/toxsci/kfq303
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bates D., 2007, LME4 PACKAGE R PACKA
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Brazma A, 2006, NAT BIOTECHNOL, V24, P1321, DOI 10.1038/nbt1106-1321
   Bryce SM, 2010, ENVIRON MOL MUTAGEN, V51, P260, DOI 10.1002/em.20544
   Daston GP, 2010, BIRTH DEFECTS RES C, V90, P110, DOI 10.1002/bdrc.20178
   Dickinson DA, 2004, MUTAT RES-FUND MOL M, V549, P29, DOI 10.1016/j.mrfmmm.2004.01.009
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004
   Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Godderis L, 2004, ENVIRON MOL MUTAGEN, V44, P293, DOI 10.1002/em.20069
   Godderis L, 2007, MUTAGENESIS, V22, P209, DOI 10.1093/mutage/gem005
   Hamadeh HK, 2002, TOXICOL PATHOL, V30, P470, DOI 10.1080/01926230290105712
   Hauptmann M, 2003, J NATL CANCER I, V95, P1615, DOI 10.1093/jnci/djg083
   Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145
   Hu T, 2004, MUTAT RES-FUND MOL M, V549, P5, DOI 10.1016/j.mrfmmm.2003.11.012
   Huang R, 2011, ENV HLTH PERSPECT, V119
   Islaih M, 2005, MUTAT RES-FUND MOL M, V578, P100, DOI 10.1016/j.mrfmmm.2005.04.012
   Islaih M, 2004, ENVIRON MOL MUTAGEN, V44, P401, DOI 10.1002/em.20065
   Johansson F, 2004, MUTAT RES-GEN TOX EN, V563, P35, DOI 10.1016/j.mrgentox.2004.05.017
   Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063
   Kanehisa M, 2002, NOVART FDN SYMP, V247, P91
   Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896
   Kauppinen T, 2000, OCCUP ENVIRON MED, V57, P10, DOI 10.1136/oem.57.1.10
   Kienhuis AS, 2011, TOXICOL APPL PHARM, V250, P96, DOI 10.1016/j.taap.2010.10.013
   Kirsch-Volders M, 2003, MUTAT RES-GEN TOX EN, V540, P153, DOI 10.1016/j.mrgentox.2003.07.005
   KOGEVINAS M, 1994, SCAND J WORK ENV HEA, V20, P251, DOI 10.5271/sjweh.1400
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Le Fevre AC, 2007, MUTAT RES-FUND MOL M, V619, P16, DOI 10.1016/j.mrfmmm.2006.12.007
   Lee M, 2003, ENVIRON MOL MUTAGEN, V42, P91, DOI 10.1002/em.10177
   Li HH, 2007, MUTAT RES-FUND MOL M, V623, P98, DOI 10.1016/j.mrfmmm.2007.03.013
   LITTLE JB, 1995, J BIOL CHEM, V270, P11033, DOI 10.1074/jbc.270.19.11033
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404
   Mahadevan B, 2011, ENVIRON MOL MUTAGEN, V52, P339, DOI 10.1002/em.20653
   Mathijs K, 2009, TOXICOL SCI, V112, P374, DOI 10.1093/toxsci/kfp229
   McHale CM, 2009, GENOMICS, V93, P343, DOI 10.1016/j.ygeno.2008.12.006
   McHale CM, 2010, ENV HLTH PERSPECT, V119
   Moller P, 2005, BASIC CLIN PHARMACOL, V96, P9
   Moore MM, 2002, ENVIRON MOL MUTAGEN, V40, P292, DOI 10.1002/em.10122
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Newton RK, 2004, ENVIRON HEALTH PERSP, V112, P420, DOI 10.1289/txg.6709
   NISHI Y, 1984, CANCER RES, V44, P3270
   Sarma SN, 2011, ENVIRON TOXICOL PHAR, V32, P285, DOI 10.1016/j.etap.2011.06.001
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Stang A, 2009, MUTAT RES-GEN TOX EN, V675, P5, DOI 10.1016/j.mrgentox.2009.01.007
   Team R. D. C., 2009, R LANG ENV STAT COMP
   Thomas R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r44
   Thomas RS, 2007, TOXICOL SCI, V98, P240, DOI 10.1093/toxsci/kfm092
   TORNQVIST M, 1995, J OCCUP ENVIRON MED, V37, P1077
   Tsuda S, 2000, MUTAT RES-GEN TOX EN, V467, P83, DOI 10.1016/S1383-5718(00)00014-0
   van Dartel DAM, 2011, TOXICOLOGY IN PRESS
   van Dartel DAM, 2010, TOXICOLOGY LETT
   van Delft JHM, 2005, MUTAT RES-FUND MOL M, V575, P17, DOI 10.1016/j.mrfmmm.2005.02.006
   van Delft JHM, 2004, CARCINOGENESIS, V25, P1265, DOI 10.1093/carcin/bgh108
   van Leeuwen DM, 2005, TOXICOL SCI, V86, P200, DOI 10.1093/toxsci/kfi168
   Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005
   WONG O, 1994, OCCUP ENVIRON MED, V51, P386, DOI 10.1136/oem.51.6.386
   Wood DK, 2010, P NATL ACAD SCI USA, V107, P10008, DOI 10.1073/pnas.1004056107
   XIA F, 1995, CANCER RES, V55, P12
NR 67
TC 15
Z9 15
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 18
PY 2012
VL 7
IS 6
AR e39205
DI 10.1371/journal.pone.0039205
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 962XO
UT WOS:000305583300116
PM 22723965
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Vaas, LAI
   Sikorski, J
   Michael, V
   Goker, M
   Klenk, HP
AF Vaas, Lea A. I.
   Sikorski, Johannes
   Michael, Victoria
   Goeker, Markus
   Klenk, Hans-Peter
TI Visualization and Curve-Parameter Estimation Strategies for Efficient
   Exploration of Phenotype Microarray Kinetics
SO PLOS ONE
LA English
DT Article
ID METABOLIC RECONSTRUCTION; LONGITUDINAL DATA; SPLINE FUNCTIONS; GROWTH;
   BIOLOGY; MODELS; EVOLUTION; NETWORKS
AB Background: The Phenotype MicroArray (OmniLog (R) PM) system is able to simultaneously capture a large number of phenotypes by recording an organism's respiration over time on distinct substrates. This technique targets the object of natural selection itself, the phenotype, whereas previously addressed '-omics' techniques merely study components that finally contribute to it. The recording of respiration over time, however, adds a longitudinal dimension to the data. To optimally exploit this information, it must be extracted from the shapes of the recorded curves and displayed in analogy to conventional growth curves.
   Methodology: The free software environment R was explored for both visualizing and fitting of PM respiration curves. Approaches using either a model fit (and commonly applied growth models) or a smoothing spline were evaluated. Their reliability in inferring curve parameters and confidence intervals was compared to the native OmniLog (R) PM analysis software. We consider the post-processing of the estimated parameters, the optimal classification of curve shapes and the detection of significant differences between them, as well as practically relevant questions such as detecting the impact of cultivation times and the minimum required number of experimental repeats.
   Conclusions: We provide a comprehensive framework for data visualization and parameter estimation according to user choices. A flexible graphical representation strategy for displaying the results is proposed, including 95% confidence intervals for the estimated parameters. The spline approach is less prone to irregular curve shapes than fitting any of the considered models or using the native PM software for calculating both point estimates and confidence intervals. These can serve as a starting point for the automated post-processing of PM data, providing much more information than the strict dichotomization into positive and negative reactions. Our results form the basis for a freely available R package for the analysis of PM data.
C1 [Vaas, Lea A. I.; Sikorski, Johannes; Michael, Victoria; Goeker, Markus; Klenk, Hans-Peter] DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany.
RP Goker, M (reprint author), DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany.
EM markus.goeker@dsmz.de
OI Goker, Markus/0000-0002-5144-6200
FU Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; European
   Union [222886 MICROME]; German Research Foundation (DFG) [SFB/TRR 51];
   DFG [SI1352/1-2]
FX Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH funded this
   research through the employment of all authors, who contributed to all
   aspects of the study. This work was supported by the European Union
   grant 222886 MICROME and the German Research Foundation (DFG) SFB/TRR
   51, which is gratefully acknowledged. Also, the DFG grant SI1352/1-2 to
   JS is gratefully acknowledged. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abu-Asab MS, 2011, OMICS, V15, P105, DOI 10.1089/omi.2010.0023
   Akaike H., 1983, INT STAT I, V50, P277
   Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_
   Baba Tomoya, 2008, V416, P183, DOI 10.1007/978-1-59745-321-9_12
   Becker RA, 1996, TOUR TRELLIS GRAPHIC
   BiOLOG Inc, 2009, CONV FIL MAN SOFTW P
   Birch CPD, 1999, ANN BOT-LONDON, V83, P713, DOI 10.1006/anbo.1999.0877
   Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x
   Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501
   BOCHNER BR, 1977, APPL ENVIRON MICROB, V33, P434
   Bretz F., 2010, MULTIPLE COMP USING
   BRISBIN IL, 1987, AUK, V104, P552, DOI 10.2307/4087567
   Buchanan AV, 2009, BIOESSAYS, V31, P198, DOI 10.1002/bies.200800133
   Bujara M, 2010, CURR OPIN BIOTECH, V21, P586, DOI 10.1016/j.copbio.2010.07.007
   Chang WLE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-109
   Chen C-H., 2008, HDB DATA VISUALIZATI
   Christian BW, 2006, INT REV HYDROBIOL, V91, P257, DOI 10.1002/iroh.200510838
   CRAVEN P, 1979, NUMER MATH, V31, P377
   Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141
   Di Cagno R, 2010, INT J FOOD MICROBIOL, V143, P246, DOI 10.1016/j.ijfoodmicro.2010.08.018
   Dudoit S, 2008, SPRINGER SER STAT, P1
   Edwards RL, 2009, MOL MICROBIOL, V71, P1190, DOI [10.1111/j.1365-2958.2008.06593.x, 10.1111/j.1365-2958.2009.06593.x]
   EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552
   Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655
   Eugster MJA, 2009, J STAT SOFTW, V30, P1
   Everitt BS, 2010, HANDBOOK OF STATISTICAL ANALYSES USING R, 2ND EDITION, P1
   FELLER W., 1940, ACTA BIOTHEORETICA, V5, P51, DOI 10.1007/BF01602862
   Feng XY, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/460717
   Fitzmaurice G, 2004, APPL LONGITUDINAL AN
   Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618
   Fodor IK, 2005, JOINT STAT M MINN MN
   GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035
   HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458
   Hackett CA, 1997, J MICROBIOL METH, V30, P63, DOI 10.1016/S0167-7012(97)00045-6
   Hardle W. K, 1992, APPL NONPARAMETRIC R
   Hofner B, 2011, ECOLOGY, V92, P1895, DOI 10.1890/10-2276.1
   Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080
   Hutt MT, 2001, DATENANALYSE BIOL
   Jacobsen JS, 2007, 11 INT C INF VIS IV0
   Johnson R.A., 2007, APPL MULTIVARIATE ST
   Kahm M, 2010, J STAT SOFTW, V33, P1
   Kandpal RP, 2009, BIOTECHNIQUES, V46, P351, DOI 10.2144/000113137
   Laird N M, 1992, Stat Methods Med Res, V1, P225, DOI 10.1177/096228029200100302
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lay JO, 2006, TRAC-TREND ANAL CHEM, V25, P1046, DOI 10.1016/j.trac.2006.10.007
   Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515
   Legendre P., 1998, NUMERICAL ECOLOGY
   Mayr E, 1997, P NATL ACAD SCI USA, V94, P2091, DOI 10.1073/pnas.94.6.2091
   Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388
   Mitchell DA, 2004, BIOCHEM ENG J, V17, P15, DOI 10.1016/S1369-703X(03)00120-7
   Mithani A, 2011, MOL BIOL EVOL, V28, P483, DOI 10.1093/molbev/msq213
   Neysens P, 2003, MICROBIOL-SGM, V149, P1073, DOI 10.1099/mic.0.25880-0
   Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79
   Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200
   Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001
   Peugh JL, 2005, EDUC PSYCHOL MEAS, V65, P811, DOI 10.1177/0013164405278558
   Puchalka J, 2008, PLOS COMPUT BIOL, V4, P1
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI
   Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103
   RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290
   Ritz C, 2005, J STAT SOFTW, V12, pi05
   Ruppin E, 2010, CURR OPIN BIOTECH, V21, P502, DOI 10.1016/j.copbio.2010.07.002
   Sabet S, 2009, EXTREMOPHILES, V13, P643, DOI 10.1007/s00792-009-0247-1
   Sarkar D, 2008, USE R, P1
   Schaarschmidt F, 2009, HORTSCIENCE, V44, P188
   Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960
   Serroyen J, 2009, AM STAT, V63, P378, DOI 10.1198/tast.2009.07256
   Shipley B, 2000, CAUSE CORRELATION BI
   Sikorski J, 2007, ENVIRON MICROBIOL, V9, P716, DOI 10.1111/j.1462-2920.2006.01193.x
   Singer JD, 1998, J EDUC BEHAV STAT, V23, P323
   Spiegelman D, 2005, CAN J MICROBIOL, V51, P355, DOI 10.1139/W05-003
   Sturino J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1227
   Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047
   Verbyla AP, 1999, J ROY STAT SOC C-APP, V48, P269, DOI 10.1111/1467-9876.00154
   Vilchez-Vargas R, 2010, ENVIRON MICROBIOL, V12, P3089, DOI 10.1111/j.1462-2920.2010.02340.x
   Wang X, 2012, NATURE COMMUNICATION, V1, P147
   Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931
   Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033
   WOLD S, 1974, TECHNOMETRICS, V16, P1, DOI 10.2307/1267485
   Xue XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020075
   Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0
   Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003
   Zimmerman DL, 2001, TEST-SPAIN, V10, P1, DOI 10.1007/BF02595823
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 87
TC 106
Z9 106
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 20
PY 2012
VL 7
IS 4
AR e34846
DI 10.1371/journal.pone.0034846
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959UD
UT WOS:000305339200023
PM 22536335
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Driscoll, I
   Martin, B
   An, Y
   Maudsley, S
   Ferrucci, L
   Mattson, MP
   Resnick, SM
AF Driscoll, Ira
   Martin, Bronwen
   An, Yang
   Maudsley, Stuart
   Ferrucci, Luigi
   Mattson, Mark P.
   Resnick, Susan M.
TI Plasma BDNF Is Associated with Age-Related White Matter Atrophy but Not
   with Cognitive Function in Older, Non-Demented Adults
SO PLOS ONE
LA English
DT Article
ID FACTOR VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; HIPPOCAMPAL VOLUME;
   ENERGY RESTRICTION; IMPAIRMENT; HEALTHY; DISEASE; WEIGHT; IMPACT; WOMEN
AB Brain derived neurotrophic factor (BDNF) seems to be involved in regulation of synaptic plasticity and neurogenesis. BDNF plasma and serum levels have been associated with depression, Alzheimer's disease, and other psychiatric and neurodegenerative disorders. In a community sample, drawn from the Baltimore Longitudinal Study of Aging (BLSA), we examined whether BDNF plasma concentration was associated with rates of age-related change in cognitive performance (n = 429) and regional brain volume (n = 59). Plasma BDNF levels, which were significantly higher in females (p<0.05), were not associated with either concurrent cognitive performance or rates of age-related change in performance across cognitive domains (p's>0.05). Sex differences in the relationship between BDNF and the trajectories of regional brain volume changes were observed for the whole brain and frontal white matter volumes (p<0.05), whereby lower plasma BDNF was associated with steeper volume decline in females but not males. Together, our findings contribute to furthering the understanding of the relationships between plasma BDNF, structural brain integrity and cognition. Potential mechanisms mediating these relationships merit further investigation.
C1 [Driscoll, Ira; An, Yang; Resnick, Susan M.] NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA.
   [Driscoll, Ira] Univ Wisconsin Milwaukee, Dept Psychol, Milwaukee, WI USA.
   [Martin, Bronwen] NIA, Clin Invest Lab, Baltimore, MD 21224 USA.
   [Maudsley, Stuart; Mattson, Mark P.] NIA, Neurosci Lab, Baltimore, MD 21224 USA.
   [Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA.
RP Driscoll, I (reprint author), NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA.
EM driscoli@uwm.edu
RI Maudsley, Stuart/Q-4782-2019
FU Intramural Research Program of the National Institute on Aging
FX This research was supported by the Intramural Research Program of the
   National Institute on Aging. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9
   Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309
   Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022
   Carlson O, 2007, METABOLISM, V56, P1729, DOI 10.1016/j.metabol.2007.07.018
   Cirulli F, 2011, PSYCHONEUROENDOCRINO, V36, P372, DOI 10.1016/j.psyneuen.2010.10.019
   Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937
   DEFRIES JC, 1974, SCIENCE, V183, P338, DOI 10.1126/science.183.4122.338
   Delis DC, 1987, CALIFORNIA VERBAL LE
   Driscoll I, 2006, ANN NEUROL, V60, P688, DOI 10.1002/ana.21031
   Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010
   Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099
   Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030
   GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361
   Grundman M, 2002, J MOL NEUROSCI, V19, P23, DOI 10.1007/s12031-002-0006-6
   Gunstad J, 2008, J GERIATR PSYCH NEUR, V21, P166, DOI 10.1177/0891988708316860
   Harrell FE, 2001, REGRESSION MODELING
   HARTLEY HO, 1967, BIOMETRIKA, V54, P93, DOI 10.2307/2333854
   Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171
   Husson I, 2005, CEREB CORTEX, V15, P250, DOI 10.1093/cercor/bhh127
   Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005
   Kapczinski F, 2011, J PSYCHIATR RES, V45, P156, DOI 10.1016/j.psychires.2010.05.015
   Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lee HY, 2008, NEUROPSYCHOBIOLOGY, V57, P194, DOI 10.1159/000149817
   Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424
   Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002
   Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161
   Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001
   Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001
   Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796
   Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x
   Newcombe F., 1969, MISSILE WOUNDS BRAIN
   Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x
   Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004
   Piccinni A, 2008, CHRONOBIOL INT, V25, P819, DOI 10.1080/07420520802387773
   Reitan RM, 1992, TRAIL MAKING TEST MA
   Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464
   Rybakowski JK, 2006, MOL PSYCHIATR, V11, P122, DOI 10.1038/sj.mp.4001765
   Sasahara K, 2007, J NEUROSCI, V27, P7408, DOI 10.1523/JNEUROSCI.0710-07.2007
   Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x
   Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082
   Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111
   Shock NW, 1984, 842450 NIH
   Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656
   Terracciano A, 2010, GENES BRAIN BEHAV, V9, P512, DOI 10.1111/j.1601-183X.2010.00579.x
   Trajkovska V, 2007, BRAIN RES BULL, V73, P143, DOI 10.1016/j.brainresbull.2007.03.009
   van Haren NE, 2008, CURR OPIN PSYCHIATR, V21, P161, DOI 10.1097/YCO.0b013e3282f4f25b
   Wechsler D., 1981, WECHSLER ADULT INTEL
   Weinstock-Guttman B, 2007, J NEUROIMMUNOL, V188, P167, DOI 10.1016/j.jneuroim.2007.06.003
   Wilson J. R, 1978, SEXUAL BEHAV, P317
   Young E A, 1998, J Gend Specif Med, V1, P21
   ZONDERMAN AB, 1995, ARCH CLIN NEUROPSYCH, V10, P111, DOI 10.1016/0887-6177(94)00040-9
NR 52
TC 51
Z9 51
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 16
PY 2012
VL 7
IS 4
AR e35217
DI 10.1371/journal.pone.0035217
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959VO
UT WOS:000305345000049
PM 22523577
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pantazis, N
   Morrison, C
   Amornkul, PN
   Lewden, C
   Salata, RA
   Minga, A
   Chipato, T
   Jaffe, H
   Lakhi, S
   Karita, E
   Porter, K
   Meyer, L
   Touloumi, G
AF Pantazis, Nikos
   Morrison, Charles
   Amornkul, Pauli N.
   Lewden, Charlotte
   Salata, Robert A.
   Minga, Albert
   Chipato, Tsungai
   Jaffe, Harold
   Lakhi, Shabir
   Karita, Etienne
   Porter, Kholoud
   Meyer, Laurence
   Touloumi, Giota
CA CASCADE Collaboration EuroCoord AN
TI Differences in HIV Natural History among African and Non-African
   Seroconverters in Europe and Seroconverters in Sub-Saharan Africa
SO PLOS ONE
LA English
DT Article
ID CD4 CELL COUNT; ANTIRETROVIRAL THERAPY; CLINICAL-OUTCOMES; INFECTED
   ADULTS; NAIVE PATIENTS; COTE-DIVOIRE; DECLINE; PROGRESSION; PLASMA; RISK
AB Introduction: It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicable to African populations.
   Methods: We estimated CD4 cell loss in ART-naive, AIDS-free individuals using mixed models allowing for random intercept and slope, and time from seroconversion to clinical AIDS, death and antiretroviral therapy (ART) initiation by survival methods. Using CASCADE data from 20 European and 3 sub-Saharan African (SSA) cohorts of heterosexually-infected individuals, aged >= 15 years, infected >= 2000, we compared estimates between non-African Europeans, Africans in Europe, and Africans in SSA.
   Results: Of 1,959 (913 non-Africans, 302 Europeans - African origin, 744 SSA), two-thirds were female; median age at seroconversion was 31 years. Individuals in SSA progressed faster to clinical AIDS but not to death or non-TB AIDS. They also initiated ART later than Europeans and at lower CD4 cell counts. In adjusted models, Africans (especially from Europe) had lower CD4 counts at seroconversion and slower CD4 decline than non-African Europeans. Median (95% CI) CD4 count at seroconversion for a 15-29 year old woman was 607 (588-627) (non-African European), 469 (442-497) (European - African origin) and 570 (551-589) (SSA) cells/mu L with respective CD4 decline during the first 4 years of 259 (228-289), 155 (110-200), and 199 (174-224) cells/mu L (p<0.01).
   Discussion: Despite differences in CD4 cell count evolution, death and non-TB AIDS rates were similar across study groups. It is therefore prudent to apply current ART guidelines from resource-rich countries to African populations.
C1 [Pantazis, Nikos; Touloumi, Giota] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece.
   [Morrison, Charles] FHI 360, Durham, NC USA.
   [Amornkul, Pauli N.] Int AIDS Vaccine Initiat IAVI, San Francisco, CA USA.
   [Lewden, Charlotte] Univ Victor Segalen Bordeaux 2, ISPED, Bordeaux, France.
   [Salata, Robert A.] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Minga, Albert] Programme PAC CI, Abidjan, Cote Ivoire.
   [Chipato, Tsungai] Univ Zimbabwe, Harare, Zimbabwe.
   [Jaffe, Harold] Univ Oxford, Oxford, England.
   [Lakhi, Shabir] Zambia Emory HIV Res Project ZEHRP, Lusaka, Zambia.
   [Karita, Etienne] Project San Francisco, Kigali, Rwanda.
   [Porter, Kholoud] MRC, Clin Trials Unit, London, England.
   [Meyer, Laurence] Univ Paris 11, AP HP, U1018, Inserm,HIV Epidemiol, Le Kremlin Bicetre, France.
   [Lewden, Charlotte] INSERM, U897, Bordeaux, France.
RP Pantazis, N (reprint author), Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece.
EM npantaz@med.uoa.gr
RI Anglaret, Xavier/F-7333-2013; DEL AMO VALERO, JULIA/M-7020-2015; lutsar,
   irja/H-3177-2015; rezza, giovanni/D-4393-2016; SHCS, all/G-4072-2011;
   Guiguet, Marguerite/L-8480-2018
OI DEL AMO VALERO, JULIA/0000-0002-3104-540X; rezza,
   giovanni/0000-0003-0268-6790; Muga, Roberto/0000-0001-6301-431X; Porter,
   Kholoud/0000-0002-9226-6206; Ruzagira, Eugene/0000-0002-7291-1693
FU European Union [260694]; Fogarty AIDS International Training and
   Research Program (AITRP) FIC [2D43 TW001042]; United States Agency for
   International Development (USAID); Agence Nationale de Recherche sur le
   SIDA et les Hepatites Virales (ANRS) - French Agency on AIDS and Viral
   Hepatitis; Medical Research Council [MC_U122886351]
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007-2013) under
   EuroCoord grant agreement n<SUP>o</SUP> 260694. This work was also
   supported by funding from the Fogarty AIDS International Training and
   Research Program (AITRP) FIC 2D43 TW001042. This study is made possible
   by the generous support of the American people through the United States
   Agency for International Development (USAID). The contents are the
   responsibility of the International AIDS Vaccine Initiative and do not
   necessarily reflect the views of USAID or the United States Government.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; Support: Agence
   Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS) -
   French Agency on AIDS and Viral Hepatitis
CR Adolescents PoAGfAa, 2009, AD POAGFAA GUID US A
   [Anonymous], 1992, MMWR Recomm Rep, V41, P1
   Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51
   CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770
   Deuffic-Burban S, 2007, EUR J EPIDEMIOL, V22, P737, DOI 10.1007/s10654-007-9175-5
   Jaffar S, 2004, B WORLD HEALTH ORGAN, V82, P462
   Katubulushi M, 2005, AIDS, V19, P102, DOI 10.1097/00002030-200501030-00016
   Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502
   Keller M, 2009, AIDS, V23, P731, DOI 10.1097/QAD.0b013e328326f77f
   LAIRD NM, 1988, STAT MED, V7, P305, DOI 10.1002/sim.4780070131
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lewden C, 2010, JAIDS-J ACQ IMM DEF, V53, P260, DOI 10.1097/QAI.0b013e3181b84260
   Lodi S, 2010, AIDS, V24, P2697, DOI 10.1097/QAD.0b013e32833ef6c4
   Lovvorn AE, 2010, INT J STD AIDS, V21, P342, DOI 10.1258/ijsa.2009.009020
   Mekonnen Y, 2005, J INFECT DIS, V192, P739, DOI 10.1086/432545
   Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003
   MEYER L, 2007, P 4 IAS C HIV PATH T
   Minga A, 2007, B WORLD HEALTH ORGAN, V85, P116, DOI 10.2471/BLT.06.032292
   Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011
   Morrison CS, 2007, AIDS, V21, P85, DOI 10.1097/QAD.0b013e3280117c8b
   Morrison CS, 2010, AIDS, V24, P573, DOI 10.1097/QAD.0b013e32833433df
   Muller V, 2009, AIDS, V23, P1269, DOI 10.1097/QAD.0b013e32832d4096
   OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703
   PANTALEO G, 1993, NEW ENGL J MED, V328, P327
   Pantazis N, 2010, STATA J, V10, P226, DOI 10.1177/1536867X1001000204
   PHILLIPS AN, 1992, J ACQ IMMUN DEF SYND, V5, P148
   Pisell TL, 2002, AIDS, V16, P1503, DOI 10.1097/00002030-200207260-00007
   Porter K, 2000, AIDS, V14, P1899
   Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030
   Schiffer V, 2004, HIV MED, V5, P326, DOI 10.1111/j.1468-1293.2004.00231.x
   Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003
   Taylor JMG, 1998, STAT MED, V17, P2381, DOI 10.1002/(SICI)1097-0258(19981030)17:20<2381::AID-SIM926>3.3.CO;2-J
   TOLLERUD DJ, 1989, J CLIN IMMUNOL, V9, P214, DOI 10.1007/BF00916817
   Touloumi G, 1999, STAT MED, V18, P1215
   Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef
   UNAIDS, 2010, REP GLOB AIDS EP
   Urassa W, 2004, AIDS, V18, P433, DOI 10.1097/01.aids.0000104409.99588.2c
   World Health Organization, 2011, GUID INT TB CAS FIND
NR 38
TC 23
Z9 24
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 6
PY 2012
VL 7
IS 3
AR e32369
DI 10.1371/journal.pone.0032369
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 928XD
UT WOS:000303021100016
PM 22412867
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Maman, D
   Pujades-Rodriguez, M
   Subtil, F
   Pinoges, L
   McGuire, M
   Ecochard, R
   Etard, JF
AF Maman, David
   Pujades-Rodriguez, Mar
   Subtil, Fabien
   Pinoges, Loretxu
   McGuire, Megan
   Ecochard, Rene
   Etard, Jean-Francois
TI Gender Differences in Immune Reconstitution: A Multicentric Cohort
   Analysis in Sub-Saharan Africa
SO PLOS ONE
LA English
DT Article
ID ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED ADULTS; TERM IMMUNOLOGICAL
   RESPONSE; CELL COUNT; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS;
   BASE-LINE; VIROLOGICAL SUPPRESSION; VIRAL SUPPRESSION; INCOME COUNTRIES
AB Background: In sub-Saharan Africa, men living with HIV often start ART at more advanced stages of disease and have higher early mortality than women. We investigated gender difference in long-term immune reconstitution.
   Methods/Principal Findings: Antiretroviral-naive adults who received ART for at least 9 months in four HIV programs in sub-Saharan Africa were included. Multivariate mixed linear models were used to examine gender differences in immune reconstitution on first line ART. A total of 21,708 patients (68% women) contributed to 61,912 person-years of follow-up. At ART start,. Median CD4 at ART were 149 [IQR 85-206] for women and 125 cells/mu L [IQR 63-187] for men. After the first year on ART, immune recovery was higher in women than in men, and gender-based differences increased by 20 CD4 cells/mu L per year on average (95% CI 16-23; P<0.001). Up to 6 years after ART start, patients with low initial CD4 levels experienced similar gains compared to patients with high initial levels, including those with CD4>250cells/mu L (difference between patients with <50 cells/mu L and those with >250 was 284 cells/mu L; 95% CI 272-296; LR test for interaction with time p = 0.63). Among patients with initial CD4 count of 150-200 cells/mu L, women reached 500 CD4 cells after 2.4 years on ART (95% CI 2.4-2.5) and men after 4.5 years (95% CI 4.1-4.8) of ART use.
   Conclusion: Women achieved better long-term immune response to ART, reaching CD4 level associated with lower risks of AIDS related morbidity and mortality quicker than men.
C1 [Maman, David; Pujades-Rodriguez, Mar; Pinoges, Loretxu; McGuire, Megan; Etard, Jean-Francois] Med Sans Frontieres, Epictr, Paris, France.
   [Maman, David; Subtil, Fabien; Ecochard, Rene] Hosp Civils Lyon, Serv Biostat, Lyon, France.
   [Etard, Jean-Francois] UMI 233, TransVIHMI, Montpellier, France.
   [Maman, David; Subtil, Fabien; Ecochard, Rene] Univ Lyon, Lyon, France.
   [Maman, David; Subtil, Fabien; Ecochard, Rene] Univ Lyon 1, F-69622 Villeurbanne, France.
   [Maman, David; Subtil, Fabien; Ecochard, Rene] CNRS UMR5558, Lab Biometrie & Biol Evolut, Equipe Biostat Sante, Pierre Benite, France.
RP Maman, D (reprint author), Med Sans Frontieres, Epictr, Paris, France.
EM david.maman@epicentre.msf.org
RI Pujades-Rodriguez, Mar/G-4388-2014; Pujades-Rodriguez, Mar/T-1129-2018;
   Etard, Jean Francois/A-9630-2008
OI Pujades-Rodriguez, Mar/0000-0002-7778-3520; Pujades-Rodriguez,
   Mar/0000-0002-1375-1028; Etard, Jean Francois/0000-0002-4873-0788
FU Sidaction, France [BI20-3-01644]
FX DM is financially supported by Sidaction, France (BI20-3-01644). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76
   Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7
   Bila B, 2009, SOC SCI MED, V69, P854, DOI 10.1016/j.socscimed.2009.05.035
   Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46
   Braitstein P, 2006, LANCET, V367, P817
   Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353
   Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863
   Casella G., 2002, STAT INFERENCE
   Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x
   De Beaudrap P, 2009, AM J TROP MED HYG, V80, P1047, DOI 10.4269/ajtmh.2009.80.1047
   Dou ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022707
   Douek DC, 1998, NATURE, V396, P690
   Ekouevi DK, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-28
   Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713
   Falster K, 2009, JAIDS-J ACQ IMM DEF, V50, P307, DOI 10.1097/QAI.0b013e3181945ed4
   Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2
   Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x
   Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007
   Giordano TP, 2003, CLIN INFECT DIS, V37, P433, DOI 10.1086/376638
   Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb
   Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/01.aids.0000076342.42412.82
   Joint United Nations Programme on HIV/AIDS, 2010, REP GLOB HIV AIDS EP
   Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007
   Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093
   Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab
   Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59
   Lodwick RK, 2010, LANCET, V376, P340, DOI 10.1016/S0140-6736(10)60932-4
   May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6
   Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746
   Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63
   Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9
   Nicastri E, 2007, J ANTIMICROB CHEMOTH, V60, P724, DOI 10.1093/jac/dkm302
   Olsen NJ, 2011, J INVEST MED, V59, P32
   Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208
   Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9
   Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI
   Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283
   Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370
   Smith CJ, 2003, AIDS, V17, P963, DOI 10.1097/01.aids.0000060352.78202.79
   Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7
   Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002
   World Health Organization, 2010, UN ACC SCAL PRIOR HI
   World Health Organization (WHO), 2009, RAP ADV ANT THER HIV, V12, P99
NR 45
TC 27
Z9 30
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 17
PY 2012
VL 7
IS 2
AR e31078
DI 10.1371/journal.pone.0031078
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 926TC
UT WOS:000302853600107
PM 22363550
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Woodroffe, R
   Prager, KC
   Munson, L
   Conrad, PA
   Dubovi, EJ
   Mazet, JAK
AF Woodroffe, Rosie
   Prager, Katherine C.
   Munson, Linda
   Conrad, Patricia A.
   Dubovi, Edward J.
   Mazet, Jonna A. K.
TI Contact with Domestic Dogs Increases Pathogen Exposure in Endangered
   African Wild Dogs (Lycaon pictus)
SO PLOS ONE
LA English
DT Article
ID CANINE-DISTEMPER VIRUS; MADIKWE-GAME-RESERVE; KRUGER-NATIONAL-PARK;
   POPULATION DECLINES; ETHIOPIAN WOLVES; NEOSPORA-CANINUM; SOUTH-AFRICA;
   GROUP-SIZE; RABIES; DISEASE
AB Background: Infectious diseases have contributed to the decline and local extinction of several wildlife species, including African wild dogs (Lycaon pictus). Mitigating such disease threats is challenging, partly because uncertainty about disease dynamics makes it difficult to identify the best management approaches. Serious impacts on susceptible populations most frequently occur when generalist pathogens are maintained within populations of abundant (often domestic) "reservoir'' hosts, and spill over into less abundant host species. If this is the case, disease control directed at the reservoir host might be most appropriate. However, pathogen transmission within threatened host populations may also be important, and may not be controllable by managing another host species.
   Methodology/Principal Findings: We investigated interspecific and intraspecific transmission routes, by comparing African wild dogs' exposure to six canine pathogens with behavioural measures of their opportunities for contact with domestic dogs and with other wild dogs. Domestic dog contact was associated with exposure to canine parvovirus, Ehrlichia canis, Neospora caninum and perhaps rabies virus, but not with exposure to canine distemper virus or canine coronavirus. Contact with other wild dogs appeared not to increase the risk of exposure to any of the pathogens.
   Conclusions/Significance: These findings, combined with other data, suggest that management directed at domestic dogs might help to protect wild dog populations from rabies virus, but not from canine distemper virus. However, further analyses are needed to determine the management approaches - including no intervention - which are most appropriate for each pathogen.
C1 [Woodroffe, Rosie] Zool Soc London, Inst Zool, London NW1 4RY, England.
   [Woodroffe, Rosie; Prager, Katherine C.; Munson, Linda; Conrad, Patricia A.; Mazet, Jonna A. K.] Univ Calif Davis, Wildlife Hlth Ctr, Davis, CA 95616 USA.
   [Munson, Linda; Conrad, Patricia A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Dubovi, Edward J.] Cornell Univ, Coll Vet Med, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA.
RP Woodroffe, R (reprint author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.
EM rosie.woodroffe@ioz.ac.uk
RI Pessah, Isaac/K-7985-2017
OI Pessah, Isaac/0000-0002-8149-588X
FU Morris Animal Foundation; African Wildlife Foundation; Columbus Zoo;
   Denver Zoo; Disney Wildlife Conservation Fund; National Geographic
   Society; Philadelphia Zoo; SeaWorld-Busch Gardens Conservation Fund;
   Wildlife Conservation Society; Medical Research Council [G0600719B]
FX This work was supported by the Morris Animal Foundation, African
   Wildlife Foundation, Columbus Zoo, Denver Zoo, Disney Wildlife
   Conservation Fund, National Geographic Society, Philadelphia Zoo,
   SeaWorld-Busch Gardens Conservation Fund and the Wildlife Conservation
   Society. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481
   Alexander KA, 1996, J ZOO WILDLIFE MED, V27, P426
   ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P486, DOI 10.7589/0090-3558-30.4.486
   ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0
   APPEL M, 1973, AM J VET RES, V34, P1459
   Appel MJ, 1987, VIRUS INFECTIONS CAR
   Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148
   CARMICHAEL LE, 1980, AM J VET RES, V41, P784
   Cleaveland S, 1999, EPIDEMIOL INFECT, V123, P157, DOI 10.1017/S0950268899002563
   Cleaveland S., 2002, P139
   COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159
   Courtenay O, 2001, VET MICROBIOL, V81, P9, DOI 10.1016/S0378-1135(01)00326-1
   Craft ME, 2008, J ANIM ECOL, V77, P1257, DOI 10.1111/j.1365-2656.2008.01410.x
   Creel S, 1997, J WILDLIFE DIS, V33, P823, DOI 10.7589/0090-3558-33.4.823
   Creel S, 2002, AFRICAN WILD DOG BEH
   Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06
   East ML, 2001, P NATL ACAD SCI USA, V98, P15026, DOI 10.1073/pnas.261411898
   Fekadu M., 1991, The natural history of rabies. 2nd Edition.., P367
   Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296
   Fuller T. K., 1992, WILDLIFE 2001 POPULA
   GASCOYNE SC, 1993, ONDERSTEPOORT J VET, V60, P415
   Goller KV, 2010, VET MICROBIOL, V146, P245, DOI 10.1016/j.vetmic.2010.05.018
   Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010
   Haydon DT, 2002, EMERG INFECT DIS, V8, P1468
   Hofmeyr M, 2000, VET REC, V146, P50, DOI 10.1136/vr.146.2.50
   HOFMEYR M, 2004, ANIMAL CONSERVATION, V7, P193
   Holmberg TA, 2006, VET CLIN PATH, V35, P235, DOI 10.1111/j.1939-165X.2006.tb00121.x
   Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X
   KAT PW, 1995, P ROY SOC B-BIOL SCI, V262, P229, DOI 10.1098/rspb.1995.0200
   Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002
   Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004
   Mech LD, 2008, J WILDLIFE DIS, V44, P824, DOI 10.7589/0090-3558-44.4.824
   Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x
   Prager KC, 2011, BIOL CONSERV, V144, P1940, DOI 10.1016/j.biocon.2011.03.025
   Prager KC, RABIES CANI IN PRESS
   Prager KC, EFFECT PROT IN PRESS
   Prager KC, 2011, INVESTIGATION INFECT
   Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004
   Richomme C, 2006, EPIDEMIOL INFECT, V134, P21, DOI 10.1017/S0950268805004693
   RISTIC M, 1972, INFECT IMMUN, V6, P226
   Ruttimann S, 2008, EUR J WILDLIFE RES, V54, P110, DOI 10.1007/s10344-007-0118-y
   Scheepers JL, 1995, S AFR J WILDL RES, V25, P138
   SilleroZubiri C, 1996, J WILDLIFE DIS, V32, P80, DOI 10.7589/0090-3558-32.1.80
   SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535
   STEVENSON-HAMILTON J., 1939, Journal of the South African Veterinary Medical Association, V10, P56
   Stich RW, 2008, VET PARASITOL, V158, P256, DOI 10.1016/j.vetpar.2008.09.013
   THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x
   Tompkins DM, 2002, P ROY SOC B-BIOL SCI, V269, P529, DOI 10.1098/rspb.2001.1897
   VANHEERDEN J, 1995, J S AFR VET ASSOC, V66, P18
   Woodroffe R, 2011, J ZOOL, V283, P88, DOI 10.1111/j.1469-7998.2010.00747.x
   Woodroffe R, 2001, ORYX, V35, P234, DOI 10.1046/j.1365-3008.2001.00186.x
   Woodroffe R, 2006, AFRICAN WILD DOGS AF
   Woodroffe R., 1997, AFRICAN WILD DOG STA
   Woodroffe R, 2009, AFRICAN WILD DOGS AF
   Woodroffe R, 2011, J APPL ECOL, V48, P1345, DOI 10.1111/j.1365-2664.2011.02059.x
   Woodroffe R, 2011, J MAMMAL, V92, P305, DOI 10.1644/10-MAMM-A-157.1
   Woodroffe R, 2009, J ANIM ECOL, V78, P818, DOI 10.1111/j.1365-2656.2009.01545.x
   Woodroffe R, 1999, ANIM CONSERV, V2, P185, DOI 10.1111/j.1469-1795.1999.tb00064.x
   Woodroffe R, 2007, J MAMMAL, V88, P181, DOI 10.1644/05-MAMM-A-405R1.1
NR 61
TC 45
Z9 46
U1 2
U2 92
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 6
PY 2012
VL 7
IS 1
AR e30099
DI 10.1371/journal.pone.0030099
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 904IR
UT WOS:000301188800059
PM 22238695
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hummelen, R
   Macklaim, JM
   Bisanz, JE
   Hammond, JA
   McMillan, A
   Vongsa, R
   Koenig, D
   Gloor, GB
   Reid, G
AF Hummelen, Ruben
   Macklaim, Jean M.
   Bisanz, Jordan E.
   Hammond, Jo-Anne
   McMillan, Amy
   Vongsa, Rebecca
   Koenig, David
   Gloor, Gregory B.
   Reid, Gregor
TI Vaginal Microbiome and Epithelial Gene Array in Post-Menopausal Women
   with Moderate to Severe Dryness
SO PLOS ONE
LA English
DT Article
ID BACTERIAL VAGINOSIS; EPIDERMAL DIFFERENTIATION; REPLACEMENT THERAPY;
   ATROPHY; EXPRESSION; DIVERSITY; DATABASE; IMPACT; FLORA
AB After menopause, many women experience vaginal dryness and atrophy of tissue, often attributed to the loss of estrogen. An understudied aspect of vaginal health in women who experience dryness due to atrophy is the role of the resident microbes. It is known that the microbiota has an important role in healthy vaginal homeostasis, including maintaining the pH balance and excluding pathogens. The objectives of this study were twofold: first to identify the microbiome of postmenopausal women with and without vaginal dryness and symptoms of atrophy; and secondly to examine any differences in epithelial gene expression associated with atrophy. The vaginal microbiome of 32 post-menopausal women was profiled using Illumina sequencing of the V6 region of the 16S rRNA gene. Sixteen subjects were selected for follow-up sampling every two weeks for 10 weeks. In addition, 10 epithelial RNA samples (6 healthy and 4 experiencing vaginal dryness) were acquired for gene expression analysis by Affymetrix Human Gene array. The microbiota abundance profiles were relatively stable over 10 weeks compared to previously published data on premenopausal women. There was an inverse correlation between Lactobacillus ratio and dryness and an increased bacterial diversity in women experiencing moderate to severe vaginal dryness. In healthy participants, Lactobacillus iners and L. crispatus were generally the most abundant, countering the long-held view that lactobacilli are absent or depleted in menopause. Vaginal dryness and atrophy were associated with down-regulation of human genes involved in maintenance of epithelial structure and barrier function, while those associated with inflammation were up-regulated consistent with the adverse clinical presentation.
C1 [Hummelen, Ruben; Macklaim, Jean M.; Bisanz, Jordan E.; Hammond, Jo-Anne; McMillan, Amy; Gloor, Gregory B.; Reid, Gregor] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada.
   [Hummelen, Ruben] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.
   [Macklaim, Jean M.; Bisanz, Jordan E.; Hammond, Jo-Anne; McMillan, Amy; Gloor, Gregory B.; Reid, Gregor] Univ Western Ontario, London, ON, Canada.
   [Vongsa, Rebecca; Koenig, David] Kimberly Clark Inc, Corp Res & Engn Microbial Control, Neenah, WI USA.
RP Hummelen, R (reprint author), Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada.
EM gregor@uwo.ca
RI Gloor, Greg/D-1671-2013
OI Gloor, Gregory/0000-0001-5803-3380
FU Kimberly Clark Corporation, USA
FX The study was funded by a grant-in-aid from Kimberly Clark Corporation,
   USA. Two Kimberly Clark scientists (BV, DK) provided input into the
   study design with GR, but had no role in data collection or decision to
   publish. They provided at the other authors' request some statistical
   analysis and input into the manuscript, but no content or data was
   altered as a result of their corporate positions. Rather, they were true
   scientific collaborators.
CR AGRESTI L, 2002, CATEGORICAL DATA ANA, P600
   ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509
   Brotman RM, 2010, SEX TRANSM INFECT, V86, P297, DOI 10.1136/sti.2009.040592
   Burton JP, 2002, J INFECT DIS, V186, P1770, DOI 10.1086/345761
   Cheng XL, 2009, J BIOL CHEM, V284, P30897, DOI 10.1074/jbc.M109.011213
   Cotreau MM, 2007, MATURITAS, V58, P366, DOI 10.1016/j.maturitas.2007.09.009
   Lara LAD, 2009, J SEX MED, V6, P3097, DOI 10.1111/j.1743-6109.2009.01407.x
   Dahn A, 2008, MICROBES INFECT, V10, P620, DOI 10.1016/j.micinf.2008.02.007
   DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802
   Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044
   Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406
   Heinemann C, 2005, CAN J MICROBIOL, V51, P777, DOI 10.1139/W05-070
   Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078
   Ibe C, 2010, J SEX MED, V7, P1042, DOI 10.1111/j.1743-6109.2009.01692.x
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x
   Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631
   Kim S, 2009, EXP DERMATOL, V18, P1016, DOI 10.1111/j.1600-0625.2009.00894.x
   Kirjavainen PK, 2008, INT J PROBIOTICS, V3, P99
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488
   Mac Bride MB, 2010, MAYO CLIN PROC, V85, P87, DOI 10.4065/mcp.2009.0413
   Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005
   Magurran A. E., 1988, ECOLOGICAL DIVERSITY
   NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297
   Park GT, 2002, J BIOL CHEM, V277, P45195, DOI 10.1074/jbc.M205380200
   Puthenedam M, 2011, INFLAMM BOWEL DIS, V17, P260, DOI 10.1002/ibd.21443
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107
   RAZ R, 1993, NEW ENGL J MED, V329, P753, DOI 10.1056/NEJM199309093291102
   Santoro N, 2009, J SEX MED, V6, P2133, DOI 10.1111/j.1743-6109.2009.01335.x
   Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08
   Simon JA, 2009, MENOPAUSE, V16, P73, DOI 10.1097/gme.0b013e31817b614a
   Spear GT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019560
   Sturdee DW, 2010, CLIMACTERIC, V13, P509, DOI 10.3109/13697137.2010.522875
   Ting AY, 2004, BIOL REPROD, V71, P1397, DOI 10.1095/biolreprod.104.030023
   Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411
NR 39
TC 83
Z9 87
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 2
PY 2011
VL 6
IS 11
AR e26602
DI 10.1371/journal.pone.0026602
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 849WB
UT WOS:000297154900007
PM 22073175
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ginestet, CE
   Nichols, TE
   Bullmore, ET
   Simmons, A
AF Ginestet, Cedric E.
   Nichols, Thomas E.
   Bullmore, Ed T.
   Simmons, Andrew
TI Brain Network Analysis: Separating Cost from Topology Using
   Cost-Integration
SO PLOS ONE
LA English
DT Article
ID SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS;
   EFFICIENCY; BEHAVIOR; SCHIZOPHRENIA; ORGANIZATION; FREQUENCY; DYNAMICS;
   MODELS
AB A statistically principled way of conducting brain network analysis is still lacking. Comparison of different populations of brain networks is hard because topology is inherently dependent on wiring cost, where cost is defined as the number of edges in an unweighted graph. In this paper, we evaluate the benefits and limitations associated with using cost-integrated topological metrics. Our focus is on comparing populations of weighted undirected graphs that differ in mean association weight, using global efficiency. Our key result shows that integrating over cost is equivalent to controlling for any monotonic transformation of the weight set of a weighted graph. That is, when integrating over cost, we eliminate the differences in topology that may be due to a monotonic transformation of the weight set. Our result holds for any unweighted topological measure, and for any choice of distribution over cost levels. Cost-integration is therefore helpful in disentangling differences in cost from differences in topology. By contrast, we show that the use of the weighted version of a topological metric is generally not a valid approach to this problem. Indeed, we prove that, under weak conditions, the use of the weighted version of global efficiency is equivalent to simply comparing weighted costs. Thus, we recommend the reporting of (i) differences in weighted costs and (ii) differences in cost-integrated topological measures with respect to different distributions over the cost domain. We demonstrate the application of these techniques in a re-analysis of an fMRI working memory task. We also provide a Monte Carlo method for approximating cost-integrated topological measures. Finally, we discuss the limitations of integrating topology over cost, which may pose problems when some weights are zero, when multiplicities exist in the ranks of the weights, and when one expects subtle cost-dependent topological differences, which could be masked by cost-integration.
C1 [Ginestet, Cedric E.; Simmons, Andrew] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England.
   [Ginestet, Cedric E.; Simmons, Andrew] Kings Coll London, NIHR, Biomed Res Ctr Mental Hlth, Inst Psychiat, London WC2R 2LS, England.
   [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England.
   [Bullmore, Ed T.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Sch Clin Med, Cambridge, England.
RP Ginestet, CE (reprint author), Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England.
EM cedric.ginestet@kcl.ac.uk
RI Ginestet, Cedric/B-8722-2012; Simmons, Andrew/B-8848-2008; Bullmore,
   Ed/C-1706-2012
OI Ginestet, Cedric/0000-0003-2412-7690; Simmons,
   Andrew/0000-0003-2306-5811; Bullmore, Ed/0000-0002-8955-8283; Nichols,
   Thomas/0000-0002-4516-5103
FU United Kingdom National Institute for Health Research (NIHR) Biomedical
   Research Centre for Mental Health (BRC-MH) at the South London; Maudsley
   NHS Foundation Trust; King's College London; Guy's and St Thomas'
   Charitable Foundation; South London; Maudsley Trustees; Medical Research
   Council [G0900908]
FX CEG and AS were supported by a fellowship from the United Kingdom
   National Institute for Health Research (NIHR) Biomedical Research Centre
   for Mental Health (BRC-MH) at the South London and Maudsley NHS
   Foundation Trust and King's College London. This work has also been
   funded by the Guy's and St Thomas' Charitable Foundation as well as the
   South London and Maudsley Trustees. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006
   Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017
   ASTOLFI L, 2009, C P IEEE ENG MED BIO, P2208
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008
   Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bernardo J. M., 1994, BAYESIAN THEORY
   Billingsley Patrick, 1995, WILEY SERIES PROBABI
   Bollobas B, 2003, HANDBOOK OF GRAPHS AND NETWORKS: FROM THE GENOME TO THE INTERNET, P1
   Cecchi G. A, 2007, BMC CELL BIOL, V8, P1
   Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102
   Fallani FDV, 2008, NEUROINFORMATICS, V6, P23, DOI 10.1007/s12021-007-9006-6
   Gilks WR, 1996, INTRO MARKOV CHAIN M
   GINESTET CE, 2011, NEUROIMAGE, V5, P688
   Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102
   Hagmann P, 2008, PLOS BIOL, V6, pe159, DOI DOI 10.1371/JOURNAL.PBIO.0060159
   He Y, 2009, PLOS ONE, V4, P1
   He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149
   He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089
   Kaiser M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083042
   Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701
   Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5
   Lin RH, 2006, BAYESIAN ANAL, V1, P915, DOI 10.1214/06-BA130
   Minka T, 2001, THESIS MIT
   Newman M. E. J., 2010, NETWORKS INTRO
   Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra
   Pachou E, 2008, BRAIN TOPOGR, V21, P128, DOI 10.1007/s10548-008-0062-5
   PINHEIRO J, 2000, MIXED EFFECTS MODE S
   Robert C., 2004, MONTE CARLO STAT MET
   Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003
   Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018
   Simmons A, 1999, MAGNET RESON MED, V41, P1274, DOI 10.1002/(SICI)1522-2594(199906)41:6<1274::AID-MRM27>3.3.CO;2-T
   Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127
   Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008
   SUPEKAR K, 2009, PLOS BIOL, V7, P1
   Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978
   van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009
   van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
NR 42
TC 99
Z9 100
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 28
PY 2011
VL 6
IS 7
AR e21570
DI 10.1371/journal.pone.0021570
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 799KC
UT WOS:000293284600005
PM 21829437
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, HJ
   Joo, HJ
   Kim, YH
   Ahn, S
   Chang, J
   Hwang, KB
   Lee, DH
   Lee, KJ
AF Kim, Hee-Jung
   Joo, Hye Joon
   Kim, Yung Hee
   Ahn, Soyeon
   Chang, Jun
   Hwang, Kyu-Baek
   Lee, Dong-Hee
   Lee, Kong-Joo
TI Systemic Analysis of Heat Shock Response Induced by Heat Shock and a
   Proteasome Inhibitor MG132
SO PLOS ONE
LA English
DT Article
ID UBIQUITIN-DEPENDENT DEGRADATION; INTESTINAL EPITHELIAL-CELLS; NEWLY
   SYNTHESIZED PROTEINS; STRESS-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR;
   ABNORMAL PROTEINS; GENE-ONTOLOGY; C/EBP-BETA; THERMOTOLERANCE;
   ACTIVATION
AB The molecular basis of heat shock response (HSR), a cellular defense mechanism against various stresses, is not well understood. In this, the first comprehensive analysis of gene expression changes in response to heat shock and MG132 (a proteasome inhibitor), both of which are known to induce heat shock proteins (Hsps), we compared the responses of normal mouse fibrosarcoma cell line, RIF- 1, and its thermotolerant variant cell line, TR-RIF-1 (TR), to the two stresses. The cellular responses we examined included Hsp expressions, cell viability, total protein synthesis patterns, and accumulation of poly-ubiquitinated proteins. We also compared the mRNA expression profiles and kinetics, in the two cell lines exposed to the two stresses, using microarray analysis. In contrast to RIF-1 cells, TR cells resist heat shock caused changes in cell viability and whole-cell protein synthesis. The patterns of total cellular protein synthesis and accumulation of poly-ubiquitinated proteins in the two cell lines were distinct, depending on the stress and the cell line. Microarray analysis revealed that the gene expression pattern of TR cells was faster and more transient than that of RIF-1 cells, in response to heat shock, while both RIF-1 and TR cells showed similar kinetics of mRNA expression in response to MG132. We also found that 2,208 genes were up-regulated more than 2 fold and could sort them into three groups: 1) genes regulated by both heat shock and MG132, (e. g. chaperones); 2) those regulated only by heat shock (e. g. DNA binding proteins including histones); and 3) those regulated only by MG132 (e. g. innate immunity and defense related molecules). This study shows that heat shock and MG132 share some aspects of HSR signaling pathway, at the same time, inducing distinct stress response signaling pathways, triggered by distinct abnormal proteins.
C1 [Kim, Hee-Jung; Kim, Yung Hee; Chang, Jun; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea.
   [Joo, Hye Joon; Lee, Dong-Hee] Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Bioinspired Sci, Dept Life Sci, Seoul, South Korea.
   [Hwang, Kyu-Baek] Soongsil Univ, Sch Comp Sci & Engn, Seoul, South Korea.
   [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Dept Res & Educ, Songnam, South Korea.
RP Kim, HJ (reprint author), Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea.
EM kjl@ewha.ac.kr
OI Lee, Kong-Joo/0000-0001-7972-6020; CHANG, JUN/0000-0002-8423-5987
FU Center for Cell Signaling Research and Drug Discovery Research (CCS &
   DDR) at Ewha Womans University [R15-2006-020]; WCU
   [R31-2008-000-10010-0]; Brain Korea 21 (BK21) Project
FX This work was supported through the Center for Cell Signaling Research
   and Drug Discovery Research (CCS & DDR, R15-2006-020) at Ewha Womans
   University from the National Core Research Center (NCRC) program and by
   WCU project (R31-2008-000-10010-0). HJ Kim and HJ Joo were supported by
   Brain Korea 21 (BK21) Project. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938
   Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859
   Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bibeau-Poirier A, 2008, CYTOKINE, V43, P359, DOI 10.1016/j.cyto.2008.07.012
   Bush KT, 1997, J BIOL CHEM, V272, P9086
   Caraglia M, 2004, AMINO ACIDS, V26, P409, DOI 10.1007/s00726-004-0085-5
   CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135
   Daino H, 2000, BLOOD, V95, P2577
   GABAI VL, 1995, FEBS LETT, V375, P21, DOI 10.1016/0014-5793(95)01152-5
   Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033
   Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440
   HAHN GM, 1988, CANCER RES, V48, P1803
   Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004
   Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001
   HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025
   Hungness ES, 2002, J AM COLL SURGEONS, V195, P619, DOI 10.1016/S1072-7515(02)01342-X
   Hungness ES, 2002, BIOCHEM BIOPH RES CO, V290, P469, DOI 10.1006/bbrc.2001.6168
   Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264
   Kaspari M, 2008, FEBS LETT, V582, P666, DOI 10.1016/j.febslet.2008.01.040
   Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1600-0854.2003.00140.x
   Kim HJ, 2007, MOL CELLS, V23, P123
   Kim HJ, 2002, MOL CELL BIOCHEM, V229, P139, DOI 10.1023/A:1017941131744
   Kim HJ, 2002, J BIOL CHEM, V277, P23193, DOI 10.1074/jbc.M201007200
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lee DH, 1996, MOL CELL BIOL, V16, P4773
   Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4
   LEE KJ, 1988, J CELL PHYSIOL, V136, P411, DOI 10.1002/jcp.1041360304
   Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996
   Liebermann DA, 2003, BLOOD CELL MOL DIS, V31, P213, DOI 10.1016/S1079-9796(03)00160-8
   Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834
   Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001
   Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   MOSSER DD, 1992, J CELL PHYSIOL, V151, P561, DOI 10.1002/jcp.1041510316
   Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317
   Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037
   Ott DE, 2003, J VIROL, V77, P3384, DOI 10.1128/JVI.77.6.3384-3393.2003
   Park JE, 1998, ARCH PHARM RES, V21, P46, DOI 10.1007/BF03216752
   Pinheiro J., 2010, NLME LINEAR NONLINEA, P1
   Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844
   Robinson PN, 2004, BIOINFORMATICS, V20, P979, DOI 10.1093/bioinformatics/bth040
   Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089
   Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057
   Schubert U, 2000, NATURE, V404, P770
   SHERMAN MY, 2006, SCI STKE, pPE16
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tacchini L, 2003, INT J BIOCHEM CELL B, V35, P316, DOI 10.1016/S1357-2725(02)00164-4
   Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876
   Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2
   Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738
   Woo Yong, 2004, J Biomol Tech, V15, P276
NR 52
TC 19
Z9 19
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 30
PY 2011
VL 6
IS 6
AR e20252
DI 10.1371/journal.pone.0020252
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 786GP
UT WOS:000292291800003
PM 21738571
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ng, OT
   Lin, L
   Laeyendecker, O
   Quinn, TC
   Sun, YJ
   Lee, CC
   Leo, YS
AF Ng, Oon Tek
   Lin, Li
   Laeyendecker, Oliver
   Quinn, Thomas C.
   Sun, Yong Jiang
   Lee, Cheng Chuan
   Leo, Yee Sin
TI Increased Rate of CD4+T-Cell Decline and Faster Time to Antiretroviral
   Therapy in HIV-1 Subtype CRF01_AE Infected Seroconverters in Singapore
SO PLOS ONE
LA English
DT Article
ID DISEASE PROGRESSION; VIRAL SUBTYPE; THAILAND; UGANDA; HEALTH; IMPACT
AB Background: It remains controversial as to whether HIV-1 subtypes influence disease progression. Singapore offers a unique opportunity to address this issue due to the presence of co-circulating subtypes. We compared subtype CRF01_AE and non-CRF01_AE infected patients, with regards to estimated annual rate of CD4+ T-cell loss and time from estimated data of seroconversion (EDS) to antiretroviral therapy (ART).
   Methods: We recruited ART-naive patients with known dates of seroconversion between October 2002 and December 2007 at the Singapore Communicable Disease Centre, the national reference treatment centre. Multilevel mixed-effects models were used to analyse the rate of CD4+ T-cell decline. Time from EDS to ART was analyzed with the Kaplan-Meier survival method and compared with Cox proportional hazards models.
   Results: 54 patients with previously assigned HIV-1 subtypes (24 CRF01_AE, 17 B, 8 B', 1 CRF33_01B, 3 CRF34_01B and 1 G) were observed for 89 patient-years. Subtype CRF01_AE and non-CRF01_AE infected patients did not differ in age, gender, risk factor, rate of symptomatic seroconversion, baseline CD4+ T-cell count, log(10) viral load or haemoglobin concentration. The estimated annual rate of CD4+ T-cell loss was 58 cells/mm(3)/year (95% CI: 7 to 109; P = 0.027) greater in subtype CRF01_AE infected patients compared to non-CRF01_AE patients, after adjusting for age, baseline CD4+ T-cell count and baseline log(10) viral load. The median time from EDS to ART was 1.8 years faster comparing CRF01_AE to non-CRF01_AE infected patient with a 2.5 times (95% CI: 1.2-5.0; P = 0.013) higher hazard for ART initiation, after controlling for age, baseline CD4+ T-cell count and baseline log(10) viral load.
   Conclusions: Infecting subtype significantly impacted the rate of CD4+ T-cell loss and time to treatment in this cohort. Studies to understand the biological basis for this difference could further our understanding of HIV pathogenesis.
C1 [Ng, Oon Tek; Laeyendecker, Oliver; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.
   [Ng, Oon Tek; Lin, Li; Sun, Yong Jiang; Lee, Cheng Chuan; Leo, Yee Sin] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.
   [Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Baltimore, MD USA.
RP Ng, OT (reprint author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.
EM oong@jhsph.edu
RI Laeyendecker, Oliver/B-9331-2009
OI Laeyendecker, Oliver/0000-0002-6429-4760
FU Singapore National Medical Research Training Fellowship [MH 95:03/8-169]
FX A Singapore National Medical Research Training Fellowship grant (MH
   95:03/8-169) provided salary support for OT Ng. Additional support was
   provided by the Division of Intramural Research, National Institute of
   Allergy and Infectious Diseases, National Institutes of Health. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Babiker A, 2000, LANCET, V355, P1131
   Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682
   Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4
   Hu DJ, 2001, AIDS, V15, P683, DOI 10.1097/00002030-200104130-00003
   Joint United Nations Program on HIV/AIDS (UNAIDS) WHOW, 2007, AIDS EP UPD
   Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130
   Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1
   Keller M, 2009, AIDS, V23, P731, DOI 10.1097/QAD.0b013e328326f77f
   Kiwanuka N, 2009, J ACQUIRED IMMUNE DE
   Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lee CC, 2009, HIV MED, V10, P370, DOI 10.1111/j.1468-1293.2009.00698.x
   Nelson KE, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000299410.37152.17
   Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23
   Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737
   Touloumi G, 2003, JAIDS-J ACQ IMM DEF, V34, P76, DOI 10.1097/00126334-200309010-00012
   *US DEP HHS, GUID US ANT AG HIV 1
   WHO, 2008, WHO STAT INF SYST CO
NR 18
TC 31
Z9 34
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 27
PY 2011
VL 6
IS 1
AR e15738
DI 10.1371/journal.pone.0015738
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 712JV
UT WOS:000286663900017
PM 21298051
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dunne, DW
   Shaw, A
   Bockenstedt, LK
   Allore, HG
   Chen, S
   Malawista, SE
   Leng, L
   Mizue, Y
   Piecychna, M
   Zhang, L
   Towle, V
   Bucala, R
   Montgomery, RR
   Fikrig, E
AF Dunne, Dana W.
   Shaw, Albert
   Bockenstedt, Linda K.
   Allore, Heather G.
   Chen, Shu
   Malawista, Stephen E.
   Leng, Lin
   Mizue, Yuka
   Piecychna, Marta
   Zhang, Lin
   Towle, Virginia
   Bucala, Richard
   Montgomery, Ruth R.
   Fikrig, Erol
TI Increased TLR4 Expression and Downstream Cytokine Production in
   Immunosuppressed Adults Compared to Non-Immunosuppressed Adults
SO PLOS ONE
LA English
DT Article
ID MIGRATION INHIBITORY FACTOR; TOLL-LIKE RECEPTOR-4; RHEUMATOID-ARTHRITIS;
   IMMUNE-RESPONSES; MACROPHAGE; ACTIVATION; LUPUS; GENE; RECOGNITION;
   INTERFERON
AB Background: An increasing number of patients have medical conditions with altered host immunity or that require immunosuppressive medications. While immunosuppression is associated with increased risk of infection, the precise effect of immunosuppression on innate immunity is not well understood. We studied monocyte Toll-like receptor (TLR) expression and cytokine production in 137 patients with autoimmune diseases who were maintained on immunosuppressive medications and 419 non-immunosuppressed individuals.
   Methodology/Principal Findings: Human peripheral blood monocytes were assessed for surface expression of TLRs 1, 2, and 4. After incubation with TLR agonists, in vitro production of the cytokines IL-8, TNF alpha, and MIF were measured by ELISA as a measure of TLR signaling efficiency and downstream effector responsiveness. Immunosuppressed patients had significantly higher TLR4 surface expression when compared to non-immunosuppressed adults (TLR4 %-positive 70.12 +/- 2.28 vs. 61.72 +/- 2.05, p = 0.0008). IL-8 and TNF-alpha baseline levels did not differ, but were significantly higher in the autoimmune disease group following TLR stimulation. By contrast, baseline MIF levels were elevated in monocytes from immunosuppressed individuals. By multivariable analyses, IL-8 and TNF alpha, but not MIF levels, were associated with the diagnosis of an underlying autoimmune disease. However, only MIF levels were significantly associated with the use of immunosuppressive medications.
   Conclusions/Significance: Our results reveal that an enhanced innate immune response is a feature of patients with autoimmune diseases treated with immunosuppressive agents. The increased risk for infection evident in this patient group may reflect a dysregulation rather than a simple suppression of innate immunity.
C1 [Dunne, Dana W.; Shaw, Albert; Bockenstedt, Linda K.; Allore, Heather G.; Chen, Shu; Malawista, Stephen E.; Leng, Lin; Piecychna, Marta; Zhang, Lin; Towle, Virginia; Bucala, Richard; Montgomery, Ruth R.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.
   [Mizue, Yuka] Sapporo Immuno Diagnost Lab, Sapporo, Hokkaido, Japan.
   [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA.
RP Dunne, DW (reprint author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.
EM dana.dunne@yale.edu
OI Mizue, Yuka/0000-0002-2208-0772; Montgomery, Ruth/0000-0002-8661-4454;
   Allore, Heather/0000-0001-7685-8175
FU National Institutes of Health [N01-AI-50031, R37-AI-049200-09S1]; Yale
   Claude D. Pepper Older Americans Independence Center [P30AG21342];
   NCRR/GCRC Program [M01-RR00125, AR050498, AR049610]
FX Grant support was provided by the National Institutes of Health
   (N01-AI-50031, R37-AI-049200-09S1, Yale Claude D. Pepper Older Americans
   Independence Center P30AG21342, the NCRR/GCRC Program M01-RR00125,
   AR050498, and AR049610). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732
   Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj/gene/6363867
   Berdeli G, 2006, RHEUMATOL INT, V26, P726, DOI 10.1007/s00296-005-0062-7
   CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895
   Chen YC, 2002, J VIROL, V76, P9877, DOI 10.1128/JVI.76.19.9877-9887.2002
   Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013
   Franklin J, 2007, ANN RHEUM DIS, V66, P308, DOI 10.1136/ard.2006.057265
   Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112
   Kang I, 2003, CURR OPIN RHEUMATOL, V15, P528, DOI 10.1097/00002281-200309000-00002
   Kim HR, 2007, J RHEUMATOL, V34, P927
   Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a
   Leech M, 2003, ARTHRITIS RHEUM, V48, P1881, DOI 10.1002/art.11165
   Lovgren T, 2004, ARTHRITIS RHEUM, V50, P1861, DOI 10.1002/art.20254
   Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957
   Martinez A, 2007, HUM IMMUNOL, V68, P744, DOI 10.1016/j.humimm.2007.06.007
   McCullagh P., 1989, GEN LINEAR MODELS
   Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131
   Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246
   Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102
   Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558
   Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024
   Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285
   Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021
   Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513
   Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a
   Sacre SM, 2008, J IMMUNOL, V181, P8002, DOI 10.4049/jimmunol.181.11.8002
   Sampey AV, 2001, ARTHRITIS RHEUM-US, V44, P1273, DOI 10.1002/1529-0131(200106)44:6<1273::AID-ART219>3.0.CO;2-8
   van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970
   VERBEKE G, 1997, SAS ORIENTED APPROAC
NR 35
TC 7
Z9 7
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 28
PY 2010
VL 5
IS 6
AR e11343
DI 10.1371/journal.pone.0011343
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 617DB
UT WOS:000279259900016
PM 20596538
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Melekhin, VV
   Shepherd, BE
   Stinnette, SE
   Rebeiro, PF
   Barkanic, G
   Raffanti, SP
   Sterling, TR
AF Melekhin, Vlada V.
   Shepherd, Bryan E.
   Stinnette, Samuel E.
   Rebeiro, Peter F.
   Barkanic, Gema
   Raffanti, Stephen P.
   Sterling, Timothy R.
TI Antiretroviral Therapy Initiation Before, During, or After Pregnancy in
   HIV-1-Infected Women: Maternal Virologic, Immunologic, and Clinical
   Response
SO PLOS ONE
LA English
DT Article
AB Background: Pregnancy has been associated with a decreased risk of HIV disease progression in the highly active antiretroviral therapy (HAART) era. The effect of timing of HAART initiation relative to pregnancy on maternal virologic, immunologic and clinical outcomes has not been assessed.
   Methods: We conducted a retrospective cohort study from 1997-2005 among 112 pregnant HIV-infected women who started HAART before (N=12), during (N=70) or after pregnancy (N=30).
   Results: Women initiating HAART before pregnancy had lower CD4+ nadir and higher baseline HIV-1 RNA. Women initiating HAART after pregnancy were more likely to receive triple-nucleoside reverse transcriptase inhibitors. Multivariable analyses adjusted for baseline CD4+ lymphocytes, baseline HIV-1 RNA, age, race, CD4+ lymphocyte count nadir, history of ADE, prior use of non-HAART ART, type of HAART regimen, prior pregnancies, and date of HAART start. In these models, women initiating HAART during pregnancy had better 6-month HIV-1 RNA and CD4+ changes than those initiating HAART after pregnancy (-0.35 vs. 0.10 log(10) copies/mL, P=0.03 and 183.8 vs. -70.8 cells/mm(3), P=0.03, respectively) but similar to those initiating HAART before pregnancy (-0.32 log(10) copies/mL, P=0.96 and 155.8 cells/mm(3), P=0.81, respectively). There were 3 (25%) AIDS-defining events or deaths in women initiating HAART before pregnancy, 3 (4%) in those initiating HAART during pregnancy, and 5 (17%) in those initiating after pregnancy (P=0.01). There were no statistical differences in rates of HIV disease progression between groups.
   Conclusions: HAART initiation during pregnancy was associated with better immunologic and virologic responses than initiation after pregnancy.
RP Melekhin, VV (reprint author), Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.
EM vlada.melekhin@vanderbilt.edu
OI Rebeiro, Peter/0000-0003-1951-9104
FU PHS HHS [K24 A1065298]; NIAID NIH HHS [P30 AI54999, T32 AI007474, P30
   AI054999, T32 AI07474-10]
CR Alliegro MB, 1997, ARCH INTERN MED, V157, P2585, DOI 10.1001/archinte.157.22.2585
   Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201
   Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104
   Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008
   Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015
   Bardeguez AD, 2003, JAIDS-J ACQ IMM DEF, V32, P170, DOI 10.1097/00126334-200302010-00009
   Bardeguez AD, 2008, JAIDS-J ACQ IMM DEF, V48, P408, DOI 10.1097/QAI.0b013e31817bbe80
   Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181
   Bessinger R, 1998, AM J EPIDEMIOL, V147, P434
   BIGGAR RJ, 1989, AM J OBSTET GYNECOL, V161, P1239, DOI 10.1016/0002-9378(89)90674-1
   Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x
   *CDCP, 1992, MMWR-MORBID MORTAL W, V41, P1
   Chaix ML, 2006, J INFECT DIS, V193, P482, DOI 10.1086/499966
   Cheng DM, 2007, ALCOHOL CLIN EXP RES, V31, P829, DOI 10.1111/j.1530-0277.2007.00381.x
   Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484
   DESCHAMPS MM, 1993, J ACQ IMMUN DEF SYND, V6, P446
   Dietz PM, 2007, PAEDIATR PERINAT EP, V21, P62, DOI 10.1111/j.1365-3016.2007.00862.x
   Dronda F, 2004, AIDS, V18, P2210, DOI 10.1097/00002030-200411050-00018
   Eastman PS, 1998, J INFECT DIS, V177, P557, DOI 10.1086/514228
   Ebrahim SH, 2000, JAMA-J AM MED ASSOC, V283, P361, DOI 10.1001/jama.283.3.361
   Effros RB, 2003, CURR HIV RES, V1, P153, DOI 10.2174/1570162033485348
   Ekpini RA, 2002, AIDS, V16, P625, DOI 10.1097/00002030-200203080-00015
   FINGERHUT LA, 1990, AM J PUBLIC HEALTH, V80, P541, DOI 10.2105/AJPH.80.5.541
   Giuliano M, 2003, AIDS, V17, P1570, DOI 10.1097/01.aids.0000076264.76134.b1
   Golub ET, 2008, CLIN INFECT DIS, V46, P305, DOI 10.1086/524752
   HOCKE C, 1995, OBSTET GYNECOL, V86, P886, DOI 10.1016/0029-7844(95)00257-R
   Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012
   Kakehasi FM, 2007, AIDS RES HUM RETROV, V23, P1515, DOI 10.1089/aid.2007.0025
   Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007
   Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35
   Kully C, 1999, J INFECT DIS, V179, P705, DOI 10.1086/314615
   KUMAR RM, 1995, INT J GYNECOL OBSTET, V49, P137, DOI 10.1016/0020-7292(95)02356-H
   Kuritzkes DR, 2007, J INFECT DIS, V195, P1169, DOI 10.1086/512619
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lucas GM, 2002, AIDS, V16, P767, DOI 10.1097/00002030-200203290-00012
   Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208
   MINKOFF H, 1987, OBSTET GYNECOL, V69, P285
   Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756
   Mofenson L., 2006, Morbidity and Mortality Weekly Report, V55, P592
   *PAN ANT GUID ADU, 2008, GUID US ANT AG HIV 1
   *PER HIV GUID GROU, 2008, PUBL HLTH SERV TASK
   Perez-Elias MJ, 2005, HIV CLIN TRIALS, V6, P312, DOI 10.1310/B3NK-V5XQ-6VX9-5DEK
   Polanczyk MJ, 2004, J IMMUNOL, V173, P2227, DOI 10.4049/jimmunol.173.4.2227
   Vaz MJR, 2007, INT J STD AIDS, V18, P28, DOI 10.1258/095646207779949808
   Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064
   Saada M, 2000, AIDS, V14, P2355, DOI 10.1097/00002030-200010200-00017
   Sanchez-Ramon S, 2005, IMMUNOL LETT, V96, P195, DOI 10.1016/j.imlet.2004.09.004
   Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601
   SCOTT GB, 1985, JAMA-J AM MED ASSOC, V253, P363, DOI 10.1001/jama.253.3.363
   Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x
   Tai JH, 2007, J INFECT DIS, V196, P1044, DOI 10.1086/520814
   Thea DM, 1997, AIDS, V11, P437, DOI 10.1097/00002030-199704000-00006
   *UN JOINT PROGR HI, 2008, 2007 AIDS EP UPD
   Waller DK, 2000, PAEDIATR PERINAT EP, V14, P263, DOI 10.1046/j.1365-3016.2000.00275.x
   Weisser M, 1998, J ACQ IMMUN DEF SYND, V17, P404, DOI 10.1097/00042560-199804150-00004
   Welles SL, 2000, AIDS, V14, P263, DOI 10.1097/00002030-200002180-00008
NR 56
TC 10
Z9 10
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2009
VL 4
IS 9
AR e6961
DI 10.1371/journal.pone.0006961
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 491ZI
UT WOS:000269622500022
PM 19742315
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Letenneur, L
   Peres, K
   Fleury, H
   Garrigue, I
   Barberger-Gateau, P
   Helmer, C
   Orgogozo, JM
   Gauthier, S
   Dartigues, JF
AF Letenneur, Luc
   Peres, Karine
   Fleury, Herve
   Garrigue, Isabelle
   Barberger-Gateau, Pascale
   Helmer, Catherine
   Orgogozo, Jean-Marc
   Gauthier, Serge
   Dartigues, Jean-Francois
TI Seropositivity to Herpes Simplex Virus Antibodies and Risk of
   Alzheimer's Disease: A Population-Based Cohort Study
SO PLOS ONE
LA English
DT Article
AB Background: Herpes Simplex Virus (HSV) infection has been proposed as a possible risk factor of Alzheimer's Disease (AD) notably because it is neurotropic, ubiquitous in the general population and able to establish lifelong latency in the host. The fact that HSV was present in elderly subjects with AD suggests that the virus could be a co-factor of the disease. We investigated the risk of developing AD in anti-HSV immunoglobulin G (IgG) positive subjects (indicator of a lifelong infection to HSV) and IgM-positive subjects (indicator of primary infection or reactivation of the virus) in a longitudinal population-based cohort of elderly subjects living in the community.
   Methods: Cox proportional hazard models were used to study the risk of developing AD according to the presence or not of anti-HSV IgG and IgM antibodies, assessed in the sera of 512 elderly initially free of dementia followed for 14 years.
   Results: During the follow-up, 77 incident AD cases were diagnosed. Controlled for age, gender, educational level and Apolipoprotein E4 (APOE4) status, IgM-positive subjects showed a significant higher risk of developing AD (HR = 2.55; 95% CI [1.38-4.72]), although no significant increased risk was observed in IgG-positive subjects (HR = 1.67; 95% CI [0.75-3.73]). No modification effect with APOE4 status was found.
   Conclusion: Reactivation of HSV seropositivity is highly correlated with incident AD. HSV chronic infection may therefore be contributive to the progressive brain damage characteristic of AD.
C1 [Letenneur, Luc; Peres, Karine; Fleury, Herve; Barberger-Gateau, Pascale; Helmer, Catherine; Orgogozo, Jean-Marc; Dartigues, Jean-Francois] INSERM, U897, Bordeaux, France.
   [Letenneur, Luc; Peres, Karine; Fleury, Herve; Garrigue, Isabelle; Barberger-Gateau, Pascale; Helmer, Catherine; Orgogozo, Jean-Marc; Dartigues, Jean-Francois] Univ Victor Segalen Bordeaux 2, Bordeaux, France.
   [Garrigue, Isabelle] Univ Victor Segalen Bordeaux 2, Lab Virol, Bordeaux, France.
   [Gauthier, Serge] McGill Univ, Ctr Studies Aging, Montreal, PQ H3A 2T5, Canada.
RP Letenneur, L (reprint author), INSERM, U897, Bordeaux, France.
EM luc.letenneur@inserm.fr
RI HELMER, Catherine/I-6581-2015
OI HELMER, Catherine/0000-0002-5169-7421; LETENNEUR,
   Luc/0000-0002-3274-937X
FU Fondation de France; Novartis Laboratories; IPSEN laboratories; Conseil
   General de la Gironde; Conseil Regional d'Aquitaine; SCOR Insurance
   (France)
FX The PAQUID study was supported by grants from Fondation de France,
   Novartis Laboratories, IPSEN laboratories, Conseil General de la
   Gironde, Conseil Regional d'Aquitaine, SCOR Insurance (France). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532.5415.2006.00796.x
   APA, 1987, DIAGN STAT MAN MENT
   Beffert U, 1998, LANCET, V351, P1330, DOI 10.1016/S0140-6736(05)79057-7
   Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016/j.nbd.2006.01.004
   Bunzli D, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-10
   Chaudhuri A, 2002, POSTGRAD MED J, V78, P575, DOI 10.1136/pmj.78.924.575
   FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198
   FORSGREN M, 1989, SERODIAG IMMUN INF D, V3, P259, DOI 10.1016/0888-0786(89)90006-1
   Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5
   Itzhaki Ruth, 2004, Herpes, V11 Suppl 2, p77A
   JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498
   Kammerman EM, 2006, MED HYPOTHESES, V66, P294, DOI 10.1016/j.mehy.2005.07.033
   Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005
   KNIPE DM, 2001, FIELDS VIROLOGY
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Letenneur L, 1999, J NEUROL NEUROSUR PS, V66, P177, DOI 10.1136/jnnp.66.2.177
   Malkin JE, 2002, SEX TRANSM INFECT, V78, P201, DOI 10.1136/sti.78.3.201
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Morrow R, 2006, CLIN MICROBIOL INFEC, V12, P463, DOI 10.1111/j.1469-0691.2006.01370.x
   OUNANIAN A, 1990, J CLIN LAB ANAL, V4, P367, DOI 10.1002/jcla.1860040510
   Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015
   Pyles R B, 2001, Herpes, V8, P64
   RENVOIZE EB, 1987, AGE AGEING, V16, P311, DOI 10.1093/ageing/16.5.311
   Strandberg TE, 2003, STROKE, V34, P2126, DOI 10.1161/01.STR.0000086754.32238.DA
   Thackray AM, 2004, J VIROL, V78, P13697, DOI 10.1128/JVI.78.24.13697-13707.2004
   Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X
   Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271
   Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964
NR 28
TC 91
Z9 94
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 4
PY 2008
VL 3
IS 11
AR e3637
DI 10.1371/journal.pone.0003637
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 432LJ
UT WOS:000265134300007
PM 18982063
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Veerapathran, A
   Joshi, R
   Goswami, K
   Dogra, S
   Moodie, EEM
   Reddy, MVR
   Kalantri, S
   Schwartzman, K
   Behr, MA
   Menzies, D
   Pai, M
AF Veerapathran, Anandharaman
   Joshi, Rajnish
   Goswami, Kalyan
   Dogra, Sandeep
   Moodie, Erica E. M.
   Reddy, M. V. R.
   Kalantri, Shriprakash
   Schwartzman, Kevin
   Behr, Marcel A.
   Menzies, Dick
   Pai, Madhukar
TI T-Cell Assays for Tuberculosis Infection: Deriving Cut-Offs for
   Conversions Using Reproducibility Data
SO PLOS ONE
LA English
DT Article
AB Background: Although interferon-gamma release assays (IGRA) are promising alternatives to the tuberculin skin test, interpretation of repeated testing results is hampered by lack of evidence on optimal cut-offs for conversions and reversions. A logical start is to determine the within-person variability of T-cell responses during serial testing.
   Methodology/Principal Findings: We performed a pilot study in India, to evaluate the short-term reproducibility of QuantiFERON-TB Gold In Tube assay (QFT) among 14 healthcare workers (HCWs) who underwent 4 serial QFT tests on day 0, 3, 9 and 12. QFT ELISA was repeated twice on the same sets of specimens. We assessed two types of reproducibility: 1) test-retest reproducibility (between-test variability), and 2) within-person reproducibility over time. Test-retest reproducibility: with dichotomous test results, extremely high concordance was noticed between two tests performed on the same sets of specimens: of the 56 samples, the test and re-test results agreed for all but 2 individuals (k = 0.94). Discordance was noted in subjects who had IFN-gamma values around the cut-off point, with both increases and decreases noted. With continuous IFN-gamma results, re-test results tended to produce higher estimates of IFN-gamma than the original test. Within-person reproducibility: when continuous IFN-gamma data were analyzed, the within-person reproducibility was moderate to high. While persons with negative QFT results generally stayed negative, positive results tended to vary over time. Our data showed that increases of more than 16% in the IFN-gamma levels are statistically improbable in the short-term.
   Conclusions: Conservatively assuming that long-term variability might be at least twice higher than short-term, we hypothesize that a QFT conversion requires two conditions to be met: 1) change from negative to positive result, and 2) at least 30% increase in the baseline IFN-gamma response. Larger studies are needed to confirm our preliminary findings, and determine the conversion thresholds for IGRAs.
C1 [Veerapathran, Anandharaman; Joshi, Rajnish; Goswami, Kalyan; Reddy, M. V. R.; Kalantri, Shriprakash] Mahatma Gandhi Inst Med Sci, Dept Biochem, Sevagram, Maharashtra, India.
   [Veerapathran, Anandharaman; Joshi, Rajnish; Goswami, Kalyan; Reddy, M. V. R.; Kalantri, Shriprakash] Mahatma Gandhi Inst Med Sci, Dept Med, Sevagram, Maharashtra, India.
   [Joshi, Rajnish] Univ Calif, Sch Public Hlth, Div Epidemiol, Berkeley, CA USA.
   [Dogra, Sandeep] Acharya Shri Chander Coll Med Sci & Hosp, Jammu, India.
   [Moodie, Erica E. M.; Schwartzman, Kevin; Behr, Marcel A.; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol, Biostat & Occupat Hlth, Montreal, PQ, Canada.
   [Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.
   [Behr, Marcel A.] McGill Univ Hlth Ctr, Div Infect Dis & Med Microbiol, Montreal, PQ, Canada.
RP Veerapathran, A (reprint author), Mahatma Gandhi Inst Med Sci, Dept Biochem, Sevagram, Maharashtra, India.
EM madhukar.pai@mcgill.ca
RI Goswami, Kalyan/H-2825-2019
OI Pai, Madhukar/0000-0003-3667-4536
FU Canadian Institutes of Health Research (CIHR) [MOP-81362, New
   Investigator Award]; training fellowship Fogarty AIDS International
   Training Program [AITRP] [1-D43-TW00003-17]; Fonds de la Recherche en
   Sante du Quebec (FRSQ), Canada
FX This project was supported in part by a grant from the Canadian
   Institutes of Health Research (MOP-81362). MP is supported by a New
   Investigator Award from the Canadian Institutes of Health Research
   (CIHR). RJ is a recipient of a training fellowship from the Fogarty AIDS
   International Training Program [AITRP] (grant 1-D43-TW00003-17), USA.
   KS, MB and DM are recipients of career awards from the Fonds de la
   Recherche en Sante du Quebec (FRSQ), Canada. Cellestis Limited
   (Victoria, Australia) donated the QuantiFERON-TB Gold In Tube kits. This
   company did not provide funding for this study and was not involved in
   the preparation, review or submission of this manuscript.
CR *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_
   Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004
   Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422
   BLAND JM, 1986, LANCET, V1, P307
   *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P1
   CORBETT EL, 2006, INT J TUBERC LUNG D, V10, pS231
   DIGGLE PJ, 1988, BIOMETRICS, V44, P959, DOI 10.2307/2531727
   Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007
   Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC
   Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192
   Hill PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000183
   Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49
   Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120
   Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006
   Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746
   Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z
   Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5
   Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208
   Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7
   Pai M, 2006, EMERG INFECT DIS, V12, P1311, DOI 10.3201/eid1209.051663
   Pai M, 2006, INT J TUBERC LUNG D, V10, P942
   Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC
NR 24
TC 78
Z9 79
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2008
VL 3
IS 3
AR e1850
DI 10.1371/journal.pone.0001850
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 370KZ
UT WOS:000260762400012
PM 18365006
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sandkuhler, S
   Bhattacharya, J
AF Sandkuehler, Simone
   Bhattacharya, Joydeep
TI Deconstructing Insight: EEG Correlates of Insightful Problem Solving
SO PLOS ONE
LA English
DT Article
ID HUMAN THETA-OSCILLATIONS; WORKING-MEMORY TASK; BRAIN OSCILLATIONS; ALPHA
   OSCILLATIONS; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX;
   VISUAL-ATTENTION; RIGHT-HEMISPHERE; NEURAL ACTIVITY; EFFECTS MODELS
AB Background. Cognitive insight phenomenon lies at the core of numerous discoveries. Behavioral research indicates four salient features of insightful problem solving: (i) mental impasse, followed by (ii) restructuring of the problem representation, which leads to (iii) a deeper understanding of the problem, and finally culminates in (iv) an "Aha!'' feeling of suddenness and obviousness of the solution. However, until now no efforts have been made to investigate the neural mechanisms of these constituent features of insight in a unified framework. Methodology/Principal Findings. In an electroencephalographic study using verbal remote associate problems, we identified neural correlates of these four features of insightful problem solving. Hints were provided for unsolved problems or after mental impasse. Subjective ratings of the restructuring process and the feeling of suddenness were obtained on trial-by-trial basis. A negative correlation was found between these two ratings indicating that sudden insightful solutions, where restructuring is a key feature, involve automatic, subconscious recombination of information. Electroencephalogram signals were analyzed in the space x time x frequency domain with a nonparametric cluster randomization test. First, we found strong gamma band responses at parieto-occipital regions which we interpreted as (i) an adjustment of selective attention (leading to a mental impasse or to a correct solution depending on the gamma band power level) and (ii) encoding and retrieval processes for the emergence of spontaneous new solutions. Secondly, we observed an increased upper alpha band response in right temporal regions (suggesting active suppression of weakly activated solution relevant information) for initially unsuccessful trials that after hint presentation led to a correct solution. Finally, for trials with high restructuring, decreased alpha power (suggesting greater cortical excitation) was observed in right prefrontal area. Conclusions/Significance. Our results provide a first account of cognitive insight by dissociating its constituent components and potential neural correlates.
C1 [Sandkuehler, Simone; Bhattacharya, Joydeep] Austrian Acad Sci, Commiss Sci Visualizat, A-1010 Vienna, Austria.
   [Sandkuehler, Simone] Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria.
   [Bhattacharya, Joydeep] Univ London, Dept Psychol, London, England.
RP Bhattacharya, J (reprint author), Austrian Acad Sci, Commiss Sci Visualizat, A-1010 Vienna, Austria.
EM j.bhattacharya@gold.ac.uk
FU JST.ERATO Shimojo Implicit Brain Function Project; OENB-Jubilaeumsfond
   Project [11497]
FX Supported by the JST.ERATO Shimojo Implicit Brain Function Project and
   OENB-Jubilaeumsfond Project (Nr. 11497) to JB.
CR Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355
   Ansburg PI, 2000, CURR PSYCHOL, V19, P143, DOI 10.1007/s12144-000-1011-y
   Ash IK, 2006, PSYCHON B REV, V13, P66, DOI 10.3758/BF03193814
   AUBLE PM, 1979, MEM COGNITION, V7, P426, DOI 10.3758/BF03198259
   Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023
   Beeman MJ, 2000, MEM COGNITION, V28, P1231, DOI 10.3758/BF03211823
   Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012
   BERG P, 1991, CLIN PHYS PHYSIOL M, V12, P49, DOI 10.1088/0143-0815/12/A/010
   BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9
   Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193
   Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012
   Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543
   Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539
   BOWDEN EM, 1998, PSYCHOL SCI, V9, P419
   BOWERS KS, 1990, COGNITIVE PSYCHOL, V22, P72, DOI 10.1016/0010-0285(90)90004-N
   Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357
   Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7
   Buzsaki G, 2006, RHYTHMS BRAIN
   Caplan JB, 2001, J NEUROPHYSIOL, V86, P368
   Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1
   Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8
   Davidson J. E, 1995, NATURE INSIGHT, P125
   Dominowski R. L., 1995, NATURE INSIGHT, P33
   DUNCKER K, 1945, PROBLEM SOLVING
   Efron B, 1993, INTRO BOOTSTRAP
   Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004
   Finke R. A., 1995, NATURE INSIGHT, P255
   Fiore S. M., 1997, RIGHT HEMISPHERE LAN, P349
   Fleck JI, 2004, MEM COGNITION, V32, P990, DOI 10.3758/BF03196876
   Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465
   Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259
   Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374
   Gick M. L., 1995, NATURE INSIGHT, P197
   GICK ML, 1992, J EXP PSYCHOL LEARN, V18, P623, DOI 10.1037/0278-7393.18.3.623
   Goel V, 2000, COGN NEUROPSYCHOL, V17, P415, DOI 10.1080/026432900410775
   Goel V, 2005, CEREB CORTEX, V15, P1170, DOI 10.1093/cercor/bhh217
   Greeno J. G., 1978, HDB LEARNING COGNITI, V5, P239
   Gruber H., 1995, NATURE INSIGHT, P397
   HAYES JR, 1989, COMPLETE PROBLEM SOL, P376
   Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006
   Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233
   Horvitz L A, 2002, EUREKA SCI BREAKTHRO
   Iglewicz B, 1993, DETECT HANDLE OUTLIE
   Isaak M. I., 1995, NATURE INSIGHT, P281
   Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877
   Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097
   Kahana MJ, 2006, J NEUROSCI, V26, P1669, DOI 10.1523/JNEUROSCI.3737-05c.2006
   Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645
   KAPLAN CA, 1990, COGNITIVE PSYCHOL, V22, P374, DOI 10.1016/0010-0285(90)90008-R
   Kiebel SJ, 2005, HUM BRAIN MAPP, V26, P170, DOI 10.1002/hbm.20153
   Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3
   Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99
   KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3
   Klimesch W, 1997, NEUROSCI LETT, V238, P9, DOI 10.1016/S0304-3940(97)00771-4
   Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002
   Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3
   Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003
   Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762
   Knoblich G, 1998, Z PSYCHOL, V206, P207
   Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014
   LOCKHART RS, 1988, MEM COGNITION, V16, P36, DOI 10.3758/BF03197743
   Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004
   Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069
   Mai XQ, 2004, HUM BRAIN MAPP, V22, P261, DOI 10.1002/hbm.20030
   Maier NRF, 1931, J COMP PSYCHOL, V12, P181, DOI [DOI 10.1037/H0071361, 10.1037/h0071361]
   Mayer R.E., 1992, THINKING PROBLEM SOL
   METCALFE J, 1987, MEM COGNITION, V15, P238, DOI 10.3758/BF03197722
   METCALFE J, 1986, J EXP PSYCHOL LEARN, V12, P288, DOI 10.1037/0278-7393.12.2.288
   Miller LA, 1996, NEUROPSYCHOLOGIA, V34, P387, DOI 10.1016/0028-3932(95)00116-6
   Mima T, 2001, J NEUROSCI, V21, P3942, DOI 10.1523/JNEUROSCI.21-11-03942.2001
   Momjian S, 2003, ADV TECH STAND NEUR, V28, P91
   Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5
   Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058
   OHLSSON S, 1984, SCAND J PSYCHOL, V25, P117, DOI 10.1111/j.1467-9450.1984.tb01005.x
   Ohlsson S., 1992, ADV PSYCHOL THINKING, P1
   Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006
   Papp N, 1977, Biomed Sci Instrum, V13, P135
   PERKINS DN, 1981, MINDS BEST WORK CAMB
   Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8
   PINHEIRO J, 2006, NLME LINEAR NONLINEA
   Pinheiro J. C., 2001, MIXED EFFECTS MODELS
   Qiu J, 2006, NEUROREPORT, V17, P679, DOI 10.1097/00001756-200604240-00025
   Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001
   Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018
   Sauseng P, 2004, NEUROSCI LETT, V354, P123, DOI 10.1016/j.neulet.2003.10.002
   Sawyer K., 1995, NATURE INSIGHT, P329, DOI [10.1002/j.2162-6057.1998. tb00816.x, DOI 10.1002/J.2162-6057.1998.TB00816.X]
   Schack B, 2003, HUM BRAIN MAPP, V19, P18, DOI 10.1002/hbm.10104
   SCHOOLER JW, 1993, J EXP PSYCHOL GEN, V122, P166, DOI 10.1037/0096-3445.122.2.166
   Seifert C. M., 1995, NATURE INSIGHT, P65, DOI DOI 10.1111/1467-8721.00065
   SHEER DE, 1989, BRAIN DYNAMICS
   Siegler RS, 2000, CURR DIR PSYCHOL SCI, V9, P79, DOI 10.1111/1467-8721.00065
   SIEGLER RS, 2006, UNCONSCIOUS CONSCIOU, P4
   SMITH SM, 1991, AM J PSYCHOL, V104, P61, DOI 10.2307/1422851
   Soanes C., 2005, COMPACT OXFORD ENGLI
   TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0
   Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306
   Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012
   Weisberg R. W, 1995, NATURE INSIGHT, P157
   Wertheimer M., 1959, PRODUCTIVE THINKING
   WURTZ RH, 1982, SCI AM, V246, P124, DOI 10.1038/scientificamerican0682-124
NR 102
TC 89
Z9 102
U1 1
U2 31
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 23
PY 2008
VL 3
IS 1
AR e1459
DI 10.1371/journal.pone.0001459
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 366SO
UT WOS:000260503900005
PM 18213368
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

EF